118
Joseph Biederman, M.D. Revision: 5/7/08 CURRICULUM VITAE Name: Joseph Biederman Address: 523 Boylston Street Brookline, Massachusetts 02445 Place of Birth: Prague, Czechoslovakia Education: M.D., cum laude, Buenos Aires University Medical School, Buenos Aires, Argentina 1971 Postdoctoral Training: Internship and Residencies: 1971-1972 Rotating internship, Hadassah University Hospital, Hebrew University, Jerusalem, Israel 1972-1977 Resident in Psychiatry, Hadassah University Hospital, Hebrew University, Jerusalem, Israel 1975-1976 Research Fellow, Jerusalem Mental Health Center, Hebrew University, Jerusalem, Israel 1977-1979 Clinical Fellow in Child Psychiatry, Children's Hospital Medical Center/Judge Baker Guidance Center/Developmental Evaluation Clinic, Harvard Medical School, Boston, MA 1977-1981 Clinical Fellow in Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA Licensure and Certification: 1971 ECFMG Certificate No. 1499383 1978 FLEX, Massachusetts Board of Registration and Discipline in Medicine 1983 General Psychiatry, American Board of Psychiatry and Neurology 1984 Child Psychiatry, American Board of Psychiatry and Neurology Academic Appointments: 1966-1970 Teaching Assistant in History and Embryology, University of Buenos Aires Medical School 1976-1979 Instructor in Psychiatry, Hadassah Medical School and Hebrew University, Jerusalem, Israel 1977-1981 Clinical Fellow in Psychiatry, Harvard Medical School, Boston, MA 1981-1984 Instructor in Psychiatry, Harvard Medical School, Boston, MA 1984-1988 Assistant Professor in Psychiatry, Harvard Medical School, Boston, MA 1988-1995 Associate Professor in Psychiatry, Harvard Medical School, Boston, MA 1995- Professor of Psychiatry, Harvard Medical School, Boston, MA 1998-2000 Affiliated Faculty, Massachusetts Institute of Techonology Hospital Appointments: 1979-1981 Psychiatrist II (Child Psychiatrist), Department of Mental Health, Boston, MA 1979-1981 Research Associate, Department of Psychiatry, Children's Hospital Medical Center, Boston, MA 1981-1983 Clinical Assistant, Department of Psychiatry, Massachusetts General Hospital, Boston, MA 1984-1986 Assistant in Psychiatry, Massachusetts General Hospital, Boston, MA 1987-1989 Assistant Psychiatrist, Massachusetts General Hospital, Boston, MA 1989-1991 Associate Psychiatrist, Massachusetts General Hospital, Boston, MA 1

Joseph Biederman, M - HuffPost

  • Upload
    others

  • View
    4

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

Revision: 5/7/08

CURRICULUM VITAE Name: Joseph Biederman Address: 523 Boylston Street Brookline, Massachusetts 02445 Place of Birth: Prague, Czechoslovakia Education: M.D., cum laude, Buenos Aires University Medical School, Buenos Aires, Argentina 1971 Postdoctoral Training:

Internship and Residencies: 1971-1972 Rotating internship, Hadassah University Hospital, Hebrew University, Jerusalem, Israel 1972-1977 Resident in Psychiatry, Hadassah University Hospital, Hebrew University, Jerusalem, Israel 1975-1976 Research Fellow, Jerusalem Mental Health Center, Hebrew University, Jerusalem, Israel 1977-1979 Clinical Fellow in Child Psychiatry, Children's Hospital Medical Center/Judge Baker

Guidance Center/Developmental Evaluation Clinic, Harvard Medical School, Boston, MA 1977-1981 Clinical Fellow in Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA Licensure and Certification: 1971 ECFMG Certificate No. 1499383 1978 FLEX, Massachusetts Board of Registration and Discipline in Medicine 1983 General Psychiatry, American Board of Psychiatry and Neurology 1984 Child Psychiatry, American Board of Psychiatry and Neurology Academic Appointments: 1966-1970 Teaching Assistant in History and Embryology, University of Buenos Aires Medical School 1976-1979 Instructor in Psychiatry, Hadassah Medical School and Hebrew University, Jerusalem, Israel 1977-1981 Clinical Fellow in Psychiatry, Harvard Medical School, Boston, MA 1981-1984 Instructor in Psychiatry, Harvard Medical School, Boston, MA 1984-1988 Assistant Professor in Psychiatry, Harvard Medical School, Boston, MA 1988-1995 Associate Professor in Psychiatry, Harvard Medical School, Boston, MA 1995- Professor of Psychiatry, Harvard Medical School, Boston, MA 1998-2000 Affiliated Faculty, Massachusetts Institute of Techonology Hospital Appointments: 1979-1981 Psychiatrist II (Child Psychiatrist), Department of Mental Health, Boston, MA 1979-1981 Research Associate, Department of Psychiatry, Children's Hospital Medical Center, Boston, MA 1981-1983 Clinical Assistant, Department of Psychiatry, Massachusetts General Hospital, Boston, MA 1984-1986 Assistant in Psychiatry, Massachusetts General Hospital, Boston, MA 1987-1989 Assistant Psychiatrist, Massachusetts General Hospital, Boston, MA 1989-1991 Associate Psychiatrist, Massachusetts General Hospital, Boston, MA

1

Page 2: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

1991- Psychiatrist, Massachusetts General Hospital, Boston, MA 1993- Consultant in Psychiatry, McLean Hosptial, Belmont, MA 1999- Board of Directors, Mood and Anxiety Disorders Initiative, Massachusetts General Hospital, Boston,

MA Principal Clinical and Hospital Service Responsibilities: 1981- Chief, Pediatric Psychopharmacology Unit, Child Psychiatry Service, Massachusetts General Hospital, Boston, MA. 1981- Staff Psychiatrist, Adult Psychopharmacology Clinic, Massachusetts General Hospital, Boston, MA. 1981- Research Committee, Department of Psychiatry, Massachusetts General Hospital, Boston, MA. 1984-1987 Chairman, Research Committee, Adult Psychopharmacology Unit, Massachsuetts General Hospital, Boston, MA. 1986- Grand Rounds Committee, Department of Psychiatry, Massachusetts General Hospital, Boston, MA. 1989- Member, Steering Committee, Department of Psychiatry, Massachusetts General Hospital, Boston, MA. 1992-2002 Chief, Joint Program in Pediatric Psychopharmacology, McLean Hospital, Belmont, MA and Massachusetts General Hospital, Boston, MA. 1999- Partners Psychiatry and Mental Health System Research Committee, Boston, MA 2000 Task Force Member, Steering Committee, Department of Psychiatry, Massachusetts General

Hospital, Boston, MA 2000- Chief Clinical and Research Program in Pediatric Psychopharmacology, Massachusetts General

Hospital, Boston, MA 2000- Chief Adult ADHD Progam, Massachusetts General Hospital, Boston, MA Supervision: 1977- Clinical Supervisor, Child Psychiatry Service, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA. 1977- Clinical Supervisor, Clinical Psychopharmacology Unit, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA. 1981- Clinical Supervisor, Pediatric Psychopharmacology Unit, Child Psychiatry Service, Massachusetts General Hospital and Harvard Medical School, Boston, MA. 1982-1983 Research Preceptor, Psychiatric Research Program, Massachusetts General Hospital and Harvard Medical School, Boston, MA. 1982- Research Supervisor, Pediatric Psychopharmacology Unit and Child Psychiatry Service, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA. 1985-1988 Clinical Consultant, Child Psychiatry, Westwood Lodge Hospital, Westwood, MA. 1985-1988 Clinical Consultant, Child Psychiatry, Pembroke Hospital, Pembroke, MA. Other Academic (Harvard Medical School) Responsibilities: 1991- Member, Research Committee Division of Child Psychiatry, Consolidated Department of Psychiatry, Harvard Medical School, Boston, MA. 1999-2002 Member, Standing Committee on Promotions, Reappointments and Appointments. Faculty of

Medicine, Harvard Medical School. 2004 Member, Ad-Hoc Professorship Committee for Larry Seidman, PhD. Faculty of Medicine, Harvard

Medical School. 2004 Member, Search Committee, President of Judge Baker Guidance Center, Harvard Medical School.

2

Page 3: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

2004 Member, Ad Hoc Evaluation Committee for Dr. Michael Shannon appointment as Professor of Pediatrics, full time, Clinician Teacher Criteria, Children’s Hospital

Visiting Professorships: 1984 Visiting Professor, Department of Psychiatry, The Cleveland Clinic Foundation, Cleveland, OH 1987 Visiting Scholar, Department of Psychiatry, College of Medicine, University of VT,

Burlington, VT 1988 Pfizer Visiting Professor, Department of Psychiatry, Health Science Center, University of Texas, Dallas, TX 1990 Visiting Professor, Department of Psychiatry, University of Manitoba, Manitoba, Canada 1991 Visiting Professor, Department of Psychiatry, University of Minnesota 1993 Pfizer Visiting Professor, Department of Psychiatry, Louisiana State University, New Orleans, LA 1994 Lilly Clinical Scholar and Visiting Professor 1994 Division of Child and Adolescent Psychiatry, Cornell Medical Center 1995 Western Psychiatric Institute and Clinic, Pittsburgh, PA 1996 Visiting Professor, Universidade Federal Do Rio Grande Do Sul, Department of Psychiatry & Forensic Medicine, Porto Alegre, Brazil 1997 Guest Professor, Department of Psychiatry, Universidade Federal Do Rio Grande Do Sul, Division of Child and Adolescent Psychiatry, Porto Alegre, Brazil 2004 Guest Professor, Department of Psychiatry, University of Toronto, Division of Child and Adolescent Psychiatry 2006 Visiting Professor, Dennis Cantwell Lecture Semel Institute Grand Rounds, UCLA Awards and Honors: 1971 M.D., cum laude, Buenos Aires Medical School, Buenos Aires, Argentina 1977 Research Prize in Medicine (Psychiatry), Hebrew University and Hadassah Medical School: "Cyclic AMP in CSF of patients with schizophrenia" Brit. J. Psychiat 130: 64-67, 1977. 1978 Bornstein Prize for Research in Psychiatry and Neurology (All Israel Prize): "The Effect of L-Dopa and Propranolol on Human CSF Cyclic Nucleotides" Psychopharmacology 58: 307-310, 1978. 1986 Fellow, American Academy of Child Psychiatry 1991 Selected for inclusion in Marquis' Who's Who in America 1991 Fellow, American Psychiatric Association 1992- Selected for inclusion in the first and subsequent editions of The Best Doctors in America 1993 American Psychiatric Association Blanche Ittelson Award for Excellence in Child Psychiatric Research 1993 Physician of the Year, Massachusetts General Hospital, Boston, MA 1995 CHADD (Children and Adults with ADHD) Hall of Fame for leadership, clinical practice and research on ADHD 1996 Invited Nominator, Nobel Assembly at the Karolinska Institute to nominate for the Nobel Prize in Physiology or Medicine for 1997 1997 Teach of the year Award, MGH/McLean Hospital Joint Program in Child and Adolescent Residency Training 1997 Dean's List for the best first course in Harvard University's Post-Graduate Courses for 1997: "ADHD Across the Life Cycle" 1997 Elaine Schlosser Lewis Award for Research (To Janet Wozniak, M.D.): "Mania-like symptoms suggestive of childhood onset bipolar disorder in clinically referred children". 1997 Elaine Schlosser Lewis Award for Research (To Thomas Spencer, M.D.): "Growth deficits in ADHD children revisited: Evidence for disorder-associated growth delays?" 1997 Annual Exemplary Psychiatrist Award

3

Page 4: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

1998- Selected for inclusion in Woodward/White, Inc.'s The Best Doctors in America 1998 NAMI (National Alliance for the Mentally Ill) Exemplary Psychiatrist Award 2000 During the decade of the 1990's, Dr. Biederman was the fourth highest producer of high

impact papers in psychiatry as determined by the Institute for Scientific Information (Science, 2000, Vol 288, pg 959)

2001- Selected for inclusison in Castle Connolly’s premier edition of America’s Top Doctors

2002 NARSAD Senior Investigator Award

2005 The Institute for Scientific Information (ISI) ranked Dr. Biederman at #1 in terms of total citations to his papers published on ADD/ADHD in the past decade -- 294 papers (meeting the search criteria), with a total of 6,866 cites ((http://esi-topics.com)

2005 The Institute for Scientific Information (ISI) ranked Dr. Biederman at #2 highest producer of high impact papers in psychiatry ((http://esi-topics.com)

2005 Selected for inclusion in Boston Magazine edition City’s Best Doctor’s for February 2006 issue 2006 Expert consultant (2/3/06) The President’s Council on Bioethics Washington, DC 2006 John Keith Barlow Memorial Lecture-“Advances in the Neurobiology of ADHD” Massachusetts

General Hospital 2006 Dennis Cantwell Lecture at the Semel Institute Grand Rounds-“ Advances in the Neurobiology of

ADHD” University of California Los Angeles 2007 Recipient of the 2007 Outstanding Psychiatrist Award for Research given by the Massachusetts

Psychiatric Society Awards committee 2007 Recepient of the award for “Excellence in Research” by the “New England Council of Child &

Adolescent Psychiatry (NEECCAP) 2007 Recipient of the Mentorship Award by the Department of Psychiatry at the Massachusetts General

Hospital National and Regional: 1983-1986 Committee of Developmental Disabilities, American Academy of Child Psychiatry 1986 Examiner, Child Psychiatry Board, American Board of Psychiatry and Neurology 1986 Examiner, Adult Psychiatry Board, American Board of Psychiatry and Neurology 1987-1989 Member, Research Committee, American Academy of Child and Adolescent Psychiatry 1988 Member, Research Committee, Department of Psychiatry, Massachusetts General Hospital 1989 Member, DSM-IV Committee on Disruptive Behaviors of Childhood 1989 National Recruitment Conference on Child and Adolescent Psychiatry 1989 Reviewer for the American Academy of Child and Adolescent Psychiatry of the Institute of Medicine Report: "Research on Children and Adolescents with Mental, Behavioral, and Developmental Disorders" 1990 Chairman, Research Committee, American Academy of Child and Adolescent Psychiatry 1989-1990 Member, Work Group on Research, American Academy of Child and Adolescent Psychiatry 1990 Ad-Hoc Reviewer, Psychopathology IRG, NIMH 1990 Member, Expert Advisory Panel on Psychiatric Disease, The United States Pharmacopoeia Convention, Inc. 1990 Co-Chair, Work Group on Research, American Academy of Child and Adolescent Psychiatry 1990 Consultant, NIMH Conference: "Research Strategies for the Disruptive Behavioral Disorders" 1990 Participant, NIMH Workshop: "Development-Specific Research Directions to Implement the National Plan for Research on Child and Adolescent Mental Health" 1991 Participant, NIMH Conference: "Child and Adolescent Mental Health Research: Problems and Prospects for the 1990's"; Executive Secretary, Work group on Research on ADHD 1991 Reviewer, Special Review Committee, Treatment Development and Assessment Review Committee, NIMH, Project Center Grant 1991 Co-Chair, Section on Opportunities for Training and Research, NIMH-Academy of Child and Adolescent Psychiatry Conference: "The Interface Between Child and General Psychiatry"

4

Page 5: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

1991 Ad-Hoc Reviewer, NIMH Board of Scientific Counselor's Meeting, Child Psychiatry Branch (CHP) 1991 Scientific Advisory Board, Attention Deficit Disorder Association (ADDA) 1991 Consultant, AMA Drug Evaluations 1991 Chair, American Academy of Child and Adolescent Psychiatry Task Force on Desipramine and Sudden Death 1992 Program Committee, Society of Biological Psychiatry 1992-1995 Member, Child Psychopathology and Treatment Review Committee, NIMH 1992 Reviewer, NIMH/AACAP Physician Scientist Development Award 1993 Professional Advisory Board, Attention Deficit Information Network, Inc. 1993 Invited Participant, NIMH Conference: "Ethical and Human Subjects Issues in Mental Health: Research with Children and Adolescents" 1993 Acting Chair, NIMH Child Psychopathology and Treatment Review Committee 1994 Invited Member, Planning Meeting, NIMH Psychopharmacology in Children and Adolescents Current Problems, Future Prospects scheduled for Spring 1994 1994-1996 Board of Directors, American Society of Clinical Psychopharmacology 1994 Invited Participant, NIMH Conference: "ADHD and Gender" 1995 Invited Participant and Section Co-Chair, NIMH Conference: "Pediatric Psychopharmacology" 1995 Ad-Hoc Reviewer, NIMH Board of Scientific Counselor's Meeting, Child Psychiatry Branch (CHP) 1995 NIH Reviewers Reserve 1994 Ad-Hoc Consultant, Pfizer Pharmaceutical 1995 Ad-Hoc Consultant, Abbott Laboratories 1995 Ad-Hoc Consultant, Ciba-Geigy Laboratories 1995 Ad-Hoc Consultant, Medeva Laboratories 1995 Invited Participant, NIH Workshop: "Alternative Pharmacology of Attention Deficit- Hyperactivity Disorder" 1996 Invited Participant, NIMH Conference: "Bridging Efficacy and Effectiveness in Child Mental Health Treatment" 1996-1997 Consultant, Committee on Psychiatric Diagnosis and Assessment, Council on Research,

American Psychiatric Association (APA) 1996- Professional Advisory Board, CHADD. 1996- Ad-Hoc Consultant, Bristol-Myers Squibb Pharmaceutical Company 1997 Invited Participant, NIMH Workshop: "Prepubertal Bipolar Disorder" 1997- Consultant, Committee on Psychiatric Diagnosis and Assessment, Council on Research, American Psychiatric Association (APA) 1998 Invited Speaker, NIH/NIDA Consensus Conference "Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder" 1998 Consultant, ADHD Advisory Board Meeting. Watson Laboratories 1998 Invited Participant, CNS Summit Meeting, Janssen Pharmaceutical Research Foundation. 1999 Invited Participant, Child and Adolescent Psychiatry Consultants Meeting: “Depression and

Beyond”. Wyeth Ayerst Research. 1999 Participant, National Institute of Mental Health “Early Recognition and Treatment of Schizophrenia

and Bipolar Disorder in Children and Adolescents”. 1999 Member, Professional Advisory Committee of the Child and Adolescent Bipolar Foundation. 2000 Invited Participant, NIMH Roundtable: “Bipolar Disorder in Children” 2000 Invited Participant Natiaonal Institute of Mental Health “ Psychopharmacology for Young Children:

Clinical Needs and Research Opportunities”. 2000 Advisor, Metadate Advisory Board II, Medeva Pharmaceuticals, Inc 2000 Invited Participant, ADHD Expert Panel Meeting, Johnson and Johnson Consumer Companies, Inc. 2001 Invited Participant, CNS Summit Meeting, Janssen Pharmaceutical Research Foundation 2001 Invited Participant, Global Neuroscienc Advisory Board Meeting, Eli Lilly 2001 Invited Participant, National Institute of Mental Health “ NIMH Breaking Ground, Breaking

Through: Strategic Plan for Mood Disorders Research”

5

Page 6: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

2001 Member, National Depressive and Manic-Depressive Association Scientific Advisory Board 2001 Invited Participant, Annual Pediatric Psychiatry Advisory Board, Janssen Pharmaceutica Inc 2001 Consultant, Research Protocol Meeting, Office for Human Rearch Protections 2002 Invited Participant, 2nd Worldwide Pfizer Neuroscience Consultants Forum Faculty Briefing meeting 2002 Invited Participant, Concerta National Advisory Board Meeting, McNeil 2002 Invited Participant, Metadate CD Advisory Board Meeting, Celltech Pharmaceuticals, Inc 2002 Invited Participant, NIMH Roundtable: “Research Roundtable on Pediatric Bipolar-NOS 2003 Invited Participant Pediatric Bipolar Disorder Advisory Board Meeting, Shire US, Inc 2003 Invited Participant Annenberg Sunnylands Trust Foundation Commission 2003 Ad Hoc Committee Member Search for a Professor at Harvard Medical School to serve as President

of Judge Baker Children’s Center 2003 Ad Hoc Evauation Committee Dr. Larry Seidman be evaluated for appointment as Professor of

Psychiatry, full time, Investigator Criteria, serve at Massachusetts Mental Health Center International:

1987 Consultant in Child Psychiatry, Pan American Health Organization, World Health Organization 1988 Consultant, The Ontario Mental Health Foundation 1989 Co-leader, Regional Seminar for Central America and Panama: "Rational Use of Psychotropics in Adults and Children", WHO (Pan-American Health Organization), Tegucigalpa, Honduras 2000 Consultant, Janssen CDMR Pediatric International Advisory Board meeting,

Antwerp, Belgium 2005 Chair of the newly established section on ADHD at the World Psychiatric Association Memberships and Offices in Professional Societies: 1972-1977 Israeli Medical Association 1973-1977 Israeli Psychiatric Association 1978- American Psychiatric Association 1978- Massachusetts Psychiatric Association 1978-1988 American Medical Association 1979- American Academy of Child and Adolescent Psychiatry 1985- New England Council of Child and Adolescent Psychiatry 1990- Society of Biological Psychiatry 1991- Society of Research in Child and Adolescent Psychopathology 1994-1996 American Society of Clinical Psychopharmacology (Board Member) 1995-1996 American Medical Association 2004 Collegium Internationale Neuro-Psychopharmacologicum (CINP) 2005- Chair of the newly established section on ADHD at the World Psychiatric Association Editorial Boards of Publications and Scientific Journals: 1986- Editorial Board, Biological Therapies in Psychiatry 1987- Editorial Board, Journal of Clinical Psychiatry 1989-1995 Editorial Board, Journal of American Academy of Child and Adolescent Psychiatry 1989- Advisory Board, New England Index: Information on Disabilities Exchange 1991- Scientific Advisor, Attention Deficit Disorder Association (ADDA) 1991- Editorial Board, Journal of Child and Family Studies 1991- Editorial Board, ADHD Report (Russell Barkley, Ph.D., Editor) 1992- Editorial Board, Harvard Review of Psychiatry

6

Page 7: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

1992 Guest Editor, Special Section on Pediatric Psychopharmacology, Journal of the American Academy of Child and Adolescent Psychiatry 1995 Editorial Board, Journal of Attention Disorders 1996-1997 Assistant Editor, Journal of the American Academy of Child and Adolescent Psychiatry 1997 Guest Editor, Special Section on Pediatric Psychopharmacology, Journal of the American Academy of Child and Adolescent Psychiatry 1998 Ad-Hoc Review, American Journal of Speech-Language Pathology 1998 Senior Associate Editor, Journal of Child and Adolescent Psychopharmacology 2002 Editorial Board, Journal of Affective Disorders 2002 Associate Editor Biological Psychiatry 2004 Editorial Board, Behavioral and Brain Functions 2004 Editorial Board, Current Psychiatry Reviews 2005-2006 Deputy Editor Biological Psychiatry 2005 Editorial Board, International Journal of Clinical Health Psychology 2007- The International Journal of Neuropsychopharmacology 2008- CNS Neuroscience and Therapeutics Reviewer for Scientific Journals: New England Journal of Medicine Journal of Pediatrics Journal of Psychiatric Research Psychiatry Research Journal of the American Academy of Child and Adolescent Psychiatry Journal of Clinical Psychopharmacology Journal of Psychiatry American Journal of Psychiatry European Child & Adolescent Psychiatry Psychosomatic Medicine Archives of General Psychiatry Psychosomatics Journal of Mental and Nervous Diseases Neuropsychologia Journal of Research on Adolescence Biological Psychiatry American Journal of Speech-Language Pathology Journal of Development and Behavioral Pediatrics Acta Paediatrica Scandinavica Depression and Anxiety Comprehensive Psychiatry (Clinical Perspectives) European Archives of Psychiatry and Clinical Neuroscience Archives of Peditric and Adolescent Medicine Canadian Journal of Psychiatry Journal of the American Medical Association European Archives of Psychiatry and Clinical Neuroscience APA Journal, Neuropsychology Journal of Psychiatry & Neuroscience British Medical Journal Research Grants: 1980-1981 Amitriptyline in Anorexia Nervosa: A Double Blind Placebo Controlled Study. NIMH MH34921

7

Page 8: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

(Principal Investigator) 1982-1988 Pediatric Psychopharmacology Research. Charlupski Foundation (Principal Investigator) 1982 A Controlled Family Study of Attention Deficit Disorder. Milton Fund (Principal

Investigator) 1985-1986 Desipramine in the Treatment of Attention Deficit Disorder. Merrell Dow Pharmaceutical Company (Principal Investigator) 1986-1989 Anafranil in the Treatment of Obsessive-Compulsive Disorders in Children and Adolescents. CIBA-GEIGY Pharmaceutical Company (Principal Investigator) 1989-1991 A Controlled Family Study of Attention Deficit Disorder. NIMH MH41314 (Principal Investigator) 1991-1996 A Prospective High Risk Study of Attention-Deficit Hyperactivity and Related Disorders. NIMH MH41314 (Principal Investigator) 1991-2003 Sertraline in the Treatment of Obsessive-Compulsive Disorders in Children and Adolescents. Pfizer Pharmaceutical Company (Principal Investigator) 1993-1998 A Family Genetic Study of Girls with ADHD. NIMH MH 50657 (Principal Investigator) 1993-1998 Risk Factors for Anxiety Disorders in Young Children. NIMH MH47077 (Co-Principal Investigator; J. Rosenbaum, M.D., Principal Investigator) 1993-2005 A Longitudinal Follow-Up of Children at Risk for Anxiety Disorders. NIMH MH47077 (Principal

Investigator J Rosenbaum, MD) 1994-1996 Sertraline in Adolescent Depression. Pfizer Pharmaceutical Company (Principal Investigator) 1994-1999 Desipramine in Children and Adolescents with ADHD and Tic Disorders. NIMH MH01169 (Co-Principal Investigator; T. Spencer, M.D., Principal Investigator) 1995-1996 Tomoxetine in the Treatment of Adults with ADHD. Lilly Pharmaceutical Company (Principal

Investigator) 1995-1997 Pemoline in the Treatment of Adolescents with ADHD. Abbott Pharmaceutical Company (Principal Investigator) 1996-2001 A Prospective High Risk Study of Attention-deficit Hyperactivity and Related Disorders. NIMH MH41314 (Principal Investigator) 1997-2002 Drug Abuse and ADHD in ADHD Adults and their High Risk Offspring. NIMH FIRST Award 1 1997-1999 Eli Lilly Pharmaceuticals: Study O. (Principal Investigator) 1997-1999 GlaxoWellcome Pharmaceuticals: Study B. (T. Wilens, M.D., Principal Investigator) 1998-1999 Alza Pharmaceuticals: Study A. (Principal Investigator) 1998-1999 Solvay Pharmaceuticals:. Study A. (Principal Investigator) 1998-1999 Juvenile Mania Award. Stanley Foundation. (Principal Investigator) 1998-2000 Novartis Pharmaceuticals: Saturday Research Project: A, B. (Principal Investigator) 1998-2001 Eli Lilly Pharmaceuticals: Studies C,D,E,F. (Co-Principal Investigator; Principal Investigator, T. Spencer, M.D.) 1998-2002 Prevention of Cigarette Smoking in ADHD Youth. NIMH RO1CA8025 (Principal Investigator) 1998-2003 Testing the Validity of Adult Attention Deficit Hyperactivity Disorder NIMH MH57934 (Steven Faraone, Ph.D., Principal Investigator) 1998-2003 A Double Blind Comparison of Methylphenidate and Placebo in Adults with ADHD. NIMH FIRST Award 1 R29 MH57511 (T. Spencer, M.D.,Principal Investigator). 1998-2003 Long-term Outcome of Attention Deficit Hyperactivity Disorders. NIMH: HD36317 (Principal Investigator) 1998-2003 Longitudinal Follow-up of ADHD Girls and Their Siblings. NIMH MH50657 (Principal Investigator) 1998-2003 Collaborative ADHD Genetic Conference. NIMH: R13 MH59126-01 (Steven Faraone, Ph.D., Principal Investigator) 1998-2008 Outcome of Attention Deficit Hyperactivity Disorder NIMH HD36317 1999-2004 Prevention and ADHD: An Ecogenetic Approach (Steven Faraone, Ph.D) 1999-2005 A Longitudinal Follow-up of Children at Risk for Anxiety Disorders. NIMH MN7077 (Co-Principal Investigator; Principal Investigator, J. Rosenbaum, M.D.)

8

Page 9: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

1999-2004 A Genetic Linkage Study of Children with ADHD. NIMH HD37694 (Stephen Faraone, Ph.D., Principal Investigator)

2000-2005 Substance Abuse in Juvenile Bipolar Disorder NIH/NIDA DA12945 (Timothy Wilens, MD, Principal Investigator)

2001-2003 Combined and Relative Effects of Pharmacotherapy and Cognitive Behavioral Therapy in the Treatment of Childhood Bipolar Disorder (Ross Greeene, Ph.D)

2001-2005- Stanley Foundation The MGH Center for the Treatment of Pediatric Bipolar Disorder 2001-2006 Study of Young Children at Risk for Depression in ADHD NIMH MH63683 (Dina Hirshfeld-Becker,

PhD, Principal Investigator) 2002-2004 Johnson and Johnson Center for Pediatric Psychopathology Research 2002-2005 ADHD: Genetics, Cognition, and Neuroimaging NIMH MH66191 (Stephen Faraone, PhD, Principal

Investigator) 2002-2006 Substance Abuse in ADHD Girls NIMH DA14419 (Timothy Wilens, MD, Principal Investigator) 2002-2007 Consortium International Multi-Center ADHD Genetics Project NIMH MH62873 (Stephen Faraone,

Ph.D., Principal Investigator) 2002-2007 Neuroanatomy of Adult ADHD: An MRI Morphometric Study NIMH MH62152 (Larry Seidman,

Ph.D., Principal Investigator) 2002-2004 Distinguished Investigator Award (NARSAD) Neuropsychology and Neuroimaging Study of Mania 2003-2008 Collaborative Pediatric Bipolar Disorder Conference NIMH MH64077 2003-2008 DAT Binding by Pet in Adult ADHD NIMH MH64019 (Thomas Spencer, MD, Principal

Investigator) 2003-2008 Longitudinal Family Study of Pediatric Bipolar Disorder NIMH MH66237 (Janet Wozniak, MD,

Principal Investigator) 2003-2005 Prechter Center for the Study of the Genetics of Bipolar Disorder 2004-2008 Lilly Center for the Study of ADHD and its Comorbidities 2007-2009 Course of Psychopathology in Female Youth: Analysis with Extant Longitudinal Data NIMH

MH079954 (Joseph Biederman, MD, Principal Investigator) 2007-2012 Risk Factors for Adverse Outcomes in Young Offspring of Bipolar Parents NIMH MH076923 (Dina

Hirshfeld-Becker,PhD, Principal Investigator) Mentor in Career Development Grants: 1994-1999 Mentor, NIMH Career Development Award (K20) to Tim Wilens, M.D.: A High Risk Study of Parents with Addictive Disorders. 1994-1999 Mentor, NIMH Career Development Award (K20) to Tom Spencer, M.D.: Desipramine in the Treatment of Children with ADHD and Comorbid Tic Disorder. 1993-1994 Mentor, Eli Lilly Research Award, AACAP to Janet Wozniak, M.D.: A Family-Genetic Study of Prepubertal Children with Bipolar Disorder. 1993-1995 Mentor, NARSAD Junior Investigator Award to Janet Wozniak, M.D.: A Family-genetic Study of Prepubertal Children with Bipolar Disorder. 1993-1995 Mentor, Tourette's Society Junior Investigator Award to Tom Spencer, M.D.: Desipramine in the Treatment of Children with ADHD and Comorbid Tic Disorder. 1994-1995 Mentor, AACAP Lilly Pilot Research Award to Dan Geller, M.D.: "Developmental Factors in Juvenile OCD: Significance of Age of Onset. 1995 Mentor, NIMH Career Development Award (K20) to Barbara Coffey, M.D.: Longitudinal

Course of Tourette's Syndrome (in development). 1995-1996 Mentor, AACAP Lilly Pilot Research Award to Jeff Daily, M.D.: Autonomic Function and Developmental Psychopathology. 1995-1996 Mentor, AACAP Lilly Pilot Research Award to Jeff Bostic, M.D.: A Double Blind Study of Pemoline in Adolescents with ADHD. 1995-2000 Mentor, NIMH Career Development Award (K20) to Jim Hudziak, M.D. 1996-2001 Mentor, NIMH Career Development Award to Barbara Coffey, M.D.: A Follow up Study of Patients with Tourettes Syndrome.

9

Page 10: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

1997-1999 Mentor, NIDA Career Development Award to Sharon Milberger, D.Sc.: Antecedents of Substance Abuse in High risk Children.

1997-1999 Mentor, NIMH Career Development Award (K08) to Dina Hirshfeld Ph.D.: Early Intervention for Children at Risk for Anxiety Disorders. 1997-2002 Mentor, NIMH Career Development Award (K08) to Janet Wozniak M.D.: Developmental

Subtypes of Juvenile Bipolar Disorder. 1998-2003 Mentor, NIMH Career Development Award (K08) to Daniel Geller, M.D.: Developmental Subtypes of OCD. 1998-2003 Mentor, NIMH Career Development Award (K08) to Jean Frazier, M.D.: Brain Anatomic MRI in Childhood Bipolar Disorder. 2000-2005 Mentor, NIMH Career Development Award (K08) to Ross Greene, Ph.D. Prevention of Substance

Abuse in High Risk ADHD Children. 2000-2005 Mentor, NIMH Career Development Award (K08) to Louise G. Cohen, Pharm D. Developmental

Pharmacokinetic of Psychotropic Drugs. 2003-2008 Mentor, NIMH Career Development Award (K01) to Eric Mick ScD 2003-2008 Mentor, NIMH Career Development Award (K01) to Alysa Doyle PhD 2003-2008 Mentor, NIMH Career Development Award (K08) to Joe Gonzalez MD 2005-2010 Mentor, NIMH Career Development Award (K01) to Eve Valera, PhD Doctoral Dissertation Advisor (On Datasets from my Research Laboratory): 1994 Sharon Milberger, D.Sc., Doctor in Science in Psychiatric Epidemiology Program, Harvard School of Public Health 1994-1995 Susan Buckminster, M.A., Doctoral Candidate in Pediatric Psychology, State University of New York at Albany 1994 Dina Hirshfeld, Ph.D., Doctorate in Clinical Psychology, Boston University 1995 Eric Mick, Ph.D., Doctorate, Psychiatric Epidemiology Program, Harvard School of Public Health 1997 Luis Augusto Rohde, M.D., Doctorate Child Psychology specializing in ADHD: Epidemiological Study of Adolescent ADHD in Porto Alegra, Brazil. 2002 Michael Monuteaux, Ph.D, Doctorate, Psychiatric Epidemiology Program, Harvard School of Public

Health Other Mentorships: 1985-1990 Ron Steingard, M.D.: Pediatric Psychopharmacology Research 1993- Larry Seidman, Ph.D.: Neuropsychology of ADHD 1995- Ross Greene, Ph.D.: Social Disability in ADHD Major Research Interests: 1. Attention Deficit Disorder in Children, adolescents, and Adults 2. Obsessive Compulsive Disorders in Children and Adolescents 3. High Risk Studies of Children of Parents with Major Psychopathology 4. Pharmacotherapy of Juvenile Anxiety Disorders 5. Novel Pharmacological Approaches to ADHD 6. Pharmacotherapy of Adult ADHD 7. Juvenile Bipolar Disorder 8. Juvenile Mania 9. TIC Disorders

10

Page 11: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

10. Juvenile OCD 11. Psychosis, Pervasive Developmental Disorders and Neuroimaging 12. Genetics and Epidemiology of ADHD in Children, Adolescents and Adults 13. Juvenile Depression, Substance Abuse and Addiction

Teaching Experience:

Lecturer to Medical Students and Residents 1966-1971 Lecturer, core curriculum on Embryology and History, Department of Histology and Embryology, University of Buenos Aires Medical School, Buenos Aires, Argentina. 1973-1977 Lecturer, core clinical curriculum in Psychiatry, Department of Psychiatry, Hadassah Medical Center and Hebrew University, Jerusalem, Israel. 1979- Lecturer, core clinical curriculum, Child Psychiatry Service, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA. 1979- Lecturer, core clinical curriculum, Clinical Psychopharmacology Unit, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA. 1988- Director, Clinical Curriculum on Pediatric Psychopharmacology, Child Psychiatry Training Program, Massachusetts General Hospital and Harvard Medical School, Boston, MA. 1989-1992 Co-Director, curriculum on Research Methodology, Child Psychiatry Training Program, Massachusetts General Hospital and Harvard Medical School, Boston, MA. 1995- Course Director, MGH-Harvard Medical School Post-graduate Course on Pediatric Psychopharmacology, Boston, MA. 1996- Course Director, MGH-Harvard Medical School Post-graduate Course on Pediatric Psychopharmacology (bi-yearly course), Boston, MA. 1997- Course Director, MGH-Harvard Medical School Post-graduate Course on ADHD Across the Lifecycle (bi-yearly course), Boston, MA. Original Reports:

1. Biederman J, Rimon R, Ebstein R, Zohar J, Belmaker RH. Neuroleptics reduce spinal fluid cyclic AMP in schizophrenic patients. Neuropsychobiology 1976; 2:324-327.

2. Ebstein RP, Biederman J, Rimon R, Zohar J, Belmaker RH. Cyclic GMP in the CSF of patients with schizophrenia

before and after neuroleptic treatment. Psychopharmacol 1976; 51:71-4.

3. Biederman J, Rimon R, Ebstein R, Belmaker RH, Davidson JT. Cyclic AMP in the CSF (cerebrospinal fluid) of patients with schizophrenia. Br J Psychiatry 1977;130:64-67.

4. Zohar J, Biederman J, Rimon R, Ebstein R, Belmaker RH. Clinical correlates of CSF cyclic nucleotides in

schizophrenia. Am J Psychiatry 1978; 135:253-5.

5. Lichtshtein D, Dobkin J, Ebstein RP, Biederman J, Rimon R, Belmaker RH. Gamma-aminobutyric acid (GABA) in the CSF of schizophrenic patients before and after neuroleptic treatment. Br J Psychiatry 1978;132:145-148.

6. Belmaker RH, Ebstein RP, Biederman J, Stern R, Berman M, van Praag HM. The effect of L-dopa and propranolol on

human CSF cyclic nucleotides. Psychopharmacol 1978; 58:307-10.

7. Biederman J, Lerner Y, Belmaker RH. Combination of lithium carbonate and halperidol in schizo-affective disorder. Arch Gen Psychiatry 1979; 36:327-333.

11

Page 12: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

8. Biederman J, Lerner J, Belmaker RH. Diagnostic problems in manic psychosis. Harefuah 1979; 97:28-30.

9. Biederman J, Herzog DB, Rivinus TM, Ferber RA, Harper GP, Orsulak PJ, et al. Urinary mhpg in anorexia nervosa

patients with and without a concomitant major depressive disorder. J Psychiatr Res 1984;18:149-160.

10. Biederman J, Jellinek MS. Psychopharmacology in children. N Eng J Med 1984; 310:968-972.

11. Rivinus T, Biederman J, Herzog DB, Kemper K, Harper GP, Harmatz JS, et al. Anorexia nervosa and affective disorders: A controlled family history study. Am J Psychiatry 1984; 141:1414-11418.

12. Biederman J, Rivinus T, Herzog DB, Ferber RA, Harper GP, Orsulak PJ, et al. Platelet MAO activity in anorexia

nervosa patients with and without a major depressive disorder. Am J Psychiatry 1984; 141:1244-1247.

13. Gastfriend DR, Biederman J, Jellinek MS. Desipramine in the treatment of adolescents with attention deficit disorder. Am J Psychiatry 1984; 141:906-908.

14. Biederman J, Rivinus TM, Herzog DB, Harmatz JS, Shanley K, Yunis EJ. High frequency of HLA-Bw16 in patients

with anorexia nervosa. Am J Psychiatry 1984; 141:1109-1110.

15. Biederman J, Herzog DB, Rivinus TM, Harper GP, Ferber RA, Rosenbaum JF, et al. Amitriptyline in the treatment of anorexia nervosa: A double-blind, placebo-controlled study. J Clin Psychopharmacol 1985;5:10-16.

16. Gastfriend DR, Biederman J, Jellinek MS. Desipramine in the treatment of attention deficit disorder in adolescents.

Psychopharma 1985; 21:144-145.

17. Biederman J, Gastfriend D, Jellinek MS, Goldblatt A. Cardiovascular effects of desipramine in children and adolescents with attention deficit disorder. J Pediatrics 1985; 106:1017-1020.

18. Szymanski LS, Biederman J. Depression and anorexia nervosa of persons with Down syndrome. Am J Ment Defic

1984; 89:246-51.

19. Biederman J, Rivinus T, Kemper K, Hamilton D, MacFadyen J, Harmatz J. Depressive disorders in relatives of anorexia nervosa patients with and without a current episode of nonbipolar major depression. Am J Psychiatry 1985; 142:1495-1497.

20. Biederman J, Baldessarini RJ, Harmatz JS, Rivinus TM, Arana GW, Herzog DB, et al. Heterogeneity in anorexia

nervosa. Biol Psychiatry 1986; 21:213-216.

21. Hoge SK, Biederman J. A case of Tourette's syndrome with symptoms of attention deficit disorder treated with desipramine. J Clin Psychiatry 1986;47:478-479.

22. Biederman J, Habelow W, Rivinus T, Harmatz J, Wise J. MMPI profiles in anorexia nervosa patients with and without

major depression. Psychiatry Res 1986; 19:147-154.

23. Biederman J, Munir K, Knee D, Habelow W, Armentano M, Autor S, et al. A family study of patients with attention deficit disorder and normal controls. J Psychiatr Res 1986;20:263-274.

24. Biederman J, Gas friend DR, Jellinek MS. Desipramine in the treatment of children with attention deficit disorder. J

Clin Psychopharmacol 1986;6:359-363.

25. Hoge SK, Biederman J. Liver function tests during treatment with desipramine in children and adolescents. J Clin Psychopharmacol 1987;7:87-89.

12

Page 13: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

26. Biederman J, Keller M, Lavori P, Harmatz J, Knee D, Dubey D, et al. HLA haplotype A26-B38 in affective disorders: Lack of association. Biol Psychiatry 1987; 22:221-224.

27. Biederman J, Munir K, Knee D, Armentano M, Autor S, Waternaux C, et al. High rate of affective disorders in

probands with attention deficit disorder and in their relatives: A controlled family study. Am J Psychiatry 1987; 144:330-333.

28. Tesar GE, Rosenbaum JF, Biederman J, Weilburg JB, Pollack MH, Gross CC, et al. Orthostatic hypotension and

antidepressant pharmacotherapy. Psychopharmacol Bull 1987; 23:182-6.

29. Biederman J, Munir K, Knee D. Conduct and oppositional disorder in clinically referred children with attention deficit disorder: A controlled family study. J Am Acad Child Adolesc Psychiatry 1987; 26:724-727.

30. Biederman J. Clonazepam in the treatment of prepubertal children with panic-like symptoms. J Clin Psychiatry

1987;48:38-41.

31. Dec GW, Biederman J, Hougen TJ. Cardiovascular findings in adolescent inpatients with anorexia nervosa. Psychosom Med 1987; 49:285-290.

32. Munir K, Biederman J, Knee D. Psychiatric comorbidity in patients with attention deficit disorder: A controlled study. J

Am Acad Child Adolesc Psychiatry 1987; 26:844-848.

33. Steingard R, Biederman J. Lithium responsive manic-like symptoms in two individuals with autism and mental retardation. J Am Acad of Child and Adolescent Psychiatry 1987; 26:932-5.

34. Zusky PM, Biederman J, Rosenbaum JF, Manschreck TC, Gross CC, Weilberg JB, et al. Adjunct low dose lithium

carbonate in treatment-resistant depression: a placebo-controlled study. J Clin Psychopharmacol 1988;8:120-4.

35. Biederman J. Pharmacological treatment of adolescents with affective disorders and attention deficit disorder. Psychopharmacology 1988; 24:81-87.

36. Rosenbaum JF, Biederman J, Gersten M, Hirshfeld DR, Meminger SR, Herman JB, et al. Behavioral inhibition in

children of parents with panic disorder and agoraphobia. A controlled study. Arch Gen Psychiatry 1988; 45:463-70.

37. Biederman J, Gonzalez E, Bronstein B, De Monaco H, Wright V. Desipramine and cutaneous reactions in pediatric outpatients. J Clin Psychiatry 1988;49:178-183.

38. Cohen LS, Biederman J. Further evidence for an association between affective disorders and anxiety disorders: Review

and case reports. J Clin Psychiatry 1988;49:313-316.

39. Biederman J, Baldessarini RJ, Wright V, Knee D, Harmatz J. A double-blind placebo controlled study of desipramine in the treatment of attention deficit disorder: I. Efficacy. J Am Acad Child Adolesc Psychiatry 1989; 28:777-784.

40. Biederman J, Baldessarini RJ, Wright V, Knee D, Harmatz J, Goldblatt A. A double-blind placebo controlled study of

desipramine in the treatment of attention deficit disorder II: Serum drug levels and cardiovascular findings. J Am Acad Child Adolesc Psychiatry 1989; 28:903-911.

41. Weilburg JB, Rosenbaum JF, Biederman J, Sachs GS, Pollack MH, Kelly K. Fluoxetine added to non-MAOI

antidepressants converts nonresponders to responders: a preliminary report. J Clin Psychiatry 1989;50:447-9.

42. Biederman J, Rosenbaum JF, Hirshfeld DR, Faraone SV, Bolduc EA, Gersten M, et al. Psychiatric correlates of behavioral inhibition in young children of parents with and without psychiatric disorders. Arch Gen Psychiatry 1990; 47:21-6.

13

Page 14: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

43. Biederman J, Faraone SV, Knee D, Munir K. Retrospective assessment of DSM-III attention deficit disorder in non-referred individuals. J Clin Psychiatry 1990;51:102-106.

44. Herman JB, Brotman AW, Pollack MH, Falk WE, Biederman J, Rosenbaum JF. Fluoxetine-induced sexual

dysfunction. J Clin Psychiatry 1990;51:25-27.

45. Biederman J. The diagnosis and treatment of adolescent anxiety disorders. J Clin Psychiatry 1990;51:20-26.

46. Biederman J, Faraone SV, Keenan K, Knee D, Tsuang MT. Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder. J Am Acad Child Adolesc Psychiatry 1990; 29:526-533.

47. Biederman J, Keenan K, Faraone SV. Parent based diagnosis of attention deficit disorder predicts a diagnosis based on

teacher report. J Am Acad Child Adolesc Psychiatry 1990; 29:698-701.

48. Steingard R, Biederman J, Keenan K, Moore C. Comorbidity in the interpretation of rates of dexamethasone nonsupression in clinically referred children. Biol Psychiatry 1990; 28:193-202.

49. Faraone SV, Biederman J, Keenan K, Tsuang MT. A family-genetic study of girls with DSM-III attention deficit

disorder. Am J Psychiatry 1991, 148:112-117.

50. Biederman J, Faraone SV, Keenan K, Steingard R, Tsuang MT. Familial association between attention deficit disorder and anxiety disorders. Am J Psychiatry 1991, 148:251-256.

51. Rosenbaum JF, Biederman J, Hirshfeld DR, Bolduc EA, Faraone SV, Kagan J, et al. Further evidence of an association

between behavioral inhibition and anxiety disorders: results from a family study of children from a non- clinical sample. J Psychiatr Res 1991;25:49-65.

52. Faraone SV, Biederman J, Keenan K, Tsuang MT. Separation of DSM-III attention deficit disorder and conduct

disorder: Evidence from a family-genetic study of American child psychiatric patients. Psychol Med 1991; 21:109-121.

53. Biederman J, Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry 1991,148:564-577.

54. Biederman J. Sudden death in children treated with a tricyclic antidepressant. J Am Acad Child Adolesc Psychiatry

1991; 30:495-497.

55. Biederman J, Faraone SV, Keenan K, Tsuang MT. Evidence of familial association between attention deficit disorder and major affective disorders. Arch Gen Psychiatry 1991; 48:633-642.

56. Jellinek MS, Bishop SJ, Murphy JM, Biederman J, Rosenbaum JF. Screening for dysfunction in the children of

outpatients at a psychopharmacology clinic. Am J Psychiatry 1991; 148:1031-6.

57. Biederman J, Rosenbaum JF, Bolduc EA, Faraone SV, Hirshfeld DR. A high risk study of young children of parents with panic disorder and agoraphobia with and without comorbid major depression. Psychiatry Res 1991; 37:333-348.

58. Rosenbaum JF, Biederman J, Hirshfeld DR, Bolduc EA, Chaloff J. Behavioral inhibition in children: a possible

precursor to panic disorder or social phobia. J Clin Psychiatry 1991;52:5-9.

59. Wilens TE, Steingard R, Biederman J. Clomipramine for comorbid conditions. J Am Acad Child Adolesc Psychiatry 1992; 31:171.

60. Biederman J. New developments in pediatric psychopharmacology. J Am Academy Child Adolesc Psychiatry

1992;31:14-15.

14

Page 15: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

61. DeVeaugh-Geiss J, Moroz G, Biederman J, Cantwell D, Fontaine R, Greist J, et al. Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder: A multicenter trial. J. Am. Acad. Child Adolesc Psychiatry 1992; 31:45-49.

62. Hirshfeld DR, Rosenbaum JF, Biederman J, Bolduc EA, Faraone SV, Kagan J. Stable behavioral inhibition and its

association with anxiety disorders. J Am Acad Child Adolesc Psychiatry 1992; 31:103-111.

63. Spencer T, Biederman J, Wright V, Danon M. Growth deficits in children treated with desipramine: A controlled study. J Am Acad Child Adolesc Psychiatry 1992; 31:235-243.

64. Keller MB, Lavori PW, Beardslee WR, Wunder J, Schwartz C, Biederman J. The disruptive behavioral disorders in

children and adolescents: Comorbidity and clinical course. J Am Acad Child Adolesc Psychiatry 1992; 31:204-210.

65. Rosenbaum JF, Biederman J, Bolduc EA, Hirshfeld DR, Faraone SV, Kagan J. Comorbidity of parental anxiety disorders as risk for childhood-onset anxiety in inhibited children. Am J Psychiatry 1992; 149:475-81.

66. Steingard R, Biederman J, Doyle A, Sprich-Buckminster S. Psychiatric comorbidity in attention deficit disorder: Impact

on the interpretation of Child Behavior Checklist results. J Am Acad Child Adolesc Psychiatry 1992; 31:449-454.

67. Semrud-Clikeman MS, Biederman J, Sprich S, Krifcher B, Norman D, Faraone S. Comorbidity between ADHD and learning disability: A review and report in a clinically referred sample. J Am Acad Child Adolesc Psychiatry 1992; 31:439-448.

68. Wilens TE, Biederman J, Baldessarini RJ, Puopolo PR, Flood JG. Developmental changes in serum concentrations of

desipramine and 2-Hydroxydesipramine during treatment with desipramine. J Am Acad Child Adolesc Psychiatry 1992; 31:691-698.

69. Biederman J, Faraone SV, Keenan K, Benjamin J, Krifcher B, Moore C, et al. Further evidence for family-genetic risk

factors in attention deficit hyperactivity disorder. Patterns of comorbidity in probands and relatives psychiatrically and pediatrically referred samples Arch Gen Psychiatry 1992; 49:728-38.

70. Wilens TE, Biederman J, Baldessarini RJ, McDermott SP, Puopolo PR, Flood JG. Fluoxetine inhibits desipramine metabolism [letter; comment]. Arch Gen Psychiatry 1992; 49:752.

71. Faraone S, Biederman J, Chen WJ, Krifcher B, Keenan K, Moore C, et al. Segregation analysis of attention deficit

hyperactivity disorder: Evidence for single gene transmission. Psychiatr Genet 1992; 2:257-275.

72. Wilens TE, Biederma J. The Stimulants. Psychiatric Clinics of North America, 1992, 15 1 191-222.

73. Biederman J, Baldessarini RJ, Wright V, Keenan K, Faraone S. A double-blind placebo controlled study of desipramine in the treatment of attention deficit disorder: III. Lack of impact of comorbidity and family history factors on clinical response. J Am Acad Child Adolesc Psychiatry 1993; 32:199-204.

74. Spencer T, Biederman J, Wilens T, Steingard R, Geist D. Nortriptyline in the treatment of children with attention deficit

hyperactivity disorder and tic disorder or Tourette's syndrome. J of Am Acad Child Adolesc Psychiatry 1993; 32:205-210.

75. Faraone SV, Biederman J, Sprich S, Buckminster S, Chen W, Tsuang M. Efficiency of diagnostic criteria for attention

deficit disorder: Toward an empirical approach to designing and validating diagnostic algorithms. J Am Acad Child Adolesc Psychiatry 1993; 32:166-174.

76. Wilens TE, Biederman J, Spencer T, Geist DE. A retrospective study of serum levels and electrocardiographic effects

of nortriptyline in children and adolescents. J Am Acad Child Adolesc Psychiatry 1993;32:270-277.

15

Page 16: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

77. Spencer TJ, Biederman J, Steingard R, Wilens T. Bupropion exacerbates tics in children with attention deficit

hyperactivity disorder and Tourette's Disorder. J Am Acad of Child Adolesc Psychiatry 1993; 32:211-214.

78. Biederman J, Faraone SV, Milberger S, Doyle A. Diagnoses of attention deficit hyperactivity disorder from parent reports predict diagnoses based on teacher reports. J Am Acad Child Adolesc Psychiatry 1993;32:315-317.

79. Wilens TE, Biederman J, Geist DE, Steingard R, Spencer T. Nortriptyline in the treatment of attention deficit

hyperactivity disorder: A chart review of 58 cases. J Am Acad Child Adolesc Psychiatry 1993;32:343-349.

80. Steingard R, Biederman J, Spencer T, Wilens T, Gonzalez A. Comparison of clonidine response in the treatment of attention deficit hyperactivity disorder with and without comorbid tic disorders. J Am Acad Child Adolesc Psychiatry 1993; 32:350-353.

81. Spencer T, Biederman J, Kerman K, Steingard R, Wilens T. Desipramine in the treatment of children with Tic disorder

or Tourette's Syndrome and attention deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1993; 32:354-360.

82. Rosenbaum J, Biederman J, Bolduc-Murphy E, Faraone S, Chaloff J, Hirshfeld D, et al. Behavioral inhibition in

childhood: A risk factor for anxiety disorders. Harv Rev Psych 1993; 1:2-16.

83. Faraone S, Biederman J, Krifcher Lehman B, Keenan K, Norman D, Seidman L, et al. Evidence for the independent familial transmission of attention deficit hyperactivity disorder and learning disabilities: Results from a family genetic study. Am J Psychiatry 1993; 150:891-895.

84. Biederman J, Rosenbaum JF, Bolduc-Murphy EA, Faraone SV, Chaloff J, Hirshfeld DR, et al. A 3-year follow-up of

children with and without behavioral inhibition [see comments]. J Am Acad Child Adolesc Psychiatry 1993; 32:814-21.

85. Wilens T, Biederman J, Baldessarini R, Puopolo P, Flood J. Electrocardiographic effects of desipramine and 2-hydroxydesipramine in children, adolescents, and adults treated with desipramine. J Am Acad Child Adolesc Psychiatry 1993; 32:798-804.

86. Biederman J, Baldessarini R, Goldblatt A, Lapey K, Doyle A, Hesslein P. A naturalistic study of 24-hour

electrocardiographic recordings and echocardiographic finding in children and adolescents treated with desipramine. J Am Acad Child Adolesc Psychiatry 1993; 32:805-813.

87. Biederman J, Faraone SV, Doyle A, Lehman BK, Kraus I, Perrin J, et al. Convergence of the Child Behavior Checklist

with structured interview- based psychiatric diagnoses of ADHD children with and without comorbidity. J Child Psychol Psychiatry 1993; 34:1241-51.

88. Biederman J, Faraone S, Chen W. Social adjustment inventory for children and adolescents: Concurrent validity in

ADHD children. J Am Acad Child Adolesc Psychiatry 1993; 32:1059-1064.

89. Sprich-Buckminster S, Biederman J, Milberger S, Faraone S, Krifcher Lehman B. Are perinatal complications relevant to the manifestation of ADD? Issues of comorbidity and familiality. J Am Acad Child Adolesc Psychiatry 1993; 32:1032-1037.

90. Faraone SV, Biederman J, Krifcher Lehman B, Spencer T, Norman D, Seidman L, et al. Intellectual performance and

school failure in children with attention deficit hyperactivity disorder and in their siblings. J Abnorm Psychol 1993;102:616-623.

91. Biederman J, Faraone SV, Spencer T, Wilens T, Norman D, Lapey KA, et al. Patterns of psychiatric comorbidity,

cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 1993; 150:1792-1798.

16

Page 17: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

92. Wilens T, Biederman J. Psychopathology in preadolescent children at high risk for substance abuse: A review of the

literature. Harv Rev Psych 1993; 1:207-218.

93. Faraone S, Biederman J. Is attention deficit hyperactivity disorder familial? Harv Rev Psych 1994; 1:271-287.

94. Wilens T, Biederman J, Spencer T. Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1994; 33:424-426.

95. Faraone S, Biederman J, Milberger S. An exploratory study of ADHD among second-degree relatives of ADHD

children. Biol Psychiatry 1994; 35:398-402.

96. Frick PJ, Lahey BB, Applegate B, Kerdyck L, Ollendick T, Hynd GW, et al. DSM-IV field trials for the disruptive behavior disorders: symptom utility estimates. J Am Acad Child Adolesc Psychiatry 1994; 33:529-39.

97. Wilens T, Biederman J, Spencer T, Frances R. Comorbidity of attention deficit hyperactivity and psychoactive

substance use disorders. Hospital and Community Psychiatry 1994; 45:421-435.

98. Biederman J, Milberger S, Faraone SV, Guite J, Warburton R. Associations between childhood asthma and ADHD: Issues of psychiatric comorbidity and familiality. J Am Acad Child Adolesc Psychiatry 1994; 33:842-848.

99. Semrud-Clikeman MS, Filipek PA, Biederman J, Steingard R, Kennedy D, Renshaw P, et al. Attention-deficit

hyperactivity disorder: Magnetic resonance imaging morphometric analysis of the corpus callosum. J Am Acad Child Adolesc Psychiatry 1994; 33:875-881.

100. Belmaker R, Biederman J. Genetic markers, temperament, and psychopathology.Biol Psychiatry 1994; 36:71-72.

101. Biederman J, Lapey KA, Milberger S, Faraone SV, Reed ED, Seidman LJ. Motor preference, major depression and

psychosocial dysfunction among children with ADHD. J Psychiatr Res 1994; 28:171-184.

102. Rosenbaum J, Biederman J, Pollock R, Hirshfield D. The etiology of social phobia. J Clin Psychiatry 1994;55:10-16.

103. Biederman J, Faraone SV, Spencer T, Wilens T, Mick E, Lapey KA. Gender differences in a sample of adults with attention deficit hyperactivity disorder. Psychiatry Res 1994; 53:13-29.

104. Spencer T, Wilens T, Biederman J. Tricyclic antidepressant treatment of hyperactivity. Current Opinion in Psychiatry

1994; 7:304-307.

105. Lahey B, Applegate B, McBurnett K, Biederman J, Greenhill L, Hynd G, et al. DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents. Am J Psychiatry 1994; 151:1673-1685.

106. Chen W, Faraone S, Biederman J, Tsuang M. Diagnostic accuracy of the child behavior checklist scales for attention

deficit hyperactivity disorder: A receiver operating characteristic analysis. J Consult Clin Psychol 1994;62:1017-1025.

107. Spencer T, Biederman J, Wilens T, Faraone S. Is attention deficit hyperactivity disorder in adults a valid disorder? Harv Rev Psych 1994; 1:326-335.

108. Lahey B, Applegate B, Barkley R, Garfinkel B, McBurnett K, Kerdyk L, et al. DSM-IV field trials for oppositional

defiant disorder and conduct disorder in children and adolescents. Am J Psychiatry 1994; 151:1163-1172.

109. Spencer T, Biederman J, Wilens T. Tricyclic antidepressant treatment of children with ADHD and tic disorders. Journal of the American Academy of Child and Adolescent Psychiatry 1994, 33: 1203-1204.

17

Page 18: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

110. Wozniak J, Biederman J, Kiely K, Ablon S, Faraone S, Mundy E, et al. Mania-like symptoms suggestive of childhood onset bipolar disorder in clinically referred children. J Am Acad Child Adolesc Psychiatry 1995; 34:867-876.

111. Biederman J, Santangelo S, Faraone SV, Kiely K, Guite J, Mick E, et al. A comprehensive evaluation of the association

between enuresis and ADHD in referred pediatric samples. J Child Psychol Psychiatry 1995; 36:865-877.

112. Werry JS, Biederman J, Thisted R, Greenhill L, Ryan N. Resolved: Cardiac arrhythmias make desipramine an unacceptable choice in children. J Am Acad Child Adolesc Psychiatry 1995; 34:1239 -1249.

113. Biederman J, Milberger S, Faraone SV, Seidman LJ, Lapey KA, Reed ED. No confirmation of Geschwind's hypothesis

of associations between reading disability, immune disorders, and motor preference in ADHD. J Abnorm Child Psychol 1995; 23:545-552.

114. Milberger S, Biederman J, Faraone SV, Murphy J, Tsuang MT. Attention Deficit Hyperactivity Disorder and comorbid

disorders: Issues of overlapping symptoms. Am J Psychiatry 1995; 152:1793-1800.

115. Geller DA, Biederman J, Reed ED, Spencer T, Wilens TE. Similarities in response to fluoxetine in the treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 1995; 34:36-44.

116. Wilens TE, Spencer T, Biederman J, Wozniak J, Connor D. Combined pharmacotherapy: an emerging trend in pediatric

psychopharmacology. J Am Acad Child and Adolesc Psychiatry 1995; 34:110-2.

117. Biederman J, Faraone SV, Mick E, Spencer T, Wilens TE, Keily K, et al. High risk for attention deficit hyperactivity disorder among children of parents with childhood onset of the disorder: A pilot study. Am J Psychiatry 1995; 152:431-435.

118. Wilens TE, Biederman JB, Mick E, Spencer T. A systematic assessment of tricyclic antidepressants in the treatment of

adult attention-deficit hyperactivity disorder. J Nerv Ment Dis 1995;183:48-50.

119. Biederman J, Thisted R, Greenhill L, Ryan N. Estimation of the association between desipramine and the risk for sudden death in 5- to14-year-old children. J Clin Psychiatry 1995;56:87-93.

120. Biederman J, Wozniak J, Kiely K, Ablon S, Faraone S, Mick E, et al. CBCL clinical scales discriminate prepubertal

children with structured-interview derived diagnosis of mania from those with ADHD. J Am Acad Child Adolesc Psychiatry 1995; 34:464-471.

121. Biederman J, Faraone S, Mick E, Lelon E. Psychiatric comorbidity among referred juveniles with major depression:

Fact or artifact? J Am Acad Child Adolesc Psychiatry 1995; 34:579-590.

122. Wilens T, Biederman J, Kiely K, Bredin E, Spencer T. Pilot study of behavioral and emotional disturbances in the high-risk children of parents with opioid dependence. J Am Acad Child Adolesc Psychiatry 1995; 34:779-785.

123. Faraone SV, Biederman J, Chen WJ, Milberger S, Warburton RM, Tsuang MT. Genetic heterogeneity in attention

deficit hyperactivity disorder: Gender, psychiatric comorbidity and maternal ADHD. J Abnorm Psychol 1995;104:334-345.

124. Spencer T, Wilens T, Biederman J, Faraone SV, Ablon JS, Lapey K. A double-blind, crossover comparison of

methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1995; 52:434-443.

125. Biederman J, Milberger S, Faraone SV, Kiely K, Guite J, Mick E, et al. Family-environment risk factors for attention

deficit hyperactivity disorder: A test of Rutter's indicators of adversity. Arch Gen Psychiatry 1995; 52:464-470.

18

Page 19: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

126. Spencer T, Biederman J, Wilens T, Guite J, Harding M. ADHD and thyroid abnormalities: A research note. J Child Psychol Psychiatry 1995; 36:879-885.

127. Faraone S, Biederman J, Milberger S. How reliable are maternal reports of their children's psychopathology? One year

recall of psychiatric diagnoses of ADHD children. J Am Acad Child Adolesc Psychiatry 1995; 34:1001-1008.

128. Seidman LJ, Biederman J, Faraone SV, Milberger S, Norman D, Seiverd K, et al. Effects of family history and comorbidity on the neuropsychological performance of children with ADHD: preliminary findings. J Am Acad Child Adolesc Psychiatry 1995; 34:1015-24.

129. Wilens T, Prince J, Biederman J, Spencer T, Frances R. Attention-deficit hyperactivity disorder and comorbid

substance use disorders in adults. Psychiatr Serv 1995; 46:761-763.

130. Wilens T, Biederman J, Spencer T, Prince J. Pharmacotherapy of adult attention deficit/hyperactivity disorder: A review. J Clin Psychopharmacol 1995; 15:270-279.

131. Spencer T, Biederman J, Harding M, Wilens T, Faraone S. The relationship between tic disorders and Tourette's

Syndrome revisited. J Am Acad of Child Adolesc Psychiatry 1995;34:1133-1139.

132. Wilens T, Spencer T, Biederman J. Are attention-deficit hyperactivity disorder and the psychoactive substance use disorders really related? Harv Rev Psych 1995; 3:160-162.

133. Biederman J, Milberger SV, Faraone S, Kiely K, Guite J, Mick E, et al. Impact of adversity on functioning and

comorbidity in children with attention- deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1995; 34:1495-1503.

134. Biederman J, Wilens T, Mick E, Milberger S, Spencer T, Faraone S. Psychoactive substance use disorder in adults with

attention deficit hyperactivity disorder: effects of ADHD and psychiatric comorbidity. Am J Psychiatry 1995; 152:1652-1658.

135. Wilens TE, Biederman J, Spencer TJ. Venlafaxine for adult ADHD [letter]. Am J Psychiatry 1995; 152:1099-100.

136. Biederman J, Faraone S. Childhood mania revisited. Israel Journal of Medical Sciences 1995; 31:647-651.

137. Wozniak J, Biederman J, Mundy E, Mennin D, Faraone SV. A pilot family study of childhood-onset mania. J Am Acad

Child Adolesc Psychiatry 1995; 34:1577-1583.

138. Biederman J. Developmental subtypes of juvenile bipolar disorder. Harv Rev Psych 1995; 3:227-230.

139. Seidman LJ, Benedict KB, Biederman J, Bernstein JH, Seiverd K, Milberger S, et al. Performance of children with ADHD on the Rey-Osterrieth complex figure: a pilot neuropsychological study. J Child Psychol Psychiatry 1995; 36:1459-73.

140. Pollock R, Rosenbaum JF, Marrs A, Miller BS, Biederman J. Anxiety disorders of childhood, Implications for adult

psychopathology. Psychiatr Clin North Am 1995, 18:745-766.

141. Biederman J, Santangelo S, Faraone S, Kiely K, Guite J, Mick E, Reed ED, Kraus I, Jellinek M, Perrin J. Clinical correlates of enuresis in ADHD and non-ADHD children. Journal of Child Psychology and Psychiatry & Allied Disciplines, 1995, 36: 865-877.

142. Biederman J, Faraone SV, Milberger S, Curtis S, Chen L, Marrs A, et al. Predictors of persistence and remission of

ADHD: results from a four-year prospective follow-up study of ADHD children. J Am Acad Child Adolesc Psychiatry 1996; 35:343-351.

19

Page 20: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

143. Spencer TJ, Biederman J, Wilens T, Harding M, O'Donnell D, Griffin S. Pharmacotherapy of attention deficit hyperactivity disorder across the lifecycle: a literature review. J Am Acad Child Adolesc Psychiatry 1996; 35:409-432.

144. Greene R, Biederman J, Faraone S, Ouellette C, Penn C, Griffin S. Toward a new psychometric definition of social

disability in children with Attention-Deficit Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry 1996; 35:571-578.

145. Prince J, Wilens T, Biederman J, Spencer T, Wozniak J. Clonidine for ADHD related sleep disturbances: A systematic

chart review of 62 cases. J Am Acad Child Adolesc Psychiatry 1996; 35:599-605.

146. Faraone SV, Biederman J, Mick E, Wozniak J, Kiely K, Guite J, et al. Attention deficit hyperactivity disorder in a multigenerational pedigree. Biol Psychiatry 1996; 39:906-908.

147. Daly J, Biederman J, Bostic J, Maraganore A, Lelon E, Jellinek M, et al. The relationship between childhood asthma

and attention deficit hyperactivity disorder: A review of the literature. J Attent Disord 1996;1:31-40.

148. Biederman J, Faraone SV, Mick E, Moore P, Lelon E. Child behavior checklist (CBCL) findings further support comorbidity between ADHD and major depression in a referred sample. J Am Acad Child Adolesc Psychiatry 1996; 35:734-742.

149. Wozniak J, Biederman J. A pharmacological approach to the quagmire of comorbidity in juvenile mania. J Am Acad

Child Adolesc Psychiatry 1996; 35:826-828.

150. Biederman J, Faraone S, Milberger S, Guite J, Mick E, Chen L, et al. A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders. Arch Gen Psychiatry 1996; 53:437-46.

151. Alpert JE, Maddocks A, Nierenberg AA, O'Sullivan R, Pava JA,Worthington JJ, 3rd, et al. Attention deficit

hyperactivity disorder in childhood among adults with major depression. Psychiatry Res 1996; 62:213-9.

152. Milberger S, Faraone SV, Biederman J, Testa M, Tsuang MT. New phenotype definition of ADHD in relatives for genetic analyses. Neuropsychiatric Genetics 1996; 67:369-377.

153. Biederman J, Faraone SV, Mick E, Wozniak J, Chen L, Ouellette C, et al. Attention deficit hyperactivity disorder and

juvenile mania: An overlooked comorbidity? J Am Acad Child Adolesc Psychiatry 1996; 35:997-1008.

154. Milberger S, Biederman J, Faraone S, Chen L, Jones J. Is maternal smoking during pregnancy a risk factor for attention deficit hyperactivity disorder in children? Am J Psychiatry 1996; 153:1138-1142.

155. Wilens TE, Biederman J, Prince J, Spencer TJ, Faraone SV, Warburton R, et al. Six-week, double-blind, placebo-

controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry 1996; 153:1147-1153.

156. Biederman J, Faraone SV, Milberger S, Garcia Jetton J, Chen L, Mick E, et al. Is childhood oppositional defiant

disorder a precursor to adolescent conduct disorder? Findings from a four-year follow-up study of children with ADHD. J Am Acad Child Adolesc Psychiatry 1996; 35:1193-1204.

157. Faraone SV, Biederman J, Mennin D, Gershon J, Tsuang M. A prospective four year follow-up study of children at risk

for attention deficit hyperactivity disorder: Psychiatric, neuropsychological and psychosocial outcome. J Am Acad Child Adolesc Psychiatry 1996; 35:1449-1459.

158. Mick E, Biederman J, Faraone SV. Is season of birth a risk factor for attention deficit hyperactivity disorder? J Am

Acad Child Adolesc Psychiatry 1996; 35:1470-1476.

20

Page 21: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

159. Wilens T, Biederman J, Baldessarini R, Geller B, Schleifer D, Spencer T, et al. Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents. J Am Acad Child Adolesc Psychiatry 1996;35:1491-1501.

160. Spencer T, Biederman J, Harding M, O'Donnell D, Faraone S, Wilens T. Growth deficits in ADHD children revisited:

Evidence for disorder-associated growth delays? J Am Acad Child Adolesc Psychiatry 1996; 35:1460-1469.

161. Wilens T, Biederman J, Abrantes A, Spencer T. A naturalistic assessment of protriptyline for attention deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1996; 35:1485-1490.

162. Geller DA, Biederman J, Griffin S, Jones J, Lefkowitz TR. Comorbidity of juvenile obsessive-compulsive disorder with

disruptive behavior disorders: A review and a report. J Am Acad Child Adolesc Psychiatry 1996; 35:1637-1646.

163. Wilens T, Biederman J, Spencer T. Case study: Adverse effects of smoking marijuana while receiving tricyclic antidepressants. J Am Acad Child Adolesc Psychiatry 1996; 36:45-48.

164. Milberger S, Biederman J, Faraone S, Guite J, Tsuang M. Pregnancy delivery and infancy complications and ADHD:

Issues of gene-environment interactions. Biol Psychiatry 1997; 41:65-75.

165. Hirshfeld D, Biederman J, Brody L, Faraone S, Rosenbaum J. Associations between expressed emotion and child behavioral inhibition and psychopathology: A pilot study. J Am Acad Child Adolesc Psychiatry 1997; 36:205-213.

166. Biederman J, Faraone SV, Marrs A, Moore P, Garcia J, Ablon JS, et al. Panic disorder and agoraphobia in

consecutively referred children and adolescents. J Am Acad Child Adolesc Psychiatry 1997; 36:214-223.

167. Samuel V, Curtis S, Thornell A, George P, Taylor A, Brome D, et al. The unexplored void of ADHD and african-american research: A review of the literature. J Attent Disord 1997;1:197-208.

168. Seidman L, Biederman J, Faraone S, Weber W, Mennin D, Jones J. A pilot study of neuropsychological function in

ADHD girls. J Am Acad Child Adolesc Psychiatry 1997; 36:366-373.

169. Faraone SV, Biederman J. Do attention deficit hyperactivity disorder and major depression share familial risk factors? J Nerv Ment Dis 1997;185:533-541.

170. Filipek PA, Semrud-Clikeman M, Steingrad R, Kennedy D, Biederman J. Volumetric MRI analysis: Comparing

subjects having attention-deficit hyperactivity disorder with normal controls. Neurology 1997; 48:589-601.

171. Milberger S, Biederman J, Faraone SV, Chen L, Jones J. Attention deficit hyperactivity disorder is associated with early initiation of cigarette smoking in children and adolescents. J Am Acad Child Adolesc Psychiatry 1997; 36:37-44.

172. Faraone S, Biederman J, Garcia Jetton J, Tsuang M. Attention deficit disorder and conduct disorder: Longitudinal

evidence for a familial subtype. Psychol Med 1997; 27:291-300.

173. Seidman LJ, Biederman J, Faraone SV, Weber W, Ouellette C. Toward defining a neuropsychology of attention deficit-hyperactivity disorder: performance of children and adolescents from a large clinically referred sample. J Consult Clin Psychol 1997;65:150-160.

174. Biederman J, Faraone SV, Baldessarini RJ, Flood J, Meyer M, Wilens T, et al. Predicting desipramine levels in children

and adolescents: A naturalistic clinical study. J Am Acad Child Adolesc Psychiatry 1997; 36:384-389.

175. Milberger S, Biederman J, Faraone S, Chen L, Jones J. Further evidence of an association between attention-deficit/hyperactivity disorder and cigarette smoking: Findings from a high-risk sample of siblings. Am J Addict 1997; 6:205-217.

21

Page 22: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

176. Biederman J, Wilens TE, Mick E, Faraone SV, Weber W, Curtis S, et al. Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 1997; 36:21-29.

177. Wilens T, Spencer T, Biederman J, Schleifer D. Case study: Nefazodone for juvenile mood disorders. J Am Acad

Child Adolesc Psychiatry 1997; 36:481-485.

178. Greene R, Biederman J, Faraone S, Sienna M, Garcia Jetton J. Adolescent outcome of boys with attention-deficit/ hyperactivity disorder and social disability: Results from a 4-year longitudinal follow-up study. J Consult Clin Psychol 1997;65:758-767.

179. Faraone SV, Biederman J, Wozniak J, Mundy E, Mennin D, O'Donnell D. Is comorbidity with ADHD a marker for

juvenile onset mania? J Am Acad Child Adolesc Psychiatry 1997; 36:1046-1055.

180. Hirshfeld DR, Biederman J, Brody L, Faraone SV, Rosenbaum JF. Expressed emotion toward children with behavioral inhibition: Associations with maternal anxiety disorder. J Am Acad Child Adolesc Psychiatry 1997; 36:910-917.

181. Wilens TE, Biederman J, Mick E, Faraone SV, Spencer T. Attention deficit hyperactivity disorder (ADHD) is

associated with early onset substance use disorders. J Nerv Ment Dis 1997;185:475-482.

182. Faraone SV, Biederman J, Mennin D, Wozniak J, Spencer T. Attention-deficit hyperactivity disorder with bipolar disorder: a familial subtype? J Am Acad Child Adolesc Psychiatry 1997; 36:1378-87; discussion 1387-90.

183. Applegate B, Lahey B, Hart E, Biederman J, Hynd G, Barkley R, et al. Validity of the age of onset criterion for

attention-deficit/hyperactivity disorder: a report from the DSM-IV field trials. J Am Acad Child Adolesc Psychiatry 1997; 36:1211-1221.

184. Biederman J, Faraone S, Hatch M, Mennin D, Taylor A, George P. Conduct disorder with and without mania in a

referred sample of ADHD children. J Affect Disord 1997; 44:177-188.

185. Barkley RA, Biederman J. Toward a broader definition of the age-of-onset criterion for attention- deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1997; 36:1204-10.

186. Milberger S, Biederman J, Faraone S, Wilens T, Chu M. Associations between ADHD and psychoactive substance use

disorders: Findings from a longitudinal study of high-risk siblings of ADHD children. Am J Addict 1997; 6:318-329.

187. Biederman J, Faraone SV, Weber W, Russell RL, Rater M, Park K. Correspondence between DSM-III-R and DSM-IV Attention Deficit Hyperactivity Disorder (ADHD). J Am Acad Child Adolesc Psychiatry 1997; 36:1682-1687.

188. Wozniak J, Biederman J, Faraone S, Frazier J, Kim J, Millstein R, et al. Mania in children with pervasive

developmental disorder revisited. J Am Acad Child Adolesc Psychiatry 1997; 36:1552-1560.

189. Wilens T, Biederman J, Abrantes AM, Spencer TJ. Clinical characteristics of psychiatrically referred adolescent outpatients with substance use disorder. J Am Acad Child Adolesc Psychiatry 1997; 36:941-947.

190. Faraone S, Biederman J, Mick E. Symptom reports by adults with attention deficit hyperactivity disorder: are they

influenced by attention deficit hyperactivity disorder in their children? J Nerv Ment Dis 1997;185:583-584.

191. Bostic JQ, Wilens TE, Spencer T, Biederman J. Juvenile mood disorders and office psychopharmacology. Pediatric Clin North Am 1997; 44:1487-1503.

192. Wilens TE, Spencer TJ, Biederman J. Sudden (un)explained death [letter]. J Am Acad Child Adolesc Psychiatry 1997;

36:1487-8.

22

Page 23: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

193. Millstein R, Wilens T, Biederman J, Spencer T. Presenting ADHD symptoms and subtypes in clinically referred adults with ADHD. J Attent Disord 1997;2:159-166.

194. Wozniak J, Biederman J. Childhood mania: insights into diagnostic and treatment issues. J Assoc Acad Minor Phys

1997; 8:78-84.

195. Wozniak J, Biederman J. Mania in Children with PDD. J American Academy Child Adolescent Psychiatry 1997; 12:1646-7.

196. Biederman J, Mick E, Faraone S. Normalized functioning in youths with persistent ADHD. J Pediatrics 1998; 133:544-

551.

197. Biederman J, Mick E, Bostic J, Prince J, Daly J, Wilens T, et al. The naturalistic course of pharmacologic treatment of children with manic-like symptoms: A systematic chart review. J Clin Psychiatry 1998;59:628-637.

198. Biederman J, Faraone SV, Taylor A, Sienna M, Williamson S, Fine C. Diagnostic continuity between child and

adolescent ADHD: findings from a longitudinal clinical sample. J Am Acad Child Adolesc Psychiatry 1998; 37:305-313.

199. Geller D, Biederman J, Jones J, Shapiro S, Schwartz S, Park K. Obsessive-compulsive disorder in children and

adolescents: A review. Harv Rev Psych 1998; 5:260-273.

200. Biederman J, Mick E, Faraone S. Depression in attention deficit hyperactivity disorder (ADHD) children: "True" depression or demoralization. J Affect Disord 1998; 47:113-122.

201. Faraone SV, Biederman J, Mennin D, Russell RL. Bipolar and antisocial disorders among relatives of ADHD children:

Parsing familial subtypes of illness. Neuropsychiatric Genetics 1998; 81:108-116.

202. Faraone S, Biederman J, Mennin D, Russell R, Tsuang M. Familial subtypes of attention deficit hyperactivity disorder: A 4-year follow-up study of children from antisocial-ADHD families. J Child Psychol Psychiatry 1998; 39:1045-1053.

203. Spencer T, Biederman J, Harding M, O'Donnell D, Wilens T, Faraone S, et al. Disentangling the overlap between

Tourette's disorder and ADHD. J Child Psychol Psychiatry 1998; 39:1037-44.

204. Biederman J, Wilens T, Mick E, Faraone S, Spencer T. Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence? Biol Psychiatry 1998; 44:269-273.

205. Geller D, Biederman J, Jones J, Park KS, Schwartz S, Shapiro S, et al. Is juvenile obsessive-compulsive disorder a

developmental subtype of the disorder? A review of the pediatric literature. J Am Acad Child Adolesc Psychiatry 1998; 37:420-427.

206. Biederman J. Attention-Deficit/Hyperactivity Disorder: A life span perspective. J Clin Psychiatry 1998;59:4-16.

207. Milberger S, Faraone SV, Biederman J, Chu MP, Wilens T. Familial risk analysis of the association between attention-

deficit/hyperactivity disorder and psychoactive substance use disorders. Arch Pediatr Adolesc Med 1998; 152:945-951.

208. Spencer T, Biederman J, Wilens T, Prince J, Hatch M, Jones J, et al. Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. Am J Psychiatry 1998; 155:693-695.

209. Biederman J, Russell R, Soriano J, Wozniak J, Faraone S. Clinical features of children with both ADHD and mania:

Does ascertainment source make a difference? J Affect Disord 1998; 51:101-112.

210. Samuel V, Biederman J, Faraone S, George P, Mick E, Thornell A, et al. Clinical characteristics of attention deficit hyperactivity disorder in African American children. Am J Psychiatry 1998; 155:696-698.

23

Page 24: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

211. Biederman J. A 55 Year Old Man with Attention Deficit Disorder. JAMA 1998; 280:1086-1092.

212. Spencer T, Biederman J, Wilens T. Growth deficits in children with attention deficit hyperactivity disorder. Pediatrics

1998; 102:501-6.

213. Seidman LJ, Biederman J, Weber W, Hatch M, Faraone SV. Neuropsychological function in adults with attention-deficit hyperactivity disorder. Biol Psychiatry 1998; 44:260-268.

214. Faraone SV, Biederman J. Neurobiology of attention-deficit hyperactivity disorder. Biol Psychiatry 1998; 44:951-958.

215. O'Donnell D, Biederman J, Jones J, Wilens TE, Milberger S, Mick E, et al. Informativeness of child and parent reports

on substance use disorders in a sample of ADHD probands, control probands, and their siblings. J Am Acad Child Adolesc Psychiatry 1998; 37:752-758.

216. Biederman J. Resolved: Mania is mistaken for ADHD in prepubertal children. Affirmative. J Am Acad Child Adolesc

Psychiatry 1998; 37:1091-1093.

217. Spencer T, Biederman J, Wilens TE, Faraone SV. Adults with attention-deficit/hyperactivity disorder: a controversial diagnosis. J Clin Psychiatry 1998;59:59-68.

218. March J, Biederman J, Wolkow R, Safferman A, Mardekian J, E. C, et al. Sertraline in children and adolescents with

obsessive-compulsive disorder. A multicenter randomized controlled trial. JAMA 1998; 280:1752-1756.

219. Milberger S, Biederman J, Faraone SV, Jones J. Further evidence of an association between maternal smoking during pregnancy and attention deficit hyperactivity disorder: Findings from a high-risk sample of siblings. J Clin Child Psychol 1998; 27:352-358.

220. Faraone SV, Biederman J. Depression: a family affair. Lancet 1998; 351:158.

221. Coffey BJ, Miguel EC, Biederman J, Baer L, Rauch SL, O'Sullivan RL, et al. Tourette's disorder with and without

obsessive-compulsive disorder in adults: are they different? J Nerv Ment Dis 1998;186:201-6.

222. Wilens T, Biederman J, Spencer T. Pharmacotherapy of attention deficit hyperactivity disorder in adults. CNS Drugs 1998; 9:347-356.

223. Wilens TE, Biederman J, Mick E. Does ADHD impact the course of substance abuse? Findings from a sample of adults

with and without ADHD. Am J Addict 1998; 7:156-163.

224. Biederman J, Mick E, Faraone S. Biased maternal reporting of child psychopathology? Journal of the American Academy of Child & Adolescent Psychiatry 1998, 37:10-2.

225. Faraone S, Biederman J, Weber W, Russell R. Psychiatric, neuropsychological, and psychosocial features of DSM-

IVsubtypes of attention-deficit/hyperactivity disorder: results from a clinically referred sample. Journal of the American Academy of Child and Adolescent Psychiatry 1998: 185-193.

226. Samuel V, George P, Thornell A, Curtis S, Taylor A, Brome D, et al. A pilot controlled family study of DSM-III-R and

DSM-IV ADHD in african-american children. J Am Acad Child Adolesc Psychiatry 1999; 38:34-39.

227. Wozniak J, Crawford M, Biederman J, Faraone S, Spencer T, Taylor A, et al. Antecedents and complications of trauma in boys with ADHD: Findings from a longitudinal study. J Am Acad Child Adolesc Psychiatry 1999; 38:48-55.

228. Cohen LG, Biederman J, Wilens TE, Spencer TJ, Mick E, Faraone SV, et al. Desipramine clearance in children and

adolescents: absence of effect of development and gender. J Am Acad Child Adolesc Psychiatry 1999; 38:79-85.

24

Page 25: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

229. Biederman J, Faraone SV, Chu MP, Wozniak J. Further evidence of a bidirectional overlap between juvenile mania and

conduct disorder in children. J Am Acad Child Adolesc Psychiatry 1999; 38:468-476.

230. Wilens T, Biederman J, Millstein R, Wozniak J, Hahsey A, Spencer T. Risk for substance use disorders in youths with child- and adolescent-onset bipolar disorder. J Am Acad Child Adolesc Psychiatry 1999; 36:680-685.

231. Wilens TE, Biederman J, March JS, Wolkow R, Fine CS, Millstein RB, et al. Absence of cardiovascular adverse effects

of sertraline in children and adolescents. J Am Acad Child Adolesc Psychiatry 1999; 38:573-7.

232. Ambrosini P, Dineen Wagner K, Biederman J, Glick I, Tan C, Elia J, et al. Multi-Center open label sertraline study in adolescent outpatient with major depression. J Am Acad Child and Adol Psychiatry 1999; 38:566-572.

233. Bush G, Frazier JA, Rauch SL, Seidman LJ, Whalen PJ, Jenike MA, et al. Anterior cingulate cortex dysfunction in

attention deficit/hyperactivity disorder revealed by fMRI and the counting stroop. Biol Psychiatry 1999; 45:1542-1552.

234. Cohen LG, Prince J, Biederman J, Wilens T, Faraone SV, Whitt S, et al. Absence of effect of stimulants on the phamacokinetics of desipramine in children. Pharmacotherapy 1999; 19:746-52.

235. Greene RW, Biederman J, Faraone SV, Wilens TE, Mick E, Blier HK. Further validation of social impairment as a

predictor of substance use disorders: findings from a sample of siblings of boys with and without ADHD. J Clin Child Psychol 1999; 28:349-54.

236. Biederman J, Faraone S, Mick E, Williamson S, Wilens T, Spencer T, et al. Clinical correlates of attention deficit

hyperactivity disorder in females: Findings from a large group of pediatrically and psychiatrically referred girls. J Am Acad Child Adolesc Psychiatry 1999; 38:966-975.

237. Wilens T, Spencer T, Biederman J. Pharmacotherapy of attention deficit hyperactivity disorder. Current Opinion in

CPNS Investigational Drugs 1999; 1:453-465.

238. Biederman J, Wilens T, Mick E, Spencer T, Faraone SV. Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics 1999; 104:-20.

239. Biederman J, Spencer T. Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol Psychiatry

1999; 46:1234-42.

240. Faraone SV, Biederman J, Weiffenbach B, Keith T, Chu MP, Weaver A, et al. Dopamine D4 gene 7-repeat allele and attention deficit hyperactivity disorder. Am J Psychiatry 1999; 156:768-70.

241. Wilens TE, Biederman J, Spencer TJ, Bostic J, Prince J, Monuteaux MC, et al. A pilot controlled clinical trial of ABT-

418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder. Am J Psychiatry 1999; 156:1931-7.

242. Wilens T, McDermott S, Biederman J, Abrantes A, Hahesy A, Spencer T. Cognitive therapy in the treatment of adults

With ADHD: a systematic chart review of 26 cases. J Cognitive Psychotherapy 1999;13:215-226.

243. Rohde LA, Biederman J, Busnello EA, Zimmermann H, Schmitz M, Martins S, et al. ADHD in a school sample of Brazilian adolescents: a study of prevalence, comorbid conditions, and impairments. J Am Acad Child Adolesc Psychiatry 1999; 38:716-22.

244. Frazier JA, Meyer MC, Biederman J, Wozniak J, Wilens TE, Spencer TJ, et al. Riseridone treatment for juvenile

bipolar disorder: a retrospective chart review. J Am Acad Child Adolesc Psychiatry 1999; 38:960-5.

25

Page 26: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

245. Spencer T, Biederman J, Coffey B, Geller D, Wilens T, Faraone S. The 4-year course of tic disorders in boys with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999; 56:842-847.

246. Biederman J, Spencer T. Depressive disorders in childhood and adolescence: a clinical perspective. J Am Acad Child

Adolesc Psychiatry 1999; 9:233-7.

247. Biederman J, Mick E, Prince J, Bostic JQ, Wilens TE, Spencer T, et al. Systematic chart review of the pharmacologic treatment of comorbid attention deficit hyperactivity disorder in youth with bipolar disorder. J Child Adolesc Psychopharmacol 1999;9:247-56.

248. Milberger S, Faraone SV, Biederman J, Chu MP, Feighner JA. Substance use disorders in high-risk adolescent

offspring. Am J Addict 1999; 8:211-9.

249. Spencer T, Biederman J, Wilens T, Attention-deficit/hyperactivity disorder and comorbidity. Pediatric Clinics of North America 1999, 5:915-27.

250. Wilens T, Biederma J, Spencer T, Bostic J, Prince J, Monuteaux M, Soriano J, Fine C, Abrams A, Rater M, Polisner D.

Controlled trial of high doses of pemoline for adults with attention-deficit/hyperactivity disorder. Journal of Clinical Psychopharmacology 1999, 19:257-64.

251. Bostic J, Wilens TE, Spencer T, Biederman J. Antidepressant treatment of juvenile depression. Int J Psychiatry in Clin

Practice 1999; 3: 171-179.

252. Mennin D, Biederman J, Mick E, Faraone SV. Towards defining a meaningful anxiety phenotpye for research in ADHD children. J Attent Disord 2000;3:192-199.

253. Faraone SV, Biederman J, Monuteaux MC. Toward guidelines for pedigree selection in genetic studies of attention

deficit hyperactivity disorder. Genet Epidemiol 2000; 18:1-16.

254. Faraone S, Biederman J, Friedman D. Validity of DSM-IV subtypes of attention-deficit/hyperactivity disorder: A family study perspective. J Am Acad Child Adolesc Psychiatry 2000; 39:300-307.

255. Mick E, Santangelo S, Wypij D, Biederman J. Impact of maternal depression on ratings of comorbid depression in

adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2000; 39:314-319.

256. Semrud-Clikeman M, Steingard RJ, Filipek P, Biederman J, Bekken K, Renshaw PF. Using MRI to examine brain-behavior relationships in males with attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry 2000; 39:477-84.

257. Lunetta KL, Faraone SV, Biederman J, Laird NM. Family-based tests of association and linkage that use unaffected

sibs, covariates, and interactions. Am J Hum Gen 2000; 66:605-14.

258. Biederman J, Mick E, Faraone SV. Age dependent decline of symptoms of attention deficit hyperactivity disorder:Impact of remission Definition and symptom type. Am J Psychiatry 2000; 157:816-818.

259. Coffey BJ, Biederman J, Geller DL, Orav J. Distinguishing illness severity from tic severity in referred children and

adolescents with Tourette’s Disorder. J Am Acad Child Adolesc Psychiatry 2000; 39:556-561.

260. Coffey BJ, Biederman J, Smoller JW, Geller DA, Sarin P, Schwartz S, Kim GS. Anxiety disorders and tic severity in juveniles with tourette’s disorder. J Am Acad Child Adolesc Psychiatry 2000; 39:562-568.

261. Seidman LJ, Biederman J, Monuteaux MC, Weber W, Faraone SV. Neuropsychological functioning in nonreferred

siblings of children with attention deficit/hyperactivity disorder. J Abnorm Psychol 2000;109:252-265.

26

Page 27: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

262. Doyle AE, Biederman J, Seidman LJ, Weber W, Faraone SV. Diagnostic efficiency of neuropsychological test scores for discriminating boys with and without attention deficit-hyperactivity disorder. J Consult Clin Psychol 2000;68:477-488.

263. Faraone SV, Biederman J, Mick E, Williamson S, Wilens TE, Spencer T, Weber W, Jetton J, Kraus I, Pert J, Zallen B.

Family study of girls with attention deficit hyperactivity disorder. Am J Psychiatry 2000; 157:1077-1083.

264. Faraone SV, Biederman J, Spencer T, Wilens TE, Seidman LJ, Mick E, Doyle A. Attention-deficit/hyperactivity disorder in adults: An overview. Biol Psychiatry 2000; 48:9-20.

265. Faraone SV, Biederman J, Monuteaux MC. Attention deficit disorder and conduct disorder in girls: Evidence for a

familial subtype. Biol Psychiatry 2000; 48:21-29.

266. Swanson J, Greenhill L, Pelham W, Wilens T, Wolraich M, Abikoff H, Atkins M, August G, Biederman J, Bukstein O, Conners CK, Efron L, Fiebelkorn K, Fried J, Hoffman M, Lambrecht L, Lerner M, Leventhal B, mcBurnett K, Morse E, Palumbo D, Pfiffner L, Stein M, Wigal S, Winans E. Initiating Concerta™ (OROS® methylphenidate HCl) qd in children with attention-deficit hyperactivity disorder. J Clin Res 2000;3:59-76.

267. Wilens TE, Biederman J, Hahesy A, Millstein R, Goldman S, Wozniak J, Spencer T. Is bipolar disorder a risk for

cigarette smoking in ADHD youth? Am J Addict 2000; 9:187-195.

268. Biederman J, Mick E, Faraone SV, Spencer T, Wilens TE, Wozniak J. Pediatric mania: A developmental subtype of bipolar disorder? Biol Psychiatry 2000; 48:458-466.

269. Biederman J, Spencer T. Genetics of childhood disorders: XIX. ADHD, Part 3: Is ADHD a noradrenergic disorder? J

Am Acad Child Adolesc Psychiatry 2000; 39:1330-1333.

270. Biederman J, Mick E, Spencer TJ, Wilens TE, Faraone SV. Therapeutic dilemmas in the pharmacotherapy of bipolar depression in the young. J Child Adolesc Psychopharmacol 2000;10:185-192.

271. Prince JB, Wilens TE, Biederman J, Spencer TJ, Millstein R, Polisner DA, Bostic JQ. A controlled study of

nortriptyline in children and adolescents with attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 2000;10:193-204.

272. Bostic JQ, Biederman J, Spencer TJ, Wilens TE, Prince JB, Monuteaux MC, Sienna M, Polisner DA, Hatch M.

Pemoline treatment of adolescents with attention deficit hyperactivity disorder: A short-term controlled trial. J Child Adolesc Psychopharmacol 2000;10:205-216.

273. Wilens TE, Biederman J, Wong J, Spencer TJ, Prince JB. Adjunctive donepezil in attention deficit hyperactivity

disorder youth: Case series. J Child Adolesc Psychopharmacol 2000;10:217-222.

274. Mick E, Biederman J, Jetton J, Faraone SV. Sleep disturbances associated with attention deficit hyperactivity disorder: The impact of psychiatric comorbidity and pharmacotherapy. J Child Adolesc Psychopharmacol 2000;10:223-231.

275. Biederman J, Faraone SV, Monuteaux M, Feighner J. Patterns of alcohol and drug use in adolescents can be predicted

by parental substance use disorders. Pediatrics 2000; 106:792-797.

276. Coffey, BJ, Biederman J, Geller DA, Spencer T, Park KS, Shapiro SJ, Garfield SB. The course of tourette’s disorder: A literature review. Harv Rev Psychiatry 2000; 8:192-198.

277. Sprich S, Biederman J, Crawford MH, Mundy E, Faraone SV. Adoptive and biological families of children and

adolescents with ADHD. J Am Acad Child Adolesc Psychiatry 2000; 39:1432-1437.

27

Page 28: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

278. Biederman J, Faraone SV, Wozniak J, Monuteaux MC. Parsing the association between bipolar, conduct disorder and substance use disorders: A familial risk analysis. Biol Psychiatry 2000; 48:1037-1044.

279. Faraone SV, Biederman J, Spencer T, Wilens TE. The drug-placebo response curve: A new method for assessing drug

effects in clinical trials. J Clin Psychopharmacol 2000;20:673-679.

280. Rosenbaum JF, Biederman J, Hirshfeld-Becker DR, Kagan J, Snidman N, Friedman D, Nineberg A, Gallery D, Faraone SV. A controlled study of behavioral inhibition in children of parents with panic disorder and depression. Am J Psychiatry 2000; 157:2002-2010.

281. Faraone SV, Biederman J. Nature, nurture, and attention deficit hyperactivity disorder. Dev Rev 2000; 20:568-581.

282. Biederman J, Spencer T. Non-stimulant treatments for ADHD. Eur Child Adolesc Psychiatry 2000; 9(suppl 1) 51-59.

283. Geller D, Biederman J, Faraone SV, Frazier J, Coffey BJ, Kim G, Bellorde CA. Clinical correlates of obsessive

compulsive disorder in children and adolescents referred to specialized and non-specialized clinical settings. Depress Anxiety 2000; 11:163-168.

284. Coffey B, Biederman J, Spencer T, Geller D, Faraone S, Bellordre C. Informativeness of structured diagnostic

interviews in the identification of Tourette’s disorder in referred youth. Journal of Nervous & Mental Disease. 2000; 9: 583-8.

285. Rohde L, Biederman J, Zimmermann H, Schmitz M, Martins S, Tramontina S. Exploring ADHD age-of-onset criterion

in Brazilian adolescents. European Child and Adolescent Psychiatry. 2000, 9 3 212-8.

286. Spencer T, Biederman J, Wilens T. Pharmacotherapy of attention deficit hyperactivity disorder. Child and Adolescent Psychiatric Clinics of North America. 2000, 1 77-97.

287. Faraone SV, Biederman J, Feighner JA, Monuteaux MC. Assessing symptoms of attention deficit hyperactivity disorder

in children and adults: Which is more valid? J Consult Clin Psychol. 2000; 68: 834-842

288. Biederman J, Faraone SV, Hirshfeld-Becker D, Friedman D, Robin JA, Rosenbaum JF. Patterns of psychopathology and dysfunction in a large controlled study of high risk children of parents with panic disorder and major depression. Am J Psychiatry 2001; 158:49-57.

289. Wilens T, Spencer TJ, Biederman J, Girard K, Doyle R, Prince J, Polisner D, Solhkhah R, Comeau S, Monteaux MC,

Parekh A. A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. Am J Psychiatry 2001; 158:282-288.

290. Biederman J, Mick E, Faraone SV, Burback M. Patterns of remission and symptom decline in conduct disorder: A 4

year prospective study of an ADHD sample. J Am Acad Child Adolesc Psychiatry 2001; 40:290-298.

291. Spencer T, Biederman J, Faraone SV, Mick E, Coffey B, Geller D, Kagan J, Bearman S, Wilens T. Impact of tic disorders on ADHD outcome across the life cycle: findings from a large group of adults with and without ADHD. Am J Psychiatry 2001: 158: 611-617.

292. Smoller JW, Rosenbaum JF, Biederman J, Susswein LS, Kennedy J, Kagan J, Snidman NC, Laird N, Tsuang MT,

Faraone SV, Schwarz A, Slaugenhaupt SA. Genetic association analysis of behavioral inhibition using candidate loci from mouse models. Am J Med Genet 2001,105:226-35.

293. Greene RW, Biederman J, Faraone SV, Monuteaux MC, Mick E, Dupre EP, Fine CS and Goring JC: Social impairment

in girls with ADHD: patterns, gender comparisons and correlates. Journal of the American Academy of Child and Adolescent Psychiatry 2001, 40:704-10.

28

Page 29: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

294. Wozniak J, Biederman J, Faraone SV, Blier H, Monuteaux MC. Heterogeneity of conduct disorder: Further evidence of a subtype of conduct disorder linked to bipolar disorder. J Affect Disorders 2001, 64: 121-131.

295. Seidman L, Biederman J, Monuteaux MC, Doyle A, Faraone SV Learning Disabilities and Executive Dysfunction in

Boys with Attention Deficit Hyperactivity Disorder Neuropsychology 2001; 15: 544-556.

296. Faraone SV, Biederman J, Monuteaux MC. Attention deficit hyperactivity disorder with bipolar disorder in girls: Further evidence for a familial subtype? J Affect Disord 2001, 64: 19-26.

297. Wozniak J, Biederman J, Richards JA. Diagnostic and therapeutic dilemmas in the management of pediatric-onset

bipolar disorder. J Clin Psychiatry. 2001, 62 Suppl 14:10-5.

298. Biederman J, Rohde L, Knijnik M, Ketzer C, Chachamovich E, Vieira GM, Pinzon V. Exploring different information sources for DSM-IV ADHD diagnoses in Brazilian adolescents. J Attent Disord (In press).

299. Spencer T, Biederman J, Wilens TE, Faraon SV, Prince J, Gerard K, Parekh A, Doyle R, Kagan J, Bearman SK.

Efficacy of a mixed amphetamine salts compound in adults with attention deficit hyperactivity disorder. Arch Gen Psychiatry 2001, 58: 775-82.

300. Smoller JW, Acierno JS, Rosenbaum JF, Biederman J, Pollack MH, Meminger S, Pava J, Helbling L, White C,

Bulzacchelli M, Slaugenhaupt SA. Targeted genome screen of panic disorder and anxiety disorder proneness using homology to murine QTL regions. Am J Med Genet (Neuropsychiatric Genetics) 2001, 105: 195-206.

301. Faraone SV, Pliszka SR, Olvera RL, Skolnik R, Biederman J. Efficacy of adderall and methylphenidate in attention-

deficit/hyperactivity disorder: A drug-placebo response curve analysis. J Child Adolesc Psychopharmacol 2001, 11: 171-80.

302. Faraone SV, Biederman J, Mick E, Doyle AE, Wilens T, Spencer T, Frazier E, Mullen K: A Family study of psychiatric

comorbidity in girls and boys with attention deficit hyperactivity disorder. Biological Psychiatry 2001, 50: 586-92.

303. Biederman J, Hirshfeld-Becker DR, Rosenbaum JF, Perenick S, Wood J, Faraone SV: Lack of Association Between Parental Alcohol or Drug Addiction and Behavioral Inhibition in Children. American Journal of Psychiatry 2001, 158: 173-3.

304. Spencer T, Biederman J, Heiligenstein J, Wilens T, Faries D, Prince J, Faraone SV, Rea J, Witcher J, Zervas S. An

open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol. 2001 Fall;11 3:251-65.

305. Frazier JA, Biederman J, Tohen M, Feldman PD, Jacobs TG, Toma V, Rater MA,Tarazi RA, Kim GS, Garfield SB,

Sohma M, Gonzalez-Heydrich J, Risser RC, Nowlin ZM. A prospective open-label treatment trial of olanzapine monotherapy in childrenand adolescents with bipolar disorder. J Child Adolesc Psychopharmacol. 2001 11 3:239-50.

306. Spencer T, Biederman J, Coffey B, Geller D, Faraone S, Wilens T. Tourette disorder and ADHD. Adv Neurol. 2001;

85:57-77.

307. Faraone SV, Biederman J. ADHD: disorder or discipline problem? Science. 2001; 291 5508:1488-9.

308. Geller DA, Biederman J, Faraone SV, Bellordre CA, Kim GS, Hagermoser L, Cradock K, Frazier J, Coffey BJ. Disentangling chronological age from age of onset in children and adolescents with obsessive compulsive disorder. Int J Neuropsychopharmacol. 2001, 2:169-78

309. Spencer TJ, Biederman J, Wozniak J, Faraone SV, Wilens TE, Mick E. Parsing pediatric bipolar disorder from its

associated comorbidity with the disruptive behavior disorders. Biol Psychiatry. 2001; 49 12:1062-70.

29

Page 30: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

310. Geller DA, Biederman J, Faraone S, Agranat A, Cradock K, Hagermoser L, Kim G, Frazier J, Coffey BJ. Developmental aspects of obsessive compulsive disorder: findings in children,adolescents, and adults. J Nerv Ment Dis. 2001; 189 7:471-7

311. Faraone SV, Doyle AE, Mick E, Biederman J. Meta-analysis of the association between the 7-repeat allele of the

dopamine D(4) receptor gene and attention deficit hyperactivity disorder. Am J Psychiatry. 2001 158 7:1052-7.

312. Cook EH, Wagner KD, March JS, Biederman J, Landau P, Wolkow R, Messig M. Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 2001 Oct;40 10:1175-81

313. Biederman J, Hirshfeld-Becker DR, Rosenbaum JF, Herot C, Friedman D, Snidman N, Kagan J, Faraone SV. Further

evidence of association between behavioral inhibition and social anxiety in children. Am J Psychiatry. 2001 Oct;158 10:1673-9.

314. Braaten E, Biederman J, DiMauro A, Mick E, Monuteaux M, Muehl K, Faraone S. Methodological complexities in the

diagnosis of major depression in youth: an analysis of mother and youth self-reports. Journal of Child and Adolescent Psychopharmacology 2001 Oct 11: 395-407.

315. Cohen LG, Biederman J. Treatment of risperidone-induced hyperprolactinemia with a dopamine agonist in children.

Journal of Child Adolescent Psychopharmacology 2001 Winter; 114:435-40.

316. Tramontina S. Martins S, Michalowski MB, Ketzer CR, Eizirik M, Biederman J, Rohde LA. School dropout and conduct disorder in Brazilian elementary school students. Canada Journal of Psychiatry. 2001 Dec; 46 10: 941-7.

317. Biederman J, Monuteaux MC, Greene RW, Braaten E, Doyle AE, Faraone SV. Long-term stability of the Child

Behavior Checklist in a clinical sample of youth with attention deficit hyperactivity disorder. Journal Clinical Child Psychology. 2001

318. Doyle AE, Faraone SV, DuPre EP, Biederman J. Separating attention deficit hyperactivity disorder and learning

disabilities in girls: a familial risk analysis. Am J Psychiatry. 2001 Oct;158 10:1666-72.

319. Mick E, Biederman J, Prince J, Fishcer MJ, Faraone SV. Impact of low birth weight on attention-deficit hyperactivity disorder. Journal of Development Behavior Pediatrics 2002 Feb 1: 16-22.

320. Wilens TE, Biederman J, Brown S, Monuteaux M, Prince J, Spencer TJ. Patterns of psychopathology and dysfunction

in clinically referred preschoolers. Journal of Development Behavior Pediatrics 2002 Feb; 23 (1 Suppl): S31-36

321. Mick E, Biederman J, Faraone S, Sayer J, Kleinman S. Case control study of Attention-Deficit/Hyperactivity Disorder and maternal smoking, alcohol use, and drug use during pregnancy. Journal of the American Academy of Child and Adolescent Psychiatry 2002 41 4 378-385.

322. Hahesy A, Wilens T, Biederman J, Van Patten S, Spencer T. Temporal association between childhood

psychopathology and substance use disorders: Findings from a sample of adults with opiod or alcohol dependency. Psychiatric Research 2002 109 3 245-253.

323. Hirshfeld-Becker D, Biederman J, Faraone S, Violette H, Wrightsman J, Rosenbaum J. Temperamental correlates of

disruptive behavior disorders in young children: Prelimnary findings. Biological Psychiatry 2002 51(7) 563-574

324. Hirshfeld-Becker D, Biederman J. Rationale and principles for early intervention with young children at risk for anxiety disorders. Clinical & Family Psychology Review 2002 5 3 161-72.

30

Page 31: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

325. Kratochvil CJ, Heiligenstein J, Dittmann R, Spencer T, Biederman J, Newcorn J, Casat C, Milton D and Michelson D. Atomoxetine and Methylphenidate Treatment in Children with ADHD: A prospective randomized, open-label trial. Journal of the American Academy of Child and Adolescent Psychiatry 2002 41 7 776-784.

326. Faraone SV, Short EJ, Biederman J, Findling RL, Roe C, Manos MJ. Efficacy of Adderall and Methylphenidate in

attention deficit hyperactivity disorder: a drug-placebo and drug-drug response curve analysis of a naturalistic study. International Journal of Neuropsychopharmaoclogy 2002 5 2 121-129.

327. Biederman J, Faraone SV, Monuteaux MC. Impact of exposure to parental attention-deficit hyperactivity disorder on

clinical features and dysfunction in the offspring. Psychological Medicine 2002 32 5:817-27.

328. Biederman J, Lopez F, Boellner S, Chandler M. A randomized, double blind, placebo-controlled , parallel group study of SL1381 (Adderall XR) in children with attention-deficit hyperactiviy disorder. Pediatrics 2002 110(2 Pt 1):258-66.

329. Busch B, Biederman J, Cohen L, Sayer J, Monuteaux M, Mick E, Zallen B, Faraone S. Correlates of ADHD among

children in pediatric and psychiatric clinics. Psychatric Services 2002 53 9: 1103-11.

330. Faraone S.V, Biederman J. Efficacy of Adderall for Attention-Deficit/Hyperactivity Disorder: A meta analysis. Journal of Attention Disorders. 2002 6 2: 69-75.

331. Costello E, Pine D, Hammen C, March J, Plotsky P, Weissman M, Biederman J, Goldsmith H, Kaufman J, Lewinsohn

P, Hellander M, Hoagwood K, Koretz D, Nelson C, Leckman J. Links development and natural history of mood disorders. Biological Psychiatry 2002 52 6: 529-542.

332. Wagner KD, Weller EB, Carlson GA, Sachs G, Biederman J, Frazier J, Wozniak P, Tracy K, Weller R, Bowdern C.

An Open-Label Trial off Divalproex in Children and Adolescents with Bipolar Disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2002 41: 1224-30.

333. Wilens T, Cohen L, Biederman J, Abrams A, Neft D, Faird N, Sinha V. Fluoxetine pharmacokinetics in pediatric

patients. Journal of Clinical Psychopharmacology. 2002 6: 568-75.

334. Biederman, J., Mick, E., Faraone, S. V., Braaten, E., Doyle, A., Spencer, T., Wilens, T. E., Frazier, E. and Johnson, M. A. Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiatry. 2002 159: 36-42.

335. Wilens, T. E., Biederman, J. and Spencer, T. J. Attention Deficit/Hyperactivity Disorder across the Lifespan. Annu Rev

Med. 2002; 53: 113-131.

336. Wilens, T., Spencer, T. and Biederman, J. A review of the pharmacotherapy of adults with attention-deficit/hyperactivity disorder. J Attent Disord. 2002 5: 189-202.

337. Wilens T, Biederman J, Brown S, Tanguay S, Monuteaux M, Blake C, Spencer T. Psychiatric comorbidity and

functioning in clinically referred preschool children and school-age youths with ADHD. Journal of the American Academy of Child & Adolescent Psychiatry 2002 42 2 127-8.

338. Wilens T, Biederman J, Bredin E, Hahesy A, Abrantes A, Neft D, Millstein R, Spencer T. A family study of the high

risk children of opiod-and alcohol-dependent parents. American Journal on Addictions. 2002 11 1 41-51.

339. Spencer, T., Biederman, J., Coffey, B., Geller, D., Crawford, M., Bearman, S. K., Tarazi, R. and Faraone, S. V. A Double-blind Comparison of Desipramine and Placebo in Children and Adolescents With Chronic Tic Disorder and Comorbid Attention- Deficit/Hyperactivity Disorder. Arch Gen Psychiatry. 2002 59: 649-56.

31

Page 32: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

340. Greene, R. W., Biederman, J., Zerwas, S., Monuteaux, M. C., Goring, J. C. and Faraone, S. V. Psychiatric comorbidity, family dysfunction, and social impairment in referred youth with oppositional defiant disorder. Am J Psychiatry. 2002; 159: 1214-24.

341. Wilens, T., Biederman, J. and Spencer, T. Tips to Individualize drug therapy. Current Psychiatry. 2002; 1: 33-41.

342. Geller D, Faraone S, Cradock K, Hagermoser L, Zaman N, Frazier J, Coffey B, Spencer T. Attention-deficit

hyerpactiviy disorder in children and adolescents with obsessive-compulsive disorder: fact or articact? Journal of the American Academy of Child and Adolescent Psychiatry. 2002; 41: 52-8.

343. Faraone, S., Biederman, J. and Monuteaux, M. Further evidence for the diagnostic continuity between child and

adolescent ADHD. Journal of the Attention Disorders. 2002; 6: 5-13.

344. Wozniak, J., Biederman, J., Monuteaux, M. C., Richards, J. and Faraone, S. V. Parsing the comorbidity between bipolar disorder and anxiety disorders: A familial risk analysis. J Child Adolesc Psyhopharmacol. 2002; 12: 101-111.

345. Roman, T., Szobot, C., Martins, S., Biederman, J., Rohde, L. A. and Hutz, M. H. Dopamine transporter gene and

response to methylphenidate in attention- deficit/hyperactivity disorder. Pharmacogenetics. 2002; 12: 497-499.

346. Biederman, J., Faraone, S. V. and Monuteaux, M. C. Differential effect of environmental adversity by gender: Rutter's index of adversity in a sample of boys and girls with and without ADHD. Am J Psychiatry. 2002; 159: 1556-1562.

347. Costello, E. J., Pine, D., March, J., Plotsky, P., Hammen, P., Weissman, M., Biederman, J., Kaufman, J., Lewinsohn, P.,

Hellander, M., Goldsmith, H., Earls, F., Hoagwood, K., Koretz, D., Nelson, C. and Leckman, J. Development and Natural History of Mood Disorders. Biol Psychiatry. 2002; 52: 529-542.

348. Faraone, S. V., Biederman, J. and Roe, C. M. Comparative efficacy of adderall and methylphenidate in attention-

deficit/hyperactivity disorder: a meta-analysis. J Clin Psychopharmacol. 2002; 22: 468-73.

349. Biederman, J., Heiligenstein, J., Faries, D., Galil, N., Dittmann, R., Emslie, G. J., Kratochvil, C., Laws, H., Schuh, K. J. and group, A. A. s. Efficacy of Atomoxetine versus Placebo in School-Age Girls with Attention-Defict/Hyperactivity Disorder. Pediatrics. 2002; 110: E75.

350. Greenhill, L., Beyer, D. H., Finkleson, J., Shaffer, D., Biederman, J., Connors, C. K., Gillberg, C., Huss, M., Jensen, P.,

Kennedy, J. L., Klein, R., Rapoport, J. L., Sagvolden, T., Spencer, T., Swanson, J. M. and Volkow, N. Guidelines and algorithms for the use of methylphenidate in children with attention-defict/ hyperactivity disorder. J Attent Disord. 2002; 6: 89-100.

351. Biederman, J. and Faraone, S. Current concepts on the neurobiology of attention deficit hyperactivity disorder. J Attent

Disord. 2002; 6: 7-16.

352. Biederman, J. and Spencer, T. Methylphenidate in treatment of adults with attention deficit hyperactivity disorder (ADHD). J Attent Disord. 2002; 6: 101-108.

353. Geller, D. A., Biederman, J., Faraone, S. V., Cradock, K., Hagermoser, L., Zaman, N., Frazier, J. A., Coffey, B. J. and

Spencer, T. J. Attention-deficit/hyperactivity disorder in children and adolescents with obsessive-compulsive disorder: fact or artifact? Journal of the American Academy of Child & Adolescent Psychiatry. 2002; 41: 52-58.

354. Spencer, T. and Biederman, J. Non-stimulant treatment for attention-deficit/hyperactivity disorder. J Attent Disord.

2002; 6: 109-119.

355. Spencer, T., Biederman, J., Wilens, T. and Faraone, S. V. Novel treatments for attention-deficit/hyperactivity disorder in children. J Clin Psychiatry. 2002; 63: 16-22.

32

Page 33: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

356. Spencer, T., Heiligenstein, J., Biederman, J., Faries, D., Kratochvil, C., Conners, C. K. and Potter, W. Z. Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2002; 63: 1140-1147.

357. Roman, Tatiana a. Szobot, Claudia b. Martins, Silvia b. Biederman, Joseph c. Rohde, Luis A. b. Hutz, Mara H. a.

Dopamine transporter gene and response to methylphenidate in attention-deficit/hyperactivity disorder. Pharmacogenetics. 12 6:497-499, 2002.

358. Biederman, Joseph M.D.. Faraone, Stephen V. Ph.D.. Monuteaux, Michael C. B.A.. Differential Effect of

Environmental Adversity by Gender: Rutter's Index of Adversity in a Group of Boys and Girls With and Without ADHD. American Journal of Psychiatry. 159 9:1556-1562, 2002.

359. Faraone, Stephen V. PhD Biederman, Joseph MD . Roe, Christine RNCS, MS, FPNP . Comparative Efficacy of

Adderall and Methylphenidate in Attention-deficit/Hyperactivity Disorder: A Meta-Analysis. Journal of Clinical Psychopharmacology. 22 5:468-473, 2002.

360. Biederman J. Treatment of ADHD. Seishin Shinkeigaku Zasshi-Psychiatria et Neurologia Japonica. 104 12 1147-59,

2002

361. Faraone S, Short E, Biederman J, Findling RL, Roe CM, Manos M: Efficacy of Adderall and Methylphenidate in attention deficit hyperactivity disorder: a drug-placebo and drug-drug response curve analysis of a naturalistic study. International Journal of Neuropsychopharmacology; 5:121-129 2002

362. Wilens T., Faraone S, Biederman J, and Gunawardene S. Does Stimulant Therapy of Attention Deficit Hyperactivity

Disorder Beget Later Substance Abuse? A Meta-Analytic Review of the Literature. Pediatrics, 111 1, 179-185. 2002

363. Biederman J. Pharmacotherapy for attention deficit hyperactivity disorder decreases the risk for substance abuse: findings from a longitudinal follow up of youths with and without ADHD. Journal of Clinical Psychiatry. 64(Suppl) 11:3-8, 2003

364. Doyle A, Biederman J, Monuteaux M, Cohan S, Schofield H, Faraone S. Diagnostic Threshold for conduct disorders in

girls and boys. Journal of Nervous & Mental Disease. 191 6: 379-86, 2003

365. Biederman, J., Faraone, S. V., Monuteaux, M., Plunkett, E., Gifford, J., & Spencer, T. Growth deficits and ADHD revisited: Impact of gender, development and treatment. Pediatrics, 111 5, 1010-1016. 2003

366. Geller D, Biederman J, Stewart S, Mullin B, Farrell C, Wagner K, Emslie G, Carpenter D. Impact of comorbidity on

treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials? Journal of Child & Adolescent Psychopharmacology, Supplement 1:S19-29. 2003

367. Braaten, E., Biederman, J., Monuteaux, M., Mick, E., Calhoun, E., Cattan, G., & Faraone, S. Revisiting The

Association Between Attention Deficit Hyperactivity Disorder And Anxiety Disorders: A Familial Risk Analysis. Biological Psychiatry, 53, 93-99. 2003

368. Faraone, S. V., Monuteaux, M. C., Biederman, J., Cohan, S. L., & Mick, E. Does parental ADHD bias maternal reports

of ADHD symptoms in children? Journal of Consulting and Clinical Psychology, 71 1, 168-175. 2003.

369. Geller DA, Coffey B, Faraone S, Hagermoser L, Zaman NK, Farrell CL, Mullin B, Biederman J. Does comorbid attention-deficit/hyperactivity disorder impact the clinical expression of pediatric obsessive-compulsive disorder? CNS Spectrum, 8 4, 259-64. 2003.

33

Page 34: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

370. Rohde, L. A., Roman, T., Szobot, C., Cunha, R. D., & Biederman, J. Dopamine Transporter Gene, Response to methylphenidate and cerebral blood flow in Attention-Deficit/Hyperactivtiy Disorder: A pilot study. Synapse, 48 2, 87-89 2003.

371. Wilens, T., Biederman, J., Spencer, T., & Monuteaux, M. Psychiatric diagnosis in preschool children. Journal of the

American Academy of Child and Adolescent Psychiatry, 42 2, 128-129. 2003.

372. McCracken JT, Biederman J, Greenhill L, Swanson J, McGough J, Spencer T, et al. Analog Classroom Assessment of a Once-Daily Mixed Amphetamine Formulation, Sli381 (Adderall XR), in Children with ADHD. J Am Acad Child Adolesc Psychiatry, 42 6: 673-683 2003.

373. McGough J, Biederman J, Greenhill L, McCracken J, Spencer T, Posner K, Wigal S, Gornbein J, Tulloch S, Swanson J.

Pharmacokinetics of SL1381 (Adderall XR) an extended release formulation of Adderall. Journal of the American Child & Adolescent Psychiatry, 42 6 684-91 2003.

374. Biederman J. Pediatric Bipolar Disorder Coming of Age. Biological Psychiatry 53 11: 931-934. 2003.

375. Biederman J, Mick E, Wozniak J, Monuteaux M, Galdo M and Faraone S. Can a Subtype of Conduct Disorder Linked

to Bipolar Disorder Be Identified? Integration of Findings from the Massachusetts General Hospital Pediatric Psychopharmacology Research Program. Biological Psychiatry 53 11: 952-960 2003.

376. Hirshfeld-Becker DR, Biederman J, Calltharp S, Rosenbaum ED, Faraone SV and Rosenbaum JF. Behavioral

Inhibition and Disinhibition as Hypothesized Precursors to Psychopathology: Implications for Pediatric Bipolar Disorder. Biological Psychiatry 53 11: 985-999 2003.

377. Mick E, Biederman J, Pandina G and Faraone SV. A Preliminary Meta-Analysis of the Child Behavior Checklist in

Pediatric Bipolar Disorder. Biological Psychiatry 53 11: 1021-1027 2003.

378. Mick E, Biederman J, Santangelo S, Wypig D. The influence of gender in the familial association between ADHD and major depression. Journal of Nervous and Mental Disease. 191: 699-705 2003.

379. Wozniak J, Monuteaux M, Richards J, Lail K, Faraone SV and Biederman J. Convergence between Structured

Diagnostic Interviews and Clinical Assessment on the Diagnosis of Pediatric-Onset Bipolar Disorder. Biological Psychiatry 53 11: 938-944 2003.

380. Smoller J, Rosenbaum J, Biederman J, Kennedy J, Dai, D, Racette S, Laird N, Kagan J, Snidman, N, Hirshfeld-Becker

D, Tsuang M, Sklar P, Slaugenhaupt S. Corticotropin Releasing Hormone Locus with Behavioral Inhibition. Biological Psychiatry 2003; 12: 1376-81.

381. Geller, D., Biederman, J., Stewart, E., Mullin, B., Martin, A., Spencer, T., & Faraone, S. V. Which SRI? A meta-

analysis of pharmacotherapy trials in pediatric obsessive compulsive disorder. American Journal of Psychiatry 2003; 160:1919-1928.

382. Wilens T, Biederman J, Kwon A, Chase R, Greenberg L, Mick E, Spencer T. A systematic chart review of the nature of

psychiatric adverse events in children and adolescents treated with selective serotonin reuptake inhibitors. J Child Adolesc Psychopharmacol. 2003; 13 2:143-52.

383. Witcher J, Long A, Smith B, Sauer J, Heilgenstein J, Wilens T, Spencer T, Biederman J. Atomoxetine

pharmacokinetics in children and adolescents with attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol. 2003 Spring; 13 1:53-63.

384. Wilens, T, Prince, J, Spencer, T, et al. An Open Trial of Bupropion for the Treatment of Adults with Attention Deficit

Hyperactivity Disorder and Bipolar Disorder. Biol Psychiatry. 2003; 4: 9-16.

34

Page 35: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

385. Wilens, T, Biederman, J, Wozniak, J, et al. Can Adults with Attention-Deficit Hyperactivity Disorder Be Distinguished from Those with Comorbid Bipolar Disorder: Findings from a Sample of Clinically Referred Adults. Biol Psychiatry. 2003; 54: 1-8.

386. Wilens, T Does the medicating ADHD increase or decrease the risk for later substance abuse? Rev Bras Psiquiatr, 2003

25, 127-128.

387. Faraone SV, Sergeant J, Gillberg C and Biederman J. The Worldwide Prevalence of ADHD: Is it an American Condition? World Psychiatry 2003; 2 2: 104-113.

388. Biederman J, Mick E, Faraone S, et al. Current Concepts in the Validity, Diagnosis and Treatment of Pediatric Bipolar

Disorder. International Journal of Neuropsychopharmacology. 2003; 6 3 293-300.

389. Biederman J, Quinn D, Weiss M, et al. Efficacy and Safety of Ritalin LA, a New, Once-Daily, Extended-Release Dosage Form of Methylphenidate Hydrochloride, in Children with ADHD. Pediatric Drugs 2003 5 12: 833-841.

390. Wilens T, Biederman J, Forkner et al. Patterns of Comorbidity and Dysfunction in Clinically Referred Preschoolers

with Bipolar Disorder. J Child Adolescent Psychopharmacology 2003; 13 4: 495-505.

391. Mick E, Biederman J, Faraone S, Murray K and Wozniak J. Defining a Developmental Subtype of Bipolar Disorder in a Sample of Non-Referred Adults by Age-at Onset. J Child Adolesc Psychopharmacology 2003; 13 4: 453-462.

392. Biederman J, Kwon A, Wozniak J, Mick E, Markowitz S, Fazio V, Faraone SV. Absence of gender differences in

pediatric bipolar disorder: findings from a large sample of referred youth. Journal Affective Disoders 2004; 83: 207-14

393. Biederman J: Impact of comorbidity in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry 2004; 65 3-7.

394. Biederman J, Faraone SV: The Massachusetts General Hospital studies of gender influences on attention-

deficit/hyperactivity disorder in youth and relatives. Psychiatr Clin North Am 2004; 27 225-32.

395. Biederman J, Faraone SV, Monuteaux M, Spencer T, Wilens T, Bober M, Cadogan E: Gender effects of attention deficit hyperactivity disorder in adults, revisited. Biol Psychiatry 2004; 55 692-700.

396. Biederman J, Spencer T, Wilens T: Evidence based pharmacotherapy for attention deficit hyperactivity disorder.

International Journal of Neuropsychopharmacology 2004; 7 77-97.

397. Faraone SV, Spencer T, Aleardi M, Pagano C, Biederman J: Meta-analysis of the efficacy of methylphenidate for treating adult attention deficit hyperactivity disorder. J Clin Psychopharmacol 2004; 54 24-29.

398. Hirshfeld-Becker D, Biederman J, Rosenbaum J: Behavioral Inhibition, in Anxiety disorders in children and

adolescents. Edited by Morris TL, March J. New York, NY., The Guilford Press, 2004; 27-58.

399. Hirshfeld-Becker DR, Biederman J, Faraone SV, Segool N, Buchwald J, Rosenbaum JF: Lack of association between behavioral inhibition and psychosocial adversity factors in children at risk for anxiety disorders. Am J Psychiatry 2004; 161 547-555.

400. Lowe N, Kirley A, Hawi Z, Sham P, Wickham H, Kratochvil CJ, Smith SD, Lee SY, Levy F, Kent L, Middle F, Rohde

RA, Roman T, Tahir E, Yazgan Y, Asherson P, Mill J, Thapar A, Payton A, Todd RA, Stephens T, Ebstein RB, Manor I, Barr CL, Wigg KJ, Sinke RJ, Buitelaar JK, Smalley SL, Nelson SF, Biederman J, Faraone SV, Gill M: Joint Analysis Of DRD5 Marker Concludes Association with ADHD Confined to the Predominantly Inattentive and Combined Subtypes. Am J Hum Genet 2004; 74 348-356.

35

Page 36: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

401. Mick E, Faraone S, Biederman J: Age-dependent expression of attention-deficit/hyperactivity disorder symptoms. Psychiatry Clin North Am 2004; 27 215-24.

402. Prince J, Wilens T, Biederman J, Spencer T: Psychopharmacology for children and adolescents, in Massachusetts

General Hospital Handbook of General Hospital Psychiatry. Edited by Stern TA, Fricchione GL, Cassem NH, Jellinek M, Rosenbaum J. Boston, MA, Mosby, 2004; 411-445

403. Spencer T, Biederman J, Wilens T: Stimulant treatment of adult attention-deficit/hyperactivity disorder. Psychiatr Clin

North Am 2004; 27 361-372.

404. Spencer T, Biederman J, Wilens T: Nonstimulant treatment of adult attention-deficit/hyperactivity disorder. Psychiatr Clin North Am 2004; 27 373-83.

405. Swanson JM, Wigal S, Wigal T, Sonuga-Barke E, Greenhill L, Biederman J, Kollins S, Nguyen AS, DeCory HH,

Dirksen SJ, Hatch SJ: A Comparison of Once-Daily Extended-Release Methylphenidate Formulations in Children With Attention-Deficit/Hyperactivity Disorder in the Laboratory School (The Comacs Study). Pediatrics 2004; 113 E206-E216.

406. Wilens TE, Biederman J, Lerner M, The Concerta Study Group: Effects of once-daily osmotic-release methylphenidate

on blood pressure and heart rate in children with attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 2004; 24 36-41.

407. Hirshfeld-Becker DR, Biederman J, Faraone SV, Robin JA, Friedman D, Rosenthal J, Rosenbaum JF. Pregnancy

complications associated with childhood anxiety disorders. Depression and Anxiety 2004;19 :152-62.

408. Biederman J, Petty C, Faraone SV, et al. Moderating effects of major depression on patterns of comorbidity in referred adults with panic disorder: A controlled study. Psychiatry Research. 2004;126:143-149.

409. Biederman J, Faraone S, Monuteaux M, Grossbard J: How informative are parent reports of ADHD symptoms for

assessing outcome in clinical trials of long-acting treatments?? A pooled analysis of parents' and teachers' reports. Pediatrics 2004; 113:1667-1671

410. Geller D, Biederman J, Faraone S, et al. Re-Examining Comorbidity of Obsessive Compulsive and Attention-

Deficit/Hyperactivity Disorder Using an Empirically Derived Taxonomy. European Child & Adolescent Psychiatry. 2004; 13: 83-91

411. Yang L, Wang Y, Qian Q, Biederman J, Faraone SV. DSM-IV subtypes of ADHD in a Chinese outpatient sample.

Journal of the American Academy Child and Adolescent Psychiatry. 2004;43:248-250.

412. Szobot CM, Ketzer C, Parente MA, Biederman J, Rohde LA (2004), The acute effect of methylphenidate in brazilian male children and adolescents with ADHD: A randomized clinical trial. Journal of Attention Disorders 8: 37-43

413. Biederman J, Monuteaux M, Faraone SV, Hirshfeld-Becker D, Henin A, Gilbert J and Rosenbaum J: Does referral bias

impact findings in high-risk offspring for anxiety disorders? A controlled study of high risk children of non-referred parents with panic disorder/agoraphobia and major depression. Journal of Affective Disorders 2004; 82:209-216

414. Biederman J, Mick E, Faraone S, VanPatten S, Burback M, Wozniak J. A Prospective Follow Up Study of Pediatric

Bipolar Disorder in Boys with Attention-Deficit/Hyperactivity Disorder. Journal of Affective Disorders 2004; 82S; S17-S23.

415. Biederman J, Faraone S, Wozniak J, Mick E, Kwon A, Aleardi M: Further evidence of unique developmental

phenotypic correlates of pediatric bipolar disorder: Findings from a large sample of clinically referred preadolescent children assessed over the last 7 years. J Affect Disord 2004; 82: S45-S58.

36

Page 37: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

416. Biederman J, Mick E, Faraone S, Wozniak J: PEDIATRIC BIPOLAR DISORDER OR DISRUPTIVE BEHAVIOR DISORDER? Primary Psychiatry 2004; 11:36-41.

417. Biederman J, Monuteaux M, Seidman L, Doyle AE, Mick E, Wilens T, Ferrero F, Morgan C, Faraone SV: Impact of

Executive Function Deficits and ADHD on Academic Outcomes in Children. J Consult Clin Psychol 2004; 72: 757-766

418. Biederman J, Petty C, Faraone S, Seidman L: Phenomenology of childhood-onset psychosis: Findings from a large sample of psychiatrically referred youth. J Nerv Ment Dis 2004; 192:607-614

419. Faraone SV, Spencer T, Montano CB, Biederman J: Attention Deficit Hyperactivity Disorder in Adults: A Survey of

Current Practice in Psychiatry and Primary Care. Arch Intern Med 2004; 164:1221-1226

420. Gonzalez-Heydrich J, Pandina G, Fleisher CA, Hsin O, Raches D, Bourgeois BF, Biederman J: No sezure excerbation from risperidone in youth with comorbid epilepsy and psychiatric disorders: A case series. J Child Adolesc Psychopharmacol 2004; 14:295-310

421. Monuteaux M, Fitzmaurice G, Blacker D, Buka S, Biederman J: Specificity in the familial aggregation of overt and

covert conduct disorder symptoms in a referred ADHD sample. Psychol Med 2004; 34:1-15

422. Wozniak J, Spencer T, Biederman J, Kwon A, Monuteaux M, Rettew J, Lail K. The Clinical Characteristics of Unipolar versus Bipolar Major Depression in ADHD Youth. Journal of Affective Disorders 2004; 82:S59-S69

423. Biederman, J and Faraone, SV. Attention-Deficit/Hyperactivity Disorder: A Worldwide Concern. J Nerv Ment Dis.

2004; 192: 453-454

424. Biederman J, Spencer T, Wilens T. Evidence Based Pharmacotherapy for Attention Deficit Hyperactivity Disorder. Int J Neuropsychopharmacology. 2004; 7(1) 77-97

425. Biederman J, James RS: Furthering the scientific foundation of pediatric bipolar disorder. J Affect Disord 2004; 82

Suppl 1:S1-3

426. Wilens T, Biederman J, Kwon A, Ditterline J, Forkner P, Chase R, Moore H, Swezey A, Snyder L, Morris M, Henin A, Wozniak J, Faraone SV. Risk for substance use disorders in adolescents with bipolar disorder. Journal of American Academy Child and Adolescent Psychiatry. 2004; 43(11) 1380-1386

427. Wilens T, Faraone SV, Biederman J. Attention-Deficit/Hyperactivity Disorder in Adults. JAMA. 2004; 292(5) 619-23

428. Biederman J, Spencer T: Psychopharmacology of adults with Attention-deficit/hyperactivity disorder. Primary

Psychiatry 2004; 11:57-62

429. Faraone S, Biederman J: Guest editors' note. Primary Psychiatry 2004; 11:26-27

430. Mick E, Faraone SV, Biederman J, Spencer T: The course and outcome of ADHD. Primary Psychiatry 2004; 11:42-48

431. Wilens T, Biederman J, Kwon A, Ditterline J, Forkner P, Chase R, Moore H, Swezey A, Snyder L, Morris M, Henin A, Wozniak J, Faraone SV: Risk for substance use disorders in adolescents with bipolar disorder. Journal of American Academy Child and Adolescent Psychiatry 2004; 43:1380-1386

432. Wilens T, Faraone SV, Biederman J: Attention-Deficit/ Hyperactivity Disorder in Adults. JAMA 2004; 292:619-23

433. Labellarte M, Biederman J, Emslie G, Ferguson J, Khan A, Ruckle J, Sallee R, Riddle M: Multiple-Dose

Pharmacokinetics of Fluvoxamine in Children and Adolescents. J Am Acad Child Adolesc Psychiatry 2004; 43:1497-1505

37

Page 38: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

434. Michelson D, Buitelaar JK, Danckaerts M, Gillberg C, Spencer TJ, Zuddas A, Faries DE, Zhang S, Biederman J: Relapse Prevention in Pediatric Patients with ADHD Treated with Atomoxetine: A Randomized, Double-Blind, Placebo-Controlled Study. J Am Acad Child and Adolesc Psychiatry 2004; 43:896-904

435. Coffey BJ, Biederman J, Geller D, Frazier J, Spencer T, Doyle R, Gianini L, Small A, Frisone DF, Magovcevic M,

Stein N, Faraone SV: Reexamining Tic Persistence and Tic-Associated Impairment in Tourette's Disorder: Findings From a Naturalistic Follow-Up Study. J Nerv Ment Dis 2004; 192:776-780

436. Faraone S, Biederman J: Guest editors' note. Primary Psychiatry 2004; 11:26-27

437. Spencer T, Newcorn J, Kratochvil C, Ruff D, Michelson D, Biederman J: Effects of atomoxetine on growth after 2-year

treatment in pediatric patients with ADHD. Pediatrics 2005; 116(1) 74-80

438. Smoller JW, Yamaki L, Fagerness JA et al. The Corticotropin Releasing Hormone Gene and Behavioral Inhibition in Children at Risk for Panic Disorder. Biological Psychiatry. 2005; 57(12) 1485-92

439. Safren SA, Otto M, Sprich S, et al. Cognitive-Behavioral Therapy for ADHD in Medication-Treated Adults with

Continued Symptoms. American Journal Psychiatry. 2005; 43(7) 831-42

440. Newcorn JH, Spencer T, Biederman J, Milton D and Michelson D. Atomoxetine Treatment in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder. Journal American Academy Child Adolescent Psychiatry. 2005; 44(3) 240-8

441. Hammerness P, Monuteaux M, Faraone SV, Biederman J. Re-Examining the Association between Childhood Asthma

and Attention Deficit Hyperactivity Disorder. Journal Attention Disorders. 2005; 8(3) 136-143.

442. Frazier J, Chiu S, Breeze J, et al. Structural Brain Magnetic Resonance Imaging of Limbic and Thalamic Volumes in Pediatric Bipolar Disorder. American Journal Psychiatry. 2005; 162(7) 1256-65.

443. Biederman J, Kwon A, Aleardi M, et al. Absence of Gender Effects on Attention-Deficit/Hyperactivity Disorder.

Findings in a Non-Referred Sample. American Journal Psychiatry. 2005; 162(6) 1083-9

444. Monuteaux M, Faraone SV, Herzig K, Navsaria N, Biederman J: Attention-deficit/hyperactivity disorder and dyscalculia evidence for independent familial transmission. J Learn Disabil 2005; 38: 86-93

445. Seidman L, Biederman J, Valera E, Monuteaux M, Doyle AE, Faraone S: Impact of Gender and age on Executive

Functioning: Do Girls and Boys with and without attention deficit hyperactivity disorder differ neuropsychologically in pre-teen and teenage years? Developmental Neuropsychology 2005; 27: 79-105

446. Biederman J, McDonnell MA, Wozniak J, Spencer T, Aleardi M, Falzone R, Mick E: Aripiprazole in the treatment of

pediatric bipolar disorder: A systematic chart review. CNS Spectrums 2005; 10:141-8

447. Spencer T, Biederman J, Wilens T, Faraone SV, Doyle RD, Surman C, Prince J, Mick E, Aleardi M, Herzig K: A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 2005; 57:456-63

448. Valera EM, Faraone SV, Biederman J, Poldrack RA, Seidman LJ: Functional neuroanatomy of working memory in

adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 2005; 57:439-47

449. Wilens T, Hammerness P, Biederman J, Kwon A, Spencer T, Clark S, Scott M, Ditterline J, Moore H, Morris M: Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry 2005; 66:253-259

38

Page 39: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

450. Biederman J, Petty C, Faraone SV, Hirshfeld-Becker D, Henin A, Pollack M, Rosenbaum J: Patterns of Comorbidity in Panic Disorder and Major Depression: Findings from a Non-Referred Sample. Depression and Anxiety 2005; 21:55-60

451. Faraone SV, Biederman J, Zimmerman BA: Correspondence of Parent and Teacher Reports in Medication Trials.

European Child and Adolescent Psychiatry 2005; 14:20-27

452. Makris N, Schlerf JE, Hodge SM, Haselgrove C, Albaugh MD, Seidman LJ, Rauch SL, Harris G, Biederman J, Caviness VS, Jr., Kennedy DN, Schmahmann JD: MRI-based surface-assisted parcellation of human cerebellar cortex: an anatomically specified method with estimate of reliability. Neuroimage 2005; 25:1146-1160

453. McGough J, Biederman J, Wigal S, Lopez FA, T. MJ, Spencer T, Zhang Y, Tulloch SJ: Long-term Tolerability and

Effectiveness of Once-Daily Mixed Amphetamine Salts (Adderall XR®) in Children with ADHD. J Am Acad Child Adolesc Psychiatry 2005; 44:530-538

454. Faraone SV, Biederman J, Spencer T: Long-term effects of extended-release mixed amphetamine salts treatment of

attention-deficit/hyperactivity disorder on growth. J Child Adolesc Psychopharmacol 2005; 15:191-202

455. Biederman J, Mick E, Wozniak J, Aleardi M, Spencer T, Faraone SV: An Open-Label Trial of Risperidone in Children and Adolescents with Bipolar Disorder. J Child Adolesc Psychopharmacol 2005; 15:311-317

456. Wilens T, Hahesy A, Biederman J, Bredin E, Tanguay S, Kwon A, Faraone SV: Influence of Parental SUD and ADHD

on ADHD in their offspring: Preliminary Results from a Pilot Controlled Family Study. Am J Addictions 2005; 14:179-187

457. Biederman J: Attention Deficit Hyperactivity Disorder: A Selective Overview. Biological Psychiatry 2005;

57(11):1215-1220

458. Adler L, Spencer T, Faraone SV, et al. Training Raters to Assess Adult ADHD: Reliability of Ratings. Journal Attention Disorders 2005; 8(3) 121-6

459. Biederman J, Petty C, Faraone S, Hirshfeld-Becker DR, Henin A, Rauf A, Scott M, Pollack M, Rosenbaum

J,Childhood antecedents to panic disorder in referred and non referred adults. Journal of Child and Adolescent Psychopharmacology 15: 549-562 2005

460. Reimer B, D’Ambrosio LA, Gilbert J, et al. Behavior differences in drivers with attention deficit hyperactivity disorder:

The driving behavior questionnaire. Accid Anal Prev 2005; 37:996-1004. 2005

461. Biederman J, Faraone SV: Attention Deficit Hyperactvitiy Disorder. Lancet ,366:237-248 2005

462. Biederman J, Faraone SV, Wozniak J, Mick E, Kwon A, Cayton GA, Clark SV: Clinical correlates of bipolar disorder in a large, referred sample of children and adolescents. J Psychiatr Res 2005; 39:611-622

463. Biederman J, James R: Advances in the neurobiology of pediatric bipolar disorder. Biol Psychiatry 2005; 58:515-516

464. Biederman J, Mick E, Hammerness P, Harpold T, Aleardi M, Dougherty M, Wozniak J: Open-Label, 8-Week Trial of

Olanzapine and Risperidone for the Treatment of Bipolar Disorder in Preschool-Aged Children. Biol Psychiatry 2005; 58:589-594

465. Biederman J, Monuteaux M, Kendrick E, Klein K, Faraone S: The CBCL as a screen for psychiatric comorbidity in

paediatric patients with ADHD. Arch Dis Child 2005; 90:1010-5

466. Biederman J, Monuteaux M, Mick E, Wilens T, Fontanella J, Poetzl KM, Kirk T, Masse J, Faraone SV: Is Cigarette Smoking a Gateway Drug to Subsequent Alcohol and Illicit Drug Use Disorders? A Controlled Study of Youths with and without ADHD. Biol Psychiatry 2005

39

Page 40: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

467. Biederman J, Petty C, Faraone SV, Hirshfeld-Becker DR, Henin A, Dougherty M, LeBel T, Pollack M, Rosenbaum J:

Parental predictors of pediatric panic disorder/agoraphobia: A controlled study in high risk offspring. Depression and Anxiety 2005; 15:549-61

468. Doyle AE, Biederman J, Seidman L, Reske-Nielsen J, Faraone SV: Neuropsychological functioning in relatives of girls

with and without ADHD. Psychol Med 2005; 35:1121-32

469. Doyle AE, Faraone SV, Seidman LJ, Willcutt EG, Nigg JT, Waldman ID, Pennington BF, Peart J, Biederman J: Are endophenotypes based on measures of executive functions useful for molecular genetic studes of ADHD? J Child Psychol Psychiatry 2005; 46:774-803

470. Doyle AE, Wilens T, Kwon A, Seidman LJ, Faraone SV, Fried R, Swezey A, Snyder L, Biederman J:

Neuropsychological functioning in youth with bipolar disorder. Biol Psychiatry 2005

471. Doyle AE, Willcutt EG, Seidman LJ, Biederman J, Chouinard VA, Silva J, Faraone SV: Attention-deficit/hyperactivity disorder endophenotypes. Biol Psychiatry 2005; 57:1324-35

472. Faraone SV, Biederman J, Spencer T, Michelson D, Adler L, Reimherr F, Glatt S: Efficacy of Atomoxetine in Adult

Attention-Deficit/Hyperactivity Disorder: A Drug-Placebo Response Curve Analysis. Behavioral and Brain Functions 2005; 1:16

473. Findling RL, Biederman J, Wilens T, Spencer T, McGough J, Lopez FA, Tulloch S: Short and Long-term

cardiovascular effects of mixed amphetamine salts extended release (Adderall XR) in Children. J Pediatrics 2005; 147:348-354

474. Harpold T, Wozniak J, Kwon A, Gilbert J, Wood J, Smith L, Biederman J: Examining the association between pediatric

bipolar disorder and anxiety disorders in psychiatrically referred children and adolescents. J Affect Disord 2005; 88:19-26

475. Henin A, Biederman J, Sachs G, Mick E, Siegel RS, Hirshfeld-Becker DR, McMurrish S, Grandin L, Neirenberg A:

Psychopathology in the Offspring of Parents with Bipolar Disorder: A Controlled Study. Biol Psychiatry 2005; 58:554-561

476. Kessler R, Adler L, Barkley R, Biederman J, Conners CK, Faraone SV, Greenhill LG, Jaeger S, Secnik K, Spencer T,

Ustun B, Zaslavsky AM: Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication. Biol Psychiatry 2005; 57:1442-51

477. Kratochvil CJ, Newcorn JH, Arnold LE, Duesenberg D, Emslie GJ, Quintana H, Sarkis EH, Wagner KD, Gao H,

Michelson D, Biederman J: Atomoxetine Alone or Combined With Fluoxetine for Treating ADHD With Comorbid Depressive or Anxiety Symptoms. J Am Acad Child Adolesc Psychiatry 2005; 44:915-924

478. Mick E, Spencer T, Wozniak J, Biederman J: Heterogeneity of Irritability in ADHD Subjects with and without Mood

Disorders. Biol Psychiatry 2005; 58:576-582

479. Smoller JW, Biederman J, Arbeitman L, Doyle AE, Fagerness J, Perlis R, Sklar P, Faraone SV: Association between the 5HT1B Receptor Gene (HTR1B) and the Inattentive Subtype of ADHD. Biol Psychiatry 2005; 57:1485-92

480. Spencer TJ, Biederman J, Madras BK, Faraone SV, Dougherty DD, Bonab AA, Fischman AJ: In vivo neuroreceptor

imaging in attention-deficit/hyperactivity disorder: a focus on the dopamine transporter. Biol Psychiatry 2005; 57:1293-300

481. Wilens T, Spencer T, Biederman J: Academic Supplement: Short- and long-term cardiovascular effects of mixed

amphetamine salts extended-release in adolescents with ADHD. CNS Spectrums 2005; 10:22-30

40

Page 41: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

482. Wozniak J, Biederman J, Kwon A, Mick E, Faraone SV, Orlovsky K, Schnare L, Cargol C, Van Grondelle A: How

cardinal are cardinal symptoms in pediatric bipolar disorder?: An examination of clinical correlates. Biol Psychiatry 2005; 58:583-588

483. Solhkhah R, Wilens TE, Daly J, Prince JB, Patten SL, Biederman J. Bupropion SR for the Treatment of Substance-

Abusing Outpatient Adolescents with Attention-Deficit/Hyperactivity Disorder and Mood Disorders. Journal Child Adolesc Psychopharmacology 2005; 5: 777-86

484. Gignac M, Wilens TE, Biederman J, Kwon A, Mick E, Swezey A. Assessing cannabis use in adolescents and young

adults: what do urine screen and parental report tell you. Journal Child Adolescent Psychopharmacology 2005; 5:742-50

485. Faraone SV, Biederman J, Spencer T, Michelson D, Adler L, Reimherr F, Seidman L. Atomoxetine and stroop task

performance in adult attention-deficit/hyperactivity disorder. Journal Child Adolescent Psychopharmacology 2005; 4: 664-70

486. Wilens TE, Biederman J. Alchohol, drugs and attention-deficit/hyperactivity disorder: a model for the study of

addictions in youth. Journal Psychopharmacology 2005

487. Wilens, T., A. Kwon, et al. (2005). "Characteristics of adults with attention deficit hyperactivity disorder plus substance use disorder: the role of psychiatric comorbidity." American Journal on Addictions 14(4): 319-328

488. Biederman J, Swanson J, Wigal S, Kratochvil C, Boellner SW, Earl C, Jiang J, Greenhill LL: Efficacy and Safety of

Modafinil Film-Coated Tablets in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Study. Pediatrics 2005 Dec;116(6):e777-84

489. Monuteaux M, Faraone SV, Herzig K, Navsaria N, Biederman J: Attention-deficit/hyperactivity disorder and

dyscalculia evidence for independent familial transmission. J Learn Dis 2005; 38(1): 86-93

490. Moore C, Biederman J, Renshaw P:Bipolar Disorder plus ADHD versus ADHD: A proton magnetic resonance study (MRS). Biological Psychiatry 2005; 57(8 30 Suppl): 9S-10S

491. Wilens T, Waxmonsky J, Scott M, Swezey A, Kwon A, Spencer T, Biederman J: An open trial of adjunctive donepezil

in ADHD: Journal of Child and Adolescent Psychopharmacology 2005 Dec;15(6):947-55.

492. Nierenberg A, Henin A, Mick E, et al.: Relationship between comorbid psychopathology among adults with bipolar disorder and their offspring: phenotypic implications for genetic studies. Bipolar Disorrd 2005; 7(Suppl 2): 82

493. Biederman J, Mick E, Fried R, et al. The Impact of Adhd in Adults During a Simulated Workplace Experience.

Psychiatric Services 2005; 56: 1617-20.

494. Biederman J, Arnsten AF, Faraone SV, Doyle AE, Spencer TJ, Wilens TE, Weiss MD, Safren SA & Culpepper L New Developments in the Treatment of ADHD. Journal of Clinical Psychiatry (2006).

495. Biederman J, Monuteaux M, Mick E, Spencer T, Wilens T, Silva J, Snyder L and Faraone S. Young Adult Outcome of

Attention Deficit Hyperactivity Disorder: A Controlled 10 Year Prospective Follow-Up Study. Psychological Medicine 2006 36: 167-179.

496. Faraone S, Biederman J, Mick E. The Age Dependent Decline of Attention-Deficit/Hyperactivity Disorder: A Meta-

Analysis of Follow-Up Studies. Psychological Medicine 2006 36: 159-165.

41

Page 42: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

497. Hirshfeld-Becker DR, Biederman J, Henin A, Faraone SV, Cayton GA and Rosenbaum J. Laboratory-observed behavioral disinhibition in the young offspring of parents with bipolar disorder: A controlled pilot study. American Journal of Psychiatry 2006 163:265-71.

498. Moore CM, Biederman J, Wozniak J, Mick E, Aleardi M, Wardrop M, Dougherty M, Harpold T, Hammerness P,

Randall E & Renshaw P. Differences in brain chemistry in children and adolescents with attention deficit hyperactivity disorder with and without comorbid bipolar disorder: a proton magnetic resonance spectroscopy study. American Journal Psychiatry 2006 163:316-8.

499. Swanson JM, Greenhill LL, Lopez FA, Sedillo A, Earl CQ, Jiang JG and Biederman J. Modafinil Film-Coated Tablets

in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Results of a Randomized, Double-Bind, Placebo-Controlled, Fixed Dose Study Followed by Abrupt Discontinuation. Journal of Clinical Psychiatry 2006 67:137-147.

500. Biederman J, Mick E, Faraone SV, Hammerness P, Surman C, Harpold T, Dougherty M, Aleardi M, Spencer T: A

double –blind comparision of galantamine HBr and placebo in adults with attention-deficit hyperactivity disorder: A pilot study. Journal Clinical Psychopharmacology 2006; 26:163-166.

501. Biederman J, Mick E, Surman C, Doyle R, Hammerness P, Harpold T, Dunkel S, Dougherty M, Aleardi M, Spencer T:

A randomized, placebo-controlled trial of OROS-methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 2006; 59:829-835.

502. Geller DA, Doyle R, Shaw D, Mullin B, Coffey B, Petty C, Vivas F, Biederman J: A quick and reliable screening

measure for OCD in youth: Reliability and validity of the obsessive compulsive scale of the child behavior checklist. Comp Psychiatry 2006; 47:234-240.

503. Seidman LJ, Biederman J, Valera EM, Monuteaux MC, Doyle AE, Faraone SV: Neuropsychological functioning in

girls with attention-deficit/hyperactivity disorder with and without learning disabilities. Neuropsychology 2006; 20:166-77.

504. Spencer T, Faraone SV, Biederman J, Lerner M, Cooper K, Zimmerman B, CONCERTA® Study Group: Does

Prolonged Stimulant Therapy Suppress Growth in Children with ADHD? Analysis of Data from 21 Months of Therapy with Once-Daily OROS® MPH. Journal of the American Academy Child and Adolescent Psychiatry 2006; 45:527-537.

505. Biederman J, Swanson J, Wigal S, Boellner S, Earl C, Lopez F.A. and for the Modafinil ADHD Study Group. A

Comparision of Once-Daily and Divided Doses of Modafinil in Children with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled Study. Journal of Clinical Psychiatry 2006; 67: 727-735.

506. Wilens T, Zusman R, Hammerness P, Podolski A, Whitley J, Spencer T, Biederman J. An Open-Label Study of the

Tolerability of Mixed Amphetamine Salts in Adults with ADHD and Treated Primary Essential Hypertension. Journal of Clinical Psychiatry 2006; 67: 696-702.

507. Wilens T, Biederman J. Alcohol, drugs, and ADHD: A Model for the Study of Addictions in Youth. Journal of

Psychopharmacology 2006; 20: 580-588.

508. Biederman, J., C. Petty, et al “A controlled longitudinal five year follow-up study of children at high and low risk for panic disorder and major depression." Psychology Medicine 2006; 36:1141-1152.

509. Biederman J, Spencer T, Wilens T, Prince J, Faraone S: Treatment of ADHD with stimulant medications: Response to

Nissen Perspective in the New England Journal of Medicine. Journal of the American Academy Child and Adolescent Psychiatry 2006;45(10):1147-50

42

Page 43: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

510. Monuteaux M, Blacker D, Biederman J, Fitzmaurice G, Buka S: Maternal smoking during pregnancy and the risk for offspring overt and covert disorder symptoms. A longitudinal study. Journal Child Psychology Psychiatry 2006; 47: 883-90.

511. Wilens T, Spencer T, Prince J, Biederman J: Stimulants and Sudden Death: What is a Physician to do? Pediatrics

118:1215-9.

512. Biederman J, Petty C, Fried R, Fontanella J, Doyle A, Seidman L, Faraone S: Impact of psychometrically defined deficits of executive functioning in adults with ADHD. American Journal Psychiatry 2006; 163: 1730-8.

513. Faraone S, Biederman J, Spencer T, Mick E, Murray K, Petty C, Adamson J, Monuteaux M: Diagnosing adult ADHD:

are late onset and subthreshold diagnoses valid? American Journal Psychiaty 2006; 163: 1720-9.

514. Biederman J. “The evolving face of pediatric mania.” Biol Psychiatry. 2006 Nov 1;60(9):901-2.

515. Biederman, J., C. Petty, et al.. "Antecedents to panic disorder in non-referred adults." Journal of Clinical Psychiatry. 2006;67(8):1179-86

516. Geller D, Petty C, Vivas F, Johnson J, Pauls D, Biederman. “Examining the Relationship Between Obsessive-

Compulsive Disorder and Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Familial Risk Analysis.” Biological Psychiatry. 2007 Feb 1;61(3):316-2

517. Biederman, J., H. Gao, et al. "Comparison of parent and teacher reports of attention-deficit/hyperactivity disorder

symptoms." Biological Psychiatry. 2006 Nov 15;60(10):1106-10.

518. Biederman, J., C. Petty, et al. "Effects of parental anxiety disorders in children at high risk for panic disorder a controlled study." Journal of Affective Disorders.2006 Aug;94(1-3):191-7.

519. Biederman, J., M. Monuteaux, et al. "Psychopathology in females with attention-deficit/hyperactivity disorder: A

controlled, five-year prospective study." Biological Psychiatry. 2006 Nov 15;60(10):1098-105

520. Adler LA, Spencer T, Faraone SV, Kessler RC, Howes MJ, Biederman J, Secnik K. “Validity of pilot Adult ADHD Self- Report Scale (ASRS) to Rate Adult ADHD symptoms.”Ann Clin Psychiatry. 2006 Jul-Sep;18(3):145-8.

521. Makris N, Kaiser J, Haselgrove C, Seidman LJ, Biederman J, Boriel D, Valera EM, Papadimitriou GM, Fischl B,

Caviness VS Jr, Kennedy DN. “Human cerebral cortex: a system for the integration of volume- and surface-based representations.” Neuroimage. 2006 Oct 15;33(1):139-53.

522. Faraone, S. V., J. Biederman, et al. . "Neuropsychological Studies of Late Onset and Subthreshold Diagnoses of Adult

ADHD." Biological Psychiatry. 2006 Nov 15;60(10):1081-1087.

523. Seidman LJ, Valera EM, Makris N, Monuteaux MC, Boriel DL, Kelkar K, Kennedy DN, Caviness VS, Bush G, Aleardi M, Faraone SV, Biederman J. “Dorsolateral Prefrontal and Anterior Cingulate Cortex Volumetric Abnormalities in Adults with Attention-Deficit/Hyperactivity Disorder Identified by Magnetic Resonance Imaging.” Biol Psychiatry. 2006 Nov 15;60(10):1071-1080

524. Lasky-Su J, Biederman J, Doyle AE, Wilens T, Monuteaux M, Smoller JW, Faraone S. “ Family based association

analysis of statistically derived quantitative traits for drug use in ADHD and the dopamine transporter gene.” Journal of Addict Behav. 2006 Jun;31(6):1088-99

525. Reimer B, D'Ambrosio LA, Coughlin JE, Kafrissen ME, Biederman J. “Using self-reported data to assess the validity of

driving simulation data.” Behav Res Methods. 2006 May;38(2):314-24.

43

Page 44: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

526. Makris N, Biederman J, Valera EM, Bush G, Kaiser J, Kennedy DN, Caviness VS, Faraone SV, Seidman LJ. “Cortical Thinning of the Attention and Executive Function Networks in Adults with Attention-Deficit/Hyperactivity Disorder.” Cereb Cortex. 2006.

527. Fried, R., C. Petty, et al. "Characterizing Impaired Driving in Adults with ADHD: A Controlled Study." Journal of

Clinical Psychiatry. 2006 Apr;67(4):567-74.

528. Biederman, J., S. V. Faraone, et al. "Functional Impairments in Adults with Self-Reports of Diagnosed ADHD: A Controlled Study of 1,000 Adults in the Community." Journal of Clinical Psychiatry 2006 Apr;67(4):524-40.

529. Biederman, J., E. Mick, et al. "An Open-Label Trial of OROS-Methylphenidate in Adults with Attention-

Deficit/Hyperactivity Disorder-Not Otherwise Specified." CNS Spectrums. 2006 May;11(5):390-6.

530. Mick E, Biederman J, Spencer T, Faraone SV, Sklar P: Absence of association with DAT1 polymorphism and response to methylphenidate in a sample of adults with ADHD. Am J Med Genet B Neuropsychiatr Genet 2006; 141(8):890-4.

531. Surman, C., R. Thomas, et al. "Adults with ADHD and Sleep Complaints – A Pilot Study Identifying Sleep Disordered

Breathing Using Polysomnography and Sleep Quality Assessment." Journal of Attention Disorders. 2006 Feb;9(3):550-5.

532. Wozniak J, Biederman J, Mick E, Waxmonsky J, Hantsoo L, Best C, Cluette-Brown JE, Laposata M: Omega-3 fatty

acid monotherapy for pediatric bipolar disorder: a prospective open-label trial. Eur Neuropsychopharmacol 2007; 17(6-7):440-7.

533. Ahn MS, Breeze JL, Makris N, Kennedy DN, Hodge SM, Herbert MR, Seidman LJ, Biederman J, Caviness VS, Frazier

JA: Anatomic brain magnetic resonance imaging of the basal ganglia in pediatric bipolar disorder. J Affect Disord 2007. 2007 Dec; 104(1-3):147-54.

534. Spencer TJ, Biederman J, Madras BK, Dougherty DD, Bonab AA, Livni E, Meltzer PC, Martin J, Rauch S, Fischman

AJ: Further Evidence of Dopamine Transporter Dysregulation in ADHD: A Controlled PET Imaging Study Using Altropane. Biol Psychiatry 2007.

535. Lasky-Su J, Biederman J, Laird N, Tsuang M, Doyle AE, Smoller JW, Lange C, Faraone SV: Evidence for an

Association of the Dopamine D5 Receptor Gene on Age at Onset of Attention Deficit Hyperactivity Disorder. Ann Hum Genet 2007.

536. Faraone SV, Adamson JJ, Wilens TE, Monuteaux MC, Biederman J: Deriving phenotypes for molecular genetic studies

of substance use disorders: a family study approach. Drug Alcohol Depend 2007; 88(2-3):244-50.

537. Faraone SV, Biederman J, Zimmerman B: An Analysis of Patient Adherence to Treatment During a 1-Year, Open-label Study of OROS(R) Methylphenidate in Children With ADHD. J Atten Disord 2007 Sep;11(2):157-66.

538. Biederman J, Ball SW, Monuteaux MC, Kaiser R, Faraone SV: CBCL Clinical Scales Discriminate ADHD Youth with

Structured-Interview Derived Diagnosis of Oppositional Defiant Disorder (ODD). J Atten Disord 2007.

539. Lasky-Su J, Faraone SV, Lange C, Tsuang MT, Doyle AE, Smoller JW, Laird NM, Biederman J: A Study of how Socioeconomic Status Moderates the Relationship between SNPs Encompassing BDNF and ADHD Symptom Counts in ADHD Families. Behav Genet 2007; 37(3):487-97.

540. Gonzalez-Heydrich J, Dodds A, Whitney J, MacMillan C, Waber D, Faraone SV, Boyer K, Mrakotsky C, DeMaso D, Bourgeois B, Biederman J: Psychiatric disorders and behavioral characteristics of pediatric patients with both epilepsy and attention-deficit hyperactivity disorder. Epilepsy Behav 2007; 10(3):384-8.

44

Page 45: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

541. Biederman J, Ball SW, Mick E, Monuteaux MC, Kaiser R, Bristol E, Faraone SV: Informativeness of maternal reports on the diagnosis of ADHD: an analysis of mother and youth reports. J Atten Disord 2007; 10(4):410-7.

542. Faraone SV, Biederman J, Wilens TE, Adamson J: A naturalistic study of the effects of pharmacotherapy on substance

use disorders among ADHD adults. Psychol Med 2007: Dec;37(12):1743-52.

543. Buitelaar JK, Michelson D, Danckaerts M, Gillberg C, Spencer TJ, Zuddas A, Faries DE, Zhang S, Biederman J: A randomized, double-blind study of continuation treatment for attention-deficit/hyperactivity disorder after 1 year. Biol Psychiatry 2007; 61(5):694-9.

544. Biederman J, Petty CR, Fried R, Fontanella J, Doyle AE, Seidman LJ, Faraone SV: Can self-reported behavioral scales

assess executive function deficits? A controlled study of adults with ADHD. J Nerv Ment Dis 2007; 195(3):240-6.

545. Biederman J, Krishnan S, Zhang Y, McGough JJ, Findling RL: Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study. Clin Ther 2007; 29(3):450-63.

546. Hammerness P, Harpold T, Petty C, Menard C, Zar-Kessler C, Biederman J: Characterizing non-OCD anxiety disorders

in psychiatrically referred children and adolescents. J Affect Disord 2007.

547. Geller D, Petty C, Vivas F, Johnson J, Pauls D, Biederman J: Further evidence for co-segregation between pediatric obsessive compulsive disorder and attention deficit hyperactivity disorder: a familial risk analysis. Biol Psychiatry 2007; 61(12):1388-94.

548. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA: The worldwide prevalence of ADHD: a systematic

review and metaregression analysis. Am J Psychiatry 2007; 164(6):942-8.

549. Makris N, Biederman J, Valera EM, Bush G, Kaiser J, Kennedy DN, Caviness VS, Faraone SV, Seidman LJ: Cortical thinning of the attention and executive function networks in adults with attention-deficit/hyperactivity disorder. Cereb Cortex 2007; 17(6):1364-75.

550. Hirshfeld-Becker DR, Biederman J, Henin A, Faraone SV, Davis S, Harrington K, Rosenbaum JF: Behavioral

inhibition in preschool children at risk is a specific predictor of middle childhood social anxiety: a five-year follow-up. J Dev Behav Pediatr 2007; 28(3):225-33.

551. Wilens TE, Biederman J, Adamson J, Monuteaux M, Henin A, Sgambati S, Santry A, Faraone SV: Association of

bipolar and substance use disorders in parents of adolescents with bipolar disorder. Biol Psychiatry 2007; 62(2):129-34.

552. Biederman J, Boellner SW, Childress A, Lopez FA, Krishnan S, Zhang Y: Lisdexamfetamine Dimesylate and Mixed Amphetamine Salts Extended-Release in Children with ADHD: A Double-Blind, Placebo-Controlled, Crossover Analog Classroom Study. Biol Psychiatry 2007.

553. Spencer TJ, Biederman J, Mick E: Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and

neurobiology. J Pediatr Psychol 2007; 32(6):631-42.

554. Harpold T, Biederman J, Gignac M, Hammerness P, Surman C, Potter A, Mick E: Is Oppositional Defiant Disorder a Meaningful Diagnosis in Adults?: Results From a Large Sample of Adults With ADHD. J Nerv Ment Dis 2007; 195(7):601-605.

555. Antshel KM, Faraone SV, Stallone K, Nave A, Kaufmann FA, Doyle A, Fried R, Seidman L, Biederman J: Is attention

deficit hyperactivity disorder a valid diagnosis in the presence of high IQ? Results from the MGH Longitudinal Family Studies of ADHD. J Child Psychol Psychiatry 2007; 48(7):687-94.

45

Page 46: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

556. Spencer TJ, Biederman J, Mick E: Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology. Ambul Pediatr 2007; 7(1 Suppl):73-81.

557. Otto MW, Henin A, Hirshfeld-Becker DR, Pollack MH, Biederman J, Rosenbaum JF: Posttraumatic stress disorder

symptoms following media exposure to tragic events: Impact of 9/11 on children at risk for anxiety disorders. J Anxiety Disord 2007.

558. Biederman J, Spencer TJ, Newcorn JH, Gao H, Milton DR, Feldman PD, Witte MM: Effect of comorbid symptoms of

oppositional defiant disorder on responses to atomoxetine in children with ADHD: a meta-analysis of controlled clinical trial data. Psychopharmacology (Berl) 2007; 190(1):31-41.

559. Hirshfeld-Becker DR, Biederman J, Henin A, Faraone SV, Micco JA, Grondelle AV, Henry B, Rosenbaum JF: Clinical

Outcomes of Laboratory-Observed Preschool Behavioral Disinhibition at Five-Year Follow-up. Biol Psychiatry 2007.

560. Mrakotsky C, Masek B, Biederman J, Raches D, Hsin O, Forbes P, de Moor C, Demaso DR, Gonzalez-Heydrich J: Prospective open-label pilot trial of mirtazapine in children and adolescents with social phobia. J Anxiety Disord 2007.

561. Geller D, Petty C, Vivas F, Johnson J, Pauls D, Biederman J: Examining the relationship between obsessive-

compulsive disorder and attention-deficit/hyperactivity disorder in children and adolescents: a familial risk analysis. Biol Psychiatry 2007; 61(3):316-21.

562. Antshel KM, Faraone SV, Fremont W, Monuteaux MC, Kates WR, Doyle A, Mick E, Biederman J: Comparing ADHD

in Velocardiofacial Syndrome to Idiopathic ADHD: A Preliminary Study. J Atten Disord 2007; 11(1):64-73.

563. Monuteaux MC, Faraone SV, Michelle Gross L, Biederman J: Predictors, clinical characteristics, and outcome of conduct disorder in girls with attention-deficit/hyperactivity disorder: a longitudinal study. Psychol Med 2007:1-11.

564. Kim JW, Biederman J, Arbeitman L, Fagerness J, Doyle AE, Petty C, Perlis RH, Purcell S, Smoller JW, Faraone SV,

Sklar P: Investigation of variation in SNAP-25 and ADHD and relationship to co-morbid major depressive disorder. Am J Med Genet B Neuropsychiatr Genet 2007.

565. Petty CR, Rosenbaum JF, Hirshfeld-Becker DR, Henin A, Hubley S, Lacasse S, Faraone SV, Biederman J: The child

behavior checklist broad-band scales predict subsequent psychopathology: A 5-year follow-up. J Anxiety Disord 2007.

566. Kim JW, Waldman ID, Faraone SV, Biederman J, Doyle AE, Purcell S, Arbeitman L, Fagerness J, Sklar P, Smoller JW: Investigation of parent-of-origin effects in ADHD candidate genes. Am J Med Genet B Neuropsychiatr Genet 2007.

567. Moore CM, Biederman J, Wozniak J, Mick E, Aleardi M, Wardrop M, Dougherty M, Harpold T, Hammerness P,

Randall E, Lyoo IK, Renshaw PF: Mania, glutamate/glutamine and risperidone in pediatric bipolar disorder: a proton magnetic resonance spectroscopy study of the anterior cingulate cortex. J Affect Disord 2007; 99(1-3):19-25.

568. Henin A, Mick E, Biederman J, Fried R, Wozniak J, Faraone SV, Harrington K, Davis S, Doyle AE: Can bipolar

disorder-specific neuropsychological impairments in children be identified? J Consult Clin Psychol 2007; 75(2):210-20.

569. Henin A, Biederman J, Mick E, Hirshfeld-Becker DR, Sachs GS, Wu Y, Yan L, Ogutha J, Nierenberg AA: Childhood antecedent disorders to bipolar disorder in adults: a controlled study. J Affect Disord 2007; 99(1-3):51-7.

570. Doyle R, Mick E, Biederman J: Convergence between the Achenbach youth self-report and structured diagnostic

interview diagnoses in ADHD and non-ADHD youth. J Nerv Ment Dis 2007; 195(4):350-2.

571. Biederman J, Wilens TE, Spencer TJ, Adler LA: Diagnosis and treatment of adults with attention-deficit/hyperactivity disorder. CNS Spectr 2007; 12(4 Suppl 6):1-15.

46

Page 47: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

572. Wilens TE, Adamson J, Sgambati S, Whitley J, Santry A, Monuteaux MC, Biederman J: Do individuals with ADHD self-medicate with cigarettes and substances of abuse? Results from a controlled family study of ADHD. Am J Addict 2007; 16 Suppl 1:14-21; quiz 22-3.

573. Faraone SV, Wilens TE, Petty C, Antshel K, Spencer T, Biederman J: Substance use among ADHD adults: implications

of late onset and subthreshold diagnoses. Am J Addict 2007; 16 Suppl 1:24-32; quiz 33-4.

574. Biederman J, Fried R, Monuteaux MC, Reimer B, Coughlin JF, Surman CB, Aleardi M, Dougherty M, Schoenfeld S, Spencer TJ, Faraone SV: A laboratory driving simulation for assessment of driving behavior in adults with ADHD: a controlled study. Ann Gen Psychiatry 2007; 6:4.

575. Biederman J, Petty C, Fried R, Doyle AE, Spencer T, Seidman L, Gross L, Poetzl KM, Faraone SV: Stability of

executive function deficits into young adult years: A Prospective longitudinal follow-up study of grown up youth with ADHD. Acta Psychiatrica Scandinavica. 116(2):129-36, 2007 Aug.

576. Reimer B, D’Ambrosio LA, Coughlin JF, Fried R, Biederman J. Task-induced fatigue and collisions in adult drivers

with attention deficit hyperactivity disorder. Traffic Inj Prev. 2007 Sep; 8(3):290-9.

577. Monuteauc MC, Wilens TE, Biederman J. Does social class predict substance problems in young adults with ADHD? Am J Addict. 2007 Sep=Oct; 16(5):403-9.

578. Biederman J, Mick E, Spencer TJ, Doyle R, Gagan J, Hammerness P, Dougherty M, Aleardi M, Wozniak J: A

prospective open-label trial of aripiprazole monotherapy in children and adolescents with bipolar disorder. CNS Spectrums 2007 Sep; 12 (9):683-9.

579. Kim JW, Biederman J, McGrath CL, Doyle AE, Mick E, Fagerness J, Purcell S, Smoller JW, Sklar P, Faraone SV.

Further evidence of association between two NET single-nucleotide polymorphisms with ADHD. Mol Psychiatry. 2007 Sep 18.

580. Biederman J, Mick E, Surman C, Doyle R, Hammerness P, Michel E, Martin J, Spencer T: Comparative acute efficacy

and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with attention deficit hyperactivity disorder. BMC Psychiatry 2007 Sep 18.

581. Makris N, Buka SL, Biederman J, Papadimitriou GM, Hodge SM, Valera EM, Brown AB, Bush G, Monuteaux MC,

Caviness VS, Kennedy DN, Seidman LJ. Attention and Executive Systems Abnormalities in Adults with Childhood ADHD: A DT-MRI Study of Connections. Cereb Cortex. 2007 Sep 30.

582. Tohen M, Kryzhanovskaya L, Carlson G, Delbello M, Wozniak J, Kowatch R, Wagner K, Findling R, Lin D,

Robertson-Plouch C, Xu W, Dittmann RW, Biederman J. Olanzapine versus placebo in the treatment of adolescents with bipolar mania. Am J Psychiatry 2007 Oct; 164(10):1547-56.

583. Mick E, Faraone SV, Spencer T, Zhang HF, Biederman J: Assessing the Validity of the Quality of Life Enjoyment and

Satisfaction Questionnaire -Short Form in Adults with ADHD. Journal of Attention Disorders 2007 Oct 12.

584. Biederman J, Petty CR, Fried R, Black S, Faneuil A, Doyle AE, Seidman LJ, Faraone SV. Discordance between psychometric testing and questionnaire-based definitions of executive function deficits in individuals with ADHD. J Atten Disord 2007 Oct 12.

585. Biederman J, Makris N, Valera E, Monuteaux MC, Goldstein JM, Buka S, Boriel DL, Bandyopadhyay S, Kennedy

DN, Caviness VS, Bush G, Aleardi M, Faraone SV, Seidman LJ: Towards further understanding of the comorbidity between attention-deficit/hyperactivity disorder and bipolar disorder: An MRI study of brain volumes. Psychological Medicine . 2007 Oct 15:1-12

47

Page 48: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

586. Adler LA, Spencer TJ, Levine LR, Ramsey JL, Tamura R, Kelsey D, Ball SG, Allen AJ, Biederman J. Functional outcomes in the treatment of adults with ADHD. J Atten Disord 2007 Oct 29.

587. Arnold LE, Lindsay RL, Lopez FA, Jacob SE, Biederman J, Findling RL, Ramadan Y. Treating attention-

deficit/hyperactivity disorder with a stimulant transdermal patch: the clinical art. Pediatrics 2007 Nov; 120(5)1100-6.

588. Biederman J, Petty C, Faraone SV, Hirshfeld-Becker D, Henin A, Fraire M, Henry B, McQuade J, Rosenbaum J: Developmental trajectories of anxiety disorders in offspring at high risk for panic disorder. Psychiatry Research. 2007 Dec 3; 153(3):245-52.

589. Biederman J, Petty CR, Doyle AE, Spencer T, Henderson CH, Marion B, Fried R, Faraone SV. Stability of executive

function deficits in girls with ADHD: a prospective longitudinal follow-up study into adolescence. Developmental Neuropsychology 2008; 33(1) 44-61.

590. Biederman J, Mick E, Spencer TJ, Dougherty M, Aleardi M, Wozniak J. A prospective open-label treatment trial of

ziprasidone monotheray in children and adolescents with bipolar disorder. Bipolar Disord. 2007 Dec; 9(8): 888-94.

591. Monuteaux MC, Spencer TJ, Faraone SV, Wilson AM, Biederman J. A Randomized, Palcebo-Controlled Clinical Trial of Bupropion for the Prevention of Smoking in Children and Adolescents with Attention-DeficitHyperactivity Disorder. J Clin Psychiatry. 2007 Jul; 68(7): 1094-101.

592. Biederman J, Petty CR, Wilens TE, Fraire MG, Purcell CA, Mick E, Monuteaux MC, Faraone SV. Familial risk

analyses of ADHD and substance use disorders. Am J Psychiatry. 2008 Jan; 165(1):107-15.

593. Biederman J, Boellner SW, Childress A, Lopez FA, Krishnan S, Zhang H. Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: A double-blind, placebo-controlled, crossover analog classroom study. Biological Psychiatry. 2007 Nov 1; 62(9): 970-6.

594. Biederman J, Spencer T. Psychopharmacological Interventions. Child Adolexc Psychiatr Clin N Am 2008 Apr;

17(2):439-58.

595. Biederman J, Pliszka SR. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents. J Pediatr. 2008 Mar; 152(3): 394-9.

596. Biederman J, Petty CR, Fried R, Doyle AE, Mick E, Aleardi M, Monuteaux MC, Seidman LJ, Spencer T, Faneuil AR,

Holmes L, Faraone SV: Utility of an abbreviated questionnaire to identify individuals with ADHD at risk for functional impairments. J Psychiatr Res 2008 Mar; 42(4):304-10.

597. Lasky-Su J, Lange C, Biederman J, Tsuang M, Doyle AE, Smoller JW, Laird N, Faraone S: Family-based association

analysis of a statistically derived quantitative traits for ADHD reveal an association in DRD4 with inattentive symptoms in ADHD individuals. Am J Med Genet B Neuropsychiatr Genet. 2008 Jan 5; 147(1):100-6.

598. Biederman J, Hammerness P, Doyle R, Joshi G, Aleardi M, Mick E. Risperidone treatment for ADHD in children and

adolescents with bipolar disorder. Neuropsychiatric Disease and Treatment. 2008:4(1) 203-207. In Press

1. Surman C, Randall E, Biederman J: Attention-Deficit/Hyperactivity Disorder, Binge Eating and Obesity. Journal of

Clinical Psychiatry in press.

48

Page 49: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

2. Hammerness P, Geller D, Petty C, Lamb A, Brystol E, Biederman J: Does ADHD moderate the manifestation of anxiety disorders in children? European Child and Adolescent Psychiatry in press.

3. Hirshfeld-Becker DR, Petty C, Micco JA, Henin A, Park J, Beilin A, Rosenbaum JF, Biederman J. Disruptive behavior

disorders in offspring of parents with major depression: Associations with parental behavior disorders. J Aff Disorders in press.

4. Wilens T, Adamson J, Monuteaux M, Faraone S, Schillinger M, Westerberg D, Biederman J. Impact of Prior Stimulant

Treatment for Attention-Deficit Hyperactivity Disorder in the Subsequent Risk for Cigarette Smoking, Alcohol, and Drug Use Disorders in Adolescent Girls. Arch Ped Adolesc Med. 2008. in press

Submitted Manuscripts:

1. Biederman J, Mick E, Hammerness P, Aleardi M, Dougherty M, Wozniak J: An open-label long-term treatment trial of risperidone monotherapy in children with bipolar disorder. Clinical Therapeutics submit

2. Biederman J, Ball SW, Monuteaux MC, Mick E, Spencer TJ, McCreary M, Cote M, Faraone SV: Towards

Understanding the Comorbidity Between Attention Deficit Hyperactivity Disorder and Major Depression in Girls. Archives of General Psychiatry submit

3. Biederman J, Hammerness P, Doyle R, Joshi G, Aleardi M, Mick E: Risperidone Monotherapy and Improvement in

ADHD symptoms in Children with Bipolar Disorder. Journal of Child and Adolescent Psychopharmacology submit

4. Biederman J, Mick E, Surman C, Doyle R, Hammerness P, Dougherty M, Aleardi M, Spencer T: Long term effects of OROS methylphenidate in the treatment of late onset ADHD. Journal of Attention Disorders submit

5. Biederman J, Pliszka SR: Efficacy of Modafinil in Children and Adolescents by Subtype of Attention-

Deficit/Hyperactivity Disorder. Journal of Pediatrics submit

6. Biederman J, Seidman LJ, Petty C, Fried R, Doyle AE, Cohen DR, Kenealy DC, Faraone SV: Effects of stimulant medication on neuropsychological functioning in young adults with ADHD. Journal of Developmental and Behavioral Pediatrics submit

7. Fried R, Petty C, Fanueil A, Faraone SV, Biederman J: Subtests Of The WAIS-III Predict Negative Functional

Outcomes Of Adults With ADHD. Psychiatric Services submit

8. Hirshfeld-Becker DR, Masek BJ, Henin A, Blakely LR, Rettew D, Dufton L, Segool N, Biederman J: An Open Pilot Trial of an Early Cognitive-Behavioral Parent-Child Intervention for Young Anxious Children. Cognitive and Behavioral Practice submit

9. Spencer T, Adler LA, Weisler RH, Anderson CS, Silverberg A, Youcha SH: Triple-bead mixed amphetamine salds

SPD465, a novel, enhanced extended-release amphetamine formulation for the treatment of adults with ADHD a randomized, double-blind, multicenter, placebo-controlled study. Biological Psychiatry submit

10. Spencer T, Swanson J, Weidenman M, Veach J, Faleck H, Markabi S: Pharmacodynamic profile of Ritalin LA, a new

modified-release dosage form of Ritalin, in children with ADHD. Journal of Clinical Psychiatry submit

Other Publications:

49

Page 50: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

1. Biederman J.: New directions in pediatric psychopharmacology. Drug Therapy 12: 147-168, 1982 2. Biederman J and Hoge SK.: New approaches to childhood depression. Drug Therapy 125-136, 1985 3. Biederman J.: Fenfluramine in autism (Review). Biological Therapies, July 1985 4. Biederman J.: Desipramine in the treatment of attention deficit disorder. Biological Therapies, August 1986. 5. Biederman J.: Attention deficit disorder in adolescents. Psychiatric Annals 19(11): 587-597, 1989. 6. Biederman J.: Attention deficit disorder. Annals of Clinical Psychiatry 3; 9-22, 1991. 7. Biederman J.: Sudden death in children treated with a tricyclic antidepressant: A commentary. Biological Therapies in Psychiatry. Mosby Year Book, Littleton, MA; 1991, pp 1-4. 8. Wilens T, Steingard R, Biederman J.: Clomipramine for comorbid disorders (Letter). J Am Acad Child & Adol Psychiatry 31: 171, 1992. 9. Wilens T, Biederman J, Steingard R, Geist D, Spencer T.: Nortriptyline in the treatment of ADHD: A chart review

of 58 cases. Psychiatry Drug Alerts 7(6), 1993. 10. Wilens T, Biederman J, Spencer T, Geist D.: A retrospective study of serum levels and electrocardiographic effects of nortriptyline in children and adolescents. Psychiatry Drug Alerts 7(6), 1993. 11. Wilens T, Spencer T, Biederman J.: Pharmacotherapy of Adult ADHD. American Society of Clinical Psychopharmacology Progress Notes 5(1), 1994. 12. Wilens T, Spencer T, Biederman J.: Pharmacotherapy of Adult Attention Deficit Psyhopharmacologists 4, 1994. 13. Spencer T, Biederman J, Steingard R, Wilens T.: Bupropion exacerbates tics in children with attention-deficit hyperactivity disorder and Tourette's Syndrome. Tourette Syndrome Association, Inc. Medical Letter 6, 1994. 14. Biederman J, Thisted RA, Greenhill L, Ryan N.: Safety of desipramine in children. Progress Notes, American Society of Clinical Psychopharmacology Vol 5(3): 2-4, Summer 1994. 15. Wozniak J, Biederman J.: Childhood mania exists and coexists with ADHD. Progress Notes, American Society of Clinical Psychopharmacology Vol 6(2): 4-5, Spring 1995. 16. Spencer T, Wilens T, Biederman J.: A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Psychiatry Drug Alerts 9, 1995. 17. Spencer T, Wilens T, Biederman J.: Tricyclic antidepressant treatment of hyperactivity. Current Science Ltd 7: 304-307, 1995. 18. Spencer T, Wilens T, Biederman J.: Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. Psychiatry Drug Alerts 10(7), 1996. 19. Milberger S, Biederman J, Faraone S, Chen L and Jones J: Is maternal smoking during pregnancy a risk factor

for attention deficit hyperactivity disorder in children? (Am J Psychiatry 153: 1138-1142, 1996) The Journal of NIH Research 8: 24-25, 1996.

20. Wilens TE, Biederman J, Spencer T.: Pharmacotherapy of attention deficit hyperactivity disorder in adults. CNS Drugs 9(5): 347-356, 1998.

50

Page 51: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

21. Frazier JA, Spencer TJ, Wilens TE, Wozniak J, Biederman J.: Childhood-onset schizophrenia as the prototypic psychotic disorder of childhood. Psych Clinics of North America Annual of Drug Therapy (In Press). 22. Wilens T, Spencer T, Biederman J.: ADHD and substance abuse; and Psychopharmocology of ADHD. In: Brown T, ed. Subtypes of Attention Deficit Disorders in Children, Adolescents, and Adults. Washington DC: American Psychiatric Press, 1998: Accepted for publication. 23. Wilens T, Spencer T, Biederman J, Schleifer D.: Attention-deficit/hyperactivity disorder. In: Finberg L, ed. Saunders Manual of Pedicatric Practice. Philadelphia: WB Saunders, 1998: 168-172. 24. Wilens T, Spencer T, Frazier J, Biederman J: Psychopharmacology in children and adolescents. In: Handbook of Child Psychopathology, eds Ollendick T, Hersen M, Plenum Publishing, 3rd edition, New York; 1998: 603-636. 25. Wilens T, Biederman J, Spencer T: Pediatric Psychopharmacology. In: Psychologists Desk Reference, eds Koocher GP, Norcross JC, Hill S. Oxford University Press, London, 1998: 404-412. 26. Wilens T, Spencer T, Biederman J: Pharmacotherapy of ADHD in adults. In: Barkley R, ed. Attention Deficit

Hyperactivity Disorder: A Handbook for Diagnosis and Treatment (2nd ed), Guilford Press, New York; 1998: 592-606. 27. Wilens T, Spencer T, Biederman J: Pharmacotherapy of adult attention deficit hyperactivity disorder. In: Dunner

D, Rosenbaum J Eds. Annual Review of Psychiatry, American Psychiatric Association Press. Washington 1999. (Accepted for publication). 28. Wilens T, Biederman J, Spencer T: Attention-deficit/hyperactivity disorder in youth. In: Oldham JM, Riba M (Eds).

Annual Review of Psychiatry, American Psychiatric Association Press, Washington, 1999. (Accepted for publication). 29. Mick E, Biederman J, Faraone S: Comment on Lambert and Hartsough. Journal Learning Disabilities, July-August

2000 33(4):314-16. 30. Biederman J et al. Growth deficits and Attention Deficit/Hyperactivity Disorder revisited: Impact of gender,

development and treatment. Pediatrics, May 2003; 111: 1010-6. (Journal Watch Psychiatry) 31. Biederman, Joseph M.D Faraone, Stephen V. Ph.D Adoption Study Of ADHD: Drs. Biederman and Faraone reply.

Journal of the American Academy of Child & Adolescent Psychiatry. 41 12:1390-1391, 2002 32. Smoller JW, Yamaki L, Fagerness JA, Racette S, Rosenbaum J, Biederman J, Slaugenhaupt SA, Sklar P: The

Corticotropin Releasing Hormone Gene And Behavioral Inhibition In Children At Risk For Panic Disorder. ACNP Bulletin (Submitted)

33. Charney DS, Berrettini W, Biederman J, Innis RB, Nestler EJ, Rush AJ. Maintaing a steady course one of the “hottest

journals of the millennium”. Biological Psychiatry 58(6): 433-4, September 2005 Books/Book Chapters:

1. Kagan J, Reznik RS, Snidman N, Johnson MO, Gibbons J, Gersten M, Biederman J, Rosenbaum J.: Analog of panic disorder. In Ballenger J (Ed.) Neurobiology of Panic Disorder. Alan R. Liss, pp 71-87, 1990.

2. Rosenbaum JF, Biederman J, Gersten M.: Anxiety disorders and behavioral inhibition. In Resnick J.S. (Ed.) 3. Perspectives on Behavioral Inhibition. University of Chicago Press Chicago, pp 255-270, 1989.

4. Biederman J, and Steingard R.: Psychopharmacology for Children and Adolescents. In Jellinek M.S. and

51

Page 52: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

Herzog D.B. (Eds). MGH Handbook of Psychiatric Management of Inpatient Pediatric Patients. Yearbook Medical Publishers, Littleton MA, pp 435-367, 1990.

5. Biederman J, and Steingard R.: Pedicatric Psychopharmacology. In Gelenberg A et al (Eds). The Practitioner's Guide to

Psychoactive Drugs, Plenum Medical Book Company, pp 341-388, 1991.

6. Biederman J, and Steingard R.: Attention Deficit Hyperactivity Disorder. In Hyman SE and Jenike M (Eds) Manual of Clinical Problems in Psychiatry. Little Brown, Boston, pp 150-163, 1990.

7. Biederman J.: Familial Risk Factors in Attention Deficit Disorder. In N Amir, Rapin, I., Branski D. (Eds) Pediatric

Neurology: Behavior and Cognition in the Child with Brian Dysfunction. Pediatr Adolesc Med. Basel, Karger, vol 1 pp 70-94, 1991.

8. Biederman J, and Steingard R.: Pediatric Psychopharmacology: A Primer for the Clinician. WHO Monograph #27,

1990 (World-wide distribution).

10. Biederman J, and Steingard R.: Pediatric Psychopharmacology: A Primer for the Clinician. WHO Monograph #27, 1990, Spanish Translation (World-wide distribution).

9. Biederman J.: Psychopharmacology. In Wiener J (Ed). Textbook of Child and Adolescent Psychiatry. American

Psychiatric Press, Washington, DC. pp 545-571 1992.

10. Biederman J, and Steingard R.: Psychopharmacology for Children and Adolescents. In Cassem N. (Ed). MGH Handbook of General Hospital Psychiatry Third Edition. Yearbook Medical Publishers, Littleton, MA, 1991.

11. Wilens T, and Biederman J.: The Stimulants. Psychiatric Clinics of North America. Saunders Co., Philadelphia,

191-222, 1992.

12. Biederman J, Faraone S, Lapey K.: Comorbidity of Diagnosis in Attention Deficit Hyperactivity Disorder (ADHD). Child and Adolescent Psychiatric Clinics of North America 1(2): 335-361, 1992.

13. Biederman J, Rosenbaum JF, Faraone S, Hirshfeld DR, et al.: Behavioral inhibition as a risk factor for childhood-onset

anxiety disorders. Child and Adolescent Psychiatric Clinics of North America 2(4): 667-684, 1993.

14. Spencer T, Wilens T, Biederman J.: Tricyclic antidepressant treatment of hyperactivity. Current Opinion in Psychiatry 7: 304-307, 1994.

15. Faraone S, Biederman J.: Genetics of Attention Deficit Hyperactivity Disorder. In L. Greenhill (Ed) Child

and Adolescent Psychiatric Clinics of North America: Disruptive Behavior Disorders. Philadelphia: WB Saunders, 3: 285-302, 1994.

16. Spencer T, Wilens T, Biederman J.: Psychotropic medication for Children and Adolescents. In M. Riddle (Ed) Child

and Adolescent Psychiatric Clinics of North America: Pediatric Psychopharmacology I. Saunders Co., Philadelphia, pp 97-122, 1995.

17. Wilens T, Spencer T, Biederman J.: Pharmacotherapy of Adult ADHD. In A Comprehensive Guide to Attention Deficit

Disorder in Adults, Nadeau, K.G. (Ed), Brunner/Mazel, Inc., New York, pp 168-188, 1995.

18. Biederman J, Rosenbaum J, Chaloff J, Kagan J.: Behavioral Inhibition as a Risk Factor. In Anxiety Disorders in Children and Adolescents, J. (Ed), The Guilford Press, New York, March 1995.

19. Pollock R, Rosenbaum J, Marrs A, Miller B, Biederman J.: Anxiety Disorders of Childhood: Implications for Adult

Psychopathology. Psychiatric Clinics of North America. Saunders Co., Philadelphia, 18: 745-766, 1995.

52

Page 53: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

20. Biederman J, Spencer T, Wilens T.: ADHD: Pharmacotherapy. In Treatment of Childhood Disorders. G Gabbard, J McDermott and E. Weller (Eds). American Psychiatric Press, Washington DC, 1995.

21. Wilens T, Spencer T, Biederman J.: ADHD and Substance Abuse Disorders: In Subtypes of Attention Deficit Disorders

in Children, Adolescents, and Adults, Brown, T(Ed). American Psychiatric Press, Washington, DC, 1995.

22. Wilens T, Spencer T, Biederman J.: Attention Deficit Hyperactivity Disorder and the psychoactive substance use disorders. In Pediatric Substance Use Disorders, Jaffee, S.(Ed). Child and Adolescent Psychiatric Clinics of North America 5: 73-92, 1995.

23. Biederman J, Wilens T, Spencer T, Faraone S, Mick E, Ablon J, Kiely K.: Diagnosis and Treatment of Adults with

Attention Deficit Hyperactivity Disorder. In M.H. Pollack, M.W. Otto, & J.F. Rosenbaum (Eds.)

24. Challenges in psychiatric treatment: Pharmacologic and psyhosocial strategies. Guilford Press, New York, 1996.

25. Biederman J, Faraone S, Kiely K.: Comorbidity of Childhood Disorders. In Do They Outgrow It? Long Term Outcome of Childhood Disorders, Lily Hechtman, MD (Ed.). American Psychiatric Press, Washington, pp 39-76,1996.

26. Faraone S, Biederman J, Kiely K.: Cognitive Functioning, Learning Disability and School Failure in Attention Deficit

Hyperactivity Disorder. In Language, Learning and Behavior Disorders, J. Beitchman, et al. (Eds.).Cambridge University Press, New York, pp 247-272, 1996.

27. Biederman J, Spencer T, Wilens T.: ADHD: Pharmacotherapy. In Synopsis of Treatments of Psychiatric Disorders,

Gabbard G, Atkinson S. (Eds). American Psychiatric Press, Washington DC, 1996.

28. Spencer T, Biederman J, Wilens T.: Pharmacotherapy of ADHD: A life span perspective. Dickstein L, Riba M, Oldham J.(Eds.). American Psychiatric Press, Washington, DC 1997.

29. Biederman J, Spencer T, Wilens T.: Psychopharmacology in Children and Adolescents. In Handbook of Pediatrics,

Nelson (Ed)(In Press).

30. Spencer T, Wilens T, Biederman J.: ADHD and Depression. In Subtypes of Attention Deficit Disorders in Children, Adolescents, and Adults, Brown T(Ed). American Psychiatric Press, Washington DC (In Press).

31. Wozniak J, Biederman J, Spencer T, Wilens, T.: Pediatric Psychopharmacology. In The Practitioner's Guide to

Psychoactive Substances, A. Gelenberg and E. Bassuk (eds), 4th Edition. American Psychiatric Press (In Press).

32. Leonard H, Jensen P, Vitiello B, Ryan N, March J, Riddle M, Biederman J.: Ethical Issues in Psychopharmacological Treatment Studies in Children and Adolescents. In Ethical Issues in Research with Children and Adolescents. Lawrence Erlbaum Associates, Hillside, New Jersey (In Press).

33. Wilens T, Spencer T, Biederman J, Linehan C.: Pediatric Psychopharmacology. In Treatments of Psychiatric Disorders,

Michels R (ed.), Vol 2. J.B. Lippincott Co., Washington DC (In Press).

34. Wilens T, Spencer T, Biederman J, Schleifer D.: Attention-Deficit Hyperactivity Disorder. In Manual of Pediatric Practice, L. Finberg (ed). W.B. Saunders Press, Philadelphia 1998.

35. Biederman J, Spencer T, Wilens T.: Psychopharmacology in Children and Adolescents. In Textbook of Child

Psychiatry, Wiener J. (ed) (In Press).

36. Biederman J, Spencer T, Wilens T.: Approach to the patient with attention problems or hyperactivity. In MGH Practical Guide to Psychiatry for Primary Care Physician, T. Stern and J. Herman (eds). Little, Brown and Company, Boston, MA (In Press).

53

Page 54: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

37. Biederman J, Spencer T, Wilens T.: Psychopharmacology in Children and Adolescents. In Massachusetts General Hospital: Handbook of General Hospital Psychiatry, N. Cassem (ed). Mosby Year Book, Inc., Boston, MA.

38. Spencer TJ, Biederman J, Wilens T.: Psychopharmacology of ADHD with antidepressants. In ADHD: A Handbook for

Diagnosis and Treatment, R. Barkley. The Guilford Press, New York (In Press).

39. Wilens TE, Spencer T, Biederman J.: Pediatric psychopharmacology. In Psychologist Desk Reference, G Koocher,J Norcross and S Hill (ed.), Oxford University Press, New York (In Press).

40. Geller D, Biederman J, Jones J, Shapiro S, Schwartz S, Park K.: Obsessive-compulsive disorder in children and

adolescents: A review. In Harvard Review of Psychiatry 5(5), (In Press).

41. Wilens TE, Spencer T, Biederman J.: Pharmacotherapy of adult ADHD. In ADHD: A Handbook for Diagnosis and Treatment, R Barkley. The Guildford Press, New York (In Press).

42. Wilens TE, Biederman J, Spencer T.: Pharmacotherapy of Adult Attention Deficit Hyperactivity Disorder. In the

Psychiatric Clinics of North America: Annual of Drug Therapy, Vol.5 (In Press).

43. Bostic J, Wilens T, Biederman J, Spencer T.: Pharmacological treatment of juvenile depression. In Psychiatric Clinics of No. America: Annual of Drug Therapy, Saunders Press, Philadelphia, (6):175-191, 1999.

44. Wilens T, Biederman J, Spencer T: ADHD in youth. In Hendren RL(Ed.): Disruptive Behavior Disorders in Children and Adolescents (Review of Psychiatry Series; Oldham JO and Riba MB, Eds.). Washington, DC, American Psychiatric Press, 1999.

45. Spencer T, Biederman J, Wilens T: Attention-deficit hyperactivity disorder and comorbidity. In Pediatric Clinics of

North America 46(5): 915-927, 1999.

46. Biederman J, Spencer T: The “atypicality” of depression in youth”. In Maj M, Sartorius N (Eds.): Depressive Disorders (WPA Series: Evidence and Experience in Psychiatry, Vol. 1). John Wiley and Sons Ltd, 1999.

47. Spencer T, Wilens T, Biederman J, Wozniak J, Crawford M. ADHD with mood disorder. In Brown T, ed. Attention

Deficit Disorder and Comorbidities in Children, Adolescents, and Adults. Washington DC: American Psychiatric Press, 2000:79-124.

48. Wilens T, Spencer T, Biederman J. ADHD and Substance abuse; and Psychopharmacology of ADHD. In: Brown T, ed.

Attention Deficit Disorder and Comorbidities in Children, Adolescents, and Adults. Washington DC: American Psychiatric Press, 2000:319-340.

49. Wilens T, Spencer T, Biederman J. Psychopharmacology of ADHD. In: Brown T, ed. Attention Deficit Disorder and

Comorbidities in Children, Adolescents, and Adults. Washington DC: American Psychiatric Press, 2000:509-536.

50. Spencer T, Biederman J, Wilens T: Pharmacotherapy of attention deficit hyperactivity disorder: Child and Adolescent Psychiatric Clinics of North America of Psychopharmacology 2000;9:77-97.

51. Spencer T, Biederman J, Coffey B, Geller D, Faraone SV, Wilens T. Tourette disorder and ADHD. In Advances in

Neurology, Lipincott, Williams and Wilkins. Cohen D, Jankovic J, Goetz C, ed. 2001;85:57-78.

52. Biederman J, Spencer T, Wilens T, Greene R. Attention Hyperactivity Disorder. Treatment of Psychiatric Disorders. American Psychiatric Press, 2001.

53. Faraone SV, Biederman J: Pathophysiology of Attention-Deficit/Hyperactivity Disorder, in

Neuropsychopharmacology: The Fifth Generation of Progress. Edited by Davis KL, Charney D, Coyle JT, Nemeroff C. Philadelphia, PA, Lippincott Williams & Wilkins, 2002, pp 577-596

54

Page 55: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

54. Wilens TE, Spencer TJ, Biederman J, Schleifer D: Attention-Deficit Hyperactivity Disorder. Philadelphia, PA, W.B.

Saunders Press, 2002 55. Weissman M.M., Biederman J. Chapter Major Depression & Bipolar Disorder in Adolescents: Epidemiology,

Phenomenology Course and Comorbidty. Prepared for the Annenberg Sunnylands Trust Foundation Depression and Bipolar Disorder Consensus Committee, 2003

56. Faraone SV, Biederman J, Spencer T: New data about stimulant effects on growth, in ADHD Research Report: Special

Edition. Hasbrouck Heights, NJ, Veritas Institute for Medical Education Inc., 2003 57. Biederman J, Spencer T, Wilens T. Chapter 50:Psychopharmacology In: Textbook of Child and Adolescent Psychiatry.

Edited by Wiener JM, Dulcan M. American Psychiatric Publishing 2004 58. Biederman J: Early-Onset Bipolar Disorder. The Comprehensive Textbook of Psychiatry Eighth Edition, volume 2.

Edited by Sadock B, Sadock V. New York, NY Lippincott Williams & Wilkins 2005, pp 3274-3279.

59. Monuteaux M, Blacker D, Biederman J, Buka S: Symtomatic subtypes of conduct disorder: A critical review, in Psychology of Aggression. Edited by Morgan J. Hauppage, NY, Nova Science Publishers, 2005, pp 1-27.

60. Wilens T, Biederman J, Spencer T: The patient with attention-deficit hyperactivity disorder, in Massachusetts General

Hospital Guide to Primary Care Psychiatry. Edited by Stern T, Herman JB, Slavin PL. New York, NY, The McGraw-Hills Companies Inc., 2004

61. Biederman J, Spencer T, Wilens T: Chapter 50: Psychopharmacology, in Textbook of Child and Adolescent

Psychiatry. Edited by Wiener JM, Dulcan M. Washington, D.C., American Psychiatric Publishing, 2004, pp 931-973

62. Biederman J. (Executive Editor) ADHD Across the Lifespan: An Evidence-Based Understanding From Research to Clinical Practice.Veritas Institute for Medical Education, Inc and Medlearning, Inc, 2006.

63. Faraone SV, Middleton, FA, and Biederman, J. An integrated neurobiological model of ADHD. In J Biederman, Ed.

ADHD across the lifespan: An evidenced based understanding from research to clinical practice. Pgs 41-106 Veritas Institute, 2006.

64. Biederman J, Spencer T, Wilens T: Approach to the patient with attention problems or hyperactivity, in Practical Guide

to Psychiatry for Primary Care Clinicians. Boston, Little, Brown and Company, in press

65. Biederman J, Spencer T, Wilens T: Evidence based therapeutics approaches for the Attention Deficit Hyperactivity Disorder, in Treatments of DSM-IV-TR Psychiatric Disorders. Edited by Gabbard GO, in press

66. Wilens T, Spencer T, Biederman J: Attention Deficit/Hyperactivity Disorder, in Conn's Current Therapy. Edited by

Rakel RE, Bope ET, WB Saunders, in press

67. Biederman, Joseph;: Pediatric Bipolar Disorder: The Promise of Psychopharmacotherapy. In: Bipolar psychopharmacotherapy: Caring for the patient. Edited by Akiskal, Hagop S.; Tohen, Mauricio; Hoboken, NJ, US: John Wiley & Sons, Inc, 2006. pp. 279-299.

68. Biederman, Joseph; Spencer, Thomas; Wilens, Timothy; Psychopharmacology. In: Essentials of child and adolescent

psychiatry. Edited by Dulcan, Mina K.; Wiener, Jerry M.; Washington, DC, US: American Psychiatric Publishing, Inc., 2006. pp. 635-698.

55

Page 56: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

69. Wilens T, Prince J, Biederman J. Chapter 25: Attention-Deficit/Hyperactivity Disorder in Adults. In McBurnett K. & Pfiffner L (Eds), Attention Deficit Hyperactivity Disorder: Concepts, Controversies, New Directions. 2008. pp 273-290.

70. Stern T, Rosenbaum J, Fava M, Biederman J, Rauch S: Massachusetts General Hospital: Comprehensive Clinical

Psychiatry. Edited by Stern T and Rosenbaum J. Philadelphia, Pennsylvania, Mosby Elsevier, 2008. Abstracts and Manuscripts in Year Books and Digests and Media: 1. Biederman J, Baldessarini RJ, Harmatz J, Rivinus TM, Herzog DB, Schildkraut JJ.: Heterogeneity in anorexia

nervosa (Biological Psychiatry 21: 213-216, 1986). In Year Book of Psychiatry, 1987. 2. Biederman J.: Pharmacological treatment of adolescents with affective disorders and attention deficity disorder (Psychopharmacology Bulletin 24: 81-87, 1988). In Psychiatry Digest 8: 17-8, 1988; The Digest, Almere, Holland. 3. Biederman J, Gonzalez E, Bronstein B, De Monaco H, Wright V.: Cutaneous reactions to desipramine in pediatric patients (Journal of Clinical Psychology 49: 178-183(Lead Article), 1998). In Dermatology Digest 8: 9-10, 1988; The Digest, Almere, Holland. 4. Rosenbaum JF, Biederman J, et al.: Behavioral inhibition in children of parents with panic disorder and agoraphobia: A controlled study (Arch Gen Psychiatry 45: 463-470, 1988). In Digest of Neurology and Psychiatry, The Institute of Living, Hartford CT; 1988. 5. Rosenbaum JF, Biederman J, Gersten M, et al.: Behavorial inhibition in children of parents with panic disorder and agoraphobia: A controlled study (Arch Gen Psychiatry 45: 463-470, 1988). In Chess and Hertz, Annual Progress in Child Psychiatry and Child Development, 1989. 6. Biederman J, Rosenbaum JF, Hirshfeld DR, Gersten M, Meminger SR, Kagan J.: Psychiatric correlates of behavioral inhibition in young children of parents with and without psychiatric disorders (Arch Gen Psychiatry 47: 21-27, 1990). Psychiatry Digest, Clinical Digest Series, 1990(English and Spanish translation). 7. Biederman J, Rosenbaum JF, Hirshfeld DR, Gersten M, Meminger SR,Kagan J.: Psychiatric correlates of behavioral inhibition in young children of parents with and without psychiatric disorders (Arch Gen Psychiatry 47: 21-27, 1990). In Digest of Neurology and Psychiatry, The Institute of Living, Hartford CT; p. 80, Mar-Apr 1990. 8. Biederman J, Baldessarini R, Wright V, et al.: A double-blind placebo-controlled study of desipramine in the

treatment of attention deficit disorder: I. Efficacy (J Am Acad Child & Adol Psychiatry 28: 777-785, 1989). In Chess and Hertzig, Annual Progress in Child Psychiatry and Child Development, 1990. 9. Biederman J, Baldessarini R, Wright V, et al.: A double-blind placebo-controlled study of desipramine in the treatment of attention deficit disorder: I. Efficacy (J Am Acad Child & Adol Psychiatry 28: 777-785, 1989). In Mosby Year Book of Psychiatry, 1990. 10. Biederman J, Faraone SV, Keenan K.: Separation of DSM-III atttention deficit disorder and conduct disorder: Evidence from a family-genetic study of American child psychiatric patients. Selected Abstracts from the 1990 New Research Section of the American Academy of Child & Adol Psychiatry Annual Meeting, Chicago. J Am Acad Child & Adol Psychiatry 30: 164, 1991. 11. Biederman J, Rosenbaum JF, Hirshfeld DR, Kagan J.: Further evidence of an association between behavioral inhibition and anxiety disorders: Family-genetic findings in first-degree relatives of a longitudinal cohort of children with and without behavioral inhibition. Selected Abstracts from the 1990 New Research Section of the

56

Page 57: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

American Academy of Child & Adol Psychiatry Annual Meeting, Chicago. J Am Acad Child & Adol Psychiatry, 30: 165, 1991. 12. Steingard R, Biederman J, Keenan K, Moore C.: Comorbidity in the interpretation of rates of dexamethasone nonsuppression in clinically referred children (Biological Psychiatry 28: 193-202, 1990). In Digest of Neurology and Psychiatry, The Institute of Living, Hartford CT; p.274, Nov-Dec 1990. 13. Faraone SV, Biederman J, Keenan K, Tsuang MT.: Family-genetic and psychosocial risk factors in clinically referred girls with DSM-III attention deficit disorder (Am J Psychiatry 148: 112-117, 1991). Clinical Digest Series, 1991 (English and Spanish translation). 14. Biederman J, Rosenbaum JF, Hirshfeld DR, Gersten M, Meminger SR, Kagan J.: Psychiatric correlates of behavioral inhibition in young children of parents with and without psychiatric disorders (Arch Gen Psychiatry 47: 21-27, 1990). In Chess and Hertzig, Annual Progress in Child Psychiatry and Child Development, 1991. 15. Biederman J.: The diagnosis and treatment of adolescent anxiety disorders (J Clinical Psychiatry 51: 20-27, 1990) In Mosby Year Book of Psychiatry, 1991. 16. Biederman J.: Sudden death in children treated with a tricyclic antidepressant: A commentary (J Am Acad Child Adol Psychiatry 30: 495-497, 1991). In Bash Magazine, Monthly Journal of the Eating and Mood Disorders, 1991. 17. Biederman J, Faraone SV, Keenan K.: Evidence of familial association between attention deficit disorder and major affective disorders (Arch Gen Psychiatry 48: 633-642, 1991). In Digest of Neurology and Psychiatry, p. 259 Nov-Dec 1991. 18. Biederman J, Rosenbaum JF, Hirshfeld, DR, Bolduc EA, Kagan J.: A high risk study of young offspring with

panic disorder agoraphobia with and without comorbid major depression. (Psychiatry Research 37: 333-348, 1991). In Digest of Neurology and Psychiatry, p. 258, Nov-Dec 1991.

19. Biederman J, Rosenbaum JF, Hirshfeld DR, Bolduc EA, Kagan J.: A high risk study of young offspring with panic disorder agoraphobia with and without comorbid major depression. (Psychiatry Research 37: 333-348, 1991). Clinical Digest Series, 1992. 20. Biederman J, Newcorn J, Sprich SE.: Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders (Am J Psychiatry 148: 564-578, 1991). In Clinician's Research Digest (Am Psychological Association) 9(12): 4, 1991. 21. Biederman J, Rosenbaum JF, Hirshfeld DR, et al.: Comorbidity of parental anxiety disorders as risk for childhood onset anxiety in inhibited children (Am J Psychiatry 1992 149: 475-481). Biological Psychiatry, 31: 65A (Supplement), 1992. 22. Biederman J, Rosenbaum JF, Hirshfeld Dr, Bolduc EA, Kagan J.: A high risk study of young offspring with panic disorder agoraphobia with and without comorbid major depression (Psychiatry Research 37: 333-348, 1991). Selected Abstracts from the 1991 New Research Section of the American Academy of Child & Adol Psychiatry Annual Meeting, San Francisco. J Am Acad Child & Adol Psychiatry 31: 576, 1992. 23. Biederman J, Faraone SV, Keenan K, et al.: Family-genetic risk factors and comorbidity in psychiatrically and pediatricallly referred children with ADHD. Selected Abstracts from the 1991 New Research Section of the American Academy of Child & Adol Psychiatry Annual Meeting, San Francisco. J Am Acad Child & Adol Psychiatry 31: 576-577, 1992. 24. Biederman J, Faraone SV, Keeenan K, et al.: Family-genetic risk factors and comorbidity in psychiatrically and pediatrically referred children with ADHD. Biological Psychiatry 246A, 1992.

57

Page 58: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

25. Rosenbaum JF, Biederman J, Buldoc, et al.: Comorbidity of parental anxiety disorders as risk for childhood onset anxiety in inhibited children. Biological Psychiatry 65A, 1992. 26. Semrud-Clikeman M, Biederman J, Sprich S, Krifcher B, Faraone SV, Norman D.: Comorbidity between attention deficit disorder with hyperactivity and learning disability: A review and report in a clinically referred sample (J Am Acad Child Adol Psychiatry 31: 439-448, 1992). Psychiatry Digest 8: 13, 1992, Clinical Digest Series, PO Box 2548, Northbrook, IL 60065. 27. Rosenbaum JF, Biederman J, Hirshfeld Dr, et al.: Comorbidity of parental anxiety disorders as risk for childhood onset anxiety in inhibited children (Am J Psychiatry 149: 475-481, 1992). Digest of Neurology & Psychiatry, The Institute of Living, Hartford, CT; p. 171, Jul-Aug 1992. 28. Wilens TE, Biederman J, Baldessarini RJ, et al.: Serum Drug concentrations with fluoxetine plus desipramine (Letter, Arch Gen Psychiatry 49: 752, 1992). Psychiatry Drug Alerts Vol. VI (10): 79, Oct. 1992. 29. Biederman J, Faraone SV, Keenan K, et al.: Further evidence for family-genetic risk factors in attention deficit

hyperactivity disorder (ADHD): Patterns of comorbidity in probands and relatives in psychiatrically and pediatrically referred samples (Arch Gen Psychiatry 49: 728-738, 1992). Psychiatry Digest, 1993. Clinical Digest

Series, PO. Box 2548, Northbrook, IL 60065. 30. Biederman J, Faraone SV, Keenan K, et al.: Further evidence for family-genetic risk factors in attention deficit hyperacticity disorder (ADHD): Patterns of comorbidity in probands and relatives in psychiatrically and pediatrically referred samples (Arch Gen Psychiatry 49: 728-738, 1992). Youth Update Vol. 10, 1992, Institute for the Study of Antisocial Youth (IAY), Ontario, Canada. 31. Semrud-Clikeman M, Biederman J, Sprich S, Krifcher B, Faraone SV, Norman D.: Comorbidity between attention deficit disorder with hyperactivity and learning disability: A review and report in a clinically referred sample (J Am Acad Child Adol Psychiatry 31: 439-448, 1992). Psychiatry Digest, International Abstracts 4: 12, Jan 1993, Clinical Digest Series, P.O. Box 2548, Northbrook, IL 60065. 32. Biederman J, Faraone SV, Keenan K, et al.: Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder (ADHD): Patterns of comorbidity in probands and relatives in psychiatrically and pedicatrically referred samples (Arch Gen Psychiatry 49: 728-738, 1992). Digest of Neurology and Psychiatry, The Institute of Living, Hartford CT; p. 5, Jan-Feb 1993. 33. Biederman J, Faraone SV, Keenan K, et al.: Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder (ADHD): Patterns of comorbidity in probands and relatives in psychiatrically and pedicatrically referred samples (Arch Gen Psychiatry 49: 728-738, 1992). The Boston Globe, October 26, 1992. 34. Spencer T, Biederman J, Wright V, Danon M.: Growth deficits in children and adolescents with attention deficit hyperactivity disorder receiving treatment with desipramine: Comparison with stimulant-treated and not treated children (J Am Acad Child Adol Psychiatry 31: 235-244, 1992). Psychiatry Digest, International Abstracts, 1993, Clinical Digest Series, PO. Box 2548, Northbrook, IL 60065. 35. Spencer T, Biederman J, Wilens TE, Steingard, R.: Bupropion exacerbate tics in patients with attention deficit hyperactivity disorder and Tourette disorder (J Am Acad Child & Adol Psychiatry 32: 211-214, 1993). Psychiatry Drug Alerts 7: 35, 1993. 36. Faraone SV, Biederman J, Chen WJ, Krifcher B, Keenan K, et al.: Evidence for independent transmission of

attention deficit hyperactivity disorder and learning disability: Results from a family genetic study (Am J Psychiatry 150: 891-895, 1993). J Am Acad Child & Adol Psychiatry 32: 885, 1993.

37. Faraone SV, Biederman J, Chen WJ, Krifcher B, Keenan K, et al.: Evidence for independent transmission of

58

Page 59: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

attention deficit hyperactivity disorder and learning disability: Results from a family genetic study (Am J Psychiatry 150: 891-895, 1993). The Brown University Child and Adolescent Behavior Letter 9(7), July 1993.

38. Biederman J, Baldessarini R, Goldblatt A, Lapey K, Doyle A.: A Naturalistic study of twenty four hour ECG recordings and echocardiographic findings in children and adolescents treated with desipramine (J Am Acad Child & Adol Psychiatry 32: 805-813, 1993). Psychiatry Drug Alerts 7:59-60, 1993. 39. Wilens TE, Biederman J, Baldessarini RJ, Puopolo PR, Flood JG.: Electrocardiograpic effects of desipramine and 2-hydroxydesipramine in children and adolescents treated with desipramine (J Am Acad Child & Adol Psychiatry 32: 798-804, 1993). Psychiatry Drug Alerts 8: 59-60, 1993. 40. Wilens TE, Biederman J, Steingard R, Geist D, Spencer T.: Nortriptyline in the treatment of ADHD: A chart review of 58 cases (J Am Acad Child Adol Psychiatry 32: 343-349, 1993). Psychiatry Drug Alers Vol. VII(7), 1993. 41. Biederman J, Faraone SV, Keenan K, et al.: Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder (ADHD): Patterns of comorbidity in probands and relatives in psychiatrically and pediatrically referred samples (Arch Gen Psychiatry 49: 728-738, 1992). Newsweek, pp. 48-49, July 26, 1993. 42. Biederman J, Faraone SV, Keenan K, et al.: Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder (ADHD): Patterns of comorbidity in probands and relatives in psychiatrically and pediatrically referred samples (Arch Gen Psychiatry 49: 728-738, 1992). Psychiatry Digest, pp. 10-11, Sep 1993. 43. Biederman J, Faraone S, Doyle A, Lehman B, Kraus I, Perrin J, Tsuang M.: Convergence of the Child Behavior Checklist with structured interview-based psychiatric diagnoses of ADHD children with and without comorbidity (J Child Psychology and Psychiatry 34: 1242-1251, 1993). Clinician's Research Digest, 12(3), Mar 1994. 44. Faraone S, Biederman J, Behman B, et al.: Intellectual performance and school failure in children with attention

deficit hyperactivity disorder and in their siblings (Journal of Abnormal Psychology 102(4): 616-623. Youth Update, 12(1), Spring 1994.

45. Spencer T, Biederman J, Wilens T, Guite J.: Attention deficit hyperactivity disorder and thyroid abnormalities. Annual Meeting of the Am Acad of Child & Adol Psychiatry, San Antonio, TX, Oct. 1993. Published among top rated research abstracts in J Am Acad Child & Adol Psychiatry 33: 919, 1994. 46. Milberg S, Biederman J, Sprich-Buckminster S, Faraone S, Krifcher-Lehman B.: Are perinatal complications relevant to the manifestation of attention deficit hyperactivity disorder? Annual Meeting of the Am Acad of Child & Adol Psychiatry, San Antonio, TX, Oct. 1993. Published among top rated research abstracts in J Am Acad Child & Adol Psychiatry 33: 919, 1994. 47. Sachs G, Conklin A, Lafer B, Thibault A, Rosenbaum J, Biederman J.: Psychopathology in children of late versus early onset bipolar probands. Annual Meeting of the Am Acad of Child & Adol Psychiatry, San Antonio, TX, Oct. 1993. Published among top rated research abstracts in J Am Acad Child & Adol Psychiatry 33: 917, 1994. 48. Faraone SV, Biederman J, Milberg S.: An exploratory study of ADHD among second degree relatives (Biological Psychiatry 35: 3980402, 1994). Digest of Neurology and Psychaitry, The Institute of Living, Hartford, CT,

p. 131, Summer 1994. 49. Childhood Depression. The Boston Globe, October 25, 1994. 50. Featured interview. Currents, October 1994. 51. Spencer T, Biederman J, et al.: tricyclic antidepressant treatment of children with ADHD and tic disorders (J Am Acad Child & Adol Psychiatry 33: 1203-104, 1994). Psychiatry Drug Alerts 11: 87-88, 1994.

59

Page 60: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

52. Biederman J, Lapey K, Milberg S, et al.: Motor preference, major depression and psychosocial dysfunction among children with attention deficit hyperactivity disorder. Focus on Depression and Anxiety, 1994, PMSI bugamor B.V., The Netherlands 53. Biederman J.: Subtypes and comorbidities complicate ADHD treatment, diagnosis. Clinical Psychiatry News, 23: 1, 1995. 54. Semrud-Clikeman M, Filipek P, Biederman J.: Attention deficit disorder: Difference in the corpus callosum and shape analysis in MRI morphometric analysis (J Am Acad Child & Adol Psychiatry 33; 858-868, 1994). In ADHD Report (R. Barkley Ph.D., Editor) Vol. 2(6), December 1994. 55. Biederman J, Milberger S. Faraone SV, Guite J., Warburton R.: Associations between childhood asthma and

ADHD: Issues of psychiatric comorbidity and familiarity (J Am Acad Child & Adol Psychiatry 33: 842-848, 1994).; In ADHD Report (R. Barkley Ph.D., Editor) Vol. 2(6), December 1994.

56. Biederman J.: ADD. USA Weekend, Feb. 24-26, 1995. 57. Biederman J, Santangelo S, Faraone S, Kiely K, Guite J, Mick E, Reed E, Kraus I, Jellinek M, Perrin J.: A comprehensive evaluation of the association between enuresis and ADHD in referred pediatric samples (J Child Psychology and Psychiatry 6: 865-877, 1995). The Brown University Child and Adolescent Behavior Letter 11(2), Feb 1995. 58. Wilens T, Biederman J, Kiely K, Bredin E, Spencer T.: Emotional and behavioral disturbances in the children of

parents with opiod dependence (J Am Acad Child Adol Psychiatry (Accepted for Publication)). The Brown University Child and Adolescent Behavior Letter 11(2), Feb 1995. 59. Biederman J, Faraone S, Spencer T, Wilens T, Mick E, Lapey K.: Gender differences in a sample of adults with

attention deficit hyperactivity disorder. In Digest of Neurology and Psychiatry, The Institute of Living, Hartford CT; p. 25, Winter 1995.

60. Geller D, Biederman J, Reed E, Spencer T.: Similarities in response to fluoxetine in the treatment of children and adolescents with obsessive-compulsive disorder (J Am Acad Child Adolesc Psychiatry, 34: 36-44, 1995). Digest of Neurology & Psychiatry, The Institute of Living, Hartforde, CT; p. 67, Spring 1995. 61. Geller D, Biederman J, Reed E, Spencer T.: Similarities in response to fluoxetine in the treatment of children and adolescents with obsessive-compulsive disorder. Clinical Psychiatry News 23(6), 1995. 62. Biederman J, Jensen P, Wilens T.: High rate of comorbid illness cited in ADHD children. Primary Psychiatry 6: 16-17, 1995. 63. Biederman J.: ADD. News Edge (LA Times/Washington Post), June 21, 1995. 64. Biederman J, Faraone S, Mick E, Spencer T, et al.: High risk for attention deficit hyperactivity disorder among children of parents with childhood onset of the disorder: A pilot study. In Digest of Neurology and Psychiatry, p. 120, Sept-Oct, 1995. 65. Biederman J.: The Ritalin Generation. USA Weekend, Oct. 27-29, 1995. 66. Wozniak J, Biederman J, Kiely K, Ablon S, Faraone S, Mundy E and Mennin D.: Mania-like symptoms suggestive of childhood onset bipolar disorder in clinically referred children (J Am Acad Child Adoles Psychiatry 34: 867-876, 1995). Digest of Neurology & Psychiatry, The Institute of Living, Hartford, CT; p. 170, Fall 1995. 67. Biederman J, Faraone S.: Attention deficit hyperactivity disorder. The Harvard Mahoney Neuroscience Institute

60

Page 61: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

Letter "On The Brain" 5(1), Winter 1996. 68. Biederman J, Wilens T, Mick E, Milberger S, Faraone S, Spencer T.: Psychoative substance use disorder in adults with attention deficit hyperactivity disorder (Am J Psychiatry, 152: 1652-1658, 1995). The Institute of Living, Hartford, CT; p 25, Winter 1996. 69. Spencer T, Wilens T, Biederman J, Faraone S, Ablon S, Lapey K.: A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder (Arch Gen Psych 52: 434-443, 1996). In ADHD Report (R. Barkley Ph.D., Editor) Vol. 14, May 1996. 70. Spencer T, Wilens T, Biederman J, Faraone S, Ablon S, and Lapey K.: A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood onset attention-deficit hyperactivity (Arch Gen Psychiatry 52: 434-443, 1995). Digest of Neurology & Psychiatry, The Institute of Living, Hartford, CT; P. 165, Fall 1995. 71. Biederman J, Milberger S, Faraone S, Kiely K, Guite J, Mick E, Ablon A, Warburton R, Reed E.: Family- environment risk factors for attention-deficit hyperactivity disorder: A test of Rutter's indicators of adversity (Arch Gen Psychiatry 52: 464-470, 1995). In Mosby Year Book of Psychiatry, 1997. 72. Biederman J, Faraone S, Milberger S, Curtis S, Chen L, Marrs A, Ouellette C, Moore P, Spencer T.: Predictors of persistence and remission of ADHD into adolescence: Results from a four-year prospective follow-up study (J Am Acad Child Adolesc Psychiatry 35: 343-351). In Digest of Neurology and Psychiatry, The Institute of Living, Hartford CT; Summer 1996. 73. Prince J, Wilens T, Biederman J, Spencer T.: Clonidine for sleep disturbances associated with attention deficit hyperactivity disorder: A systematic chart review of 62 cases (J Am Acad Child Adolesc Psychiatry 35: 599-605). In Digest of Neurology and Psychiatry, The Institute of Living, Hartford CT; Summer 1996. 74. Biederman J, Wilens T, Mick E, Milberger S, Spencer T, Faraone S.: ADHD increases lifetime risk of substance abuse (Am J Psychiatry 152: 1652-1658, 1996). In Clinician's Research Digest, May 1996. 75. Biederman J.: Paying attention to ADD. Boston Parent's Paper, May 1996. 76. Milberger S, Biederman J, Faraone S, Chen L, Jones J.: Is maternal smoking during pregnancy a risk factor for attention deficit hyperactivity disorder in children? (Am J Psychiatry 153: 1138-1142, 1996). In Journal Watch for Psychiatry, November 1996. 77. Wilens T, Biederman J, Prince J, Spencer T, Faraone S, Warburton R, Schleifer D, Harding M, Linehan C.: Six-week, double-blind, placebo-controlled study of desipramine for adult attention-deficit hyperactivity disorder (Am J Psychiatry 153: 1147-1153. 1996). In Journal Watch for Psychiatry, November 1996. 78. Prince J, Wilens T, Biederman J, Spencer T, Wozniak J.: Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: A systematic chart review of 62 cases (J Am Acad Child & Adol Psychiatry 35: 599-605; 1996). In ADHD Report (R. Barkley Ph.D., Editor) Vol. 4(5), October 1996. 79. Biederman J, Faraone S, Milberger S, Guite J, Mick E, Chen L, Mennin D, Marrs A, Ouellette C, Moore P, Spencer T, Norman D, Wilens T, Kraus I, Perrin J.: A prospective four year follow-up study of attention deficit hyperactivity and related disorders (Arch Gen Psychiatry 53: 437-446, 1996) In Psychiatry Digest, December 1996. 80. Biederman J.: The Best Doctors of 1997. Boston Magazine, February 1997. 81. Biederman J, Rosenbaum J.: The prevalance of anxiety disorders. NARSAD Research Newsletter, pp. 16-17, Fall/Winter 1996.

61

Page 62: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

82. Wilens T, Biederman J, Prince J, Spencer T, Faraone S, Warburton R, Schleifer D, Harding M, Lineham C, Geller D.: Six week, double blind placebo controlled study of desipramine for adult attention deficit hyperactivity disorder (Am J Psychiatry 153: 1147-553, September 1996). In Digest of Neurology and Psychiatry, The Institute of Living, Hartford CT; p. 26, Winter 1997. 83. Biederman J, Faraone S, Marrs A, Moore P, Garcia J, Ablon JS, Mick E, Gershon J, Kearns ME.: Panic disorder and agoraphobia in consecutively referred children and adolescents (J Am Acad Child Adoles Psych 36: 214-223, 1997). In American Association of Pediatric News, April 1997. 84. Seidman L, Biederman J, Faraone S, Mennin D, Weber W, Seiverd K and Jones J.: A pilot study of neuropsychological function in ADHD girls (J Am Acad Child Adolesc Psychiatry 36: 366-73, 1997). In Digest of Neurology and Psychiatry, The Institute of Living, Hartford CT; p. 116, Summer 1997. 85. Seidmen L, Biederman J, Faraone S, Weber W, Ouellette C.: Toward defining a neuropsychology of attention deficit-hyperactivity disordre: Performance of children and adolescents from a large clinically referred sample. J Consulting and Clinical Psychology 65: 150-160, 1997. 86. Biederman J.: Resolved: Mania is mistaken for ADHD (In Press). 87. Biederman J.: Bipolar and antisocial disorders among relatives of ADHD children: Parsing familial subtypes of illness: Neuropsychiatric Genetics (In Press). 88. Faraone S, Biederman J, Mannin D, Wozniak J, Spencer T.: Attention-deficit hyperactivity disorder with bipolar disorder: A familial subtype? J Am Acad Child Adoles Psych 36: 1378-1387, 1997. 89. Faraone S, Biederman J, Jetton J, Tsuang M.: Attention deficit disorder and conduct disorder: longitudinal

evidence for a familial subtype. Psychol Med 27(2): 291-300, Mar 1997. 90. Seidman L, Biederman J, Faraone S, Weber W, Ouellett C.: Toward defining a neuropsychology of attention deficit-hyperacitivy disorder: performance of children and adolescents from a large clincially referred sample. Journal of Consult Clin Psychol 36(4): 481-485, April 1997. 91. Seidman LJ, Biederman J, Faraone S, Weber W, Mennin D, Jones J.: A pilot study of neuropsychological function in girls with AD/HD (J Am Acad Child Adolesc Psychiatry 36(3): 366-373, 1997). In Attention!, Vol. 4(1), Summer 1997. Also in Journal of Attention Disorders 2(1): 54, 1997. 92. Biederman J, Wilens T, Mick E, Faraone SV, Weber W, Curtis S, Thornell A, Pfister K, Jetton JG, Soriano J.: Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study (J Am Acad Child Adolesc Psychiatry 36: 21-29, 1997). In Journal of Attention Disorders 2(1): 56, 1997. 93. Milberger S, Biederman J, Faraone SV, Chen L, Jones J.: ADHD as associated with early initiation of cigarette smoking in children and adolescents (J Am Acad Child Adolesc Psychiatry 36: 37-44, 1997). In Journal of Attention Disorders 2(1): 57, 1997. 94. Milberger S, Biederman J, Faraone SV, Wilens TE, Chu M.: Associations between ADHD and psychoactive substance use disorders: Findings from a longitudinal study of high-risk siblings of ADHD children. Am J on Addictions 6: 318-329, 1997. 95. Biederman J, Faraone SV. Childhood mania often masked by ADHD diagnosis. Clinical Psychiatry News 26(8): (Cover article), 1998. 96. Biederman J, Wozniak J. Comorbidity high: Childhood mania, ADHD tough to tease apart. Clinical Psychiatry News. 1998.

62

Page 63: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

97. Faraone SV, Biederman J, Comorbidity with ADHD: what are the implications? Clinician's Research Digest 16(2): 5, 1998. 98. Biederman J, Faraone S, Mick E, et al.: Child Behavior Checklist findings further support comordity between ADHD and major depression in a referred sample (J Am Acad Child Adolesc Psychiatry 35: 734-742, 1996). In Year Book of Psychiatry and Applied Mental Health (In Press). 99. Biederman J, Faraone S, Mick E, et al.: Attention-deficit hyperactivity disorder and juvenile mania: An overlooked comorbidity. (J Am Acad Child Adolesc Psychiatry 35: 997-1008, 1996). In Year Book of Psychiatry and Applied Mental Health (In Press). 100. Biederman J, Faraone SV, Milberger S, et al.: Is childhood oppositional defiant disorder a precursor to adolescent conduct disorder? Findings from a four-year follow-up study of children with ADHD. (J Am Acad Child Adolesc Psychiatry 35: 1193-1204, 1996). In Year Book of Psyciatry and Applied Mental Health (In Press). 101. Biederman J, Research moves fast, but there's no cure yet. Cape Cod Times. June, 1998. 102. Biederman J, Reading, writing and Ritalin. Cape Cod Times. May 1998. 103. Biederman J, Comorbidity High, Childhood Mania, ADHD Tough to Tease Apart. International Medical News Group 1998. 104. Milberger S, Biederman J, Faraone S, Wilens T, Chu M: Associations between ADHD and psychoactive

substance use disorders: Findings from a longitudinal study of high-risk siblings of ADHD children. (Am J Addict 1997; 6: 318-329). In Brown Unversity Digest of Addiction Theory and Application 1998. 105. Seidman L, Biederman J: Neuropsychological function in adults with attention-deficit hyperactivity disorder. Digest of

Neurology and Psychiatry, The Institute of Living. 1999 106. Biederman J: Depression in attention deficit hyperactivity disorder children: “True” depression or demoralization? (J .

Affect Disorder, 47:113-22, 1998). In Digest of Neurology and Psychiatry, The Institute of Living, Hartford, CT; pring 1998 107. March JS, Biederman J, Wolkow R, Safferman A, Mardekian J, Cook EH, Cutker NR, Dominguez R, Ferguson J, Muller B, Riesenberg R, Rosenthal M, Sallee FR, Wagner KD: Sertraline in children and adolescents with obsessive-. compulsive disorder. (JAMA, 280:1752-56, 1998). In Digest of Neurology and Psychiatry, The Institute of Living, Hartford, CT; Spring 1999 108. Biederman J: Subset of children show signs of violent future. Clinical Pyschiatry News. July 1999. 109. Biederman, J: The Ritalin Riddle. LA Times. August 1999. 110 Seidman L, Biederman, J: Neuropsychological function in adults with attention deficit hypractivity disorder. Abstract in

Digest of Neurology and Psychiatry. The Institute of Living. Hartford, CT. Winter 1999. 111. Biederman J: Medications reduce incidence of substance abuse among ADHD patients. NIDA NOTES 14(4), 1999. (In

press). 112. Best Doctors in America, Woodward/White, Inc. 1998. 113. Biederman, J: “Don’t call her an airhead”. ABC News report: ADHD Not Just a Boy Problem. July 1999.

63

Page 64: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

114. Biederman J, Wilens TE, Mick E, et al: Does attention deficit hyperactivity disorder impact the developmental course of drugs and alcohol abuse and dependence? Biol Psychiatry 44:269-273, 1998. In Year Book of Psychiatry and Applied Mental Health, 2000. Mosby-Year Book, Inc.

115. Rohde LA, Biederman J, Busnello EA: ADHD in a school sample of Brazilian aadolescents: A study of prevalence,

comorbid condiditons and impairments. J Am Academy of Child Adol Psychiatry 38:716-722. In Current Literature. J Atten Disorders 3(3), October 1999.

116. Biederman J: “Study: children given hyperactivity drugs not more likely to abuse drugs”. The Patriot Ledger, August

1999. 117. Biederman J: “Study eases hyperactivity drug worry”. Associated Press. August 1999. 118. Biederman J: “Drug therapy lowers substance abuse risk in ADHD kids”. Reuters Health. August 1999. 119. Biederman J, Faraone SV, Taylor A, Sienna M, Williamson S, Fine C: Diagnostic continuity between child and

adolescent ADHD: Findings from a longitudinal clinical sample. (J Am Acad Child Adol Psychiatry 37:305-313, 1998). The ADHD Report. 1999.

120. Biederman J: “Girls, Boys Show Similar Signs of Hyperactivity”. Los Angeles Times. July 1999. 121. Biederman J, Mick E, Prince J, et al: Systematic chart review of the pharmacologic treatment of comorbid attention

deficit hyperactivity disorder in youth with bipolar disorder. (J Child and Adolescent Psychopharmacology 1999; 9: 247-256).

122. Biederman J “ Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective

follow up study” Focus: The Journal of Lifelong Learning in Psychiatry. 123. Biederman J “ Breaking News: The Social and Economic Impact of ADHD” American Medical Association

Department of Science News Media Briefing. September 2004. 124. Biederman J:”Teen Girls with ADHD at Higher Risk of Mental Illness”. USA Today. May 25, 2005 125. Biederman J: “The Lingering Legacy of ADHD”. Business Week Online. May 27, 2005 Abstracts and Presentations in National Scientific Meetings: 1. Belmaker RH and Biederman J.: Lithium plus haloperidol versus haloperidol alone in the treatment of excited schizoaffective illness. Abstracts of the 1977 Annual Meeting of the American Psychiatric Research Society, Rochester, NY. J Psychiatr Res, 1978. 2. Biederman J, Herzog DB, Rivinus TM, Orsulak P, Schildkraut JJ. Amitriptyline in the treatment of anorexia nervosa: A double blind placebo controlled study. Preliminary report. Abstracts of the Annual Meeting of the American Academy of Child Psychiatry (New Research Section), Washington DC, 1982. 3. Biederman J, Rivinus TM, Herzog DB, Orsulak P, Schildkraut JJ. Platelet MAO activity in anorexia nervosa patients with and without a major depressive disorder. Abstracts of the Annual Meeting of the American Psychiatric Association (New Research Section), New York, NY 1983. 4. Rivinus TM, Biederman J, Herzog DB, et al.: Anorexia nervosa and depression: A controlled family histroy study, Abstracts of the Annual Meeting of the American Academy of Child Psychiatry, San Francisco, CA, 1983.

5. Biederman J, Rivinus TM, Herzog DB, et al.: Urinary MHPG in anorexia nervosa patients with and without a

64

Page 65: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

major depressive disorder. Abstracts of the Annual Meeting of the American Psychiatric Association, Los Angeles, CA, 1984. 6. Biederman J, Rivinus TM, Herzog DB, et al.: Amitriptyline in the treatment of anorexia nervosa. Abstracts of the Annual Meeting of the American Psychiatric Association, Los Angeles, CA, 1984. 7. Gastfriend DR, Biederman J, Jellinek MS.: Desipramine in the treatment of attention deficit disorder in

adolescents. Abstracts of the NCEDU Meetings, FL, 1984. 8. Biederman J, Rivinus TM, Herzog DB, Harmatz JS, Schildkraut JJ. Biochemical correlates of anorexsia nervosa.

Abstracts of the Meetings of the American Academy of Child Psychiatry/Canadian Academy of Pediatrics, Toronto, Canada, 1984.

9. Biederman J, Rivinus TM, Herzog DB, Shanley K, Yunis EJ.: Excess of HLA-B16 in anorexia nervosa. Abstracts of the Meetings of the American Academy of Child Psychiatry/Canadian Academy of Pediatrics, Toronto, Canada, 1994. 10. Gastfiend DR, Biederman J, Jellinek MS.: Desipramine in adolescents with attention deficit disorder. Abstracts of the Annual Meetings of the American Academy of Child Psychiatry, Toronto, Canada, 1984. 11. Biederman J.: High familial rates of major depressive disorder in ADD children vs. normal controls. Abstracts of the Child Depression Research Consortium, Western Psychiatric Institute and Clinic, Pittsburgh, PA 1985. 12. Beiderman J, Munir K, Knee D.: A controlled family study of patients with attention deficit disorder. Abstracts of the Annual Meetings of the American Psychiatric Association, Washington DC, 1986. 13. Biederman J, Munir K, Knee D.: High rate of affective disorders in probands with attention deficit disorder and in their relatives: A controlled family study. Abstracts of the Annual Meeting of the Society of Biological Psychiatry, Washington DC, 1986. 14. Biederman J, Munir K, Knee D.: Attention deficit disorder with and without conduct disorder: A controlled family study. Abstracts of the Annual Meeting of the American Academy of Child Psychiatry, Los Angeles, CA, 1986. 15. Biederman J, Munir K, Knee D.: High rates of attention deficit disorder and major depression in relatives of ADD probands: A controlled family study. Abstracts of the Annual Meeting of the American Academy of Child Psychiatry, Los Angeles, CA, 1986. 16. Rosenbaum J, Biederman J, Gersten M, et al.: Behavioral inhibition in children of agoraphobic parents: A controlled study. Abstracts of the Annual Meeting of the American Psychiatric Association, Chicago, IL, 1987. 17. Biederman J, Munir K, Knee D.: Attention deficit disorder with and without conduct disorder: A controlled family study. Abstracts of the Annual Meeting of the American Psychiatric Association, Chicago, IL, 1987. 18. Biederman J.: Pharmacological treatment of adolescents with affective disorders and attention deficit disorder. NCEDU Meeting, Key Biscayne, FL, 1987. 19. Biederman J.: Anxiety disorders in children. Symposium on New Uses for Clonazepam in Psychiatry, Boston, MA, 1987. 20. Biederman J, Faraone SV, Knee D.: Psychiatric disorders in first degree relatives of attention deficit disorder

probands with and without childhood history of ADD: A controlled investigation. Abstracts of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Washington DC, 1987.

21. Biederman J, Rosenbaum J, Kagan J, Gersten M.: High rates of behavioral inhibition in children of parents with

65

Page 66: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

panic disorder and agoraphobia. Abstracts of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Washington DC, 1987. 22. Biederman J and Wright V.: Desipramine in the treatment of children and adolescents with attention deficit

disorder: A double-blind placeob controlled study. Abstracts of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Washington DC, 1987. 23. Biederman J.: Evidence of familial association between attention deficit disorder and major depressive disorder. Childhood Depression Consortium, Boston, MA, 1987. 24. Biederman J and Faraone S.: Evidence of familial association between attention deficit disorder and major

depressive disorder. Abstracts of the Annual Meeting of the American Psychiatric Association, Montreal, Canada, 1988. 25. Biederman J and Wright V.: Desipramine treatment of children and adolescents with attention deficit disorder. Abstracts of the Annual Meeting of the American Psychiatric Association, Montreal, Canada, 1988. 26. Biederman J, Rosenbaum J, Kagan J.: Psychiatric correlates of behavioral inhibition in clinical and

epidemiological samples of young children. Abstracts of the Annual Meeting of the American Academy of Child Psychiatry, Montreal, Canada, 1988. 27. Biederman J, Rosenbaum J, Kagan J.: Psychiatric correlates of behavioral inhibition in young children of parents with and without psychiatric disorders. Abstracts of the Annual Meeting of the American Academy of Child Psychiatry. Seattle, WA, 1988. 28. Biederman J and Faraone S.: Evidence of familial association betwen attention deficit disorder and major

depression. Abstracts of the Annual Meeting of the American Academy of Child Psychiatry, Seattle, WA, 1988. 29. Biederman J and Faraone S.: Familial association between attention deficit disorder and anxiety disorders.

Childhood Depression Consortium, New Haven, CT, 1988. 30. Biederman J and Faraone S.: Familial association between attention dificit disorder and anxiety disorders. Abstracts of the Annual Meeting of the American Psychiatric Association, San Francisco, CA, 1989. 31. Biederman J, Faraone S, Keenan K, Tsuang M.: Family genetic and psycho social risk factors in attention deficit disorder. Abstracts of the Annual Meeting of the Society of Biological Psychiatry, San Francisco CA, 1989. Biological Psychiatry 25: 145A(Supplement), 1989. 32. Rosenbaum J, Biederman J, Kagan J.: Anxiety disorders in families of inhibited children. Abstracts of the Annual Meeting of the American Psychiatric Association, San Francisco, CA, 1989. 33. Biederman J, Faraone S, Keenan K, Tsuang M.: Family genetic and psycho social risk factors in attention deficit disorder. Proceedings of the Annual Meeting of the American Academy of Child Psychiatry, New York, NY, October 1989. 34. Biederman J and Faraone S.: Familial association between attention deficit disorder and anxiety disorders. Symposium "An Overview of the Child Epidemiology Program of the NIMH" (Chair K Bourdon, NIMH). Proceedings of the Annual Meeting of the American Academy of Child Psychiatry, New York, NY, October 1989. 35. Rosenbaum J, Biederman J, Hirshfeld D.: Identifying anxiety proneness in children. Abstacts of the Annual Meeting of the American Psychiatric Association, New York, NY, 1990. 36. Biederman J, Keenan K, Faraone S.: Parent baseed diagnosis of attention deficit disorder predicts a diagnosis based on teacher report. Proceedings of the Annual Meeting of the American Academy of Child Psychiatry,

66

Page 67: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

Chicago, IL, 1990. 37. Biederman J, Faraone SV, Keenan K.: Separation of DSM_III attention deficit disorder and conduct disorder: Evidence from a family-genetic study of American child psychiatric patients. Proceedings of the Annual Meeting of the American Academy of Child Psychiatry, Chicago, IL, 1990. 38. Steingard R, Biederman J, Keenan K, Moore C.: Comorbidity in the interpretation of rates of dexamethasone non suppression in clinically referred children. Proceedings of the Annual Meeting of the American Academy of Child Psychiatry, Chicago, IL, 1990. 39. Biederman J, Rosenbaum JF, Hirshfeld DR, Kagan J.: Further evidence of an association between behavioral inhibition and anxiety disorder: Family-genetic findings in first-degree relatives of a longitudinal cohort of children with and without behavioral inhibition. Proceedings of the Annual Meeting of the American Academy of Child Psychiatry, Chicago, IL, 1990. 40. Biederman J, Faraone SV, Keenan K.: Family-genetic and psycho social risk factors in clinically referred girls with DSM-III attention deficit disorder. New Research and Proceedings of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Chicago, IL 1990. 41. Biederman J, Faraone SV, Keenan K, et al.: Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder (ADHD): Patterns of comorbidity in probands and relatives in psychiatrically and pediatrically referred samples. New Research and Proceedings of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Chicago, IL, 1990. 42. Hirshfeld DR, Rosenbaum JF, Biederman J, Bolduc EA, Kagan J.: Stability of behavioral inhibition. New Research and Proceedings of the Annual Meeting of the American Psychological Association, Los Angeles, CA, August 1991. 43. Biederman J, Faraone SV, Keenan K, et al.: Further evidence for family-genetic risk factors in attention deficit

hyperactivity disorder (ADHD): Patterns of comorbidity in probands and relatives in psychiatrically and pediatrically referred samples. New Research and Proceedings of the Annual Meeting of the American Academy of

Child and Adolescent Psychiatry, San Francisco, CA, October 1991. 44. Steingard R, Biederman J, Doyle A.: Comorbidity in the interpretation of the Child Behavior Checklist. New Research and Proceedings of the Annual Meetings of the American Academy of Child and Adolescent Psychiatry, San Francisco, CA, October 1991. 45. Biederman J, Rosenbaum JF, Hirshfeld DR, Bolduc EA, Kagan J.: A high risk study of young offspring with panic disorder agoraphobia with and without comorbid major depression. New Research and Proceedings of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, San Francisco, CA, October 1991. 46. Spencer T, Biederman J, Wright V, Danon M.: Growth deficits in children and adolescents with attention deficit hyperactivity disorder receiving treatment with desipramine: Comparison with stimulant-treated and not treated children. New Research and Proceedings of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, San Francisco, CA, October 1991. 47. Semrud-Clikeman M, Biederman J, Sprich S, Krifcher B, Norman D, Faraone S.: Comorbidity between attention

deficit disorder with hyperactivity and learning disability. New Research and Proceedings of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, San Francisco, CA, October 1991.

48. Wilens TE, Biederman J, Baldessarini RJ, et al.: Developmental changes in serum concentrations of desipramine

and 2-hydroxydesipramine during treatment with desipramine. New Research and Proceedings of the Annual Meeting of the American Academy of Child ad Adolescent Psychiatry, San Francisco, CA, October 1991.

67

Page 68: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

49. Faraone SV, Biederman J, Chen WJ, Krifcher B, Keenan K, Tsuang MT, et al.: Segregation analysis of attention deficit hyperactivity disorder: Evidence for single gene transmission. New Research and Proceedings of the Annual Meeting of the American Psychiatric Association, Washington DC, May 1992. 50. Biederman J, Faraone SV, Keenan K, et al.: Family-genetic risk factors and comorbidity in psychiatrically and pediatrically referred children with ADHD. Annual Meeting of the Society of Biological Psychiatry, Washington DC, April 1992. Biological Psychiatry 246A, 1992. 51. Rosenbaum JF, Biederman J, Bolduc, et al.: Comobidity of parental anxiety disorders as risk for childhood onset anxiety in inhibited children. Studies in Panic and Anxiety Disorders (#9); Annual Meeting of the Society of Biological Psychiatry), Washington DC, April 1992, Biological Psychiatry 243A, 1992. 52. Wilens TE, Biederman J, Baldessarini RJ, et al.: Developmental changes in serum concentrations of desipramine and 2-hydroxydesipramine during treatment with desipramine. Annual Meeting of the Society of Biological Psychiatry, Washington DC, April 1992. Biological Psychiatry 243A, 1992. 53. Lahey BB, Barkley R, Biederman J, et al.: DSM-IV Disruptive Behavior Disorder Field Trial. Symposia 42C; Proceedings of the Annual Meeting of the American Psychiatric Association, Washington DC, May 1992. 54. Biederman J.: Behavioral Inhibition as a Temperamental Risk Factor for Anxiety Disorders. Symposium "Current Controversies in Childhood Anxiety Disorders;" Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Washington DC, October 1992. 55. Biederman J, Baldessarini R, Wright V, et al.: A double-blind placebo-controlled study of desipramine in the

treatment of attention deficit disorder: III. Lack of impact of comorbidity and family history factors on clinical response. Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Washington DC, October 1992. 56. Faraone SV, Biederman J, Chen WJ, Krifcher B, Keenan K, Tsuang MT, et al.: Segregation analysis of attention deficit hyperactivity disorder: Evidence for single gene transmission. New Research and Proceedings

of the Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Washington DC, October 1992. 57. Faraone SV, Biederman J, Chen WJ, Krifcher B, Keenan K, et al.: Evidence for independent transmission in families for attention deficit hyperactivity disorder (ADHD) and learning disability: Results from a family genetic study of ADHD. New Research and Proceedings of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Washington DC, October 1992. 58. Faraone SV, Biederman J, Chen WJ, Krifcher B, et al.: Cognitive functioning, learning disability, and school failure with attention deficit hyperacitivity disorder and in their siblings: Implications of psychiatric comorbidity. New Research and Proceedings of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Washington DC, October 1992. 59. Wilens TE, Biederman J, Steingard R, Geist D, Spencer T.: A naturalistic study of nortriptyline in ADHD. New Research and Proceedings of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Washington DC, October 1992. 60. Spencer T, Biederman J, Wilens TE, Steingard R.: Bupropion exacerbate tics in patients with attention deficit

hyperactivity disorder and Tourette disorder. New Research and Proceedings of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Washington DC, October 1992.

61. Spencer T, Biederman J, Wilens TE, Steingard R.: Desipramine in the treatment of in patients with attention deficit hyperactivity disorder and Tourette disorder. New Research and Proceedings of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Washington DC, October 1992.

68

Page 69: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

62. Spencer T, Biederman J, Wilens TE, Steingard R.: Nortriptyline in the treatment of in patients with attention deficit hyperacitivity disorder and Tourette disorder. New Research and Proceedings of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Washington DC, October 1992. 63. Biederman J, Baldessarini R, Wright V, et al.: A double-blind placebo-controlled study of desipramine in the treatment of attention deficit disorder: III. Lack of impact of comorbidity and family history factors on clinical response. New Research and Proceedings of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Washington DC, October 1992. 64. Biederman J, Rosenbaum JF, Hirshfeld DR, Bolduc EA, Kagan J.: A three year follow up of children with and without behavioral inhibition: Further evidence of an association between behavioral inhibition and childhood-

onset anxiety disorders. J Am Acad Child Adol Psychiatry. New Reserch and Proceedings of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Washington DC, October 1992. 65. Biederman J, Rosenbaum JF, Hirshfeld DR, et al.: Comorbidity of parental anxiety disorders as risk for childhood onset anxiety in inhibited children. New Research and Proceedings of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Washington DC, October 1992. 66. Biederman J, Baldessarini R, Goldblatt A, Lapey K, Doyle A.: A Naturalistic study of twenty four hour ECG

recordings and echocardiographic findings in children and adolescents treated with desipramine. New Research and Proceedings of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry,

Washington DC, October 1992. 67. Steingard R, Biederman J, Spencer T, Wilens T, Gonzalez A.: Clonidine response in the treatment of ADHD with and without comorbid tic disorder. J Am Acad Child & Adol Psychiatry. New Research and Proceedings of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Washington DC, October 1992. 68. Semrud-Clikeman M, Filipek P, Biederman J.: Attention deficit disorder: Differences in the corpus callosum and shape analysis in MRI morphometric analysis. ISRCAP Annual Meeting, New Mexico, 1993. 69. Biederman J: ADD with anxiety and or depression. Symposium #37 "Subtypes of ADD;" Proceedings of the Annual Meeting of the American Psychiatric Association, San Francisco, CA, 1993. 70. Renshaw PF, Biederman J, Wilens T, Spencer T, Cohen B.: MRI abnormalities in children with ADHD. Poster 267; Annual Meeting of the Society of Biological Psychiatry, San Francisco, CA 1993. 71. Biederman J, Faraone S, Mick E, Lapey K.: Continuity of ADHD into adulthood. Poster 241; Annual Meeting

of the Society of Biological Psychiatry, San Francisco, CA, 1993. 72. Rosenbaum J, Biederman J.: Childhood Behavioral Inhibition: Marker of Risk Factor for Anxiety Disorders. Poster 246; Annual Meeting of the Society of Biological Psychiatry, San Francisco, CA, 1993. 73. Biederman J, Rosenbaum J.: Collaborative high risk studies in children and adults: The MGH Experience (Workshop I). Annual Meeting of the Society of Biological Psychiatry, San Francisco, CA, 1993. 74. Sachs G, Conklin A, Lafer B, Thibault A, Rosenbaum J, Biederman J.: Psychopathology in children of late versus early onset bipolar probands. Annual Meeting of the American Academy of Child & Adolescent Psychiatry, San Antonio, TX, October 1993. 75. Wozniak J, Biederman J, Kiely K, Ablon S, Faraone S.: Prepubertal mania revisited. Annual Meeting of the American Academy of Child & Adolescent Psychiatry, San Antonio, TX, October 1993.

69

Page 70: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

76. Todd R, Biederman J, Ciaranello R, Leckman J.: Family studies of early onset disorders: Application to the clinic. Annual Meeting of the American Academy of Child & Adolescent Psychiatry, San Antonio, TX, October 1993. 77. Spencer T, Biederman J, Wilens T, Guite J.: Attention deficit hyperactivity disorder and thyroid abnormalities. Annual Meeting of the American Academy of Child & Adolescent Psychiatry, San Antonio, TX, October 1993. 78. Spencer T, Wilens T, Biederman J, Faraone S, Ablon JS, Lapey K.: A double-blind comparison of methylphenidate and placebo in adults with ADHD. Annual Meeting of the American Academy of Child Y Adolescent Psychiatry, San Antonio, TX, October 1993. 79. Milberger S, Biederman J, Sprich-Buckminister S, Faraone S, Krifcher-Lehman B.: Are Perinatal complications relevant to the manifestation of attention deficit hyperactivity disorder? Annual Meeting of the American Academy of Child & Adolescent Psychiatry, San Antonio, TX, October 1993. 80. Biederman J, Faraone S, Spencer T, Wilens T, Mick E, Lapey K.: Gender differences in adults with attention deficit hyperactivity disorder. Annual Meeting of the American Acadey of Child & Adolescent Psychiatry, San Antonio, TX, October 1993. 81. Biederman J, Milberger S, Faraone S, Guite J, Warburton R.: Associations between childhood asthma and attention

deficit hyperactivity disorder. Annual Meeting of the American Academy of Child & Adolescent Psychiatry, San Antonio, TX, October 1993. 82. Biederman J, Lapey K, Milberger S, Faraone S, Seidman L, Reed E.: Left motor preference and ADHD is associated with depression and psychosocial function. Annual Meeting of the American Academy of Child & Adolescent Psychiatry, San Antonio, TX, October 1993. 83. Faraone S, Biederman J, Chen W, Warburton R, Tsuang M.: Genetic heterogeneity in attention deficit hyperactivity disorder. Annual Meeting of the American Academy of Child & Adolescent Psychiatry, San TX, October 1993. 84. Faraone S, Biederman J, Milberger S, Warburton R.: Attention deficit hyperactivity disorder among second degree relatives of ADHD children. Annual Meeting of the American Academy of Child & Adolescent Psychiatry, San Antonio, TX, October 1993. 85. Wilens T, Biederman J, Mick E, Spencer T.: Treatment of adult ADHD with tricyclic antidepressants: Clinical experience with 32 Patients. Annual Meeting of the American Academy of Child & Adolescent Psychiatry, San Antonio, TX, October 1993. 86. Chen W, Milberger S, Faraone S, Biederman J, Tsuang M.: Diagnostic accuracy of the Child Behavior Checklist scales for attention deficit hyperactivity disorder. Annual Meeting of the American Academy of Child & Psychiatry, San Antonio, TX, October 1993. 87. Biederman J, Faraone S, Chen W.: Concurrent validity in the Social Adjustment Inventory for Children and Adolescents. Abstracts of the Annual Meeting of the American Academy of Child & Adolescent Psychiatry (New Research Section), San Antonio, TX, October 1993. 88. Wilens T, Biederman J, Spencer T, Birmaher B, Bernstein G.: An update on tricyclic antidpressants in children and adolescents. Annual Meeting of the American Academy of Child & Adolescent Psychiatry, San Antonio, TX, October 1993. 89. Biederman J.: Cardiac side effects of tricyclic antidepressants. New Frontiers in Pediatric Psychopharmacology, Institute VII. Annual Meeting of the American Academy of Child & Adolescent Psychiatry, San Antonio, TX, October 1993.

70

Page 71: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

90. Wilens T, Kiely K, Bredin E, Spencer T, Biederman J.: Behavorial and emotional disturbances in children of parents with opioid dependence. Fourth Annual Proceedings of the American Academy of Psychiatrists in Alcoholism and Additions, December 1993. 91. Wilens T, Biederman J, Spencer T, Norman D, Lapey K, Mick E, Lehman B, Doyle A.: Rates of alcohol and drug use disorders in adults with attention deficit hyperactivity disorder. Fourth Annual Proceedings of the American Academy of Psychiatrists in Alcoholism and Addictions, December 1993. 92. Sachs GS, Lafer B, Thibault AB, Truman CJ, Biederman J, Rosenbau J.: Childhood psychopathology in 40 adult bipolar patients. Poster Presentation; Annual Meeting of the American Psychiatry Association, Philadelphia, PA, May 1994. 93. Rosenbaum JF, Biederman J, Faraone S, Bolduc-Murphy E, Kagan J.: Development of human anxiety. Abstracts of the Annual Meeting of the American Psychiatric Association (New Research Section), Philadelphia, PA, May 1994. 94. Spencer T, Wilens T, Biederman J, Faraone S, Ablon JS, Lapey K.: A double-blind comparison of methylphenidate and placebo in adults with ADHD. NCDEU, Marco Island, FL, June 1994. 95. Biederman J, Faraone S, Spencer T, Wilens T, Mick E, Lapey K.: Gender differences in adults with attention deficit hyperactivity disorder. NCDEU, Marco Island, FL, June 1994. 96. Biederman J, Santangelo S, Faraone S, Kiely K, Guite J.: Clinical correlates of enuresis in ADHD and non-ADHD children. Abstracts of the Annual Meeting of the American Academy of Child & Adolescents Psychiatry, New York, NY, October 1994. 97. Biederman J, Milberger S, Faraone S, Kiely K, Guite J.: Family environmental risk factors and ADHD: Rutter's Indicators of Adversity, Abstracts of the Annual Meeting of the American Academy of Child & Adolescent Psychiatry, New York, NY, October 1994. 98. Milberger S, Biederman J, Faraone S, Murphy J, Tsuang M.: ADHD and comorbid diagnoses: Problems of overlapping symptomatology. Abstracts of the Annual Meeting of the American Academy of Child & Adolescent Psychiatry, New York, NY, October 1994. 99. Milberger S, Biederman J, Faraone S, Guite J, Tsuang M.: Pregnancy, delivery, and infancy complications and ADHD: Issues of gene-environment interaction. Abstracts of the Annual Meeting of the American Academy of Child & Adolescent Psychiatry, New York, NY, October 1994. 100. Milberger S, Faraone S, Biederman J, Testa M, Tsuang M.: A new phenotype definition of ADHD in relative for genetic analyses. Abstracts of the Annual Meeting of the American Academy of Child & Adolescent Psychiatry, New York, NY, October 1994. 101. Geller D, Biederman J, Reed E, Spencer T, Wilens T.: Fluoxetine treatment of children and adolescents with

obsessive compulsive disorder. Abstracts of the Annual Meeting of the American Academy of Child & Adolescents Psychiatry, New York, NY, October 1994.

102. Biederman J, Faraone S, Mick E, Spencer T, Wilens T, Kiely K, Guite J, Ablon JS, Reed E, Warburton R.: High risk for ADHD in children of parents with childhood onset ADHD: A pilot study. Abstracts of the Annual Meeting of the American Acadey of Child & Adolescents Psychiatry, New York, NY, October 1994. 103. Wilens T, Biederman J, Kiely K, Bredin E, Spencer T.: Emotional and behavioral disturbances in the children of parents with opioid dependence. Abstracts of the Annual Meeting of the American Academy of Child & Adolescent Psychiatry, New York, NY, October 1994.

71

Page 72: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

104. Biederman, Faraone S, et al.: A multigenerational pedigreee of ADHD. Abstracts of the Annual Meeting of the American Academy of Child & Adolescent Psychiatry, New York, NY, October 1994. 105. Seidman L, Beiderman J, Faraone S, Milberger S, Mick E, Kiely K, Guite J.: Neuropsychological correlates of ADHD. Abstracts of the Annual Meeting of the American Academy of Child & Adolescents Psychiatry, New York, NY, October 1994. 106. Wozniak J, Biederman J, Faraone S, Mundy E.: A family-genetic pilot study of prepubertal chidlren with bipolar disorder. Abstracts of the Annual Meeting of the American Academy of Child & Adolescent Psychiatry, New York, NY, October 1994. 107. Wilens T, Biederman J, et al.: Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder: Effect of psychiatric comorbidity. Poster Presentation; American Psychiatric Association, Miami, FL, May 1995. 108. Wilens T, Biederman J, Prince J, et al.: Double-blind comparison of desipramine (DMI) and placebo in adults with attention deficit hyperactivity disorder: Final results. Poster Presentation; American Psychiatric Association, Miami, FL, May 1995. 109. Biederman J (Symposium Chairperson), Wozniak J, et al.: ADHD across the life cycle. Symposium; American Psychiatric Association, Miami, FL, May 1995. 110. Munir K, Biederman J, Knee D.: Psychiatric Comorbidity in patients with attention deficit disorder: A controlled family study. J Am Acad Child & Adol Psychiatry 26: 844-848, 1987. New Research and Proceedings of the Annual Meeting of the American Psychological Association, New York, NY, August 1995. 111. Wilens T, Biederman J, Prince J, et al.: Double-blind comparison of desipramine (DMI) and placebo in adults with attention deficit hyperactivity disorder: Final results. Abstracts of the Annual Meeting of the American Academy of Child & Adolescent Psychiatry, New Orleans, LA, October 1995. 112. Faraone S, Biederman J, Milberger S.: How reliable are maternal reports of their children's psychopathology?: One year recall of psychiatric diagnoses of ADHD children. Abstracts of the Annual Meeting of the American Academy of Child & Adolescent Psychiatry, New Orleans, LA, October 1995. 113. Faraone S, Biederman J, et al.: ADHD and bipolar disorder: A familial subtype. Abstracts of the Annual Meeting of the American Academy of Child & Adolescent Psychiatry, New Orleans, LA, October 1995. 114. Faraone S, Biederman J, et al.: Predictors of persistance and remission of ADHD: Results from a four-year prospective follow-up study of ADHD children. Abstracts of the Annual Meeting of the American Academy of Child & Adolescent Psychiatry, New Orleans, LA, October 1995. 115. Biederman J, Wilens T, et al.: Psychoactive substance use disorder in adults with ADHD. Abstracts of the Annual Meeting of the American Academy of Child & Adolescent Psychiatry, New Orleans, LA, October 1995. 116. Biederman J, Faraone S, et al.: Psychiatric comorbidity in childhood predicts syndrome specific outcomes by adolescence. Abstracts of the Annual Meeting of the Ameircan Academy of Child & Adolescent Psychiatry, New Orleans, LA, October 1995. 117. Biederman J, Faraone S, et al.: Developmental aspects of panic disorder: Findings from a referred sample of children and adolescents. Abstracts of the Annual Meeting of the American Academy of Child & Adolescent Psychiatry, New Orleans, LA, October 1995. 118. Milberger S, Biederman J, Faraone S, et al.: Maternal smoking during pregnancy is a risk factor for ADHD in

72

Page 73: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

children. Abstracts of the Annual Meeting of the American Academy of Child & Adolescent Psychiatry, New Orleans, LA, October 1995. 119. Seidman L, Biederman J, et al.: Towards a neuropsychology of ADHD. Abstracts of the Annual Meeting of the American Academy of Child & Adolescent Psychiatry, New Orleans, LA, October 1995. 120. Spencer T, Biederman J, et al.: Growth deficits in ADHD revisited: Evidence for growth delays. Abstracts of the Annual Meeting of the American Academy of Child & Adolescent Psychiatry, New Orleans, LA, October 1995. 121. Spencer T, Biederman J, et al.: Effectiveness and tolerability of Tomoxetine in adults with ADHD. Abstracts of the Annual Meeting of the American Academy of Child & Adolescent Psychiatry, New Orleans, LA, October 1995. 122. Spencer T, Biederman J, et al.: Importance of ADHD in Tic-associated psychopathology and dysfunction. Abstracts of the Annual Meeting of the American Academy of Child & Adolescent Psychiatry, New Orleans, LA, October 1995. 123. Wilens T, Biederman J, et al.: Cardiovascular effects of tricyclic antidepressants in children and adolescents: A survey of the literature. Abstracts of the Annual Meeting of the American Academy of Child & Adolescents Psychiatry, New Orleans, LA, October 1995. 124. Prince J, Wilens T, Biederman J, et al.: Coadministration of psychostimulants and DMI: Effects on serum DMI levels. Abstracts of the Annual Meeting of the American Academy of Child & Adolescent Psychiatry, New Orleans, LA, October 1995. 125. Entwistle P, Biederman J: The assessment of African-American Children with ADHD. Abstracts of the 28th Annual National Convention of the National Association of School Psychologists, Atlanta, GA, 1996. 126. Hirshfeld D, Biederman J, Brody L, Rosenbaum J.: Associations between expressed emotion, child behavioral inhibition and maternal psychopathology. Abstracts of the American Psychological Association Annual Convention, Toronto, Canada, August 1996. 127. Hirshfeld D, Biederman J, Faraone S.: Expressed emotion and its association with ADHD: A pilot study. Abstracts of the Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Philadelphia, PA October 1996. 128. Seidman S, Biederman J, Faraone S, Mennin D, Weber W, Jones J.: J A pilot study of neuropsychological function in ADHD girls. Abstracts of the Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Philadelphia, PA, October 1996. 129. Biederman J, Milberger S, Faraone S, Jones J.: ADHD and early initiation of cigarette smoking. Abstracts of the Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Phildelphia, PA, October 1996. 130. Greene R, Biederman J, Faraone S, Sienna M, Jetton J.: Adolescent outcome of ADHD children with social disability. Results from a four year longitudinal follow up study. Abstracts of the Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Philadelphia, PA, October 1996. 131. Wilens T, Biederman J, Mick E, Faraone S, Spencer T.: Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorder. Abstracts of the Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Philadelphia, PA, October 1996. 132. Hudziak J, Faraone S, Biederman J, Menen D, Blais-Hall, D.: Attention problems: Phenotypic marker for genetic studies of ADHD. Abstracts of the Annual Meeting of the American Academy of Child & Adolescent

73

Page 74: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

Psychiatry, Philadelphia, PA, October 1996. 133. Biederman J, Faraone S, Hatch M, Mennin D, Taylor A, George P.: Conduct disorder with and without mania in ADHD children. Abstracts of the Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Phildelphia, PA, October 1996. 134. Biederman J, Wilens T, Mick E, Faraone S, Weber W, Curtis S, Thornell A, Pfister K, Jetton J, Soriano J.: Is ADHD a risk for psychoactive substance use disorders? Abstracts of the Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Philadelphia, PA, October 1996. 135. Biederman J, Faraone S, Jetton J, Mick E, Greene R, Russell R.: Is childhood oppositional definat disorder a precursor to adolescent conduct disorder? Abstracts of the Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Philadelphia, PA, October 1996. 136. Faraone S, Biederman J, Jetton J.: Attention deficit disorder and conduct disorder: Longitudinal evidence for a familial subtype. Abstracts of the Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Philadelphia, PA, October 1996. 137. Faraone S, Biederman J, Mennin D.: Four-year follow-up of children from antisocial-ADHD families. Abstracts of the Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Philadelphia, PA, October 1996. 138. Faraone S, Biederman J, Wozniak J, Mennin D, O'Donnell D.: Is comorbidity with ADHD a marker for juvenile onset mania? Abstracts of the Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Philadelphia, PA, October 1996. 139. Geller D, Biederman J, Griffin S, Jones J.: Importance of developmental factors in juvenile obsessive compulsive disorder. Abstracts of the Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Philadelphia, PA, October 1996. 140. Wilens T, Frazier J, Prince J, Spencer T, Bostic J, Hatch M, Abrantes A, Sienna M, Soriano J, Milstein R, Biederman J.: A double-blind comparison of premoline in adults with atttention deficit hyperactivity disorder. Abstracts of the Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Philadelphia, PA, October 1996. 141. Biederman J, Faraone S, Baldessarini R, Flood J, Meyer M, Wilens T, Spencer T, Weber W.: Predicting

desipramine levels in children and adolescents: A naturalistic clinical study. Abstracts of the Annual Meeting American Academy of Child & Adolescent Psychiatry, Philadelphia, PA, October 1996. 142. Daly J, Biederman J, Prince J, Wilens T, Soriano J, Russell R.: The effects of psychopathology and nortriptyline on autonomic control of the heart. Abstracts of the Annual Meeting of the American Academy of Child & Adolescents Psychiatry, Philadelphia, PA, October 1996. 143. Sprich-Buckminster S, Biederman J, Harding M, Faraone S, Mundy E.: A family study of adoptees with attention deficit hyperactivity disorder. Abstracts of the Annual Meeting of the American Association of Behavioral Therapist, New York, NY, November 1996. 144. Wilens T, Biederman J, Mick E, Faraone S, Spencer T.: ADHD is associated with early onset substance use disorders. Abstracts of the Annual Meeting of the American Academy of Addiction Psychiatry, San Francisco, CA, December 1996. 145. Wilens T, Biederman J, Mick E, Faraone S, Spencer T.: ADHD is associated with early onset substance use disorders. Abstracts of the Annual Meeting of the American Academy of Addiction Psychiatry, San Francisco, CA, December 1996.

74

Page 75: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

146. Wilens T, Biederman J, Abrantes A, Spencer T.: Effect of psychopharmacological treatment in substance abusing youth. Abstracts of the Annual Meeting of the American Academy of Addiction Psychiatry, San Francisco, CA, December 1996. 147. Biederman J.: ADHD across the lifecycle. 49th Annual Meeting of the American Academy of Neurology, Boston, MA, April 1997. 148. Biederman J.: Josselytn Center of Mental Health. 8th Annual Lois Atwater Lecture, Northfield, IL, September 1997. 149. Biederman J, Faraone S, Taylor A, Sienna M, Williamson S, Fine C.: Diagnostic continuity between child and adolescent ADHD: Finding from a longitudinal clinical sample. 44th Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Toronto, Canada, October 1997. 150. Biederman J, Faraone S, Weber W, Russell R, Rater M, Park K.: Correspondence between DSM-III-R and DSM-IV attention-deficit/hyperactivity disorder. Poster Bd7,NR7; 44th Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Toronto, Canada, October 1997. 151. Samuel V, George P, Thornell A, Curtis S, Taylor A, Brome D, Mick E, Faraone S, Biederman J.: A pilot controlled family study of ADHD in african-american children. Poster Bd24,NR-24; 44th Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Toronto, Canada, October 1997. 152. Biederman J: Results of large case controlled study of girls with ADHD. Symposium #25; 44th Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Toronto, Canada, October 1997. 153. Coffey B, Biederman J, Geller D.: Tourette's disorder ascertained through specialized and general psychiatric setting. Poster Bd38,NR-78; 44th Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Toronto, Canada, October 1997. 154. Biederman J, Mick E, Faraone S.: Depression in ADHD children: "True" depression or demoralization? Poster Bd6, NR-86; 44th Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Toronto, Canada, October 1997. 155. Ambrosini P, Wagner K, Biederman J, Glick I, Tan C.: Sertraline treatment of adolescent outpatients with major depression. Poster Bd14, NR-94; 44th Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Toronto, Canada, October 1997. 156. Biederman J.: Conduct disorder with and without mania in ADHD children. Symposium #47; 44th Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Toronto, Canada, October 1997. 157. Mick E, Faraone S, Biederman J.: The CBCL as a screening tool for major depression in pediatric clinics. Poster Bd28,NR-148; 44th Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Toronto, Canada, October 1997. 158. Biederman J: Substance use disorder (SUD) in children with attention-deficit. Symposium #60; 44th Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Toronto, Canada, October 1997. 159. Biederman J, Mick E, Faraone S.: Separating function from syndromatic persistence in ADHD. Poster Bd27,NR-187; 44th Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Toronto, Canada, October 1997. 160. Frazier J, bush G, Rauch S, Seidman L, Whalen P, Faraone S, Biederman J.: Functional magnetic resonance imaging of attention in adults with ADHD. Poster Bd35,NR-195; 44th Annual Meeting of the American Academy

75

Page 76: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

of Child & Adolescent Psychiatry, Toronto, Canada, October 1997. 161. Geller D, Biederman J, Jones J, Park K, Schwartz S, Shapiro S.: Cognitive and neuropsychological function in juvenile obsessive compulsive disorder. Poster Bd38,NR-198; 44th Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Toronto, Canada, October 1997. 162. Biederman J.: Treatment of ADHD with an emphasis on stimulant medication. Conference on The Evaluation and Treatment of ADHD in Pediatrics, Boston, MA, October 1997. 163. Spencer T, Biederman J, Wilens TE: Growth deficits in children with Attention Deficit Hyperactivity Disorder. Supplement to Pediatrics, National Cooperative Growth Study: Guidance in Growth. 11th Annual Investigators Meeting, Washington, DC, September 1997. 164. Smoller JW, Rosenbaum JF, Pollack MH, Biederman J, Bulzachelli M, Moody D, Heibling L, Liebert CB, Gusella JF, Slaugenhaupt SA: The use of candidate loci from animal models in gene mapping studies of panic disorder. Anxiety Disorders Association of America, 18th National Conference, Boston, MA, March 1998. 165. Wilens TE, Biederman J, Spencer T, Bostic J, Prince J, Monuteaux M, Soriano J, Fine C, Abrams A, Rater M: A controlled trial of ABT-418 for Attention Deficit Hyperactivity Disorder in Adults. Poster No. 137; 38th Annual Meeting of the New Clinical Drug Evaluation Unit Program, Boca Raton, FL, June 1998. 166. Milberger S, Faraone S, Biederman J, Chu M, Wilens T.: Familial risk analysis of the association between ADHD and PSUD. College of Problems with Drug Dependence, Scottsdale, 1998; 14: 97. 167. Biederman J, Wilens T, Mick E, Spencer T.: Does ADHD impact remission from substance abuse. College of Problems with Drug Dependence, Scottsdale, 1998; 14: 10. 168. Wilens T, Biederman J, Bredin E, Abrantes A, Schleifer D, Hahesy A, Neft D, Milstein R, Spencer T.: Family unity associated with opioid and alcohol dependent parents and their high risk offspring. Scientific proceedings of the National Methadone Conference, October 1998, New York, NY. 169. Biederman J. A double blind placebo controlled trial of adderall and methylphenidate in the treatment of ADHD. ADHD Expert Advisory Board Meeting, June 1998, Ritz-Carlton Palm Beach, Manalapan, Florida. 170. Biederman J. ADHD throughout the life cycle. Update on Neurophsychiatric Disorders, February 1998, Tucson, Arizona. 171. Biederman J. ADHD across the life cycle. Symposium, Behavioral Health System of Brookside/New England, February 1998, Nashua, NH. 172. Biederman J. Pharmacotherapy of ADHD across the life cycle. Third Annual Psychopharmacology Conference,

October 1998, Syracuse, NY 173. Biederman J, Treatment of ADHD in adults. American Society of Clinical Pharmocology and Therapeutics. March 1998, New Orleans, LA. 174. Biederman J. Cognition: From research to rehabilitation. Janssen Summit Meeting, January 1998, Rancho Mirage, CA. 175. Biederman J. New perspectives on juvenile mania. NAMI Annual Convention, July 1998, Washington D.C. 176. Biederman J. Childhood mood disorders. Pfizer Pharmaceuticals, May 1998, Kansas City, Missouri. 177. Biederman J. Advances in the diagnosis and treatment of mood disorders. Critical Issues in Child and Adolescent

76

Page 77: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

Mental Health. September 1998, Salt Lake City, Utah. 178. Biederman J. Juvenile Anxiety Disorders. Northwest Mental Health Institute Educational Symposium, November

1998, Eugene, Oregon.

179. Biederman J. Safety and efficacy of treatments-short and long term: Nonstimulant medications. NIH Consensus Dvelopment Conference on Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder, 1998, Bethesda, MD.

180. Spencer T, Wilens T, Biederman J. Effectiveness and tolerability of Adderall in adults with ADHD. Scientific proceedings of the American Academy of Neurology, 1999. 181. Biederman J. Role of norepinephrine in pathophysiology and treatment in cognitive disorders. Norepinephrine: New

Vistas for an Old Neurotransmitter. Society of Biological Psychiatry, 1998, Key West, Florida. 182. Snidman N, Kagan J, Rosenbaum JF, Biederman J. Behavioral inhibition in children with a panic disorder parent.

Society for research in child development Biennial Meeting, April 1999, Albuquerque, NM. 183. Wilens TE, Biederman J, Millstein R, Wozniak J, Spencer T. Risk for substance use disorders in youth with child and

adolescent onset bipolar disorder. Problems of Drug Dependence 1998: Proceedings of the 60th Annual Scientific Meeting, NIDA Research Monograph 179.

184. Biederman, J. Biological and environmental bases for anti-social behavior. Workshop on Precursors of Anti-Social Behavior: National Research Council. May 1999, Washington, D.C.

185. Biederman J: An update on selected research findings in ADHD. Children and Adults with Attention Deficit Disorders’

10th Annual International Conference on Attention Deficit Disorders, October 1998, New York, NY. 186. Biederman J: “ADHD Across the Lifecycle”. New Jersey Psychiatric Association’s 24th Annual Meeting. April 1999. 187. Cohen LG, Biederman J, Gilson S, Whitt S, Frazier J, Wozniak J, Wilens T, Spencer T, Mick E: Pharmacotherapy of

Attention Deficit Hyperactivity Disorder (ADHD) in Psychiatrically Referred Girls. Poster No. 25. Annual Meeting of the New Clinical Drug Evaluation Unit Program, Boca Raton, Fl, June 1999.

188. Wilens T, Spencer T, Biederman J, Girard K, Doyle R, Prince J, Solhkhah R, Polisner D, Comeau S, Parekh A: A

Controlled Trial of Bupropion SR for Attention Deficit Hyperactivity Disorder in Adults. Poster No. 29. Annual Meeting of the New Clinical Drug Evaluation Program, Boca Raton, Fl, June 1999.

189. Spencer T, Wilens T, Biederman J, Kagan J, Bearman SK: Effectiveness and Tolerability of Adderall in Adults with

Attention Deficit Hyperactivity Disorder. Poster No. 30. Annual Meeting of the New Clinical Drug Evaluation Unit Program, Boca Raton, Fl, June 1999.

190. Sprich-Buckminster S, Biederman J, Harding M, Faraone S, Bearman S, Forsyth L: A Comparison of Adopted and

Non-Adopted Proband with ADHD. Poster No. 44; Annual Convention of AABT, Toronto, Canada, November 1999 191. Smoller J, Rosenbaum J, Biederman J, Susswein L, Kagan J, Snidman N, Faraone S, White C, Slaugenhaupt S: TDT

Analysis of the A2a Adenosine Receptor Gene in Behavioral Inhibition. Poster No. 38; Annual Meeting of the American College of Neuropsychopharmacology, Acapulco, Mexico, December 1999.

192. Williams M, Biederman J, Levin E, Faraone S, Bush G, Swanson J: Attention Deficit Hyperactivity Disorder: Toward

Novel Therapies (study group). Annual Meeting of the American College of Neuropsychopharmacology, Acapulco, Mexico, December 1999.

77

Page 78: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

193. Dougherty D, Bonab A, Biederman J, Spencer T, Rauch S, Madras B, Dragotakes S, Alpert N, Fischman A: Assessment of Dopamine Transporter Density in Patients with Attention Deficit Hyperactivity Disorder Using 123 I-Altropane. 47th Annual Meeting of the Society of Nuclear Medicine.

194. Labellarte M, Zumbrunnen T, Brennan J, Biederman J, Connor J, Emslie G, Ferguson J, Khan A, Ruckle J, Sallee R, Busch B, Biederman J, Cohen L: ADHD in Children: Does the Ascertainment Site Predict the Clinical Correlates and

Degree of Functional Impairment? Year 2000 Pediatric Academic Societies and American Academy of Pediatrics Joint Meeting, Boston, MA May 2000.

195. Biederman J, Doyle A, Braaten E: Developmental Perspectives on Childhood Pscyhopathology. 47th Annual American

Academy of Child and Adolescent Psychiatry, New York City, October 2000. 196. Becker-Hirshfeld D, Biederman J, Faraone S, Violette H, Rosenbaum J: Defining Behavioral Disinhibition:

Psychopathologic Correlates. Poster No. A10; 47th Annual American Academy of Child and Adolescent Psychiatry, New York Ciy, October 2000.

197. Wilens T, Cohen L, Biederman J, Abrams A, Neft D, Melnick K, Kurtz D, Sinha V: Pharmacokinetics of Fluxoetine in

Pediatric Patients. Poster No. A38, 47th Annual American Academy of Child and Adolescent Psychiatry, New York City, October 2000.

198. Labellarte M, Zumbrunnen T, Brennan J, Biederman J, Connor J, Emslie G, Ferguson J, Khan A, Ruckle J, Sallee F,

Riddle M: Multiple-Dose Pharmacokinetics of Fluvoxamine in Children and Adolescents. Poster No. A42, 47th Annual American Academy of Child and Adolescent Psychiatry, New York City, October 2000.

199. Seidman L, Biederman J, Monuteaux M, Doyle A, Faraone S: Neuropsychological Functioning in ADHD Boys with

and without Learning Disabilities. Poster No. B2, 47th Annual American Academy of Child and Adoelescent Psychiatry, New York City, October 2000.

200. Faraone S, Biederman J, Feighner J, Monuteaux M, Burback M: ADHD Symptoms in Children and Adults: Which is

More Valid? Poster No. B6, 47th Annual Academy of Child and Adolescent Psychiatry, New York City, October 2000. 201. Faraone S, Frazier E, Biederman J, Monuteaux M, Doyle A, Seidman L: Learning Disability Predicts Educational

Failure in ADHD Boys at Follow-up. Poster No. B7, 47th Annual Academy of Child and Adolescent Psychiatry, New York City, October 2000.

202. Heilgenstein J, Spencer T, Faries D, Biederman J, Conners C, Kratochvil: Efficacy of Tomoxetine vs. Placebo in

Pediatric Outpatients with ADHD. Poster No. B11, 47th American Academy of Child and Adolescent Psychiatry, New York City, October 2000.

203. Doyle A, Faraone S, DuPre E, Biederman J: Separating Attention-Deficit/Hyperactivity Disorder and Learning

Disabilities. Poster No. B11, 47th American Academy of Child and Adolescent Psychiatry, New York City, October 2000.

204. Mick E, DiMauro A, Biederman J: Sleep Disturbances Associated with Attention-Deficit/Hyperactivity Disorder.

Poster No. B14, 47th American Academy of Child and Adolescent Psychiatry, New York City, October 2000. 205. McCracken J, Biederman J, Greenhill L, Swanson J, Spencer T, McGough J, Tulloch S: Analog Classroom Assessment

of SL1381 for the Treatment of ADHD. Poster No. B26, 47th Academy of Child and Adolescent Psychiatry, New York City, October 2000.

78

Page 79: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

206. Biederman J, Monuteaux M, Feighner J, Frazier E, Faraone S: Exposure to Parental Substance Use Disorders Predicts Adolescent Substance Use. Poster No. B40, 47th Academy of Child and Adolescent Psychiatry, New York City, October 2000.

207. Biederman J, Becker-Hirsfeld, Rosenbaum J, Perenick S, Wrightsman J, Faraone S: No Associations between Parental

Addictions and Behavioral Inhibition in Offspring. Poster No. B41, American Academy of Child and Adolescent Psychiatry, New York City, October 2000.

208. Wilens T, Biederman J, Hahesy A, Bredin E, Abrantes A, Spencer T: Influence of Parental Psychopathology on

Children of Substance Dependent Parents. Poster No. B 42, 47th Academy of Child and Adolescent Psychiatry, New York City, October 2000.

209. Biederman J, Becker-Hirshfeld D, Herot C, Wood J, Faraone S, Rosenbaum J: Associations between Behavioral

Inhibition and Social Anxiety in Children. Poster No. C1, 47th Academy of Child and Adolescent Psychiatry, New York City, October 2000.

210. Spencer T, Wilens T, Biederman J, Bearman S: Pharmacodynamics of Adderall in Adults with Attention-

Deficit/Hyperactivity Disorder. Poster No. 32, 47th Academy of Child and Adolescent Psychiatry, New York City, October 2000.

211. Wilens T, Prince J, Doyle R, Goldman S, Girard K, Monuteaux M, Gonzalez J, Murphy K, Biederman J; Buproprion

SR for ADHD in Adults with Bipolar Disorder (BPD0 and ADHD; Preliminary Data. Poster No. C33 47th Academy of Child and Adolescent Psychiatry, New York City, October 2000.

212. Wagner K, Weller E, Biederman J, Carlson G, Frazier J, Wozniak P, Bowden C: Safety and Efficacy of Divalproex in

Childhood Bipolar Disorder. Poster No. C36, 47th Academy of Child and Adolescent Psychiatry, New York City, October 2000.

213. McGough J, Greenhill L, Biederman J, Swanson J, McCracken J, Spencer T, Tulloch S, Wigal S:

Pharmacokinetic/Pharmacodynamic Analyses of SL1381 in Pediatric ADHD. Poster No. C39, 47th Academy of Child and Adolescent Psychiatry, New York City, October 2000.

214. Mick E, Biederman J, Cohan S: Meta-Analysis of ADHD and Major Depression: Poster No. D3, 47th Academy of

Child and Adolescent Psychiatry, New York City, October 2000. 215. Faraone S, Fischer M, Biederman J, Monuteaux M: The Familial Relationship of ADHD and Bipolar Disorder in Girls.

Poster No. D10, 47th Academy of Child and Adolescent Psychiatry, New York City, October 2000. 216. Heiligenstein J, Spencer T, Faries D, Biederman J, Conners K, Potter W: Tomoxetine Hydrochloride, A Novel

Noradrenergic Enhancer for the Treatment of Pediatric and Adult Attention-Deficit/Hyperactivity Disorder (ADHD). Poster No. 96, 39th American College of Neuropsychopharmacology, San Juan, Puerto Rico, December 2000.

217. Hirshfeld-Becker DR, Biederman J, Faraone SV, Violette H, Wrightsman J, Herot C, Rosenbaum JF: Temperamental

Correlates of Disruptive Behavior Disorders in Young Children: Laboratory Assessment of Behavioral Disinhibition. Poster No. 170, 39th American College of Neuropsychopharmacology, San Juan, Puerto Rico, December 2000.

218. Frazier JA, Kennedy D, Rauch S, Herbert M, Sohma M, Klaviness S, Makris N, Lange N, Caviness V, Biederman J:

Brain Anatomic Neuroimaging in Children with Bipolar Disorder. Poster No. 164, 39th American College of Neuropsychopharmacology, San Juan, Puerto Rico, December 2000.

79

Page 80: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

219. Solhkhah R, Wilens T, Prince JB, Daly J, and Biederman J: Brupropion Sustained Release for Substance Abuse, ADHD, and Mood Disorders in Adolescents. Annual Meeting of the American Psychiatric Association, New Orleans, 2001.

220. Faraone S, Pliszka S, Olvera R, Biederman J: Adderall and Methylphenidate in ADHD. Annual Meeting of the

American Psychiatric Association, New Orleans, 2001. 221. Biederman J: An OROS Formulation of Methylphenidate in the Treatment of ADHD. Poster No 734, Annual Meeting

of the American Psychiatric Association, New Orleans, 2001. 222. Solhkhah R, Wilens T, Prince J, Daly J, Biederman J: Bupropion Sustained Release for Substance Abuse, ADHD, and

Mood Disorders in Adolescents. Poster No. 31, Annual Meeting of the American Psychiatric Association, New Orleans, 2001.

223. Petersen T, Gresham R, Smith M, Biederman J, Nirenberg A, Fava M, Alpert J: Behavioral Characteristics of Children

and Adults with Early-Onset Versus Late-Onset MDD. Poster No 93, Annual Meeting of the American Psychiatric Association, New Orleans, 2001.

224. Heiligenstein J, Biederman J, Kratochvil C, Galil N, West S, Emslile G: Efficacy of Tomoxetine Versus Placebo in

School-Age Girls with ADHD. Poster No 552, Annual Meeting of the American Psychiatric Association, New Orleans, 2001.

225. Geiss J, Biederman J, Conners K, Greenhill L, Laurenza A, Webster C, Asgharnejad M: GW320659 Treatment of

Adult ADHD. Poster No 714, Annual Meeting of the American Psychiatric Association, New Orleans 2001. 226. Gellar D, Biederman J, Carpenter D, Gallagher D, Wagner K, Emslie G: Comorbid Psychiatric Illness and Response to

Treatment in Pediatric OCD. Poster No 738, Annual Meeting of the American Psychiatric Association, New Orleans, 2001.

227. Biederman J, Wozniak J, Mick E, Faraone S, Spencer T, Wilens T, Frazier J: Symposium on theCurrent Dilemmas in

the Diagnosis and Treatment of Very Early Onset Bipolar Disorder. ISRCAP, Vancouver, 2001. 228. McCracken J, McGough J, Biederman J, Greenhill L, Swanson J: Analog Classroom Assessment of SL1381 in

Children with ADHD. Poster No 113, ISRCAP, Vancouver, 2001. 229. Biederman J, Lopez F, Chandler M, Smith W, Boellner Arnold E: A Randomized, Controlled Trial of SL1381 in a

Naturalistic Setting. Poster No 114, ISRCAP, Vancouver, 2001. 230. Biederman J, Faraone S, Spencer T, Wilens T: Symposium on the New Understandings in the Neurobiology and

Treatment of ADHD. American Academy of Pediatrics, San Francisco, 2001. 231. Biederman J: A Randomized Controlled Trial of SL1381, A Once Daily Amphetamine Formulation for the Treatment o of ADHD. Abstract # 63, American Academy of Pediatrics, San Francisco, 2001. 232. Doyle R, Cohen L, Wozniak J, Prince J, Wilens T Spencer T, Biederman J: Influence of Gender on the Phamacotherapy

of Mood Disorders with Citalpram. New Research Poster Sesion A21, Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Hawaii 2001.

233. Wozniak J, Biederma J, Spencer T, Monuteaux M, Richards J: Clinical Features of Bipolar Depression in Children.

New Research Poster Session A27, Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Hawaii 2001.

80

Page 81: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

234. Biederman J: Gender Effects and Attention-Deficit/Hyperactivity Disorder in Referred Youth. New Research Poster Session A39, Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Hawaii 2001.

235. Biederman J, Faraone S, Monuteaux: Exposure to Parental ADHD: Clinical Features and Functioning in Offspring.

New Research Poster Session A40Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Hawaii 2001.

236. Biederman J, Quinn D, Weiss M, Wigal S: Methylphenidate Hydrochloride Modified-Release Capsules: Once-Daily

Therapy for ADHD. New Research Poster Session A41 Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Hawaii 2001.

237. Biederman J, Faraone S, Monuteaux M: Effect of Adveristy on Psychopathology and Functioning: Modification by

Gender. New Research Poster Session A42 Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Hawaii 2001.

238. Hammerness P, Monuteaux M, Biederman J, Gallo L, Murphy H: Reexamining the Association between Childhood

Astma and ADHD. New Research Poster Session A43 Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Hawaii 2001.

239. Wilens T, Biederman J, Gunawardene S, Wong J, Brown S, Wozniak J, Spencer T, Prince J, Doyle R, Monuteaux M:

Clinical Characteristics of Adults with Attention-Deficit/Hyperactivity Disorder and Bipolar Disroder. New Research Poster Session A49Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Hawaii 2001

240. Biederman J, Faries D, Galil N, Dittmann R, Emslie G, Kratochvil C, Laws H, West S: Atomoxetine Efficacy vs.

Placebo in School Age Girls with ADHD. Poster Session B9 Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Hawaii 2001.

241. Hahesy A, Wilens T, Entwistle P, Biederman J: Precursors to Grade Retention among Boys with or without ADHD.

Poster session B10 Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Hawaii 2001. 242. Heiligenstein J, Dittmann J, Spencer T, Wernicke J, Newcorn J, Casat C, Milton D, Michelson D: Atomexetine and

Methylphenidate Treatment in ADHD Children: A Randomized Open-Label Trial. Poster Session B20 Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Hawaii 2001.

243. McGough J, Biederman J, Greenhill L, McCracken J, Swanson J, Posner K, Spencer T, Wigal S, Tulloch S: Plasma

Amphetamine Concentration and Adverse Events in ADHD Treatment. Poster session B29 Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Hawaii 2001.

244. Geller D, Biederman J, Faraone S et al: CBCL Findings in OCD and ADHD Children. Poster Session D14 Annual

Meeting of the American Academy of Child and Adolescent Psychiatry, Hawaii 2001. 245. Wozniak J, Biederman J, Monuteaux M, Richards J, Faraone S: Parsing the Comorbidity between Bipolar Disorder and

Anxiety Disorders. Poster session D21. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Hawaii 2001.

246. Wilens T, Biederman J et al: Comorbidity and Functioning in ADHD Preschoolers and School-Aged Youth. Poster

session D 38. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Hawaii 2001. 247. Wilens T, Hahesy A, Biederman J et al: Influence of Parental SUD and ADHD on ADHD in Offspring. Poster session

D39. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Hawaii 2001.

81

Page 82: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

248. Wilens T, Prince J, Murphy K, Biederman J et al: Bupropion SR Treatment Study in Adults with ADHD and Substance Abuse: Preliminary Findings. Poster session D40. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Hawaii 2001.

249. Faraone S, Biederman J, Roe C: Meta-Analysis of Adderall and Methphenidate in Attention-Deficit/Hyperactivity

Disorder: Poster Session E17. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Hawaii 2001.

250. Geller D, Biederman J et al: ADHD in Children and Adolescents with OCD: Fact or Artifact: Poster Session E18.

Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Hawaii 2001. 251. Braaten E, Biederman J, Monuteaux M, Mick E, Burback M, Grossbard J: ADHD and Anxiety Disorders: A Familial

Risk Analysis. Poster Session E19. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Hawaii 2001.

252. Coffey B, Biederman J, Geller D, Frazier J et al: Predicting Tic Persistence and Impairment in Youth with Tourette’s

Disorder. Poster Session E42. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Hawaii 2001.

253. Doyle A, Monuteaux M, Biederman J, Cohan S, Faraone S: Should the Diagnostic Threshold for Conduct Disorder

Differ Across Gender? Poster Session E47. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Hawaii 2001.

254. WilensT, Biederman J, Brown S, Tanguay S, Blake C, Monuteaux M, Spencer T: Comorbidity and Functioning in

Preschoolers and School-Aged Youth with ADHD. New Research 8-Poster Session. Annual Meeting of the Amercian Psychiatric Association, Philadelphia 2002.

255. Biederman J, Quinn D, Wigal S, Weiss M, Markabi S, Edson K, Karlsson G: Methylphenidate Hydrochloride Extended

Release Capsules: Once-Daily Therapy for ADHD. New Research 8-Poster Session. Annual Meeting of the Amercian Psychiatric Association, Philadelphia 2002.

256. Roman T, Szobot C, Rohde L, Hutz M, Martins S, Biederman J: Dopamine Transporter Gene and Response to

Methylphenidate in ADHD. New Research Session Poster A. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, San Francisco 2002.

257 Hirsfeld Becker D, Biederman J, Buchwald J, Segool N, Rosenbaum J: Lack of Association between Behavioral

Inhibition and Environmental Risk Factors. New Research Session Poster C. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, San Francisco 2002.

258. Wozniak J, Biederman J, Faraone S, Mick E, Lail K, Wilens T, Spencer T: Family Study of Pediatric-Onset Bipolar

Disorder Revisited. . New Research Session Poster C. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, San Francisco 2002.

259. Geller D, Faraone S, Coffey B, Martin A, Farrell C, Mulin B, Biederman J: Choosing an SSRI for Pediatric OCD: A

Meta-Analysis. New Research Session Poster D. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, San Francisco 2002

260. Coffey B, Biederman J, Geller D, Frazier J, Spencer T, Frisone D: Tourette’s Disorder with OCD: Do Tics Remit or

Persist? New Research Session Poster D. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, San Francisco 2002

82

Page 83: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

261. Biederman J, Faraone S, Mick E, VanPatten S, Pandina G, Gharabawi: Risperidione and Affective Symptoms in Children with Disruptive Behavior Disorders. New Research Session Poster F. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, San Francisco 2002

262. Doyle A, Biederman J, Seidman L, Monuteaux M, Holmgren M, Imbraguglio N, Faraone S: Screening for Executive

Function Deficits in ADHD and Non-ADHD Youth. New Research Session Poster F. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, San Francisco 2002

263. Seidman L, Biederman J, Valera E, Monuteaux M, Doyle A, Faraone S: Common Executive Function Deficits in Girls

and Boys with ADHD. New Research Session Poster F. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, San Francisco 2002

264. Biederman J, Spencer T, Wozniak J, Faraone S New Research in Pediatric Bipolar Disorder. Annual Society of

Biological Psychiatry Meeting, San Francisco 2003. 265. Biederman J, Faraone S, Mick E, VanPatten S, Pandina G, Gharabawi G, Risperidone and Affective Symptoms in

Children with Disruptive Behavior Disorders. Annual Society of Biological Psychiatry Meeting, San Francisco 2003. 266. Frazier J, Chiu S, Kennedy D, Bent E, Stein N, Rauch S, Dietrich M, Makris N, Biederman J,Brain Anatomic Magnetic

Resonance Imaging in Pediatric Bipolar Disorder. Annual Society of Biological Psychiatry Meeting, San Francisco 2003.

267. Gonzalez-Heydrich J, Raches D, Hsin O, Pravdova I, Hollander SB, Biederman J, Masek B, An Open Trial of the

Safety and Efficacy of Mirtazapine in Children and Adolescents with Social Phobia. Annual Society of Biological Psychiatry Meeting, San Francisco 2003.

268. Valera E, Seidman L, Biederman J, Faraone S, An MRI Study of Working Memory in Adults with ADHD: Age

Differences. Annual Society of Biological Psychiatry Meeting, San Francisco 2003. 269. Biederman J, Swanson J, Lopez F, Modafinil Improves ADHD Symptoms in Children in a Randomized, Double-Blind,

Placebo-Controlled Study. Annual Meeting of the Amercian Psychiatric Association, San Francisco 2003 270. Swanson J, Greenhill L, Biederman J, Modafinil in Children with ADHD: A Randomized, Placebo-Controlled Study.

Annual Meeting of the Amercian Psychiatric Association, San Francisco 2003. 271. Biederman J, Spencer T, Faraone S. Poster Session Extended Release Mixed Amphetamine Salts in ADHD: Growth

Parameter Analysis. Annual Meeting of the Amercian Psychiatric Association, San Francisco 2003. 272. Chandler M, Biederman J, Lopez F. Poster Session Long Term and Efficacy of Adderall XR in Children with ADHD.

Annual Meeting of the Amercian Psychiatric Association, San Francisco 2003. 273. Michelson D, Biederman J, Spencer T, Zuddas A, Gillberg C, Danckaerts M, Buitelaar J, Zhang S. Poster Session

Results From A Long-Term Trial of Atomoxetine in the Prevention of Relapse in ADHD. Annual Meeting of the Amercian Psychiatric Association, San Francisco 2003.

274. Faraone S, Biederman J, Mondano B, Spencer. Poster Session ADHD in Adults: A Survey of Current Practice in

Psychiatry and Primary Care. Annual Meeting of the Amercian Psychiatric Association, San Francisco 2003. 275. Weisler R, Tulloch S, Frazer N, Timothy T, Chrisman A, Biederman J. Poster Session Long-Term Safety and Efficacy

of Once-Daily Adderall Extended Release in Adults with ADHD. Annual Meeting of the Amercian Psychiatric Association, San Francisco 2003.

83

Page 84: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

276. Faraone S, Biederman J. Poster Session The Impact of Drug Holidays on OROS Methylphenidate Treatment for ADHD. Annual Meeting of the Amercian Psychiatric Association, San Francisco 2003.

277. Lopez F, Tulloch S, Michals A, Mays D, Biederman J, Chandler M. Long-Term Adderall Extended Release Treatment

Improves Quality of Life in ADHD Children. Annual Meeting of the Amercian Psychiatric Association, San Francisco 2003.

278. Faraone S, Biederman J. Using a Meta-Analysis to Draw Conclusions About ADHD Medication Effects. Annual

Meeting of the Amercian Psychiatric Association, San Francisco 2003. 279. Biederman J, Mick E, Faraone S, Johnson M, Murphy H. Poster Session Open Trial of Atypical Neuroleptics In

Preschoolers with Bipolar Disorder. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003.

280. Biederman J (Paper Session Chairperson) Childhood Psychopathology; Society of Biological Psychiatry, New York

2004. 281. Seidman L, Faraone S, Biederman J, Valera E, Rauch S, Makris N, Schlerf. Workgroup session 696 Investigation of

Structural Brain Abnormalities. Society of Biological Psychiatry, New York 2004. 282. Valera E, Seidman L, Biederman J, Faraone S. Workgroup session 697 Functional Neuroanatomy of Working Memory

in Adults with ADHD. Society of Biological Psychiatry, New York 2004. 283. Bush G, Spencer T, Surman C, Holmes J, Seidman L, Valera E, Biederman J. Workgroup session 698 Functional MRI

of Two Classes of ADHD Therapy Versus Placebo. Society of Biological Psychiatry, New York 2004. 284. Biederman J, Spencer T, Wilens T, Weisler R, Zhang Y, Tulloch S. New Research 7 Poster Session # 440 Dose-

Repsonse Efficacy of Mixed Amphetamine Salts Extended Release in Adults with ADHD. Annual Meeting Amercian Psychiatric Association, New York 2004.

285. Faraone S, Biederman J. New Research 7 Poster Session # 441 Prevalence of Adult ADHD in the US. Annual

Meeting Amercian Psychiatric Association, New York 2004. 286. Spencer T, Biederman J, Abikoff H, Pliszka S, Boellner S, Lopez F, Tulloch S. New Research Poster 7 Session # 456.

Safety and Efficacy of Mixed Amphetamine Salts Extended Release in Children with Oppositional Defiant Disorder (ODD). Annual Meeting Amercian Psychiatric Association, New York 2004.

287. Nierenberg A, Henin A, Siegel R, Wu Y, Mick E, Biederman J, Sachs G. New Research Poster Session 10 # 847.

Psychopathology in the Offspring of Bipolar Parents: A Controlled Study. Annual Meeting Amercian Psychiatric Association, New York 2004.

288. Swanson J, Biederman J, Boellner S, Lopez F Poster Session “ Modafinil as Therapy for ADHD in Children: An 8

week, Open-label study”44th Annual NCDEU Meeting, Phoenix 2004. 289. Biederman J Poster Session # 58 “ Long Term Safety and Efficacy of Adderall XR for Adult ADHD”. U.S. Psychiatric

and Mental Health Congress, San Diego 2004. 290. Frazier J, Breeze J, Makris N, Kennedy D, Giuliano A, Herbert M, Seidman L, Biederman J, Hodge S, Dieterich M,

Gerstein E, Caviness V, Phil D Poster “Cortical Gray Matter Volumes in Pediatric Bipolar Disorder” ACNP, Puerto Rico 2004.

84

Page 85: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

291. Biederman J, Mick E, Harpold T, Hammerness P, Aleardi M, Dougherty M, Menard C. Poster Session # 146. Treatment of Preschoolers with Pediatric Bipolar Disorder. Society of Biological Psychiatry, Atlanta 2005.

292. Biederman J, Faraone S. Poster Session # 147. The Economic Impact of Adult ADHD. Society of Biological

Psychiatry, Atlanta 2005. 293. Biederman J, Mick E. Poster Session # 163. Treatment of Psychotic Symptoms in Children and Adolescents with

Bipolar Disorder. Society of Biological Psychiatry, Atlanta 2005. 294. Biederman J, Spencer T, Surman C, Aleardi M, Dougherty M, Schweitzer K, Mick E. Poster Session # 384. Open-

Label Study of OROS Methylphenidate in the Treatment of Adults with ADHD-NOS. Society of Biological Psychiatry, Atlanta 2005.

295. Biederman J, Spencer T, Surman C, Mick E, Dunkel S, Dougherty M, Aleardi M. Poster Session # 385. A Double-

Blind Placebo-Controlled Randomized Study of OROS Methylphenidate in the Treatment of Adults with ADHD: An Interim Analysis. Society of Biological Psychiatry, Atlanta 2005.

296. Biederman J, Harpold T, Hammerness P, Mick E, Dougherty M, Aleardi M, Randall E. Poster Session # 386. An Open-

Label Study of Ziprasidone in Children with Bipolar Disorder. Society of Biological Psychiatry, Atlanta 2005. 297. Biederman J, Faraone S, Mick E. Poster Session # 387. Females with ADHD: A 5-Year Follow-Up Study. Society of

Biological Psychiatry, Atlanta 2005. 298. Biederman J, Faraone S, Mick E. Poster Session # 388. A 10-Year Follow-Up Study of Males with ADHD. Society of

Biological Psychiatry, Atlanta 2005. 299. Biederman J, Mick E. Poster Session # 391. Effectiveness of Risperidone for the Treatment of ADHD in Children and

Adolescents with BPD. Society of Biological Psychiatry, Atlanta 2005. 300. Biederman J, Mick E. Poster Session # 286. The Treatment of Psychotic Symptoms in Children and Adolescents with

Bipolar Disorder. American Psychiatric Association 2005 Annual Meeting, Atlanta 2005 301. Biederman J, Mick E, Harpold, T, Hammerness P, Aleardi M, Dougherty M, Menard C. Poster Session # 287.

Treatment of Preschoolers with Bipolar Disorder. American Psychiatric Association 2005 Annual Meeting, Atlanta 2005

302. Biederman J, Spencer T, Surman C, Aleardi M, Dougherty M, Schweitzer K, Mick E. Poster Session # 288. Open-

Label Study of OROS Methylphenidate in the Treatment of Adults with ADHD Not Otherwise Specified (NOS). American Psychiatric Association 2005 Annual Meeting, Atlanta 2005

303. Biederman J, Faraone S. Poster Session # 289. Economic Impact of Adult ADHD. American Psychiatric Association

2005 Annual Meeting, Atlanta 2005 304. Biederman J, Spencer T, Newcorn J, Gao H, Milton D, Feldman P. Poster Session # 290. Does the Presence of

Comorbid ODD Affect Responses to Atomoxetine. American Psychiatric Association 2005 Annual Meeting, Atlanta 2005

305. Biederman J, Faraone S, Mick E. Poster Session # 773. Females with ADHD: A Five Year, Follow-Up Study.

American Psychiatric Association 2005 Annual Meeting, Atlanta 2005

85

Page 86: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

306. Biederman J, Wigal S, Spencer T, McGough J, Mays D, Fiddler G. Poster Session # 771. Analog Classroom Study of Amphetamine and Atomoxetine in Girls with ADHD. American Psychiatric Association 2005 Annual Meeting, Atlanta 2005

. 307. Biederman J, Faraone S, Mick E. Poster Session # 772. A Ten Year Follow-Up Study of Males with ADHD. American

Psychiatric Association 2005 Annual Meeting, Atlanta 2005 308. Biederman J, Harpold T, Hammerness P, Mick E, Dougherty M, Aleardi M, Randall E. Poster Session # 774. An Open-

Label Study of Ziprasidone in Children with Bipolar Disorder. American Psychiatric Association 2005 Annual Meeting, Atlanta 2005

309. Biederman J, Spencer T, Surman C, Mick E, Dunkel S, Dougherty M, Aleardi M. Poster Session # 775. A Double-

Blind Placebo Controlled, Randomized Study of OROS Methylphenidate in the Treatment of Adults with ADHD: An Interim Analysis. American Psychiatric Association 2005 Annual Meeting, Atlanta 2005

310. Biederman J, Fried R, Mick E, Aleardi M, Potter A, Herzig K. Poster Session # 776. A Workplace Simulation:

Performance in ADHD versus Control Subjects. American Psychiatric Association 2005 Annual Meeting, Atlanta 2005 311. Biederman J, Petty C, Fried R, Aleardi M, Surman C, Schweitzer K. Poster Session # 777. Characterizing Impaired

Driving in Adults with ADHD: A Controlled Study. American Psychiatric Association 2005 Annual Meeting, Atlanta 2005

312. Biederman J, Swanson J, Boellner S. Poster Session # 99. Safety and Efficacy of Modafinil Film-Coated Tablets in Children and Adolescents with Attention-Deficit/Hyperactivity. NCDEU 45th Annual Meeting, Boca Raton, Florida 2005

313. Biederman J, Mick E, Wozniak J, Spencer. Poster Session # 55. A Long Term, Open-Label Trial of Risperidone in

Children with Bipolar Disorder and Comorbid Attention-Deficit/Hyperactivity Disorder. NCDEU 45th Annual Meeting, Boca Raton, Florida 2005

314. Kratochvil C, Biederman J, Swanson JM, Greenhill L, Earl CQ, Jiang JG. Efficacy of Modafinil Film-Coated Tablets (Modafinil-ADHD) in Attention-Deficit/Hyperactivity Disorder Established in Three Randomized Controlled Trials.CHADD 17th Annual Meeting, Dallas, Texas 2005

315. Owens J, Wigal SB, Biederman J, Swanson JM, Kratochvil C, Boellner S, Earl CQ, Jiang JG, Greenhill L. Safety and Efficacy of Modafinil Film-Coated Tablets (Modafinil-ADHD) in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder. CHADD 17th Annual Meeting, Dallas, Texas 2005

316. Rugino T, Greenhill L, Biederman J, Boellner S, Sangal RB, Earl CQ, Jiang JG, Swanson JM. Modafinil Film-Coated Tablets (Modafinil-ADHD) Significantly Improve Symptoms in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder. CHADD 17th Annual Meeting, Dallas, Texas 2005

317. Swanson JM, Greenhill L, Lopez F, Sedillo A, Earl CQ, Jiang JG, Biederman J. Modafinil Film-Coated Tablets (Modafinil-ADHD) is Effective in Attention-Deficit/Hyperactivity Disorder Without Symptom Rebound Following Abrupt Discontinuation. CHADD 17th Annual Meeting, Dallas, Texas 2005

318. Wigal SB, Greenhill L, Biederman J, Swanson JM, Earl CQ, Jiang JG. Safety and Tolerability of Modafinil Film-Coated Tablets (Modafinil-ADHD) in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder. CHADD 17th Annual Meeting, Dallas, Texas 2005

319. Biederman J, Spencer T, Newcorn J, Gao H, Milton D, Feldman P. Poster session # B4. Effects of Comorbid Symptoms of ODD on Responses to Atomoxetine. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Toronto, Canada 2005

86

Page 87: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

320. Biederman J, Petty C, Fried R, Doyle A, Seidman L, Faraone S. Poster session # B5. Psychometrically-Defined

Executive Deficits and Academic/Occupational Outcomes in ADHD Adults. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Toronto, Canada 2005

321. Biederman J, Petty C, Fried R, Doyle A, Seidman L, Faraone S. Poster session # B6. Behaviorally-Defined Executive

Function Deficits and Interpersona/Occupational Impairments in ADHD Adults. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Toronto, Canada 2005

322. Kratochvil C, Greenhill L, Boellner S, Swanson J, Biederman J. Poster session # B12. Safety and Tolerability of

Modafinil in Children and Adolescents with ADHD. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Toronto, Canada 2005

323. Wigal S, Biederman J, Kratochvil C, Swanson J, Greenhill L. Poster session # B18. Modafinil Film-Coated Tablets

Improve Symptoms of Attention-Deficit/Hyperactivity Disorder. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Toronto, Canada 2005

324. Wilens T, Biederman J, Ditterline J, Swezey A, Snyder L, Whitley J, Henin A, Wozniak J. Poster session # C1.

Psychiatric Comorbidity in Adolescents with Bipolar Disorder. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Toronto, Canada 2005

325. Biederman J, Mick E, Hammerness P, Harpold T, Aleardi M, Dougherty M, Wozniak J. Poster session # C2. Open-

Label Trial of Ziprasidone in Children and Adolescents with Bipolar Disorder. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Toronto, Canada 2005

326. Faraone S, Hudziak J, Althoff R, Biederman J. Poster session # C14. The CBCL Predicts Bipolar Disorder in Children:

An ROC Analysis. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Toronto, Canada 2005

327. Faraone S, Hudziak J, Smoller J, Sklar P, Biederman J. Poster session # C15. Association between HTR1B and the

CBCL Juvenile Bipolar Disorder Phenotype. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Toronto, Canada 2005

328. Joshi G, Geller D, Wozniak J, Petty C, Vivas F, Biederman J. Poster session # C42. Clinical Characteristics of

Comorbid Obsessive-Compulsive Disorder and Bipolar Disorder in Children and Adolescents. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Toronto, Canada 2005

329. Wilens T, Gignac M, Swezey A, Monuteaux M, Biederman J. Poster session # C62. Medications Misuse in Adolescents

and Young Adults with ADHD. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Toronto, Canada 2005

330. Faraone S, Biederman J. Poster session # C71. Adult ADHD NOS: Is It a Valid Disorder? Annual Meeting of the

American Academy of Child and Adolescent Psychiatry, Toronto, Canada 2005 331. Monuteaux M, Wilens T, Biederman J. Poster session # D39. Social Class and Substance Problems in Young Adults

with ADHD. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Toronto, Canada 2005 332. Geller D, Biederman J, Petty C, Stewart S, Haddad S, Pauls D. Poster session # D44. Age-Corrected Risk of OCD in

Relatives of Affected Youth. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Toronto, Canada 2005

333. Heydrich-Gonzalez J, Whitney J, Hsin O, Mrakotsky C, MacMillan C, Torres A, Pravdova I, DeMaso D, Bourgeois B,

Biederman, J. Poster session # D52. Tolerability of OROS-MPH for Treatment of ADHD Plus Epilepsy. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Toronto, Canada 2005

87

Page 88: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

334. Biederman J, Mays D, Hodgkins P. Poster session # E53. Placebo Effect in ADHD Parent and Teacher Ratings. Annual

Meeting of the American Academy of Child and Adolescent Psychiatry, Toronto, Canada 2005 335. Mick E, Biederman J, Faraone S, Wozniak J, Spencer T, Pandina G. Poster session # 61. Risperidone in the Treatment

of Affective Symptoms: A Secondary Analysis of a Randomized Clinical Trial in Children with Disruptive Behavioral Disorder. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Toronto, Canada 2005

336. Moore C, Biederman J, Wozniak J, Mick E, Aleardi M, Wardrop M, Dougherty M, Harpold T, Hammerness P, Randall

E, Renshaw P. Poster session # 78. Effects of Risperidone on Anterior Cingulate Cortex Glutamate in Pediatric Bipolar Disorder. Society of Biological Psychiatry. Toronto 2006.

337. Valera E, Faraone S, Biederman J, Seidman L. Poster session # 226. Alexithymia in Adults with Attention-Deficit

Hyperactive Disorder (ADHD): Relationship Between TAS-20 Subscale Scores, ADHD, and its Symptomatology. Society of Biological Psychiatry. Toronto 2006.

338. Biederman J. Poster session # 374. An Open-Label Study of Divalproex Sodium Monotherapy in Youth with Bipolar Disorder. Society of Biological Psychiatry. Toronto 2006.

339. Biederman J. Poster session # 376. Comparative and Acute Efficacy and Tolerability of OROS and Immediate Release Formulations of Methylphenidate in the Treatment of Adults with Attention Deficit Hyperactivity Disorder. Society of Biological Psychiatry. Toronto 2006.

340. Tohen M, Kryzhanovskaya L, Carlson G, Delbello M, Wozniak J, Kowatch R, Wagner K, Findling R, Lin D, Plouch C, Xu W, Huang X, Dittmann R, Biederman J. Poster session # 387. Olanzapine in the Treatment of Acute Mania in Adolescents with Bipolar I Disorder; A 3-Week Randomized Double-Blind Placebo-Controlled Study. Society of Biological Psychiatry. Toronto 2006.

341. Biederman J. Poster session # 674. Developmental Trajectories of Anxiety Disorders in Offspring at High Risk for Panic Disorder. Society of Biological Psychiatry. Toronto 2006.

342. Biederman J. Poster session # 80. An Open-Label Trial of Aripiprazole in Youth with Bipolar Disorder. Society of Biological Psychiatry. Toronto 2006.

343. Tohen M, Kryzhanovskaya L, Carlson G, Delbello M, Kowatch R, Biederman J. Poster session # 291. Olanzapine in the Treatment of Acute Mania in Adolescents with Bipolar I Disorder: A Three-Week Randomized Double-Blind Placebo-Controlled Study. American Psychiatric Association Annual Meeting, Toronto 2006.

344. Biederman J, Spencer T, Mick E. Poster session # 463. Comparative and Acute Efficacy and Tolerability of OROS and

Immediate Release Formulations of Methylpheniddate in the Treatment of Adults with ADHD. American Psychiatric Association Annual Meeting, Toronto 2006.

345. Biederman J, Mick E, Wozniak J. Poster session # 464. Comparative Efficacy of Atypical Antipsychotics in Youth with

Bipolar Disorder. American Psychiatric Association Annual Meeting, Toronto 2006. 346. Biederman J, Mick E, Hammerness P, Doyle R, Wozniak J. Poster session # 465. An Open-Label Study of Divalproex

Sodium Monotherapy in Youth With Bipolar Disorder. American Psychiatric Association Annual Meeting, Toronto 2006.

88

Page 89: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

347. Moore C, Biederman J, Wozniak J, Mick E, Harpold T, Hammerness P, Renshaw P. Poster session # 557. Effects of Risperidone on Anterior Cingulate Cortex Glutamate in Pediatric Bipolar Disorder. American Psychiatric Association Annual Meeting, Toronto 2006.

348. Wilens T, Hammerness P, Spencer T, Whitley J, Traina S, Santry A, Biederman J. Poster session # 607. Combined

OROS-Methylphenidate and Atomoxetine Treatment in Children with ADHD. American Psychiatric Association Annual Meeting, Toronto 2006.

349 Biederman J, Mick E, Wozniak J, Hammerness P, Doyle. Poster session # 629. Open-Label Trial of Aripiprazole in

Children and Adolescents with Bipolar Disorder. American Psychiatric Association Annual Meeting, Toronto 2006. 350. Biederman J, Petty C, Hirshfeld-Becker D, Henin A, Faraone S, Henry B, Rosenbaum J. Poster session # 630.

Developmental Trajectories of Anxiety Disorders in Offspring at High Risk for Panic Disorder. American Psychiatric Association Annual Meeting, Toronto 2006.

351. Biederman J, Boellner S, Childress A, Lopez F, Krishnan S, Hodgkins. Poster session # 631. Improvements in

Symptoms of ADHD in School-Aged Children with Lisdexamfetamine (SPD489/NRP104) and Extended-Release Mixed Amphetamine Salts versus Placebo. American Psychiatric Association Annual Meeting, Toronto 2006.

352. Biederman J, Hodgkins P, Krishnan S, Findling R. Poster session # 632. Efficacy and Safety of Lisdexamfetamine

(SPD489/NRP104) in Children Aged 6 to 12 Years with ADHD. American Psychiatric Association Annual Meeting, Toronto 2006.

353. Fried R, Biederman J, Monuteaux M, Petty C, Doyle A, Mick E. Poster session # 659. Psychometrically-Defined

Executive Function Deficits and Academic/Occupational Outcomes in ADHD Adults. American Psychiatric Association Annual Meeting, Toronto 2006.

354. Hirshfeld-Becker D, Biederman J, Henin A, Kaufman B, De Figueiredo, Rosenbaum J. Poster session # 670.Preschool

Behavioral Disinhibition Predisposes to Comorbid Mood and Disruptive Behavior Disorders. Poster session # 670. American Psychiatric Association Annual Meeting, Toronto 2006.

355. Mick E, Biederman J, Spencer T, Faraone S, Sklar P. Poster session # 697. Dopamine Transporter (DAT1) Genotype

and Response to Methylphenidate in Adults with ADHD. American Psychiatric Association Annual Meeting, Toronto 2006.

356. Mick E, Biederman J, Faraone S, Spencer T. Poster session # 698. Assessing the Validity of the Quality of Life

Enjoyment and Satisfaction Questionnaire in Adults with ADHD. American Psychiatric Association Annual Meeting, Toronto 2006.

357. Spencer T, Biederman J, Wilens T, Doyle R, Surman C, Mick E. Poster session # 716. A Double Blind, Six-Month

Study of Methylphenidate in Adults with ADHD. American Psychiatric Association Annual Meeting, Toronto 2006. 358. Fried R, Petty C, Monuteaux M, Mick E, Biederman J. Poster session # 921. Behaviorally-Defined Executive Function

Deficits Associated With Academic, Interpersonal, and Occupational Deficits in Adults with ADHD: A Controlled Study. American Psychiatric Association Annual Meeting, Toronto 2006.

359. Biederman J. Poster session # 3. Randomized Double-Blind of OROS Methylphenidate (Concerta) in ADHD Adults

With and Without Comorbid Depression or Anxiety Disorders. American Psychiatric Association Annual Meeting, San Diego 2007.

360. Biederman, J. Poster session # NR06. Long-Term, Open-Label Study of Guanfacine Extended Releas in Children and

Adolescents With Attention-Deficit/Hyperactivity Disorder. American Psychiatric Association Annual Meeting, San Diego 2007.

89

Page 90: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

361. Biederman J. Poster session # NR06. A Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine Extended

Release in Children With Attention-Deficit/Hyperactivity Disorder. American Psychiatric Association Annual Meeting, San Diego 2007.

362. Biederman J. Poster session # NR07. Comparatice Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in

Stimulant-Naïve for Past 12 Months and Previously Treated Children Aged 6 to 12 Years With Attention-Deficit/Hyperactivity Disorder. American Psychiatric Association Annual Meeting, San Diego 2007.

363. Biederman J. Poster session # NR07. Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Non-Caucasian

Children Aged 6 to 12 Years With Attention-Deficit/Hyperactivity Disorder: A Secondary Analysis. American Psychiatric Association Annual Meeting, San Diego 2007.

364. Geller D, Johnson J, Reicherta E, Petty C, Biederman J. Poster session # A47. Psychosocial Functioning in Children

and Adolescents with Obsessive Compulsive Disorder. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Boston 2007.

365. Henin A, Mick E, Biederman J, Micco J, Tilly C, Rindlaub L, Sachs R, Nierenberg A. Poster session # B13. Impact of

Comorbid Disorders in Bipolar Parents on Psychopathology in Offspring. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Boston 2007.

366. Xu W, Tohen M, Kryzhanovskaya L, Carlson G, DelBello M, Wozniak J, Kowatch R, Dineen Wagner K, Findling R,

Lin D, Robertson-Plouch C, Dittmann R, Biederman J. Poster session # B15. Open-Label Treatment with Olanzapine in Adolescents with Bipolar Mania. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Boston 2007.

367. Biederman J. Poster session # B19. Comparative Efficacy of Atypical Antipsychotisc for Pediatric Bipolar Disorder.

Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Boston 2007. 368. Biederman J, Lyne A, Sallee F, Whitaker T. Poster session # B20. Efficacy and Safety of Guanfacine Extended Release

(GXR) in ADHD. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Boston 2007. 369. Adler L, Goodman D, Kollins S, Weisler R, Krishnan S, Yuxin Z, Biederman J. Poster session # B34. Efficacy and

Safety of Lisdexamphetamine Dimesylate in Adults with ADHD. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Boston 2007.

370. Micco J, Henin A, Rosenbaum J, Biederman J, Simoes N, Bloomfield A, Hirshfeld-Becker D. Poster session # C44.

Temperamental Pathways to Anxiety Disorder in At-Risk Children. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Boston 2007.

371. Wilens T, Vitulana M, Upadhayaya H, Adamson J, Biederman J. Poster session # D3. Concordance Between the mFTQ

and DSM Smoking Dependence. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Boston 2007.

372. Surman C, Mick E, Biederman J. Poster session # D10. Association Between Insomnia and ADHD During a Follow-up

Study. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Boston 2007. 373. Balcioglu A, Spencer T, Biederman J, Bhide P. Poster session # E52. Bioavailability Profiles of Methylphenidate and

Ritalinic Acid in Mice. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Boston 2007. 374. Brown A, Valera E, Biederman J, Monuteaux M, Bandyopahyay S, Vitulano M, Schiller M, LaViolette P, Makris N,

Faraone S, Seidman L. Poster session # E53. Relationship Between ADHD Symptoms and Brain Functioning During Working Memory. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Boston 2007.

90

Page 91: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

375. Biederman J. Overlap of Disruptive Behavior and Mania. CHADD 19th Annual CHADD Meeting, Crystal City, Virginia 2007.

Symposia and Plenary Talks: 1. Biederman J (Chair): Studies of High Risk Children. Annual meeting of the American Psychiatric Association, 1990. 2. Biederman J (Chair): Methodological Issues in the Implementation of High Risk Studies of Child and Adolescent Mental Disorders. Research Forum; Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Seattle, WA, 1990. 3. Biederman J (Chair): Methodological Issues in the Implementation of Multisite Studies of Child and Adolescent Mental Disorders. Research Forum; Annual Meeting of the American Academy of Child & Adolescent Psychiatry, San Francisco, CA, 1991. 4. Biederman J (Chair): Comorbidity in Studies in Child and Adolescent Mental Disorders Research Forum; Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Washington DC, 1992. 5. Biederman J.: Behavioral Inhibition as a Temperamental Risk Factor for Anxiety Disorders. Presidential Symposium; Annual Meeting of the American Psychiatric Association, Washington DC, May 1992. 6. Biederman J.: Behavioral Inhibition as a Temperamental Risk Factor for Anxiety Disorders. Plenary Session, Developmental Aspects of Childhood Normal and Abnormal Behavior. Annual Meeting of the Society of Biological Psychiatry, San Francisco, CA, 1993. 7. Biederman J (Chair): Methodological Issues in Pediatric Psychopharmacology Research. Research Forum; Annual Meeting of the American Academy of Child & Adolescent Psychiatry, San Antonio, TX, 1993. 8. Biederman J (Co-Chair): Attention-Deficit Hyperactivity Disorder in Adults. Symposium #9; Annual Meeting of the American Academy of Child & Adolescent Psychiatry, San Antonio, TX, October 1993. 9. Biederman J (Co-Chair): An Update on Tricyclic Antidepressants in Children and Adolescents. Symposium #30; Annual Meeting of the American Academy of Child & Adolescent Psychiatry, San Antonio, TX, October 1993. 10. Biederman J (Chair): Current Issues and New Developments in Pediatric Psychopharmacology Research. Research

Forum; Annual Meeting of the American Academy of Child & Adolescent Psychiatry, New York, NY, October 1994.

11. Biederman J (Chair): Comorbidity of ADHD: New Findings and Old Controversies-Part I. Symposium #13; Annual Meeting of the American Academy of Child & Adolescent Psychiatry, New York, NY, October 1994. 12. Biederman J (Chair): Comorbidity of ADHD: New Findings and Old Controversies-Part II. Symposium #26; Annual Meeting of the American Academy of Child & Adolescent Psychiatry, New York, NY, October 1994. 13. Biederman J (Chair): Current Concepts in the Psychobiology and Psychopharmacology of Juvenile ADHD.

CHADD Annual Meeting, New York, NY, October 1994. 14. Biederman J (Chair): Current Concepts in the Psychobiology and Psychopharmacology of Adult ADHD. CHADD Annual Meeting, New York, NY, October 1994.

91

Page 92: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

15. Biederman J (Chair): ADHD Across the Life cycle. APA Sponsored Symposium (1400 participants); Annual Meeting of the American Psychiatric Association, Miami, FL, May 1995. 16. Biederman J (Co-Chair): New Research in Adult ADHD. Annual Meeting of the American Academy of Child & Adolescent Psychiatry, New Orleans, LA, October 1995. 17. Biederman J (Co-Chair): New Research in ADHD in Children and Adolescents, Part I. Annual Meeting of the American Academy of Child & Adolescent Psychiatry, New Orleans, LA, October 1995. 18. Biederman J (Co-Chair): New Research in ADHD in Children and Adolescents, Part II. Annual Meeting of the American Academy of Child & Adolescent Psychiatry, New Orleans, LA, October 1995. 19. Biederman J (Chair): Continuity and Discontinuity Between Childhood and Adult Psychiatric Disorders. Research Forum; Annual Meeting of the American Academy of Child & Adolescent Psychaitry, New Orleans, LA, October 1995. 20. Greene R, Biederman J, Wilens T, et al.: New Research on Psychopharmacology and Substance Abuse in Adolescents and Adults with ADHD. Annual Meeting of the American Psychological Association, Toronto, Canada, August, 1996. 21. Wilens T (Chair), Biederman J, Wozniak J, Faraone S, Frazier J, Geller B.: Does juvenile bipolar disorder exist? New research and findings: Part I. Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Philadelphia, PA, October 1996. 22. Biederman J (Chair), Wilens T, Faraone S, Greene R, Mick E, Prince J, Bostic J, Strober M.: Does juvenile bipolar

disorder exist? New research and findings: Part II. Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Philadelphia, PA, October 1996.

23. Biederman J (Chair), Spencer T, Greene R, Seidman L, Faraone S, Semrud-Clikeman M, Mick E.: New research in ADHD in children and adolescents, Part I. Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Philadelphia, PA, October 1996. 24. Biederman J (Chair), Spencer T, Greene R, Seidman L, Faraone S, Semrud-Clikeman M, Mick E.: New research in ADHD in children and adolescents, Part I. Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Philadelphia, PA, October 1996. 25. Biederman J (Chair), Spencer T, Samuel V, Mennin D, Wilens T.: New research in ADHD in children and

Adolescents, Part II. Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Philadelphia, PA, October 1996.

26. Biederman J.: Plenary speaker: ADHD Across the Lifecycle. Annual Spring Conference of the Connecticut Association of Foster and Adoptive Parents, Inc., April 1997. 27. Biederman J. (Chair), Rosenbaum JF, Faraone SV, Hirshfeld DR, Kagan J.: Behavioral Inhibition in Childhood: A risk factor for anxiety disorders. 6th World Congress of Biological Psychiatry, Nice, France, June 1997. 28. Biederman J. (Chair), Wilens T, Abrantes A, Spencer T.: The Relationship of Juvenile Psychiatric and Substance Use Disorders. 6th World Congress of Biological Psychiatry, Nice, France, June 1997. 29. Biederman J. (Chair): ADHD Across the Lifecycle. 6th World Congress of Biological Psychiatry, Nice, France, June 1997. 30. Biederman J, Wolkow R, March J, Safferman A.: A placebo-controlled trial of sertraline treatment for pediatric

OCD. 6th World Congress of Biological Psychiatry, Nice, France, June 1997.

92

Page 93: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

31. Biederman J (Chair): Psychological Aspects of Allergies, Asthama and Other Chronic Diseases, Newport, Rhode Island, September 1997. 32. Biederman J: APA Symposium. "Juvenile Mood Disorders: From Research to Clinical Practice." Ontario, Canada. 1998. 33. Wilens T. (Co-Chair) Biederman J. (Co-Chair): ADHD Persistence or Remission? Data from Longitudinal Studies.

Symposium # 5; Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Chicago, October 1999.

34. Wozniak J (Co-Chair) Biederman J (Co-Chair): New Findings in Trauma and PTSD. Symposium # 14; Annual

Meeting of the American Academy of Child and Adolescent Psychiatry, Chicago, October 1999. 35. Biederman J (Co-Chair) Hirshfeld-Becker D (Co-Chair): Family, Temperament and Attachment: Risk Factors for

Childhood Anxiety Disorders. Symposium # 29; Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Chicago, October 1999.

36. Biederman J (Co-Chair): Psychpathology in Children of Parents with Panic Disorder and Depression. Symposium #

29; Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Chicago, October 1999. 37. Biederman J (Chair): New Research on Conduct Disorder: Developmental Psychopathology Perspectives. Symposium

# 37; Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Chicago, October 1999. 38. Biederman J (Chair): Bi-Directional Overlap between Juvenile Mania and Conduct Disorder. Symposium # 37; Annual

Meeting of the American Academy of Child and Adolescent Psychiatry, Chicago, October 1999. 39. Biederman J: Pharmacotherapy of Attention-Deficit/ Hyperactivity Disorder Reduces Risk for Substance Use Disorder.

Symposium # 42; Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Chicago, October 1999.

40. Biederman J (Chair): Age-Dependent Decline of ADHD Symptoms. Symposium # 38, Annual Meeting of the

Psychiatric Associaton, Chicago, May 2000. 41. Biederman J (Chair), Spencer T, Bostic J, Prince J, Gerard K: Efficacy and Tolerability of a Mixed Amphetamine Salts

Compound in Adults with ADHD. Symposium # 38, Annual Meeting of the American Psychiatric Association, Chicago, May 2000.

42. Biederman J (co-chair): ADHD in Girls: Results from a Family Genetic Study. Symposium # 48, Annual Meeting of

the American Psychiatric Association, Chicago, May 2000. 43. Biederman J: Applications to Anxiety Disorders. Symposium # 89, Annual Meeting of the American Association, Chicago, May 2000. 44. Biederman J (co chair): Overview of Comorbid Conditions in ADHD. Symposium # 46, Annual Meeting of the

Psychiatric Association, New Orleans, May 2001. 45. Biederman J: Bridging Biological, Behavioral Science, and Drug Abuse Prevetion: Intervention and Insult Along a

Developmental Continuum. NIDA-Sponsored Workshop, Scottsdale, Arizona, June 2001. 46. Biederman J (co chair) Spencer T (co-chair) Mick E, Braaten E, Birmaher B, Wagner-Dineen K: New Research in

Childhood Depression, Part 1. Symposium # 1, Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Hawaii, October 2001.

93

Page 94: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

47. Biederman J (co chair) Spencer T (co-chair) Mick E, Emslie G:New Research in Childhood Depression, Part 2. Symposium # 8, Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Hawaii, October 2001.

48. Biederman J: (co chair) Therapeutic Implications of Comorbidity in Juvenile Bipolar Disorder. Symposium # 29,

Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Hawaii, October 2001.Biederman J: Functional Outcome and Age-Dependent Decline of ADHD Symptoms in ADHD. Annual Meeting o the American Academy of Child and Adolescent Psychiatry, Hawaii, October 2001.

49. Biederman J (chair) Spencer T, Mick E, McCracken J, Swanson J: New Research on the Treatment of ADHD.

Symposium # 48, Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Hawaii, October 2001.

50. Biederman J: Annual Meeting of the American Society for Adolescent Psychiatry, Chicago, March 2002 51. Seidman L, Biederman J, Valera E, Doyle A, Monuteaux M, Faraone S: Symposium on the Neuropsychology of Adult

ADHD. Annual Meeting of the Amercian Psychiatric Association, Philadelphia 2002. 52. Wozniak J, Biederman J, Richards J: Symposium on the Evolving Treatments for Psychiatric Disorders in Young

Patients with Evidence From Bipolar and Other Conditions. Annual Meeting of the Amercian Psychiatric Association, Philadelphia 2002.

53. Chandler M, Lopez F, Biederman J: Symposium on the Long-term Safety and Efficacy of Adderall Extended Release in

Children with ADHD. Annual Meeting of the Amercian Psychiatric Association, Philadelphia 2002. 54. Biederman J, Bush G, Faraone S, Seidman L: Symposium on Adult ADHD from Research to Clinical Practice. Annual

Meeting of the Amercian Psychiatric Association, Philadelphia 2002. 55. Biederman J, Breakfast Symposium “ Controversies in ADHD”. Annual Meeting of the Amercian Psychiatric

Association, Philadelphia 2002. 56. McDougle C, Hendren R, Scahill L, Biederman J, Cornblatt: Symposium on Diagnostic and Treatment Advances in

Pediatric Psychotic and Behavioral Disorders. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, San Francisco, 2002.

57. Biederman J, Spencer T, Faraone S, Seidman L, McCracken J: Symposium # 7 New Research in Adult ADHD Annual

Meeting of the American Academy of Child and Adolescent Psychiatry, San Francisco, 2002. 58. Greene R, Biederman J, Mick E, Dulcan M, Goring J :Symposium # 16 New Research in Oppositional Defiant

Disorder: Comorbidity, Familiality, and Treatment. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, San Francisco, 2002.

59. Hirshfeld-Becker D, Biederman J, Wozniak J, Monuteaux M, March J: Symposium 24 Childhood Anxiety Disorders:

Comorbidity, Risk, and Early Intervention. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, San Francisco, 2002.

60. Biederman J, Faraone S, Mick E, Doyle A, Monuteaux M :Symposium # 30 New Research on Phenomenology in

Attention-Deficit/Hyperactivity Disorder. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, San Francisco, 2002.

61. Wilens T, Biederman J, Bukstein O, Mick E, Solhkhah :Symposium # 38 on Substance Abuse Comorbidity with

ADHD. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, San Francisco, 2002.

94

Page 95: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

62. Biederman J, Wozniak J, Mick E, Wilens T, Frazier J, Kowatch R: Symposium # 45 Current Research Findings in Pediatric-Onset Bipolar Disorder. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, San Francisco, 2002.

63. Biederman J, Spencer T, Dolye A, Wilens T, Greenhill L: Symposium # 56 New Research on Treatment Issues in

Attention-Deficit/Hyperactivity Disorder. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, San Francisco, 2002.

64. Spencer T, Faraone S, Bush G, Biederman J, Satellite CME Symposium From Research to Clinical Practice: The

Evolution of the Understanding and Treatment of ADHD . Annual Meeting of the American Academy of Child and Adolescent Psychiatry, San Francisco, 2002.

65. Biederman J, Spencer T: Symposium # 52 New Research in Childhood Depression. Annual Meeting of the American

Academy of Child and Adolescent Psychiatry, San Francisco, 2002. 66. Biederman J: Symposium on the Neuropharmacology and the Management of Sleepiness, Fatigue and Executive

Function in Psychiatric Illness. U.S. Psychiatric & Mental Health Congress, Las Vegas, 2002 67. Spencer T, Biederman J, Faraone S, Barkley R. Treating ADHD Across the Lifecycle Part I, Breakfast. Symposium.

Annual Meeting of the Amercian Psychiatric Association, San Francisco 2003. 68. Spencer T, Biederman J. Treating ADHD Across the Lifecycle Part II, Breakfast Symposium. Annual Meeting of the

Amercian Psychiatric Association, San Francisco 2003 69 Wilens T, Spencer T, Greenhill L, Biederman J, ADHD: Longer-Term Treatment For A Chronic Disorder Symposium

# 54. Annual Meeting of the Amercian Psychiatric Association, San Francisco 2003. 70. Biederman J, Wozniak J, Mick E, Faraone S. Differentiating Bipolar Disorder and ADHD: Comorbidity Versus Single

Diagnosis. Symposium # 74. Annual Meeting of the Amercian Psychiatric Association, San Francisco 2003. 71. Wilens T, Biederman J, Wozniak J, Gonzalez-Heydrich J, Faraone S. Juvenile Bipolar Disorder: Contemporary Issues

in Research. Symposium # 47. Annual Meeting of the Amercian Psychiatric Association, San Francisco 2003. 72. Faraone S, Conners K, Wilens T. Contemporary Issues in ADHD. Annual American Psychological Meeting, Toronto

2003. 73. Wilens T, Biederman J, Wozniak J, Spencer T, Mick E, Carlson G Bipolar Disorder and Attention Deficit

Hyperactivity Disorder: A Complex and Misunderstood Comorbidity. Symposium # 2. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami, 2003.

74. Wilens T, Biederman J, Doyle A, Abikoff H, Bedard A, Hunt R Clinical Issues of Executive Functioning Disturbances

in ADHD. Symposium # 30. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami, 2003.

75. Spencer T, Faraone S, Bush G, Biederman J From Research to Clinical Practice: Evolution and Understanding of

ADHD. Symposium # 38. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami, 2003.

76. Biederman J, Fischer M, Volkow N, Kollins S, Wilens Effects of Stimulants on Substance Abuse: Mechanisms and

Outcomes. Symposium # 12. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami, 2003.

95

Page 96: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

77. Biederman J, Faraone S, Wozniak J, Mick E, Kwon A. Evidence of Unique Developmental Phenotypic Correlates of Pediatric Bipolar Disorder. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003.

78. Biederman J. Psychphamacological Treatment of ADHD Youth and the Risk for Substance Abuse. Symposium # 12.

A. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003. 79. Wilens T, Biederman J, Doyle A, Abikoff H, Bedard A, Hunt R. Clinical Issues of Executive Functioning Disturbances

(EF) In ADHD. Symposium # 30. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003.

80. Biederman J. Boys and Girls with ADHD in Childhood and Adolescence. Symposium # 38C. Annual Meeting of the

American Academy of Child and Adolescent Psychiatry, Miami 2003. 81. Wozniak J, Biederman J, Mick E, Kwon A, Faraone S, Lail K, Spencer T, Wilens T. Family Study of Pediatric-Onset

Bipolar Disorder: Characteristics and Comorbidity. Symposium # 53 C. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003.

82. Biederman J, Faraone S. Long-Term Effects of Adderall XR on Height and Weight in ADHD. Symposium # 61A.

Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003. 83. Biederman J, Spencer T, Faraone S, Seidman L, Adler L. New Research About Adult ADHD. Symposium # 66.

Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003. 84. Wilens T, Biederman J, Wozniak J, Spencer T, Mick E, Carlson G. Bipolar Disorder (BPD) and Attention Deficit

Hyperactivity Disorder (ADHD): A Complex and Misunderstood Comorbidity. Symposium # 2. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003

85. Biederman J, Faraone S, Wozniak J, Mick E, Kwon A. Evidence of Unique Developmental Phenotypic Correlates of

Pediatric Bipolar Disorder. Symposium # 2A. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003.

86. Wozniak J, Biederman J, Mick E, Faraone S, Lail K, Spencer T, Wilens T. Cosegregation of ADHD and Bipolar

Disorder: Family Genetic Findings. Symposium # 2B. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003.

87. Wilens T, Biederman J, Kwon A, Chase R, Greenberg L, Tanguay S, Mick E, Spencer T. Psychiatric Adverse Effects in

Youth Treated with SSRI Antidepressants. Symposium # 5A. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003.

88. Rohde Augusto L, Roman T, Grevet E, Zeni C, Crunba R, Bau C, Hutz M, Biederman J. The Role of Dopamine

Transporter Gene in the Response to Methlyphenidate in ADHD. Symposium # 7B. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003.

89. Wilens T, Faraone S, Biederman J, Gunawardene S. Analysis of Literature: ADHD Pharmacotherapy and Later

Substance Abuse. Symposium # 12D. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003.

90. Spencer T, Michelson D, Zhang S, Buitelaar J, Danckaerts M, Gillberg C, Zuddas A, Biederman J. Atomoxetine in the

Long-Term Prevention of Relapse in ADHD. Symposium # 22D. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003.

96

Page 97: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

91. Wilens T, Biederman J, Doyle A, Abikoff H, Bedard A, Hunt R. Clinical Issues of Executive Functioning Disturbances (EF) in ADHD. Symposium # 30. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003.

92. Biederman J, Faraone S, Monuteaux M, Mick E, Doyle A, Seidman L, Wilens T. Impact of Psychometrically-Defined

Neuropsychological Deficits on Academic and Psychosocial Functioning. Symposium # 30A. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003.

93. Doyle A, Biederman J, Seidman L, Goralnick J, Faraone S. Neuropsychological Functioning in Relatives of Girls with

and without ADHD. Symposium # 30B. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003.

94. Wilens T, Waxmonsky J, Prince J, Doyle R, Greenberg L, Scott M, Wong J, Gunawardene S, Doyle A, Kwon A, Chase

R, Hammerness P, Spencer T, Biederman J. Cholinesterase Inhibitors in the Adjunctive Treatment of ADHD and Executive Function Deficits. Symposium # 30E. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003.

95. Frazier J, Chiu S, Kennedy D, Bent E, Breeze J, Herbert M, Dieterich M, Makris N, Caviness V, Biederman J.

Neuroimaging in Pediatric Bipolar Disorder. Symposium # 34C. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003.

96. Spencer T, Faraone S, Bush G, Biederman J. From Research to Clinical Practice. Evolution and Understanding of

ADHD. Symposium # 38. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003.

97. Bush G, Spencer T, Holmes J, Surman C, Seidman L, Valera E, Biedeman J. Methlyphenidated Improves Performance

on the Multi-Source Interference Task. Symposium # 46A. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003.

98. Valera E, Seidman L, Biederman J, Faraone S. Working Memory in Adult ADHD. An FMRI Investigation.

Symposium # 46C. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003. 99. Seidman L, Faraone S, Biederman J, Valera E, Wencel H, Tsuang M. Neuroimaging of ADHD and other Disorders of

Executive Dysfunction. Symposium # 46D. . Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003.

100. Geller D, Faraone S, Stewart S, Farrell C, Mick E, Biederman J. A Family Genetic Study of OCD and ADHD.

Symposium # 47E. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003. 101. Adler L, Spencer T, Faraone S, Kessler R, Howes M, Biederman J, Secnik K. Validity of Pilot ASRS to Rate Adult

ADHD Symptoms. Symposium # A14. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003.

102. Wilens T, Kwon A, Tanguay S, Chase R, Faraone S, Biederman J. Characteristics of ADHD Plus SUD Adults: Role of

Psychiatric Comorbidity. Symposium # A18. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003.

103. Attalla A, Petty C, Biederman J. Motor Preference Among Children with Attention-Deficit/Hyperactivity Disorder.

Symposium # A36. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003. 104. Faraone S, Biederman J, Mick E, Van Patten S, Pandina G. Risperidone and Affective Symptoms in Children with

Disruptive Behavior Disorders. Symposium # B13. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003.

97

Page 98: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

105. Spencer T, Biederman J, Mick E, Faraone S, Johnson M, Murphy H. Open Label Study of Risperidone in the

Treatment of Pediatric Bipolar Disorder. Symposium # B17. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003.

106. Geller D, Coffey B, Doyle R, Shaw D, Biederman J. Validation of the Obsessive-Compulsive Scale of the CBCL.

Symposium # B19. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003. 107. Cohen L, Spencer T, Wilens T, Boydston E, Pennick C, Gordon W, Biederman J. A Population Pharmacokinetic

Model of Bupropion in Adolescents. Symposium # B30. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003.

108. Hammerness P, Wilens T, Kwon A, Biederman J, Spencer T, Prince J, Doyle R, Clark S, Scott M, Ditterline J, Moore

H, Morris M. Blood Pressure Changes Associated with ADHD Medication Treatment in Adults. Symposium # C7. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003.

109. Mick E, Biederman J, Faraone S, Johnson M, Murphy H. Treatment Psychotic Symptoms in Children with Bipolar

Disorder. Symposium # C36. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003.

110. Findling R, Biederman J, Wilens T, Lopez F, Michaels A, the SL1381.301 and SL1381.302 study groups. Symposium

# F8. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003. 111. Rohde Augusto L, Szobot , Roman T, Cunha R, Hutz M, Biederman J. Dopamine Transporter Gene, Response to

Methlyphenidate and Cerebral Blood Flow in ADHD. Symposium # F15. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003.

112. Mick E, Biederman J, Monuteaux M. Does Treatment with Stimulants Prevent Smoking Onset in ADHD Youth?

Symposium # F28. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003 113. Monuteaux M, Fitzmaurice G, Blacker D, Buka S, Biederman J. Familial Specificity of Overt and Covert Conduct

Disorder Symptoms. Symposium # F30. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003.

114. Kessler R, Adler L, Biederman J, Weiss M, Spencer T. Adult ADHD: Clinical Utility and Validity. Symposium # 4.

Annual Meeting of the Amercian Psychiatric Association, New York 2004. 115. Merikangas K, Biederman J, Thuluvath P, Glallant J. The Epidemiology and Treatment of Psychiatric Comorbidities.

Research Advances in Medicine Session. Annual Meeting of the Amercian Psychiatric Association, New York 2004. 116. Biederman J (Chair) Diagnosing and Managing Aggressive Mood Dysregulated Youth. Symposium # 66. Annual

Meeting of the Amercian Psychiatric Association, New York 2004. 117. Biederman J, Spencer T, Chrisman A, Wilens T, Tulloch S, Weisler. Long-Term Safety and Efficacy of Mixed

Amphetamine Salts Extended-Release for Adult ADHD. Scientific and Clinical Report Session # 34. Annual Meeting of the Amercian Psychiatric Association, New York 2004.

118. Mick E, Greenhill L, Biederman J, Wilens T, Cox D. Meeting the Challenge of Adolescent ADHD. Symposium # 115.

Annual Meeting of the Amercian Psychiatric Association, New York 2004.

98

Page 99: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

119. Mick E, Biederman J, Gharabawi G, Faraone S, Pandina G. Risperidone Treatment of Affective Symptoms in Mentally Retarded Youth with Conduct Disorder symposium. Annual Meeting of the Amercian Psychiatric Association, New York 2004.

120. Safren S, Otto M, Wilens T, Sprich S, Biederman J, Winette C. Cognitive-Behavioral Therapy for Residual ADHD in

Adults. Scientific and Clinical Report Session # 34. Annual Meeting of the Amercian Psychiatric Association, New York 2004.

121. Faraone S, Biederman J. A Controlled Study of Functional Impairments in 500 ADHD Adults. Scientific and Clinical

Report Session. Annual Meeting of the Amercian Psychiatric Association, New York 2004. 122. Biederman J, Wilens T. Adult ADHD: Developing Strategies to Maximize Outcomes. U.S. Psychiatric & Mental

Health Congress San Diego, CA 2004. 123. Moore C, Biederman J, Renshaw P. Bipolar Disorder plus ADHD versus ADHD: Symposium # 30. Society of

Biological Psychiatry, Atlanta 2005. 124. Biederman J, Spencer T. Long-Term Outcome of Adults Treated with Extended-Release Mixed Amphetamine Salts.

Symposium # 27E. American Psychiatric Association 2005 Annual Meeting, Atlanta 2005. 125. Biederman J, Wilens T, Lopez F. Modafinil Pediatric Formulation Has Early and Sustained Effect in ADHD.

Symposium # 48. American Psychiatric Association 2005 Annual Meeting, Atlanta 2005. 126. Biederman J, Faraone S, Mick E. Psychiatric and Functional Outcome of Adolescent Females with ADHD: A Large,

Controlled, Five-Year Longitudinal Follow-Up Study. Symposium # 42A. American Psychiatric Association 2005 Annual Meeting, Atlanta 2005.

127. Biederman J. Comparitive Efficacy of Atypical Antipsychotics for Pediatric Bipolar Disorder. Symposium # 71E.

American Psychiatric Association 2005 Annual Meeting, Atlanta 2005. 128. Biederman J, Wigal S, Hechtman L, Abikoff H. New Research Findings in the Treatment of ADHD. Symposium # 12.

NCDEU 45th Annual Meeting, Boca Raton 2005. 129. Biederman J, Mick E, Wilens T, Hammerness P, Adler L. New Research in Adult ADHD Part 2: Treatment.

Symposium # 13. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Toronto 2005. 130. Biederman J, Henin A, Petty C, Harpold T. Advances in Research on Pediatric Anxiety Disorders: Part 2. Symposium

# 13. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Toronto 2005. 131. Greenhill L, Hechtman L, March J, Biederman J, Szatmari P, Birmaher B, Fassler D, Sarles R. How are Practitioners

Using the Antidepressants and Adderall XR Drug Treatments in Light of New Regulatory Concern? Town Meeting. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Toronto 2005.

132. Wozniak J, Sklar P, Mick E, Biederman J, Doyle A. New Research in Pediatric Bipolar Disorder-Part 1. Symposium #

45. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Toronto 2005. 133. Mick E, Biederman J, Fried R, Bush G, Faraone S. Advances in the Neurobiology and Therapeutics of ADHD.

Symposium # 23. American Psychiatric Association 2006 Annual Meeting, Toronto 2006 134. Leibenluft E, Biederman J, Geller B, Kowatch R. Child and Adolescent Bipolar Disorder: Out of a Diagnostic Quandry.

Roundtable discussion. American Psychiatric Association 2006 Annual Meeting, Toronto 2006.

99

Page 100: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

135. Biederman J. How Comorbid is ADHD? Results from Epidemiological and Clinical Studies. APA Symposia, San Diego 2007.

136. Seidman L, Biederman J, Makris N, Valera E, Castellanos X. Neuroanatomy of ADHD: A Multi-Modal Magnetic

Resonance Imaging Approach. Symposium # 2. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Boston 2007.

137. Biederman J, Monuteaux M, Surman C, Hinshaw S, Newcorn J. New Research from Prospective Studies of Girls with

ADHD. Symposium # 25. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Boston 2007.

138. Biederman J, Petty C, Faraone S, Antshel K, Hammerness P, Adler L. Atypical Manifestations, Comorbidity, and

Functional Impairments of ADHD. Symposium # 50. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Boston 2007.

139. Fallu A, Biederman J, Bilkey T. Improving Outcomes in Adult ADHD: From Neuroscience to Clinical Practice.

Satellite Symposium #04. 57th Annual Canadian Psychiatric Association Congress, Montreal 2007. Institutes

1. Wozniak J, Biederman J, Spencer T, Wilens T, Faraone S, Mick E. The Pharmacotherapy of Pediatric-Onset Bipolar Disorder. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003.

2. Wozniak J, Wilens T, Biederman J, Mick E, Faraone S, Kwon A, Lail K, Forkner P, Galdo M, Spencer T. Comorbidity of Bipolar Disorders in Multiple Samples, Including Preschoolers. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Miami 2003.

3. Baliveau, Gignac, Biederman : l'institut Pinel Auditorium, January 2007 Abstracts and Presentations in International Scientific Meetings: 1. Biederman J, Rimon R, Belmaker RH, Ebstein R.: Cyclic necleotides in CSF. Abstracts of the Meeting of the Israel Physiologic and Pharmacologic Society, Jerusalem, Israel, 1977. Israel J Med Sci 13:54, 1977. 2. Belmaker RH, Biederman J, Lerner Y.: Combination of lithium plus haloperidol in schizoaffective disorders: A controlled study. Abstracts of the 11th CINP Congress, Vienna, Italy, 1978. 3. Biederman J, Rivinus TM, Herzog DB, Orsulak P, Schildkraut JJ.: Platelet MAO activity in anorexia nervosa. Proceedings of the VII World Congress of Psychiatry, Vienna, Italy, 1978. 4. Biederman J.: Pharmacological treatment of childhood depression. Childhood Depression Proceedings, Regional Meetings of the World Psychiatric Association, Buenos Aries, Argentina, 1987. 5. Biederman J, Faraone S, Keenan K, and Tsuang M.: Family genetic and psycho social risk factors in attention deficit disorder. World Federation of Societies of Biological Psychiatry, Jerusalem, Israel, April 1989. 6. Biederman J, Faraone SV, Keenan K, et al.: Family-genetic risk in an American sample of psychiatrically and pediatrically referred children with attention deficit hyperactivity disorder: Patterns of comorbidity in probands and families. Ninth Congress of the European Society of Child and Adolescent Psychiatry_ESCAP, London September 1991. 7. Biederman J.: A double-blind placebo-controlled study of desipramine in the treatment of attention deficit

disorder: III. Lack of impact of comorbidity and family history factors on clinical response. XIXth CINP Congress, Washington DC, June-July 1994.

100

Page 101: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

8. Biederman J(Chair): Affective disorders in children: Prepubertal mania revisited. Abstracts of the 2nd International Conference on New Directions in Affective Disorders, Jerusalem, Israel, 1995. 9. Biederman J.: Juvenile mania and ADHD: Two or one disorders? Second International Conference on Bipolar Disorder, Pittsburgh, PA, June 1997. 10. Biederman J (Chair): Continuities and Discoontinuities between child and adult disorders. Scientific Symposium; 6th World Congress of Biological Psychiatry, Nice, France, June 1997. 11. Biederman J.: ADHD across the lifecycle. Presenter at 6th World Congress of Biological Psychiatry, Nice, France, June 1997. 12. Seidman L, Biederman J, Faraone SV, Monuteaux M, Weber W.: Neuropsychological findings in ADHD children: Findings from a sample of high-risk siblings. Abstracts of the 44th Annual Meeting of the American Academy of Child & Adolescent Psychiatry and the 17th Annual Meeting of the Canadian Academy of Child Psychiatry, Toronto, Canada, October 1997. 13. Biederman J.: Psychiatric problems in children. First Annual Boston-to-Denmark Psychiatric Symposium, Scandanavia, Denmark, March 1998. 14. Biederman J.: Bipolarity and comorbidity: Clinical management. APA Annual Meeting, Toronto, Canada, June 1998. 15. Biederman J.: Clinical Correlates of ADHD in Females: Findings from a large group of psychiatrically- referred girls.

International Society for Research in Child and Adolescent Psychopathology, 9th Scientific Meeting, Poster Sessions II & III, Barcelona, Spain 1999.

16. Biederman J.: Current concepts on the neurobiology of ADHD, New findings on ADHD in girls. 5th Nordic

Symposium on ADHD/DAMP, Reykjavik, Iceland, October 1999. 17. Biederman J.: Psychobiology of ADHD across the lifecycle. Presenter at Salpetriere Hospital, Paris, France, December

1999. 18. Biederman J.: ADHD and Bipolar, ADHD in adults. Presenter at Goettingen University, Goettingen, Germany,

December 1999. 19. Biederman J.: Psychopharmacology in unipolar depression and mania in children and adolescents: Presenter at the

Child Neuropsychiatry Conference, Gothenburg Sweden, March 2000. 20 Biederman J: Age-dependent decline of ADHD symtoms: Presenter at the 22nd CINP Congress, Brussels, Belgium, July

2000. 21. Frazier J, Biederman J, Jacobs T.G., Tohen M.F., Toma V, Feldman P.D, Rater M.A., Tarazi R.A., Kim G.A.,

Garfield S.B., J Gonzalez-Heydrich, Nowlin Z.M. Olanzapine in the treatment of bipolar disorder in juveniles. Poster No 15.07, 22nd CINP Congress, Brussels, Belgium, July 2000.

22. Biederman J: Pediatric Mania: A developmental subtype of bipolar disorder? Presenter at 2nd European Stanley

Foundation Conference on Bipolar Disorder. Rotterdam, The Netherlands, September 2000. 23. Frazier J, Biederman J, Jacobs T.G., Tohen M.F., Toma V, Feldman P.D., Rater M.A., Tarazi R.A., Kim.

G.A.Garfield S.B., J Gonzalez-Heydrich, Nowlin Z.M. Olanzapine in the treatment of bipolar disorder in juveniles. Poster session, 2nd European Stanley Foundation Conference on Bipolar Disorder. Rotterdam, The Netherlands, September 2000.

101

Page 102: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

24. Biederman J: Neurobiology and Pharmacology of ADHD. Presenter at Opinion Leaders Meeting, Tokyo, Japan

October 2000. 25. Biederman J: ADHD Across the Lifecycle. Presenter at the Annual Meeting of the Japanese Society for Psychiatric

Diagnosis, Fukushima, Japan, October 2000. 26. Biederman J: ADHD and Juvenile Mania An Overlooked Comorbidity, Pediatric Mania-A Developmental Subtype of Bipolar Disorder. Presenter at VI International Symposium on Bipolar Disorder. Sintra, Portugal, November 2000. 27. Biederman J: An Open Prospective Study of Olanzepine Monotherapy in the Treatment of Juvenile Mania. Presenter at

the Promised Childhood Congress, Tel Aviv, Israel, May 2001. 28. Biederman J (Chair) ADHD Throughout Life: From Neuroscience to Practice. The Promised Childhood Congress, Tel

Aviv, Israel, May 2001. 29. Biederman J, Faraone S, Mick E, Wozniak J, Chen L, Ouellette C, Marrs A, Moore P, Garcia J, Mennin D, Lelon E.

Attention-Deficit Hyperactivity Disorder and Juvenile Mania: An Overlooked Comorbidity. Presenter at the the Promised Childhood Congress, Tel Aviv, Israel, May 2001.

30. Biederman J Neuropsychological and Clinical Aspects of ADHD, Temperament. Presenter at the Promised Childhood

Congress, Tel Aviv, Israel, May 2001. 31. Heilgenstein JH, Spencer T, Faries D, Biederman J, Conners C.K.Tomoxetine, Methylphenidate, Placebo: Comparison

of Treatment Effects in Stimulant-Naïve ADHD Children. Poster No 111, The Promised Childhood Congress, Tel Aviv, Israel, May 2001.

32. Biederman J: Treating Bipolar Disorder in Children. Presenter at the Lily Latin American Regional Neuroscience

Conference, Puerto Rico, July 2001. 33. Biederman J Child and Adolescent Bipolar Disorders. Presenter at the CINP International Workshop on Bipolar

Disorders, St Tropez, September 2001. 34. Biederman J Recent Advances on the nature and causes of ADHD. Speaker at the Hospital Angeles de las Lomas

/Sotano/Sociedad Medica, Mexico, September 2001. 35. Biederman J Psychopharmacological treatment (risk and benefits). Speaker at the Hospital Angeles de las

Lomas/Sotano/Sociedad Medica, Mexico, September 2001. 36. Biederman J New Investigations on ADHD (genetics, molecular studies and neuroimaging). Speaker at the Hospital

Angeles de las Lomas/Sotano/Sociedad Medica, Mexico, September 2001. 37. Biederman Behavioral Inhibition in Children: Implications for Psychopathology. Presenter at CINP Congress,

Montreal, June 2002. 38. Biederman J Advances in the Pharmacotherapy of ADHD. Programme Co-Chairperson and presenter held during the

XII World Congress of Psychiatry Yokohama, Japan August 2002. 39. Biederman J Speaker at the International ADHD Forum Tokyo, Japan Treatment of ADHD in USA August 2002.

102

Page 103: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

40. Biederman J, Faraone S Parsing the comorbidity between bipolar and conduct disorder in children. Presenter at the Third European Stanley Foundation Conference on Bipolar Disorder, Freiburg, Germany, September 2002.

41. Mick E, Biederman J, Faraone S Meta-analysis of behavior problems in children with bipolar disorder. Presenter at the

Third European Stanley Foundation Conference on Bipolar Disorder, Freiburg Germany, September 2002. 42. Biederman J Presenter at meeting Paying Attention: An Introduction to ADHD for Latin America. Miami, September

2002. 43. Biederman J Advances in the pharmacotherapy of ADHD. Presenter at the International ADHD Conference, The Haag,

September 2002. 44. Biederman J, Hirshfeld-Becker D, Rosenbaum J, Faraone S “ Temperamental risk factors for anxiety disorders in high

risk children. Presenter at the 15th Congress of the European College of Neuropsychopharmacology. Barcelona, September 2002.

45. Biederman J, Mick E “ Longitudinal course of pediatric-onset bipolar disorder.” Presenter at the 15th Congress of the

European College of Neuropsychopharmacology. Barcelona, September 2002. 46. Mick E, Biederman J, Faraone S “ A meta analysis of the core features of pediatric disorder bipolar”. Presenter at the

15th Congress of the European College of Neuropsychopharmacology. Barcelona, September 2002. 47. Brown W, Biederman J, Spencer T, Heiligenstein J, et al “ Efficacy and safety of atomoxetine in the treatment of

attention deficit/hyperactivity disorder in children and adolescents” Presenter at the 15th Congress of the European College of Neuropsychopharmacology. Barcelona, September 2002.

48. Biederman J, Wilens TE, “ Efficacy of a controlled-release formulation of methylphenidate on vital signs in school

aged youths with attention-deficit/hyperactivity disorder”. Presenter at the 15th Congress of the European College of Neuropsychopharmacology. Barcelona, September 2002.

49. Biederman J “ ADHD Across the Lifecycle”. Presenter at the 43rd Annual Meeting of the Japanese Society for Child

and Adolescent Psychiatry. Tokyo, November 2002. 50. Biederman J “ADHD Across the Lifecycle” Presenter at the 5th Congress of Child and Adolescent Psychiatry.

Switzerland, February 2003. 51. Biederman J “ ADHD Across the Lifecycle” Presenter at the Latin American Congress of ADHD. Dominican

Republic, February 2003. 52. Biederman J “Comparability of ADHD Study Populations from North American and Non North American Samples”

Poster at the European Society of Child and Adolescent Psychiatry 2003. 53. Biederman J “Evidence Based Treatment of ADHD” Presenter at the 15th Congress of the European College of

Neuropsychopharmacology. Prague, September 2003. 54. Biederman J “Current Concepts on the Neurobiology of Attention Deficit Hyperactivity Disorder” Presenter at the 15th

Congress of the European College of Neuropsychopharmacology. Prague, September 2003. 55. Biederman J “Effectiveness and safety of the once-daily OROS(trademark) formulation of methylphenidate in

adolescents with attention deficit/hyperactivity disorder” Poster session at the Congress of the European College of Neuropsychopharmacology. Prague, September 2003.

103

Page 104: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

56. Biederman J “Treatment of ADHD with the once-daily OROS formulation of methylphenidate: Effect on growth in children.” Poster session at the Congress of the European College of Neuropsychopharmacology. Prague, September 2003.

57. Biederman J “Effects of Atomoxetine treatment on executive functioning in adults with ADHD”. Poster session at the

Congress of the European College of Neuropsychopharmacology. Prague, September 2003. 58. Biederman J “ADHD Across the Lifespan” Presenter at Developmental Psychopathology symposium. Nijmegen,

Netherlands 2003. 59. Biederman J “Current Concepts in the Neurobiology and Psychopharmacology of ADHD” Presenter at the Child

Psychopharmacology Conference. Maale Hachamisah, Israel, January 2004. 60. Biederman J “Affective Disorder” Presenter at the Child Psychopharmacology Conference. Maale Hachamisah, Israel,

January 2004. 61. Biederman J “Current Concepts in the Neurobiology and Psychopharmacology of ADHD” Presenter at the Children

and adults with ADHD symposium. Copenhagen, Denmark, April 2004. 62. Biederman J, Mick E, Faraone S “ A Prospective Open-Label Treatment Trial of Risperidone Monotherapy in Children

and Adolescents with Bipolar Disorder.” Poster session at the 24th Congress of the Collegium Internationale Neuro-Psychopharmacologicum Paris, France June 2004.

63. Biederman J, Faraone S, Spencer T “ Oros Methylphenidate Treatment for ADHD: Long-Term Effect on Growth.”

Poster session at the 24th Congress of the Collegium Internationale Neuro-Psychopharmacologicum Paris, France June 2004.

64. Biederman J, Mick E, Faraone S “ Ten Year Follow-Up Study of Males with ADHD.” Poster session at the 24th

Congress of the Collegium Internationale Neuro-Psychopharmacologicum Paris, France June 2004. 65. Mick E, Biederman J, Faraone S “ Risperidone in the Treatment of Mania-Like Affective Symtoms: A Secondary

Analysis of a Randomized Clinical Trial in Children with Disruptive Behavior Disorder.” Poster session at the-24th Congress of the Collegium Internationale Neuro-Psychopharmacologicum Paris, France June 2004.

66. Jan Buitelaar, David Michelson , Marina Danckaerts, Christopher Gillberg, Thomas Spencer, Alessandro Zuddas,

Douglas Faries, Shuyu Zhang, Joseph Biederman “Continued Atomoxetine in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder after 1 Year of Treatment” Poster session at the-24th Congress of the Collegium Internationale Neuro-Psychopharmacologicum Paris, France June 2004.

67. Alexander Simpson, Christopher J Kratochvil, Jeffrey H Newcorn, Albert J Allen, Douglas Faries, Denai Milton, Peter

Feldman, David Michelson, Joseph Biederman “ Efficacy of Atomoxetine in Placebo-Controlled Studies in Children, Adolescents, and Adults with Attention-Deficit/Hyperactivity Disorder.” Poster session at the 24th Congress of the Collegium Internationale Neuro-Psychopharmacologicum Paris, France June 2004.

68. Mick E, Biederman J, Faraone S “ Five Year Follow-Up Study of Girls with ADHD.” Poster session at the 24th

Congress of the Collegium Internationale Neuro-Psychopharmacologicum Paris, France June 2004. 69. Spencer T, Biederman J, Mick E, Faraone S “ Efficacy in a 6-month Trial of Methylphenidate in Adults with Attention-

Deficit/Hyperactivity Disorder”. Poster session at the 24th Congress of the Collegium Internationale Neuro-Psychopharmacologicum Paris, France June 2004.

104

Page 105: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

70. Biederman J, Mick E “Treatrment of preschoolers with bipolar disorder”. Poster session P1.089 at the 17th Congress of the European College of Neuropsychopharmacology Stockholm, Sweden October 2004.

71. Biederman J, Mick E “Comparative open-label trial of atypical neuroleptics in children and adolescents with bipolar

disorder” Poster session # 1.088 at the 17th Congress of the European College of Neuropsychopharmacology Stockholm, Sweden October 2004.

72. Biederman J, Mick E, Faraone S “10 Year Follow Up Study of Males with ADHD”. Poster session P6.032 at the 17th

Congress of the European College of Neuropsychopharmacology Stockholm, Sweden October 2004. 73. Mick E, Biederman J “ Treatment of psychotic symptoms in children and adolescents with bipolar disorder”. Poster

session P2.087 at the 17th Congress of the European College of Neuropsychopharmacology Stockholm, Sweden October 2004.

74. Biederman J, Swanson J, Boellner S, Lopez F “ Modafinil as therapy for ADHD in children: A 4-week, double-blind,

placebo-controlled study”. Poster session P.6.018 at the 17th Congress of the European College of Neuropsychopharmacology Stockholm, Sweden October 2004.

75. Spencer T, Biederman J, Mick E, Faraone S “ Efficacy in a 6 month trial of methlphenidate in adults with attention-

deficit/hyperactivity disorder”. Poster session P6.029 at the 17th Congress of the European College of Neuropsychopharmacology Stockholm, Sweden October 2004.

76. Buitelarr J, Michelson D, Danckaerts M, Gillberg C, Spencer T, Zuddas A, Faries D, Zhang S, Biederman J “

Continued atomoxetine in pediatric patients with attention-deficit/hyperactivity disorder after 1 year of treatmen”. Poster session P.6.037 at the 17th Congress of the European College of Neuropsychopharmacology Stockholm, Sweden October 2004.

77. Biederman J Symposium # 14.01 Child neuropsychopharmacology: Current controversies. “ Is Pediatric Mania a

Developmental Subtype of Bipolar Disorder?” Presenter at the 17th Congress of the European College of Neuropsychopharmacology Stockholm, Sweden October 2004.

78. Berganza C, Biederman J, Dopfner M, Rosler M, Retz W. Symposium # IS20 “ Diagnosis and Treatment of Attention-

Deficit/Hyperactivity Disorder” Presenter at the International Congress of the World Psychiatric Association Florence, Italy November 2004.

79. Biederman J, Steinhausen Hans, Masi Gabriele, Zuddas Alessandro. Symposium “ Attention Deficit Hyperactivity

Disorder (ADHD) a Life long impairing disorder: An International Perspective” Presenter at the International Congress of the World Psychiatric Association Florence, Italy November 2004.

80. Tyano S, Buitelaar J, Manor I, Yazgan Y, Biederman J. Symposium # IS30 “ Difficult Children and Adolescents:

Underdiagnosis and Over diagnosis of Mental Disorder and Relevant Treatment Issues” Presenter at the International Congress of the World Psychiatric Association Florence, Italy November 2004.

81. Buitelaar J, Michelson D, Danckaerts M, Spencer T, Zuddas A, Faries D, Zhang S, Biederman J. “ Continued

Atomoxetine in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder After 1 Year of Treatment” Poster session at DGJKPP Congress Heidelberg, Germany March 2005.

82. Zuddas A, Simpson A, Kratochvil C, Newcorn J, Allen A, Faries D, Milton D, Feldman P, Michelson D, Pino R,

Dell’Agnello. “Efficacy of Atomoxetine in Placebo-Controlled Studies in Children, Adolescents, and Adults with Attention-Deficit/Hyperactivity Disorder” Poster session P02.209 at the International Congress of the World Psychiatric Association Florence, Italy November 2004.

105

Page 106: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

83. Biederman J “ADHD and Bipolar Disorder” Presenter at EINAQ: European Interdisciplinary Network for ADHD Quality Assurance Gottingen, Germany December 2004.

84. Simpson A, Kratochvil C, Newcorn J, Faries D, Milton D, Michelson D, Biederman J. “Efficacy of Atomoxetine in

Placebo-controlled Studies in Children, Adolescents, and Adultswith ADHD”. Poster session at DGJKPP Congress Heidelberg, Germany March 2005.

85. Biederman J “Disruptive Behavior Disorders and Bipolar Disorder” Presenter at the Pediatric CNS Educational &

Scientific Symposium, Vienna, Austria February 2005. 86. Biederman J “ Definitions and Overview of ADHD” Presenter at the International Psychopharmacology Algorithm

Project Conference on ADD/ADHD, Beijing, China March 2005. 87. Biederman J “ Patterns of Comorbidity in ADHD and Gender Differences” Presenter at the International

Psychopharmacology Algorithm Project Conference on ADD/ADHD, Beijing, China March 2005. 88. Biederman J “ Course and Outcome of ADHD” Presenter at the International Psychopharmacology Algorithm Project

Conference on ADD/ADHD, Beijing, China March 2005. 89. Biederman J “ Diagnostic and Therapeutic Advances in ADHD” Presenter at the 8th World Congress of Biological

Psychiatry, Vienna, Austria June 2005. 90. Biederman J “The Treatment of Preschoolers with Bipolar Disorder” Poster session PO-001.02 at the 8th World

Congress of Biological Psychiatry, Vienna, Austria June 2005. 91. Mick E, Biederman J “Impact of Risperidone Monotherapy on ADHD Symptoms in Children with Bipolar Disorder”

Poster session PO-034.08 at the 8th World Congress of Biological Psychiatry, Vienna, Austria June 2005. 92. Mick E, Biederman J “Comparison of Atypical Antipsychotics for Pediatric Bipolar Disorder” Poster session PO-

027.08 at the 8th World Congress of Biological Psychiatry, Vienna, Austria June 2005. 93. Biederman J “ Diagnostic and Therapeutic Advances in ADHD” Presenter at the 8th World Congress of Biological

Psychiatry, Vienna, Austria June 2005. 94. Biederman, Kennedy, Kooij, Makris, Yazgan. “Advances in ADHD Research Across the Lifecycle” Presenter at the

XIII World Congress of Psychiatry, Cairo, Egypt September 2005. 95. Rothenberger A, Van der Meulen E, Giedd J, Biederman J, Buitelaar J. “Clinical Treatment of ADHD. Presenter at the

18th ECNP Congress, Amsterdam, Netherlands October 2005. 96. Biederman J, Doyle A. Poster session # P.7.034. “Neuropsychological functioning in youth with bipolar disorder”. 18th

ECNP Congress, Amsterdam, Netherlands October 2005. 97. Biederman J, Mick E, Wozniak J, Harpold T, Aleardi M, Dougherty M. Poster session # P.7.024. A prospective open-

label long-term treatment trial of risperidone montherapy in children and adolescents with bipolar disorder. 18th ECNP Congress, Amsterdam, Netherlands October 2005.

98. Biederman J, Monuteaux M. Poster session # P.6.039. Is cigarette smoking a gateway drug to subsequent alcohol and

illicit drug use disorders: A controlled study of youth with and without ADHD. 18th ECNP Congress, Amsterdam, Netherlands October 2005.

106

Page 107: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

99. Biederman J, Mick E, Surman C, Doyle R, Hammerness P, Harpold T, Dunkel S, Dougherty M, Aleardi M, Spencer, T. Poster session # P.8.059. A randomized, double-blind, placebo-controlled study of OROS methylphenidate in the TX of adults with ADHD. 18th ECNP Congress, Amsterdam, Netherlands October 2005.

91. Biederman J, Soutullo C, Harvas A, Ramos J. “Current Concepts on the Neurobiology and Psychopharmacology of

ADHD” Presenter at the IX Congreso Nacional de Psiquiatria, Pamplona, Spain October 2005. 92. Biederman J “Current Concepts on the Neurobiology and Psychopharmacology of ADHD” Presenter at the XIX

Congreso Nacional, Los Cabos, Mexico October 2005. 93. Biederman J “ Mania, Bipolararity and Conduct Disorders” Presenter at the Congreso Internacional Multidisciplinar

sobre el Trastorno por Deficit de Atencion y trastornos de la conducta, Madrid, Spain January 2006. 94. Biederman J “Current Concepts in the Neurobiology and Psychopharmacology of ADHD Across the Lifecycle”

Presentar at the Annual Meeting of the Turkish Child Psyciatry Association, Antalya, Turkey April 2006. 95. Biederman J “Advances in the Diagnosis and Treatment of Pediatric Bipolar Disorder” Presentar at the Annual Meeting

of the Turkish Child Psyciatry Association, Antalya, Turkey April 2006. 96. Biederman J (Chairperson), Spencer T, Mick E, Makris N. “Advances in ADHD Research –1” Presenter at the World

Psychiatric Association International Congress, Istanbul, Turkey July 2006. 97. Biederman J (Chairperson), Yazgan Y, Kooij S, Manor I, Quiroga J, Banaschewski T. “Advances in ADHD Research-

2” Presenter at the World Psychiatric Association International Congress, Istanbul, Turkey July 2006. 98. Biederman J, Petty C, Hirshfeld Becker D, Henin A, Henry B, Faraone S, Rosenbaum J. Poster session P.4.a.009.

“Developmental trajectories of anxiety disorders in offspring at high risk for panic disorder.” 19th ECNP Congress, Paris, France October 2006.

99. Mick E, Biederman J, Spencer T, Faraone S, Zhang H. Poster session # P.7.d.003. “The validity of the quality of life

enjoyment and satisfaction questionnaire in adults with ADHD.” 19th ECNP Congress, Paris, France October 2006. 100. Biederman J, Spencer T, Mick E. Poster session # P.8.a.021. “Comparative acute efficacy and tolerability of OROS and

immediate release formulations of methylphenidates in the treatment of adults with ADHD.” 19th ECNP Congress, Paris, France October 2006.

101. Biederman J. “Comorbidity in ADHD.” Presenter at the 13th International Congress of the European Society of

Adolescent Psychiatry, Florence, Italy August 2007. 102. Biederman J. Poster. “Efficacy and safety of Lisdexamfetamine (LDX) in children aged 6 to 12 years with ADHD.”

13th International Congress of the European Society of Child and Adolescent Psychiatry, Florence, Italy August 2007. 103. Biederman J. (chair) “Novel research on functional deficits in ADHD.” 13th International Congress of the European

Society of Adolescent Psychiatry, Florence, Italy August 2007. 104. Biederman J."New insights into the comorbidity between ADHD and major depression in adolescent girls." Presenter at

the 13th International Congress of the European Society of Adolescent Psychiatry, Florence, Italy August 2007. 105. Biederman J. "Educational and occupational deficits in adhd subjects." Presenter at the 13th International Congress of

the European Society of Adolescent Psychiatry, Florence, Italy August 2007.

107

Page 108: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

106. Biederman J. “Advances in the neurobiology of ADHD.” Presenter at the Canadian Attention Deficit Hyperactivity Disorder Resource Alliance 2007 ADHD Conference, Montreal, Quebec October 2007.

107. Biederman J. “Advances in the pharmacotherapy of ADHD.” Presenter at the Canadian Attention Deficit Hyperactivity

Disorder Resource Alliance 2007 ADHD Conference, Montreal, Quebec October 2007. 108. Biederman J. “Understanding the interface between pediatric bipolar disorder and ADHD.” Presenter at the Canadian

Attention Deficit Hyperactivity Disorder Resource Alliance 2007 ADHD Conference, Montreal, Quebec October 2007. 109. Biederman J. (co-chair) “ADHD across the lifespan.” 20th European College of Neuropsychopharmacology Congress,

Vienna, Austria October 2007. 110. Biederman J. “Volumetric MRI in adults with ADHD.” Presenter at the 20th European College of

Neuropsychopharmacology Congress, Vienna, Austria October 2007. 111. Biederman J. “The lifelong impact of ADHD.” Presenter at the 20th European College of Neuropsychopharmacology

Congress, Vienna, Austria October 2007. Postgraduate Courses and Presentations: 1982- Psychopharmacology Update Course. Massachusetts General Hospital and Harvard Medical School Postgraduate Program: "Pediatric Psychopharmacology." 1982 New England Council of Pediatrics: "Clinical Problems in Pediatric Psychopharmacology." 1982 New England Society for Learning Disabilities: "Psychopharmacological Perspectives in Learning Disorders." 1983 Psychopharmacology Update Course. Massachusetts General Hospital and Harvard Medical School Postgraduate Program: Seminar on Clinical Problems in Psychopharmacology. 1983 Eating Disorders Course. Massachusetts General Hospital and Harvard Medical School Postgraduate Program: "Psychopharmacology of Anorexia and Bulimia." 1983 Behavioral Pediatrics Course. Massachusetts General Hospital and Harvard Medical School: "Overview of Pediatric Psychopharmacology." 1984 Framingham Youth Guidance Center. Symposium on The Emotionally Disturbed Child and Adolescent: "Overview of Pediatric Psychopharmacology." 1984 Landmark School: "Pharmacological Treatment of Attention Deficit Disorder." 1985 Program: "Treatment of Attention Deficit Disorder and Depression in Adolescents." 1985 Harvard Medical School Postgraduate Seminars at Mercy Hospital, Westchester County, NY: "Psychopharmacology in Children." 1986 Human Resource Institute Conference on Adolescents: "Attention Deficit Disorder and Affective Disorder in Adolescence." 1986 National Conference on Adolescence: "Adolescent Psychopharmacology." 1986 Eating Disorders Course. Massachusetts General Hospital and Harvard Medical School Postgraduate Program: "Anorexia Nervosa and Affective Disorders: Review and Update." 1986 Pediatric Neurology Course. Children's Hospital and Massachusetts General Hospital: "Non-stimulant Treatment for Attention Deficit Disorder." 1987 Adolescent Psychopharmacology: Conference on Adolescent Psychopathology. Jackson Brook Institute, ME. 1987 The Treatment of Attention Deficit Disorder. In Massachusetts General Hospital, Course on New Uses of Antidepressants: Newton, MA. 1987 Pediatric Neurology Update Course. Massachusetts General Hospital and Harvard Medical School Postgraduate Program: "Pediatric Psychopharmacology." 1987 "Advances in the Psychopharmacology of ADD." Lexington Attention Deficit Disorder Parent Group, Lexington, MA.

108

Page 109: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

1988 Department of Psychiatry Research Seminar. University of Texas, Southwestern Medical Center; "Family Genetics of Attention Disorders." 1988 Child Psychiatry Psychopathology Course. University of Texas, Southwestern Medical Center: "High Risk Children of Agoraphobic Parents." 1988 Eating Disorders Clinic. University of Texas, Southwestern Medical Center: "Anorexia Nervosa and Depression." 1988 Recent Advances in Psychiatry. The Ontario Medical Association: "Advances in the Pharmacotherapy of Attention Deficit Disorders." 1988 Continuing Medial Education Series. Hampton Hospital: "Attention Deficit Disorder." 1988 Biological Psychiatry Conference. St. Elizabeth's Hospital of Boston: "Family/Genetic Risk Factors in Attention Deficit Disorder." 1988 Pediatric Symposium, New Hampshire Academy of Family Physicians: "Attention Deficit Disorders," Concord Hospital, Concord, NH. 1988 Primary Care Pediatrics and Emergencies and Procedures Course, "Pharmacotherapy of Attention Deficit Disorder," Boston, MA. 1989 Michigan Psychiatric Society; "Attention Deficit Disorder in Adolescents and Young Adults, Southfield, MI. 1989 Saint Catherine's Medical Society, Saint Catherine, Ontario, Canada, "Childhood Affective Disorders and Attention Deficit Disorder." 1989 General Pediatric Conference Series, Massachusetts General Hospital: "Attention Deficit Disorders." 1989 Brookline Chapter, ADD Parent Support Group, Brookline, MA: "New Pharmacological Approaches to Attention Deficit Hyperactivity Disorder." 1989 University of British Columbia, Department of Psychiatry, Vancouver, Canada: "Depression and Attention Deficit Disorder." 1989 The Second New England Joint Conference on Specific Learning Disabilities: "Medical Management of ADD." 1989 Harding Hospital, Columbus, Ohio: The G.T. Harding III Semi Annual Symposia on Current Issues in Psychotherapy and Human Behavior, Children and Adolescents: Psycho dynamic, Cognitive, and Psychopharmacologic Issues in Treatment and Diagnosis: "Pharmacological Treatment of Adolescents with Mood Disorders and ADD. 1989 North Shore Attention Deficit Disorder Parent Support Group: Psychopharmacologic Update. 1990 Board Review Course, American Academy of Child and Adolescent Psychiatry: "Pediatric Psychopharmacology." 1990 Harvard Post Graduate Course: "The Disturbed Adolescent" on "Pediatric Psychopharmacology" Austin Psychiatric Associates Course: "Pediatric Psychopharmacology" 1998 Board Review Course, American Academy of Child and Adolescent Psychiatry: "Pediatric Psychopharmacology." 1998 Behavioral Neurology Course: "ADHD Across The Life Cycle." Fairmont Copley Hotel, Boston, MA. 1998 Harvard Medical School’s 22nd Annual Psychopharmacology Course: “Juvenile Mood Disorders”,

Westin Hotel, Boston, MA. 2000 Harvard Medical School Annual Psychopharmacology Course “Diagnosis and Assessment in Pediatric Psychopharmacology”, “Dysphoric Conduct Disorder”, “ADHD Across the Lifecycle”, Westin Hotel, Boston, MA 2000 American Psycopathological Association Annual Meeting, “Advanced Juvenile Mania”, New York,

NY 2000 Third Annual International Meeting of the College of Pyschiatric and Neurologic Pharmacists

“ADHD Throughout the Lifecycle”, Washington, DC 2001 Harvard Medical School Annual Psychopharmacology Course: “ADHD”, Westin Hotel, Boston, MA. 2001 New Research in Pediatric Psychopharmacology Conference: “ Pediatric Mania”, Robert Wood

Johnson Medical School, New Brunswick, NJ 2001 Child and Adolescent Psychiatry Developmental Psychopathology Course: “ ADHD Across the

Lifecycle”, Boston, MA

109

Page 110: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

2002 Harvard Medical School Annual Psychopharmacology Course “ Diagnosis and Assessment in Pediatric Psychopharmacology”, “ ADHD Across the Lifecycle”, “Dysphoric Conduct Disorder”,Westin Hotel, Boston, MA

2003 Harvard Medical School Annual Psychopharmacology Course “ Attention Deficit Hyperactivity Disorder Across the Life Span”, “Definitions and Overview of ADHD”, Patterns of Comorbidity in ADHD and Gender Differences”, “Course and Outcome of ADHD”, Westin Hotel, Boston, MA

2003 1st Annual NIMH Pediatric Bipolar Disorder Conference, Washington DC 2004 2nd Annual NIMH Pediatric Bipolar Disorder Conference, Boston MA 2004 Developmental Neuroscience Course “ Neurobiology of ADHD”, Westin Hotel, Boston, MA 2004 Harvard Medical School Annual Psychopharmacology Course “ ADHD Across the Life

Span”,Westin Hotel, Boston, MA 2005 Harvard Medical School Annual Psychopharmacology Course “ Definitions and Overview of ADHD,

“Patterns of Comorbidity in ADHD and Gender Differences”, “Course and Outcome of ADHD”, Westin Hotel, Boston, MA

2005 3rd Annual NIMH Pediatric Bipolar Disorder Conference, Coral Gables, FL 2006 Harvard Medical School Annual Psychopharmacology Course “ ADHD Across the Life

Span”,Westin Hotel, Boston, MA 2006 4TH Annual NIMH Pediatric Bipolar Disorder Conference, Chicago, IL 2007 Harvard Medical School Annual Psychopharmacology Course 2007 5TH Annual NIMH Pediatric Bipolar Disorder Conference, Bethesda, MD Grand Rounds and Major Academic Presentations: 1981 Pediatric Grand Rounds: "Anorexia Nervosa and Depression." Massachusetts General Hospital, Boston, MA. 1982 Psychiatric Grand Rounds: "New Research Findings in Anorexia Nervosa." Children's Hospital/Judge Baker Guidance Center, Boston, MA. 1982 Pediatric Grand Rounds: "Childhood Depression." Cambridge City Hospital, Cambridge, MA. 1983 Psychiatric Grand Rounds: "Pediatric Psychopharmacology." Massachusetts General Hospital, Boston, MA. 1983 Psychiatric Grand Rounds: "Depression in Developmentally Disabled Individuals." Shriver Center, Waltham, MA. 1984 Child Psychiatry Grand Rounds: "Pediatric Psychopharmacology." Massachusetts Mental Health Center, Boston, MA. 1985 Psychiatric Grand Rounds: "Anorexia Nervosa and Depression." Massachusetts General Hospital, Boston, MA. 1985 Child Psychiatry Grand Rounds: "New Treatment Approaches to Attention Deficit Disorder." Massachusetts Mental Health Center, Boston, MA. 1986 Psychiatric Grand Rounds: "Attention Deficit Disorder and Affective Disorders in Adolescence: Pharmacotherapy." Massachusetts Mental Health Center, Boston, MA. 1986 Psychiatric Grand Rounds: "A Controlled Family Study of Attention Deficit Disorder." Massachusetts General Hospital, Boston, MA. 1987 Grand Rounds: "New Pharmacological Approaches to Attention Deficit Disorder." Bradley Hospital. 1987 Grand Rounds: "The Treatment of Attention Deficit Disorder and Depression in Adolescents." Westwood Lodge Hospital, Westwood, MA. 1987 Grand Rounds: "The Treatment of Attention Deficit Disorder." South Shore Hospital, Weymouth, MA. 1987 Grand Rounds: "Adolescent Psychopharmacology." St. Joseph's Hospital, Nashua, NH. 1987 Grand Rounds: "Attention Deficit Disorder." Bergen Pines County Hospital, Paramus, NJ. 1987 Psychiatric Grand Rounds: "The Use of Desipramine in the Treatment of Attention Deficit Disorder." Mt. Sinai Medical Center, New York, NY.

110

Page 111: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

1987 Psychiatric Grand Rounds: "High Rates of Behavioral Inhibition in Children of Parents with Panic Disorder and Agoraphobia." Massachusetts General Hospital, Boston, MA. 1987 Psychiatric Grand Rounds: "Desipramine in the Treatment of Attention Deficit Disorder." Manhattan Psychiatric Center, New York, NY. 1987 Pediatric Grand Rounds: "Attention Deficit Disorder." Morristown Memorial Hospital, Morristown, NJ. 1988 Psychiatric Grand Rounds: "Pediatric Psychopharmacology" University of Michigan Medical School, Ann Arbor, MI. 1988 Psychiatric Grand Rounds: "New Pharmacological Approaches in Attention Deficit Disorder." Children's Hospital/Judge Baker Guidance Center, Boston, MA. 1988 Pediatric Grand Rounds: "Family/Genetic Risk Factors in Attention Deficit Disorder." Massachusetts General Hospital, Boston, MA. 1988 Psychiatric Grand Rounds: "New Approaches to the Treatment of Attention Deficit Disorder." University of Texas, Southwestern Medical Center, Dallas, TX. 1988 Pediatric Grand Rounds: "Attention Deficit Disorder." St. Joseph's Hospital, Nashua, NH 1988 Psychiatric Grand Rounds: "Family-Genetic Rick Factors in Attention Deficit Disorder," Massachusetts General Hospital, Boston, MA. 1989 Visiting Lecturer Program, "Childhood Affective Disorders and Attention Deficit Disorder." McMaster University Health Science Centre, Hamilton, Ontario, Canada. 1989 Psychiatric Grand Rounds: "Attention Deficit Disorder." The Regent Hospital, New York, NY. 1989 Psychiatric Grand Rounds: "Attention Deficit Disorder." Fair Oaks Hospital, Summit, NJ. 1989 Pediatric Grand Rounds: "Non-Stimulant Treatment for Attention Deficit Disorder." Massachusetts General Hospital, Boston, MA. 1989 Psychiatric Grand Rounds: "Family-Genetic Risk Factors in Attention Deficit Disorder." Henry Ford Hospital, Detroit, MI. 1989 MGH Neuroscience Visiting Committee: "Current Research in Biological Child Psychiatry at the MGH." 1990 Psychiatric Grand Rounds: "Family-Genetic Risk Factors in Attention Deficit Disorder." Tufts New England Medical Center, Boston, MA. 1990 Psychiatric Grand Rounds: "Attention Deficit Disorder." Saskatoon Medical School, University of Saskatoon, Canada. 1990 Symposium on High Potency Benzodiazepines, Emerging Uses in Psychiatry: "Panic Disorder in Adolescents." Boston, MA. 1990 Symposium on Severe Disorders of Adolescents, Division of Child Psychiatry: "New Developments in the Treatment of ADD." Cleveland Clinic Foundation. 1990 Rhode Island Psychological Association Annual Meeting: "Attention Deficit Hyperactivity Disorder." 1991 Child Psychiatry Grand Rounds: "Family-Genetic Risk Factors in Attention Deficit Disorder." The Johns Hopkins University School of Medicine, Baltimore, MD. 1991 Child Psychiatry Grand Rounds: "Attention Deficit Disorder: Current Concepts," Schneider Children's Hospital, Long Island Jewish Medical Center, New Hyde Park, NY. 1991 Child Psychiatry Grand Rounds: "Attention Deficit Disorder and Mood Disorders in Juveniles." Manhattan Children's Psychiatric Center, New York, NY. 1991 Psychopharmacology Rounds: "Current Concepts in the Treatment of Attention Deficit Disorder." McLean Hospital, Belmont, MA. 1991 Psychiatric Ground Rounds: "Cardiovascular Effects of Desipramine in Children" Tufts New England Medical Center, Boston, MA. 1991 Medical Grand Rounds: "Attention Deficit Disorder: Current Concepts" Massachusetts General Hospital, Boston, MA. 1991 Psychiatric Grand Rounds: "Current Concepts in the Psychobiology and Psychopharmacology of ADHD." Department of Psychiatry, Medical College of South Carolina. 1991 Psychiatric Grand Rounds: "Behavioral Inhibition as a Temperamental Risk Factor for Anxiety Disorders." Department of Psychiatry, University of Minnesota. 1991 Jackson Brook Institute Conference: "The Treatment of Juveniles with ADHD, MDD, and Anxiety Disorders." South Portland, ME.

111

Page 112: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

1991 New York Society for Adolescent Psychiatry: "Current Concepts in the Psychobiology and Pharmacology of ADHD." 1992 Psychiatric Grand Rounds: "Juvenile Mood Disorders." Department of Psychiatry, Lynn

Hospital. 1992 Psychiatric Grand Rounds: "Genetics of ADHD." Department of Psychiatry, Massachusetts General Hospital, Boston, MA. 1992 Psychiatric Grand Rounds: "Comorbidity in ADHD." Department of Psychiatry, Dartmouth Medical School, Hanover, NH. 1992 Workshop on Pediatric Psychopharmacology: "Antidepressants in Pediatric Psychiatry." American Psychological Association Annual Meeting, 1992. 1992 Psychiatric Grand Rounds: "Contemporary Issues in ADHD." Department of Psychiatry, Beth Israel Hospital, Boston, MA. 1992 Scientific Lecture: "Behavioral Inhibition as a Temperamental Risk Factor for Children at Risk." Research Committee, Massachusetts General Hospital, Boston, MA. 1992 Psychiatric Grand Rounds: "Current Concepts in the Pharmacotherapy of ADHD and Major Depression." Department of Psychiatry, Bay State Medical Center, Springfield, MA. 1992 Lecture Series on Psychopharmacology: "Genetics of ADHD." Department of Psychiatry, Psychopharmacology Unit, Massachusetts General Hospital, Boston, MA. 1993 Psychopharmacology Lectures: "ADHD Across The Life Cycle." McLean Hospital, Belmont,

MA. 1993 Pediatric Grand Rounds: "Pediatric Psychopharmacology for the Pediatrician." Children's Hospital, New Orleans, LA. 1993 Psychiatric Grand Rounds: "Behavioral Inhibition as a Temperamental Risk Factor for Anxiety Disorders." Department of Psychiatry, Louisiana State University Medical School, New Orleans, LA. 1993 Psychiatric Grand Rounds: "Current Concepts in the Psychobiology and Treatment of ADHD." New Orleans Adolescent Hospital, Louisiana State University Medical School, New Orleans,

LA. 1993 Pediatric Grand Rounds: "Family-Genetic Risk Factors in ADHD." Harvard Community Health Plan, Boston, MA. 1993 Mid Year Institute, American Academy of Child & Adol Psychiatry: "Cardiovascular Effects of TCAs in Children." San Juan, Puerto Rico. 1993 Mid year Institute, American Academy of Child & Adol Psychiatry: "Non-Stimulant Treatments for ADHD." San Juan, Puerto Rico. 1993 Mid Year Institute, American Academy of Child & Adol Psychiatry: "Anxiolytics in Children." San Juan, Puerto Rico. 1993 Research Symposium: "Behavioral Inhibition as a Temperamental Risk Factor for Anxiety Disorders." Harvard Medical School, Boston, MA. 1993 Psychiatric Grand Rounds: "ADHD Across the Life Cycle." Brigham & Women Hospital, Boston, MA. 1993 Psychiatric Grand Rounds: "Current Concepts in ADHD." Boston City Hospital, Boston, MA. 1993 Postgraduate Course on Mood Disorders: "Juvenile Mood Disorders." Massachusetts General Hospital, Boston, MA. 1993 The Raphell Sims Lakowitz Memorial Conference, Attention Deficit Disorder 1993: New Developments: "Current Concepts in ADHD." Department of Psychiatry, North Shore University Hospital-Cornell University Medical College, New York. 1993 New York State Office of Mental Health Psychopharmacology Training Program: "Current Concepts in the Diagnosis and Treatment of ADHD." Albany, NY. 1993 CHADD National Conference: "New Developments in the Pharmacotherapy of ADHD." San Diego, CA. 1993 CHADD National Conference: "Pharmacotherapy of Adult ADHD." San Diego, CA. 1993 Child Psychiatry Grand Rounds: "Patterns of Comorbidity and Familiality in ADHD." Columbia University, College of Physicians and Surgeons, New York, NY. 1994 Child Psychiatry Grand Rounds: "Patterns of Comorbidity and Familiality in ADHD."

112

Page 113: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

McLean Hospital, Harvard Medical School, Boston, MA. 1994 1994 Annual Meeting, American Society for Adolescent Psychiatry: "Psychopharmacology of Adolescent Psychiatric Disorders." 1994 Child Psychiatry Grand Rounds: "Patterns of Comorbidity and Familiality in ADHD." Brown University, Providence, RI. 1994 Ciba Symposium on ADHD. Buenos Aires, Argentina. 1994 Psychiatry Grand Rounds: "ADHD Across the Life Cycle." Columbia University, College of Physicians and Surgeons, New York, NY. 1994 Psychiatry Grand Rounds: "ADHD Across the Life Cycle." Philadelphia Child Guidance Center, Philadelphia, PA. 1994 Academic Presentation: "Juvenile Mood Disorders." North Shore Children's Hospital. 1994 1994 Childhood Depression Consortium: "Recent findings in clinically referred children with bipolar and non-bipolar major depression." Brown University, Providence, RI. 1994 Fifth Annual Psychiatric Conference Depression Through the Ages: "Juvenile Mood Disorders." Wayne State University and University of Michigan. 1994 Psychiatric Grand Rounds: "ADHD Across the Life Cycle." Tufts-New England Medical Center, Boston, MA. 1994 Child Psychiatric Grand Rounds: "ADHD Across the Life Cycle." Cornell Medical Center, New York, NY. 1994 Psychiatric Grand Rounds: "ADHD Across the Life Cycle." Lahey Clinic. 1994 Cambridge Hospital Academic Series: "ADHD Across the Life Cycle." 1995 Psychiatric Grand Rounds: "ADHD Across the Life Cycle." University of Mass Medical Center. 1995 Child and Adolescent Psychiatry Chapter of San Diego: "Psychopharmacology of Mood Disorders and Violence." 1995 Child Psychiatric Grand Rounds: "ADHD Across the Life Cycle." University of Michigan Medical Center. 1995 Psychiatric Grand Rounds: "ADHD Across the Life Cycle." University of Vermont Medical Center. 1995 Psychiatric Grand Rounds: "ADHD Across the Life Cycle." Henry Ford Medical Center, Detroit, MI. 1995 Attention Deficit Disorder Information Network Annual Meeting: "Gender Issues in ADHD." Boston, MA. 1995 Gertrude Rogers Greenblatt Memorial lecture: "ADHD Across the Life Cycle." University of California, Los Angeles, CA. 1995 Institute of Living/Hartford Hospital Psychiatric Grand Rounds: "Therapeutic Management of ADD." Trinity Colllege, Hartford, CT. 1995 Child Psychiatry Grand Rounds: "Currents Concepts in the Psychobiology and Psychopharmacology of ADD." McLean Hospital, Harvard Medical School, Boston, MA. 1995 Department of Psychiatry and Neurology: "ADHD Across the Life Cycle." Tulane University Medical Center, New Orlearns, LA. 1995 CHADD National Convention: "Recent Research on Adult ADHD." Washington, DC. 1996 MGH Depressive Disorders Course: "Juvenile Mood Disorders." 1996 Psychiatric Grand Rounds: "ADHD Across the Life Cycle." Metropolitan Hospital, New York, NY. 1996 Psychiatric Grand Rounds: "The Continuity/Discontinuity of Mood Disorders." University Hospital of Cleveland, Cleveland, OH. 1996 First Annual Psychiatry Update and Alumni Homecoming: "ADHD Across the Life Cycle." University of Texas Medical Branch at Galveston, Galveston, TX. 1996 Symposium on Portraits of Bipolar Illness Part II: Managing a Chronic Illness from Eight to Eighty: "Controversied in Juvenile Bipolar Illness." Mental Health Association in Illinois. 1996 Psychiatric Grand Rounds: "ADHD Across the Life Cycle." The University of Michigan. 1996 Bipolar and Unipolar Depressive Disorders: "New Research in Juvenile Bipolar Disorder." North Shore University Hospital, NY. 1996 Child Psychiatric Grand Rounds: "Juvenile Mood Disorders." Stanford Medical Center, CA.

113

Page 114: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

1996 Psychiatric Grand Rounds: "Depression and Conduct Disorders Across the Life Cycle." Department of Pediatrics & Dept. of Psychiatry, Fairfax Hospital, VA. 1996 Washington Society of Child and Adolescent Psychiatrists, Psychiatric Grand Rounds: "Depression and Conduct Disorders Across the Life Cycle." The Levy Center at Georgetown Hospital, Washington, DC. 1996 Psychiatric Grand Rounds: "ADHD Across the Life Cycle." The University of Chicago. 1996 Psychiatric Grand Rounds: "Attention Deficit Disorder through the Life Span." The Long Island College Hospital, NY. 1996 Cephalon, Inc. Symposium on ADHD: "Adult ADHD." West Chester, PA. 1996 Psychiatric Grand Rounds: "ADHD Throughout the Life Cycle." Department of Psychiatry, Villa Rosa Hospital, CA. 1996 Department of Psychiatry, Conference on "ADHD vs. Mania in a prepubertal adolescent." The University of Texas Health Science Center at San Antonio, San Antonio, TX. 1996 Psychiatric Grand Rounds: "ADHD Across the Life Cycle." Baystate Medical Center,

Springfield, MA. 1996 Pediatrics Postgraduate Symposium: "Current Issues in Attention Deficit Disorder." The University of Iowa Hospitals and Clinics, Iowa City, Iowa. 1996 Pediatrics Postgraduate Symposium: "Pharmacotherapy of ADD: When is Ritalin Not Enough?" The University of Iowa Hospitals and Clinics, Iowa City, Iowa. 1996 Texas Medical Association, Medicine and Mental Health: Clinical Issues in Primary Care, "ADHD Across the Life Cycle." Austin, TX. 1996 CHADD Eighth Annual International Conference on Attention Deficit Disorders, Chicago, IL. 1996 Department of Psychiatry Grand Rounds: "Bipolar Disorder/Juvenile Mood Disorders." Ellis Hospital, Schenectady, NY. 1997 Department of Psychiatry Grand Rounds: "Current Research in the Diagnosis and Treatment of Juvenile Mood Disorders." The Chicago Medical School, Chicago, IL. 1997 Connecticut Association of Foster and Adoptive Parents, Inc. Annual Spring Conference: "ADHD Across the Life Cycle." 1997 Idaho Psychological Association and the Idaho Mental Health Counselor's Association Conference on ADHD: "Current Concepts in ADHD in Children and Adolescents" and "Current Concepts in Adult ADHD." Boise, ID. 1998 Clinical Crossroads, JAMA Series Grand Rounds: "Adults ADHD." Beth Israel Deaconess Medical Center, Boston, MA. 1998 Psychiatric Grand Rounds: "ADHD Predictors of Persistance and Remission" University of Utah School of Medicine, Salt Lake City, Utah. 1998 Department of Psychiatry Grand Rounds: "Juvenile Mood Disorders." Beth Israel Medical

Center, New York, NY. 1998 Psychopharmacology Grand Rounds: "Current Concepts in the Psychobiology and Psychopharmacology of ADHD across the Life Cycle." McLean Hospital, Belmont, MA. 1998 Department of Psychiatry Grand Rounds: "Attention Deficit Hyperactivity Disorder and Depressive Disorders, Medications and Schools." North Shore Univeristy Hospital, Manhassett, NY. 1998 Psychiatric Grand Rounds: "Current Concepts on Juvenile Mania." University of Cincinnati Medical Center, Cincinnati, OH. 1998 Psychiatric Grand Rounds: "Attention Deficit Disorder Across the Life Cycle." St. Elizabeth's Hospital, Boston, MA. 1998 The Central Iowa Health System CME Committee Special Presentation: "ADHD Across the Life Cycle: Diagnosis of ADHD in the General Population." Des Moines, Iowa. 1998 Wayne State University Special Presentation: "New Advances in the Assessment and Treatment of Pediatric Obsessive-Compulsive Disorders." Children's Hospital of Michigan, Detroit, MI. 1998 Clinical Crossroads, JAMA Series Grand Rounds: "A 55-Year-Old Man with Attention Deficit/Hyperactivity Disorder." Beth Israel Deaconess Medical Center, Boston, MA. 1998 St. Francis Meidcal Center Psychiatric Grand Rounds: “ADHD Across the Life Cycle”. Pittsburgh,

PA

114

Page 115: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

1998 Psychiatric Grand Rounds: “ADHD Across the Life Cycle”. University of Florida, Gainesville, FL 1998 University of Wisconsin Medical School Grand Rounds: “Update on mood and anxiety disorders in

children and adolescents”. Gundersen Lutheran Medical Foundation, La Crosse, Wisconsin. 1998 Pediatric Grand Rounds: “Current Concepts of Psychobiology and Psychopharmacology of ADHD”.

Boston Medical Center, Boston, MA 1999 Mohawk Valley Psychiatric Center and The Department of Psychiatry: "Pharmacotherapy of Attention Deficit Disorder Across the Life Cycle." SUNY Health Science Center/Syracuse, NY. 1999 Education Symposium: “Juvenile Anxiety Disorders.” Northwest Mental Health Institute, Eugene,

Oregon. 1999 Psychiatric Grand Rounds: “ADHD Across the Lifecycle.” Univ. of Miami, Miami, FL. 1999 New Jersey Psychiatric Association: “Perspectives in Psychiatry and Medicine 1999.” New

Brunswick, NJ 1999 Congresbureau Scem Seinen Congress Event Management: “Comorbidity and course of ADHD”.

ADHD Symposium in the Netherlands, ADHD: From neuroscience to practice. 1999 Workshop on Precursors of Anti-Social Behavior. National Research Council, Board on Children,

Youth and Families, Commission on Behavioral and Social Sciences and Education, Washington, D.C.

1999 Massachusetts Mental Health Center, Psychopharmacology and Neurobiology Lecture Series: “Diagnosis and Treatment of Depression in Children and Aolescents”, Boston, MA

1999 Grand Rounds, Risperdal Visiting Faculty Program (Lecture Series): presentation on Juvenile Mania, Janssen Pharmaceuticals, Springfield, MA

1999 New Clinical Drug Evaluation Unit Program (NCDEU), 39th Annual Meeting, Poster Presentations, Boca Raton, FL.

1999 Shire Richwood ADHD Expert Advisory Board Meeting, “Results of a Study in Adults in a Naturalistic Setting”, Boca Raton, FL.

1999 Gliatech ADHD Clinical Development Meeting, “ ADHD Background and Future Clinical Directions”, Cleveland, OH

1999 University of Connecticut Health Center Grand Rounds: “ Diagnosis and treatment of Juvenile Mania”, Farmington, CT

1999 Cephalon ADHD Advisory Board Meeting, “ Use of Provigil in patients with ADHD”, Philadelphia, PA

1999 Westwood Pembroke Health System,“Childhood Mania Behavioral Interventions and Treatment”, Plymouth, MA

1999 Visiting Faculty Program “Bipolar Adolescents, New Treatment Options”, Bangor, ME 1999 US Psychiatric Mental Health Congress, “Child, Adolescent and Adult ADHD throughout the

Lifespan”, Atlanta, GA. 2000 Annual Masters of Psychiatry, “Advances in the Diagnosis and Treatment of Juvenile Depression”, University of Miami Key West, Fl 2000 Association Spring/Annual Meeting, “ Current Concepts on the Neurobiology and

Neuropharmacology of ADHD”, Columbus, OH 2000 Pediatric Academic Societies and the American Academy of Pediatrics Joint Meeting, “Advances and

Application of Psychopharmacologyy in Pediatrics”, Boston, MA 2000 Psychiatric Grand Rounds: “ADHD Across the Lifecycle”, McLean Hospital, Boston, MA 2000 Sixth Annual Clary Lecture, “ADHD Across the Lifecycle”, St. Joseph’s Hospital, Savannah, GA 2000 Psychiatric Grand Rounds “ Juvenile Depression”, Carney Hospital, Dorchester, MA 2000 National Depressive and Manic-Depressive Association 2000 Annual Conference Pediatric Mania: A Developmental Subtype of Bipolar Disorder?, Royal Sonesta, Boston, MA 2000 Psychiatric Grand Rounds: “ADHD Across the Lifecycle”, Bronx-Lebanon Hospital Center, New

York, NY 2000 Development and Psychopathology Seminar, “ADHD Across the Lifecycle”, Child Psychiatry

Fellows of the Consolidated Department of Psychiatry at Harvard Medical School, Boston, MA 2000 Psychiatric Grand Rounds: “ ADHD Across the Lifecycle”, Metropolitan Hospital Center, New York,

NY

115

Page 116: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

2000 Psychiatric Grand Rounds: “ Tempermental Risk Factors In Psychopathology”, Columbia University College of Physicians and Surgeons New York Stateee Psychiatric Institute and New York Presbyterian Hospital, New York, NY

2000 Oregon Psychological Association: “ Diagnosis and Treatment of Juvenile Mania”, “ADHD Across the Lifecycle”, Portland, Oregon

2000 Psychiatric Grand Rounds: “ ADHD Across the Lifecycle”, St. Francis Medical Center, Pittsburgh, PA

2000 Judge Bakers Children’s Center Harvard Medical School “ Juvenile Mania”, Boston, MA 2000 Westwood Lodge, “ Juvenile Depression”, Westwood, MA 2001 Psychiatric Grand Rounds: “ Current Concepts on the Diagnosis and Treatment of Juvenile Mania”, Hillside Hospital, New York, NY 2001 Psychiatric Grand Rounds: “ ADHD Across the Lifecycle”, Holy Family Hospital, Methuen, MA 2001 Psychiatric Grand Rounds: “ Tempermental Risk Factors for Anxiety and Depression”, McLean

Hospital, Boston, MA 2001 Science Lecture Series in Psychiatry: Dysphoric conduct disorder”, New England Medical Center,

Boston, MA 2001 Psychiatric Grand Rounds: “ Tempermental Risk Factors for Anxiety and Depression”, Children’s

Hospital, Boston, MA 2001 Psychiatric Grand Rounds: “ADHD Across the Lifecycle”, University of Alabama, Tuscaloosa, Al 2001 Psychiatric Grand Rounds: “Juvenile Depression”, Riverside Hospital, Newport News, VA 2001 Psychiatric Grand Rounds: “ADHD Across the Lifecycle”, St Raphael’s Hospital, New Haven, CT 2001 Psychiatric Grand Rounds: “ Juvenile Mania”, Reading Hospital and Medical Center, West Reading,

PA 2001 Pediatric Grand Rounds: “Current Concepts on the Psychobiology and Pharmacology for ADHD

Across the Lifecycle”, Alfred Dupont Hospital for Children, Wilmington, DE 2001 Psychiatric Grand Rounds: “ Current Concepts on the Diagnosis and Treatment of Juvenile Mania”,

Alfred Dupont Hospital for Children, Wilmington, DE 2001 U.S. Psychiatric & Mental Health Congress: “ADHD in the 21st Century: New Treatment Options”,

Boston, MA 2001 Psychiatric Grand Rounds “ Current Concepts on the Diagnosis and Treatment of Juvenile Mania”,

The Providence Center, Providence, RI 2002 Psychiatric Grand Rounds: “Current Concepts in the Diagnosis and Treatment of Juvenile

Depression”, Emory University School of Medicine, Atlanta, GA 2002 Sharp Healthcare presentation “Common Concepts on the Neurobiology and Psychopharmacology of

Attention Deficit Hyperactivity Across the LifeSpan”, San Diego, CA 2002 Nevada Psychiatric Association’s 7th Annual Psychopharmacology Update: “Current Concepts on

Neurobiology and Psychopharmacology of ADHD” Las Vegas, NE 2002 University of Colorado Health Sciences Center: “Treatment of Juvenile Bipolar Disorder” Winter

Park, CO 2002 Rhode Island Psychiatric Society: Attention Deficit Hyperactivity Across the LifeSpan”, Providence,

RI 2002 Current Diagnostic and Treatment Challenges in Child and Adolescent Psychiatry Conference:

“Advances in the Diagnosis and Treatment of Juvenile Mania”, Syracuse, NY 2002 Psychiatric Grand Rounds “ADHD Across the Lifecycle”, Rush-Presbyterian St Luke’s Medical

Center Rush University, Chicago, IL 2002 Psychiatric Grand Rounds “ADHD Across the Lifecycle”, Ohio State University, Columbus, OH 2002 Novartis Pharmaceuticals program “Advancing the Cornerstone of ADHD Therapy”, Chicago, IL 2002 Westwood Lodge “Dysphoric Conduct”, Westwood, MA 2002 Shire US Inc “ADHD Expert Advisory Board Meeting”, Boca Raton, Fl 2002 Depression and Bipolar Support Alliance 15th Annual Conference “Pediatric Mania”, Orlando, FL 2002 Northwest Radiology Network 7th Annual Conference “ ADHD Across the Lifecycle”, Indianapolis,

IN 2003 Ewin F. Gildea Lecture “ Advances in the Diagnosis and Treatment of Pediatric Bipolar Disorder”, St

Louis, MI

116

Page 117: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

2003 Fanciscan Children’s Grand Rounds “ Practical Treatment Options for ADHD”, Brighton, MA 2003 University of Minnesota Grand Rounds “ Advances in the Neurobiology and Psychopharmacology of

ADHD” 2003 Psychiatric Grand Rounds Metropolitan Hospital “ADHD Across the Lifecycle”, New York 2003 Psychiatric Grand Rounds Elmhurst Hospital “ADHD and Comorbidity”, New York 2003 Psychiatric Grand Rounds Wayne State University “ ADHD and Psychopathological Antecedents to

Substance Use Disorders in Youth” Detroit, MI 2003 Psychiatric Grand Rounds Maine Medical Center “ADHD Across the Lifecycle” Portland, ME 2003 Psychiatric Grand Rounds Naval Medical Center Portsmouth “ADHD Across the Lifecycle”,

Portsmouth, Virginia 2003 Clinical Aspects of Medical Psychiatry “Current Concepts in the Diagnosis and Treatment of

Pediatric Bipolar Disorder” Rockford, Illinois 2003 17th Annual Interface: Medicine Psychiatry Symposium St Joseph Medical Center “Advances in

Diagnosis and Treatment of Bipolar Disorder” Towson, Maryland 2003 16th Annual U.S. Psychiatric & Mental Health Congress, “Current Concepts on the Neurobiology and

Psychopharmacology of ADHD” Orlando, Florida 2003 Continuing Medical Education Program “Current Concepts on the Neurobiology and

Psychopharmacology of ADHD”, St Louis, Missouri 2003 Psychiatric Grand Rounds University of Iowa Health Care “ Current Concepts on the Neurobiology

and Psychopharmacology of ADHD” Iowa City, Iowa 2003 Clinical Advances in Pediatrics Seminar “Pediatric Bipolar Disorder”, Kansas City, Missouri 2003 Psychiatric Grand Rounds Scottsdale Healthcare Shea “ Attention Deficit Disorder: Current

Research:Implications for Clinical Practice” Scottsdale, Arizona 2003 Psychiatric Grand Rounds Scottsdale Healthcare Shea “ ADHD Comorbidity: The Interface Between

ADHD and Childhood Bipolar Illness” Scottsdale, Arizona 2003 Psychiatric Grand Rounds Hershey Medical Center “Current Concepts on the Neurobiology and

Psychopharmacology of ADHD” Hershey, Pennsylvania 2003 Psychiatric Grand Rounds Westchester Medical Center “Current Concepts on the Neurobiology and

Psychopharmacology of ADHD” New York 2004 Psychiatric Grand Rounds St Louis University School of Medicine “Current Concepts on the

Neurobiology and Psychopharmacology of ADHD” St. Louis 2004 Nevada Pyschiatric Associations's 9th Annual Psychopharmacology Update “Current Concepts on the

Neurobiology and Psychopharmacology of ADHD” Las Vegas 2004 Psychiatric Grand Rounds Long Island Jewish Medical Center “Current Concepts on the

Neurobiology and Psychopharmacology of ADHD” New York 2004 Psychiatric Grand Rounds Four Winds Hospital “Advances in the Diagnosis and Treatment of

Bipolar Disorder”, New York 2004 Psychiatric Grand Rounds University of Missouri-Columbia “Current Concepts on the Neurobiology

and Psychopharmacology of ADHD”, Missouri 2004 Medical Staff Educational Day Chambersburg Hospital “Current Concepts on the Neurobiology and

Psychopharmacology of ADHD”, Pennsylvania 2004 Psychiatric Grand Rounds The Hospital for Sick Children “Advances in the Diagnosis and Treatment

of Pediatric Bipolar” Toronto 2005 The Mildred Berry Center “Current Concepts in the Treatment of ADHD”, Rockford, IL 2005 2005 Annual U.S. Psychiatric & Mental Health Congress “ Presenting Four ADHD Cases: Different

Symptoms, Different Needs”, Las Vegas, NV 2006 South Carolina Psychiatric Association Annual Meeting “Current Concepts on the Neurobiology and

Psychopharmacology of ADHD”, South Carolina 2006 Massachusetts General Hospital Grand Rounds-John Keith Barlow, MD Memorial Lecture in

Neurology, Boston, MA 2006 Nevada Pyschiatric Associations's 10th Annual Psychopharmacology Update “Long term Outcome in

the Treatment of Adult ADHD” Las Vegas

2006 Psychiatric Grand Rounds Tufts New England Medical Center “Advances in the Neurobiology of

ADHD” Boston 117

Page 118: Joseph Biederman, M - HuffPost

Joseph Biederman, M.D.

118

2006 NYU Child Study Center Grand Rounds: “Advances in the Neurobiology of ADHD” 2007 St. Louis Children's Hospital -Clinical Pediatric Update "Managing Behavioral Disorders in Pediatric

Practice".